Birth Date,On Study Date,Year,Age,Race,Ethnicity,Race/Ethnicity,Gender,Protocol No.,Additional Protocol Numbers,Cancer Site,Disease Site,Histology,Subject Tumor Study Group,Phase,Protocol Type,DOWG,Management Group,Data Table 4 Report Type,RWJBH Site,Source
4/30/1943,4/12/2017,2017,74,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1943,4/12/2017,2017,74,White,Non-Hispanic,White,Female,1209,Pro2012002075,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/30/1943,4/12/2017,2017,74,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1970,7/18/2017,2017,46.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1970,7/18/2017,2017,46.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1961,8/31/2017,2017,55.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1961,8/31/2017,2017,55.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1957,9/26/2017,2017,60.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1939,9/28/2017,2017,78.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1939,9/28/2017,2017,78.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/10/1939,9/28/2017,2017,78.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1957,9/29/2017,2017,60.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1946,11/2/2017,2017,71.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1946,11/2/2017,2017,71.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1952,1/12/2018,2018,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1952,1/12/2018,2018,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1970,1/29/2018,2018,47.2,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/27/1990,2/2/2018,2018,27.6,White,Non-Hispanic,White,Male,51711,M15-916; WIRB# 20172178       Pro20170001343,Adrenal Glands,Adrenal Glands,Adrenal Cortical Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/22/2016,3/12/2018,2018,1.4,Black or African American,Non-Hispanic,Black,Male,110101,617; ANBL00B1; NCI CIRB Pro0220003367,Adrenal Glands,Adrenal Glands,"Neuroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1977,3/12/2018,2018,41,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1977,3/12/2018,2018,41,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1977,3/15/2018,2018,40.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1977,3/15/2018,2018,40.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1975,3/15/2018,2018,43.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1975,3/15/2018,2018,43.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1965,3/30/2018,2018,53.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1965,3/30/2018,2018,53.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1996,4/26/2018,2018,21.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1996,4/26/2018,2018,21.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1942,4/27/2018,2018,75.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1942,4/27/2018,2018,75.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/2016,5/11/2018,2018,1.6,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Adrenal Glands,Adrenal Glands,"Neuroblastoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/29/1978,6/14/2018,2018,40.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1978,6/14/2018,2018,40.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1958,7/5/2018,2018,59.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1958,7/5/2018,2018,59.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1989,7/13/2018,2018,28.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1989,7/13/2018,2018,28.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/31/1989,7/13/2018,2018,28.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1969,7/16/2018,2018,49.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1969,7/16/2018,2018,49.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1970,7/30/2018,2018,47.7,Asian,Non-Hispanic,Asian,Female,171701,EAY131; NCI CIRB Pro2018000037,Adrenal Glands,Adrenal Glands,Adrenal Cortical Carcinoma,Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
12/10/1970,8/13/2018,2018,47.7,Asian,Non-Hispanic,Asian,Female,171701-Z1C,EAY131-Z1C; NCI CIRB Pro2018000037,Adrenal Glands,Adrenal Glands,Adrenal Cortical Carcinoma,Precision Medicine,Phase II,Treatment,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
6/7/1955,8/22/2018,2018,63.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1955,8/22/2018,2018,63.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1954,8/30/2018,2018,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1954,8/30/2018,2018,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1964,9/18/2018,2018,54.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1964,9/18/2018,2018,54.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1958,9/18/2018,2018,60.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1958,9/18/2018,2018,60.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1974,9/25/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1974,9/25/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1973,10/2/2018,2018,45.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1973,10/2/2018,2018,45.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1961,10/18/2018,2018,56.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1961,10/18/2018,2018,56.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1975,11/1/2018,2018,43.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1975,11/1/2018,2018,43.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1957,11/19/2018,2018,61.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1957,11/19/2018,2018,61.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1974,12/13/2018,2018,44.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1974,12/13/2018,2018,44.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1966,12/13/2018,2018,52.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1966,12/13/2018,2018,52.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1959,12/13/2018,2018,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1959,12/13/2018,2018,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1953,12/20/2018,2018,65.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1953,12/20/2018,2018,65.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/2/1958,1/7/2019,2019,60.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/2/1958,1/7/2019,2019,60.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1947,1/10/2019,2019,71.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1947,1/10/2019,2019,71.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1964,1/24/2019,2019,54.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1964,1/24/2019,2019,54.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1953,2/11/2019,2019,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1953,2/11/2019,2019,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1977,3/15/2019,2019,41.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1977,3/15/2019,2019,41.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1952,3/21/2019,2019,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1952,3/21/2019,2019,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1955,3/28/2019,2019,64.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1955,3/28/2019,2019,64.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/19/1955,3/28/2019,2019,63.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1955,3/28/2019,2019,63.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/2017,4/11/2019,2019,2,White,Non-Hispanic,White,Female,110101,617; ANBL00B1; NCI CIRB Pro0220003367,Adrenal Glands,Adrenal Glands,"Neuroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1946,4/18/2019,2019,73.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1946,4/18/2019,2019,73.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/2018,4/30/2019,2019,0.9,White,Hispanic or Latino,Hispanic/Latino,Male,110101,617; ANBL00B1; NCI CIRB Pro0220003367,Adrenal Glands,Adrenal Glands,"Neuroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1980,5/16/2019,2019,38.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1961,5/21/2019,2019,57.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1961,5/21/2019,2019,57.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1970,6/20/2019,2019,48.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1970,6/20/2019,2019,48.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1957,6/27/2019,2019,61.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1957,6/27/2019,2019,61.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/25/1969,7/10/2019,2019,50.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1969,7/10/2019,2019,50.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1945,9/19/2019,2019,74,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1945,9/19/2019,2019,74,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1954,1/30/2020,2020,65.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1954,1/30/2020,2020,65.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/30/1965,1/30/2020,2020,54.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1965,1/30/2020,2020,54.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/30/1984,3/2/2020,2020,35.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1984,3/2/2020,2020,35.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1981,3/5/2020,2020,39,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1981,3/5/2020,2020,39,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Adrenal Glands,Adrenal Glands,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1981,8/2/2017,2017,35.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1981,8/3/2017,2017,35.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1952,8/7/2017,2017,65,White,Hispanic or Latino,Hispanic/Latino,Male,51705,9149; NCI CIRB Pro20170000458,Anal Canal & Anus,Anal Canal & Anus,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/17/1938,8/9/2017,2017,79,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1938,8/9/2017,2017,79,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1952,10/3/2017,2017,65.2,White,Hispanic or Latino,Hispanic/Latino,Male,51707,20170000453,Anal Canal & Anus,Anal Canal & Anus,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/7/1961,10/11/2017,2017,56.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1961,10/11/2017,2017,56.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1950,6/18/2018,2018,67.8,White,Hispanic or Latino,Hispanic/Latino,Male,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/23/1962,8/15/2018,2018,55.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1962,8/15/2018,2018,55.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1953,2/7/2019,2019,66,White,Non-Hispanic,White,Female,71819,EA2165; NCI CIRB Pro2018002470,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/20/1959,3/14/2019,2019,60.1,White,Non-Hispanic,White,Male,71819,EA2165; NCI CIRB Pro2018002470,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/15/1965,4/8/2019,2019,53.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1965,4/8/2019,2019,53.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1951,6/14/2019,2019,68.5,White,Non-Hispanic,White,Female,71820,9673; NCI CIRB Pro2018002361,Anal Canal & Anus,Anal Canal & Anus,,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/6/1947,10/7/2019,2019,72.7,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/28/1968,2/13/2020,2020,51.8,White,Non-Hispanic,White,Female,71819,EA2165; NCI CIRB Pro2018002470,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/19/1983,3/18/2020,2020,36.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1983,3/18/2020,2020,36.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Anal Canal & Anus,Anal Canal & Anus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1938,3/31/2020,2020,81.7,Black or African American,Non-Hispanic,Black,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/11/1965,6/15/2020,2020,54.5,White,Non-Hispanic,White,Female,71819,EA2165; NCI CIRB Pro2018002470,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/19/1957,8/26/2020,2020,63.3,White,Non-Hispanic,White,Female,71819,EA2165; NCI CIRB Pro2018002470,Anal Canal & Anus,Anal Canal & Anus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/30/1958,2/16/2017,2017,58.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1958,2/16/2017,2017,58.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1968,2/21/2017,2017,48.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1968,2/21/2017,2017,48.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1950,3/10/2017,2017,67,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1950,3/10/2017,2017,67,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1964,3/29/2017,2017,52.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1964,3/29/2017,2017,52.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Appendix,Appendix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/22/1964,3/29/2017,2017,52.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1969,3/30/2017,2017,47.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1969,3/30/2017,2017,47.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1945,4/21/2017,2017,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1945,4/21/2017,2017,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1943,4/26/2017,2017,73.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1960,6/21/2017,2017,57.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1973,6/21/2017,2017,43.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1973,6/21/2017,2017,43.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1947,7/26/2017,2017,69.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1947,7/26/2017,2017,69.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1993,10/11/2017,2017,24.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1993,10/11/2017,2017,24.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1962,10/12/2017,2017,55.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1962,10/12/2017,2017,55.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1957,11/10/2017,2017,60.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1957,11/10/2017,2017,60.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1978,11/22/2017,2017,39.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1978,11/22/2017,2017,39.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1983,12/5/2017,2017,34.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1983,12/5/2017,2017,34.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1953,12/6/2017,2017,64.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1953,12/6/2017,2017,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1936,12/8/2017,2017,82,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1936,12/8/2017,2017,82,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1949,2/14/2018,2018,68.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1949,2/14/2018,2018,68.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1954,2/21/2018,2018,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1954,2/21/2018,2018,63.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Appendix,Appendix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/25/1954,2/21/2018,2018,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1980,2/28/2018,2018,37.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1980,2/28/2018,2018,37.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Appendix,Appendix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/20/1980,2/28/2018,2018,37.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1960,4/12/2018,2018,58.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/19/1960,4/12/2018,2018,58.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1971,4/26/2018,2018,47.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1971,4/26/2018,2018,47.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1957,8/1/2018,2018,61.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1957,8/1/2018,2018,61.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1942,8/3/2018,2018,75.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1942,8/3/2018,2018,75.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1984,8/16/2018,2018,34.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1984,8/16/2018,2018,34.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1949,9/21/2018,2018,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/1949,9/21/2018,2018,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1947,9/27/2018,2018,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1947,9/27/2018,2018,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1953,10/10/2018,2018,65,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1953,10/10/2018,2018,65,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1969,11/6/2018,2018,49.3,American Indian or Alaska Native,Non-Hispanic,Native American,Female,131317,Pro2013003676,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1984,11/6/2018,2018,34.4,White,Non-Hispanic,White,Male,131317,Pro2013003676,Appendix,Appendix,Mucinous Adenocarcinoma,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1975,12/28/2018,2018,43.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1975,12/28/2018,2018,43.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1960,2/20/2019,2019,58.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1960,2/20/2019,2019,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1961,3/21/2019,2019,57.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1961,3/21/2019,2019,57.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1954,3/27/2019,2019,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/4/1954,3/27/2019,2019,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1999,4/22/2019,2019,20,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1999,4/22/2019,2019,20,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1955,5/1/2019,2019,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1955,5/1/2019,2019,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1969,6/3/2019,2019,50.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1969,6/3/2019,2019,50.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1935,6/14/2019,2019,83.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1935,6/14/2019,2019,83.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1957,6/21/2019,2019,61.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Appendix,Appendix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/25/1957,6/21/2019,2019,61.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1951,7/11/2019,2019,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1951,7/11/2019,2019,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1960,7/11/2019,2019,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1960,7/11/2019,2019,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/1/1959,7/15/2019,2019,60.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1959,7/15/2019,2019,60.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1966,7/15/2019,2019,53.3,White,Non-Hispanic,White,Male,171701-K2,EAY131-K2; NCI CIRB Pro2018000037,Appendix,Appendix,Signet Ring Cell Carcinoma,Precision Medicine,Phase II,Treatment,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
8/30/1966,9/16/2019,2019,53.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1966,9/16/2019,2019,53.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1963,10/18/2019,2019,56.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1963,10/18/2019,2019,56.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1960,10/21/2019,2019,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1960,10/21/2019,2019,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1951,12/12/2019,2019,69,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1951,12/12/2019,2019,69,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1958,2/25/2020,2020,62.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1958,2/25/2020,2020,62.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Appendix,Appendix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/1/1961,8/19/2020,2020,59.6,White,Non-Hispanic,White,Female,2030,NCI CIRB Pro2020001412  ; NCICOVID,Appendix,Appendix,,NTS / Lab Studies,N/A,Health Services Research,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1982,1/5/2017,2017,34.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1982,1/6/2017,2017,34.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1951,1/11/2017,2017,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1951,1/11/2017,2017,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1952,1/18/2017,2017,64.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1952,1/18/2017,2017,64.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1948,1/26/2017,2017,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1948,1/26/2017,2017,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1980,2/2/2017,2017,36.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1980,2/2/2017,2017,36.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1957,2/2/2017,2017,59.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1957,2/2/2017,2017,59.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1935,2/20/2017,2017,82.1,White,Non-Hispanic,White,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Carcinoma In Situ, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/7/1941,2/22/2017,2017,75.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1941,2/22/2017,2017,75.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1949,2/23/2017,2017,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1949,2/23/2017,2017,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1940,3/10/2017,2017,76.4,White,Non-Hispanic,White,Male,81408,9539; Pro20150001357,Bladder,Bladder,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/18/1961,3/13/2017,2017,56.1,White,Non-Hispanic,White,Female,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/26/1981,3/22/2017,2017,35.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1981,3/22/2017,2017,35.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1950,3/22/2017,2017,66.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1950,3/22/2017,2017,66.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1955,3/30/2017,2017,61.5,White,Non-Hispanic,White,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Papillary Carcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/26/1936,4/3/2017,2017,80.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1936,4/3/2017,2017,80.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1961,4/6/2017,2017,56.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1961,4/6/2017,2017,56.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1937,4/18/2017,2017,79.7,White,Non-Hispanic,White,Male,81408,9539; Pro20150001357,Bladder,Bladder,"Carcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/13/1955,4/26/2017,2017,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1955,4/26/2017,2017,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1942,4/26/2017,2017,75.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1951,5/17/2017,2017,65.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1949,5/18/2017,2017,67.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1949,5/18/2017,2017,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1941,5/22/2017,2017,76.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1941,5/22/2017,2017,76.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1931,5/22/2017,2017,85.9,White,Non-Hispanic,White,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Bladder,Bladder,Neuroendocrine Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/7/1939,6/6/2017,2017,78.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1939,6/6/2017,2017,78.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1959,6/7/2017,2017,57.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1966,6/7/2017,2017,51.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1966,6/7/2017,2017,51.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1935,6/12/2017,2017,81.6,White,Non-Hispanic,White,Female,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/7/1946,6/15/2017,2017,71,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/2/1942,6/20/2017,2017,75.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1938,6/20/2017,2017,79.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1938,6/20/2017,2017,79.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1946,6/21/2017,2017,71.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/27/1946,6/21/2017,2017,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1956,6/22/2017,2017,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1939,6/22/2017,2017,77.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1946,6/29/2017,2017,70.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1946,6/29/2017,2017,70.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1947,7/3/2017,2017,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1947,7/3/2017,2017,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1939,7/6/2017,2017,78.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1939,7/6/2017,2017,78.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1941,7/17/2017,2017,75.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/3/1941,7/17/2017,2017,75.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1958,7/19/2017,2017,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1958,7/19/2017,2017,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1947,8/2/2017,2017,70.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1949,8/2/2017,2017,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1970,8/10/2017,2017,46.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1970,8/10/2017,2017,46.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1939,8/10/2017,2017,78.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1939,8/10/2017,2017,78.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1946,8/28/2017,2017,70.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1946,8/28/2017,2017,70.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1957,8/31/2017,2017,60.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1957,8/31/2017,2017,60.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1945,9/11/2017,2017,72.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1945,9/11/2017,2017,72.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1940,9/13/2017,2017,77.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1940,9/13/2017,2017,77.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1954,9/13/2017,2017,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1954,9/13/2017,2017,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1943,9/25/2017,2017,74.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1953,9/28/2017,2017,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1953,9/28/2017,2017,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/14/1943,9/28/2017,2017,74.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1943,9/28/2017,2017,74.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1930,10/2/2017,2017,87.5,White,Non-Hispanic,White,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Carcinoma In Situ, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/9/1954,10/5/2017,2017,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1954,10/5/2017,2017,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1938,10/5/2017,2017,79.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1938,10/5/2017,2017,79.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1933,10/11/2017,2017,84.3,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1936,10/12/2017,2017,81.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1936,10/12/2017,2017,81.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1952,10/12/2017,2017,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1952,10/12/2017,2017,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1942,10/13/2017,2017,75.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1942,10/13/2017,2017,75.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1947,10/23/2017,2017,70.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1947,10/23/2017,2017,70.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1938,10/25/2017,2017,79.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1938,10/25/2017,2017,79.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1935,10/25/2017,2017,82,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1933,10/26/2017,2017,84.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1933,10/26/2017,2017,84.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1951,10/30/2017,2017,66.4,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,,Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/26/1941,10/31/2017,2017,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1941,10/31/2017,2017,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1950,11/6/2017,2017,67.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1950,11/6/2017,2017,67.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1947,11/7/2017,2017,70.2,White,Hispanic or Latino,Hispanic/Latino,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,Adenocarcinoma In Situ,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/30/1952,11/9/2017,2017,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1952,11/9/2017,2017,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1952,11/9/2017,2017,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1952,11/15/2017,2017,65.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1951,11/15/2017,2017,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1951,11/15/2017,2017,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1934,11/16/2017,2017,83.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1934,11/16/2017,2017,83.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1955,11/20/2017,2017,62.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1947,11/30/2017,2017,70.2,White; American Indian or Alaska Native,Non-Hispanic,Native American,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1964,12/19/2017,2017,53.1,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,"Transitional Cell Carcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/21/1940,12/19/2017,2017,77.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1940,12/19/2017,2017,77.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1957,12/21/2017,2017,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1957,12/21/2017,2017,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1946,1/4/2018,2018,72.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1946,1/4/2018,2018,72.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1958,1/11/2018,2018,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1958,1/11/2018,2018,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1946,1/18/2018,2018,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1946,1/18/2018,2018,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1940,1/18/2018,2018,77.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1940,1/18/2018,2018,77.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1942,1/31/2018,2018,75.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1942,1/31/2018,2018,75.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1960,2/7/2018,2018,57.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1960,2/7/2018,2018,57.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1958,2/15/2018,2018,59.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1958,2/15/2018,2018,59.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1935,2/15/2018,2018,82.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1935,2/15/2018,2018,82.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1937,2/15/2018,2018,80.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1937,2/15/2018,2018,80.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1933,2/22/2018,2018,84.2,White,Non-Hispanic,White,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/3/1939,2/26/2018,2018,78.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/5/1945,3/1/2018,2018,72.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1945,3/1/2018,2018,72.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1946,3/6/2018,2018,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1946,3/6/2018,2018,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1938,3/13/2018,2018,79.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1938,3/13/2018,2018,79.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1945,4/12/2018,2018,72.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1945,4/12/2018,2018,72.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1949,4/19/2018,2018,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1949,4/19/2018,2018,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1936,4/19/2018,2018,82.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1936,4/19/2018,2018,82.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1942,4/26/2018,2018,76,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1942,4/26/2018,2018,76,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1959,5/3/2018,2018,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1959,5/3/2018,2018,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1924,5/11/2018,2018,94.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1924,5/11/2018,2018,94.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1941,5/25/2018,2018,76.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1941,5/25/2018,2018,76.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1937,5/25/2018,2018,80.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1937,5/25/2018,2018,80.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1951,6/18/2018,2018,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1951,6/18/2018,2018,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1938,6/21/2018,2018,79.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1938,6/21/2018,2018,79.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1943,6/26/2018,2018,74.8,White,Non-Hispanic,White,Male,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,Transitional Cell Carcinoma In Situ,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/3/1963,6/26/2018,2018,54.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1963,6/26/2018,2018,54.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/3/1963,6/26/2018,2018,54.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1943,7/5/2018,2018,75.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1943,7/5/2018,2018,75.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1932,7/6/2018,2018,86.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1932,7/6/2018,2018,86.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1959,7/24/2018,2018,59.3,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,"Squamous Cell Carcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/15/1932,8/9/2018,2018,86.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1932,8/9/2018,2018,86.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1947,8/9/2018,2018,71.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1947,8/9/2018,2018,71.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1944,8/14/2018,2018,74.1,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,Bladder,Bladder,"Papillary Carcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/30/1971,8/16/2018,2018,47.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1971,8/16/2018,2018,47.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/11/1939,9/12/2018,2018,79.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1939,9/12/2018,2018,79.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/26/1947,9/18/2018,2018,70.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1947,9/18/2018,2018,70.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1945,10/2/2018,2018,73.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1945,10/2/2018,2018,73.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1941,10/22/2018,2018,77.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1941,10/22/2018,2018,77.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1963,10/30/2018,2018,55.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1963,10/30/2018,2018,55.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1950,11/5/2018,2018,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1950,11/5/2018,2018,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1936,11/5/2018,2018,82,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1936,11/5/2018,2018,82,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/8/1936,11/5/2018,2018,82,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1959,11/28/2018,2018,59.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1959,11/28/2018,2018,59.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/28/1959,11/28/2018,2018,59.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1950,12/6/2018,2018,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1950,12/6/2018,2018,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1959,12/10/2018,2018,59.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1970,1/11/2019,2019,48.3,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Bladder,Bladder,"Squamous Cell Carcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/2/1943,1/15/2019,2019,75.6,White,Non-Hispanic,White,Male,81802,BMS # CA209-9GC; HCRN GU16-287; Pro2018000875,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/15/1938,1/17/2019,2019,80.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1943,2/4/2019,2019,75.7,White,Non-Hispanic,White,Male,81804,MK-3475-676; WIRB 20182217   Pro2018001770,Bladder,Bladder,"Carcinoma In Situ, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/18/1970,2/25/2019,2019,48.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/22/1944,2/28/2019,2019,74.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1944,2/28/2019,2019,74.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1951,3/5/2019,2019,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1951,3/5/2019,2019,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1960,3/7/2019,2019,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1960,3/7/2019,2019,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1956,3/14/2019,2019,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1956,3/14/2019,2019,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1933,3/18/2019,2019,85.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1933,3/18/2019,2019,85.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1950,3/21/2019,2019,69,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1950,3/21/2019,2019,69,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1962,3/25/2019,2019,56.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/22/1962,3/25/2019,2019,56.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1957,4/3/2019,2019,61.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1957,4/3/2019,2019,61.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1934,4/5/2019,2019,85.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1934,4/5/2019,2019,85.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1926,4/11/2019,2019,92.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1926,4/11/2019,2019,92.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1935,4/18/2019,2019,83.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1935,4/18/2019,2019,83.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1939,4/25/2019,2019,79.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1939,4/25/2019,2019,79.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1958,5/9/2019,2019,60.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1958,5/9/2019,2019,60.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1943,5/9/2019,2019,76.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1943,5/9/2019,2019,76.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1949,5/20/2019,2019,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1949,5/20/2019,2019,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1946,5/23/2019,2019,72.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1946,5/23/2019,2019,72.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1932,6/7/2019,2019,87.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1932,6/7/2019,2019,87.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1961,6/27/2019,2019,58.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1961,6/27/2019,2019,58.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1956,7/16/2019,2019,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1956,7/16/2019,2019,62.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bladder,Bladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/20/1956,7/16/2019,2019,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1945,7/18/2019,2019,73.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1945,7/18/2019,2019,73.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/6/1950,8/15/2019,2019,69.2,White,Non-Hispanic,White,Female,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/27/1951,8/15/2019,2019,68.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1951,8/15/2019,2019,68.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1955,8/22/2019,2019,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1955,8/22/2019,2019,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1948,9/10/2019,2019,70.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1948,9/10/2019,2019,70.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1930,9/23/2019,2019,89,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1930,9/23/2019,2019,89,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1955,9/30/2019,2019,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1955,9/30/2019,2019,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1952,11/6/2019,2019,67.7,White,Non-Hispanic,White,Female,81804,MK-3475-676; WIRB 20182217   Pro2018001770,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/29/1933,11/14/2019,2019,85.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1933,11/14/2019,2019,85.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1958,12/18/2019,2019,61.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1958,12/18/2019,2019,61.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1945,12/19/2019,2019,74.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1945,12/19/2019,2019,74.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/6/1950,12/23/2019,2019,69.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1950,12/23/2019,2019,69.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1945,1/22/2020,2020,75,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1945,1/22/2020,2020,75,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Bladder,Bladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1936,3/4/2020,2020,83.8,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Bladder,Bladder,"Carcinoma In Situ, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/10/1936,5/12/2020,2020,84.1,White,Non-Hispanic,White,Male,81802,BMS # CA209-9GC; HCRN GU16-287; Pro2018000875,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/25/1956,5/26/2020,2020,63.8,White,Non-Hispanic,White,Male,81809,CA045-009; WIRB20183114 Pro2018002794,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/22/1952,7/8/2020,2020,68.2,White,Non-Hispanic,White,Male,81802,BMS # CA209-9GC; HCRN GU16-287; Pro2018000875,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/29/1942,8/17/2020,2020,78.4,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Bladder,Bladder,"Carcinoma, Undifferentiated Type, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1957,9/1/2020,2020,63.2,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Bladder,Bladder,"Papillary Carcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1952,10/15/2020,2020,68.6,White,Non-Hispanic,White,Female,81602,MK-3475-057; WIRB 20152548 / Pro20160000454 ; ,Bladder,Bladder,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/22/1965,1/4/2017,2017,51.1,Black or African American,Non-Hispanic,Black,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
2/8/1963,1/11/2017,2017,54,White,Non-Hispanic,White,Female,21609,,Blood & Bone Marrow,Blood & Bone Marrow,,Lymphoma / Myeloma,N/A,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Not Applicable,New Brunswick,Enrolled Patients
10/4/1958,1/17/2017,2017,58.3,White,Hispanic or Latino,Hispanic/Latino,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1947,1/17/2017,2017,69.6,White,Non-Hispanic,White,Female,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1950,1/17/2017,2017,66.7,White,Non-Hispanic,White,Female,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1987,1/17/2017,2017,29.1,White,Non-Hispanic,White,Female,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/9/1948,1/17/2017,2017,68.7,White,Non-Hispanic,White,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1954,1/17/2017,2017,62.8,White,Non-Hispanic,White,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/2015,1/17/2017,2017,2,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1997,1/18/2017,2017,19.5,White,Hispanic or Latino,Hispanic/Latino,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1968,1/18/2017,2017,49,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/15/1953,1/18/2017,2017,63.8,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/16/1960,1/18/2017,2017,57,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/25/2015,1/18/2017,2017,2,White,Non-Hispanic,White,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/17/1997,1/19/2017,2017,19.5,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/5/1945,1/20/2017,2017,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1945,1/20/2017,2017,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1971,1/24/2017,2017,45.4,Black or African American,Non-Hispanic,Black,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1940,1/24/2017,2017,76.2,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/11/1962,1/24/2017,2017,54.5,White,Non-Hispanic,White,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1946,1/24/2017,2017,70.3,White,Non-Hispanic,White,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1951,1/24/2017,2017,65.4,White,Non-Hispanic,White,Male,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1957,1/27/2017,2017,59.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1957,1/27/2017,2017,59.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1991,1/30/2017,2017,25.1,White,Non-Hispanic,White,Female,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1999,1/31/2017,2017,17.8,White,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Burkitt Lymphoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/18/1943,1/31/2017,2017,73.5,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
12/23/1958,2/1/2017,2017,58.2,Asian,Non-Hispanic,Asian,Female,1501,20150001606,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Basic Science,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/2009,2/2/2017,2017,7.9,White,Hispanic or Latino,Hispanic/Latino,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/2009,2/2/2017,2017,7.9,White,Hispanic or Latino,Hispanic/Latino,Male,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/18/2009,2/3/2017,2017,7.9,White,Hispanic or Latino,Hispanic/Latino,Male,111507,ACCL1333; Pro20150002333,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Supportive Care,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/8/1954,2/3/2017,2017,63.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1954,2/3/2017,2017,63.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/2/1953,2/14/2017,2017,63.8,White,Non-Hispanic,White,Female,11601,"MK3475-155-00; WIRB 20160050, Pro20160000544",Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Leukemia,Phase I,Treatment,Leukemia,Developmental Therapeutics-phase I; Leukemia,Interventional,New Brunswick,Enrolled Patients
12/18/1954,2/17/2017,2017,62.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1954,2/17/2017,2017,62.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/2012,2/20/2017,2017,4.3,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/2012,2/21/2017,2017,4.3,White,Non-Hispanic,White,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/25/2015,2/22/2017,2017,2.1,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/21/2014,2/28/2017,2017,2.6,White,Hispanic or Latino,Hispanic/Latino,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/21/2014,3/1/2017,2017,2.6,White,Hispanic or Latino,Hispanic/Latino,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1959,3/3/2017,2017,58.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1959,3/3/2017,2017,58.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/8/1982,3/7/2017,2017,34.4,Black or African American,Non-Hispanic,Black,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/13/1979,3/10/2017,2017,38.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1979,3/10/2017,2017,38.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1953,3/21/2017,2017,63.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1953,3/21/2017,2017,63.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1993,3/23/2017,2017,23.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1993,3/23/2017,2017,23.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1950,3/31/2017,2017,66.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1950,3/31/2017,2017,66.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1950,3/31/2017,2017,66.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1950,3/31/2017,2017,66.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1951,4/3/2017,2017,65.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1951,4/3/2017,2017,65.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1955,4/5/2017,2017,62.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1955,4/5/2017,2017,62.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1996,4/6/2017,2017,20.7,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/2015,4/6/2017,2017,2.2,White,Non-Hispanic,White,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/7/1996,4/7/2017,2017,20.7,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/28/2013,4/14/2017,2017,4,White,Non-Hispanic,White,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/28/2013,4/14/2017,2017,4,White,Non-Hispanic,White,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1969,4/17/2017,2017,48.2,Asian,Non-Hispanic,Asian,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Burkitt Cell Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/13/2007,4/19/2017,2017,10.3,Asian,Non-Hispanic,Asian,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/13/2007,4/19/2017,2017,10.3,Asian,Non-Hispanic,Asian,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,"Precursor Cell Lymphoblastic Leukemia, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/2007,4/21/2017,2017,10.3,Asian,Non-Hispanic,Asian,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
11/19/1944,4/21/2017,2017,72.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1944,4/21/2017,2017,72.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/2000,4/24/2017,2017,16.7,White,Hispanic or Latino,Hispanic/Latino,Female,111503,20150426; B1761026,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Treatment,Leukemia; Pediatric Oncology,Leukemia; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/22/1953,4/24/2017,2017,64,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/22/1953,4/24/2017,2017,64,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1984,4/25/2017,2017,32.9,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/18/1959,4/26/2017,2017,58.3,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/13/2000,4/28/2017,2017,16.7,White,Hispanic or Latino,Hispanic/Latino,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/10/1996,4/28/2017,2017,20.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1996,4/28/2017,2017,20.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/2013,4/28/2017,2017,4,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/3/2006,5/2/2017,2017,10.6,White,Hispanic or Latino,Hispanic/Latino,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/3/2006,5/2/2017,2017,10.6,White,Hispanic or Latino,Hispanic/Latino,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1973,5/2/2017,2017,44.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1973,5/2/2017,2017,44.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/2005,5/10/2017,2017,12.1,White,Non-Hispanic,White,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/22/2005,5/10/2017,2017,12.1,White,Non-Hispanic,White,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/2006,5/18/2017,2017,11.1,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/18/2006,5/18/2017,2017,11.1,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1953,5/19/2017,2017,64,White,Non-Hispanic,White,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
1/17/1966,5/31/2017,2017,51.4,White,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/21/1988,5/31/2017,2017,29.1,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/3/1950,5/31/2017,2017,67,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/29/1966,6/6/2017,2017,50.8,White,Hispanic or Latino,Hispanic/Latino,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/5/1981,6/14/2017,2017,36.3,White,Non-Hispanic,White,Male,11703,9875; NCI CIRB Pro20170000620,Blood & Bone Marrow,Blood & Bone Marrow,"Malignant Lymphoma, Non-Hodgkin",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/11/1962,6/15/2017,2017,55.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1962,6/15/2017,2017,55.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/2016,6/27/2017,2017,1.3,White,Hispanic or Latino,Hispanic/Latino,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/26/2016,6/27/2017,2017,1.3,White,Hispanic or Latino,Hispanic/Latino,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1962,7/7/2017,2017,55.4,White,Non-Hispanic,White,Female,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/26/2016,7/10/2017,2017,1.4,White,Hispanic or Latino,Hispanic/Latino,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/29/1974,7/10/2017,2017,43,White,Non-Hispanic,White,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/16/1953,7/25/2017,2017,64.1,White,Non-Hispanic,White,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, T(8;21)(Q22;Q22)",Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/12/2016,7/28/2017,2017,1.1,White,Non-Hispanic,White,Male,111502,AALL1331; NCI CIRB Pro2019001968,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/27/2015,7/31/2017,2017,1.8,Black or African American,Non-Hispanic,Black,Female,111602,AAML1531; NCI CIRB Pro20160000788,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/19/1953,8/2/2017,2017,64.1,White,Hispanic or Latino,Hispanic/Latino,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
8/3/1941,8/2/2017,2017,76,White,Non-Hispanic,White,Male,111503,20150426; B1761026,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Treatment,Leukemia; Pediatric Oncology,Leukemia; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/19/1944,8/7/2017,2017,72.7,White,Non-Hispanic,White,Female,11604,20150288; Pro20160001380 - WIRB 20162909,Blood & Bone Marrow,Blood & Bone Marrow,"Malignant Lymphoma, Non-Hodgkin",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/7/2007,8/8/2017,2017,9.9,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/7/2007,8/8/2017,2017,9.9,White,Hispanic or Latino,Hispanic/Latino,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/2007,8/9/2017,2017,9.9,White,Hispanic or Latino,Hispanic/Latino,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/12/1954,8/14/2017,2017,63.5,Asian,Non-Hispanic,Asian,Female,11604,20150288; Pro20160001380 - WIRB 20162909,Blood & Bone Marrow,Blood & Bone Marrow,"Malignant Lymphoma, Non-Hodgkin",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/29/1948,8/22/2017,2017,69.4,White,Non-Hispanic,White,Female,21604,04-30; Pro20160000646 ; WIRB 20152744,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
3/27/1963,8/22/2017,2017,54.4,White,Non-Hispanic,White,Female,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,"Leukemia, Nos",Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/25/1948,8/25/2017,2017,69.1,White,Non-Hispanic,White,Female,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,"Follicular Lymphoma, Nos",Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
3/1/1964,9/6/2017,2017,53.6,White,Non-Hispanic,White,Male,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
3/9/1956,9/8/2017,2017,61.5,White,Non-Hispanic,White,Male,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/22/1947,9/8/2017,2017,70.2,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Follicular Lymphoma, Grade 3",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/22/2005,9/27/2017,2017,12.4,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/27/2015,10/4/2017,2017,1.9,Black or African American,Non-Hispanic,Black,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/13/1952,10/4/2017,2017,65.2,White,Non-Hispanic,White,Male,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
4/17/2001,10/7/2017,2017,16.5,Black or African American,Non-Hispanic,Black,Female,111707,AALL1621; NCI CIRB Pro20170001563 ,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Leukemia,Phase II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
1/2/1943,10/9/2017,2017,74.8,White,Non-Hispanic,White,Male,21702,Pro20170000326,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
5/31/1971,10/11/2017,2017,46.4,White,Non-Hispanic,White,Male,21701,CINJ 021701; Pro20170000304,Blood & Bone Marrow,Blood & Bone Marrow,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
9/23/2002,10/12/2017,2017,15.1,Black or African American,Non-Hispanic,Black,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Precursor T-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/23/1957,10/23/2017,2017,60.5,White,Non-Hispanic,White,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"B lymphoblastic leukemia/lymphoma, NOS",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
6/21/2000,10/24/2017,2017,17.4,White,Non-Hispanic,White,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/2000,10/24/2017,2017,17.4,White,Non-Hispanic,White,Male,111409,AALL1231; NCI CIRB,Blood & Bone Marrow,Blood & Bone Marrow,Precursor T-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/29/2015,10/27/2017,2017,1.8,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/2015,10/27/2017,2017,1.8,White,Non-Hispanic,White,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/21/2000,10/27/2017,2017,17.4,White,Non-Hispanic,White,Male,111507,ACCL1333; Pro20150002333,Blood & Bone Marrow,Blood & Bone Marrow,Precursor T-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Supportive Care,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/6/2010,11/1/2017,2017,7.1,White,Hispanic or Latino,Hispanic/Latino,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/8/2001,11/29/2017,2017,16.2,White,Non-Hispanic,White,Male,111707,AALL1621; NCI CIRB Pro20170001563 ,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Leukemia,Phase II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/13/1953,12/4/2017,2017,64,White,Non-Hispanic,White,Male,21706,20170000996 : WIRB 20170572; INCB 39110-301,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
3/28/2012,12/5/2017,2017,5.7,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/2012,12/5/2017,2017,5.7,White,Non-Hispanic,White,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/2/2014,12/8/2017,2017,3.4,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1948,1/16/2018,2018,69.5,Asian,Non-Hispanic,Asian,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
11/25/1950,1/22/2018,2018,67.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1950,1/22/2018,2018,67.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1977,1/22/2018,2018,41,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1977,1/22/2018,2018,41,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1965,1/23/2018,2018,52.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1965,1/23/2018,2018,52.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/2011,1/26/2018,2018,6.7,Asian,Non-Hispanic,Asian,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/2011,1/26/2018,2018,6.7,Asian,Non-Hispanic,Asian,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/19/2016,2/2/2018,2018,1.1,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/19/2016,2/2/2018,2018,1.1,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1955,2/5/2018,2018,62.3,White,Non-Hispanic,White,Male,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/16/1954,2/12/2018,2018,63.4,White,Non-Hispanic,White,Male,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/2/1954,3/5/2018,2018,63.5,White,Non-Hispanic,White,Male,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/5/1951,3/9/2018,2018,67.1,Asian,Non-Hispanic,Asian,Female,11704,PT-112-102; Pro20170001542; 20172708,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/19/2015,3/19/2018,2018,2.5,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/2015,3/19/2018,2018,2.5,White,Non-Hispanic,White,Female,111007,AALL0932; NCI CIRB 2220100223NCI,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/18/1960,3/20/2018,2018,57.7,White,Non-Hispanic,White,Male,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/20/2012,3/23/2018,2018,5.8,American Indian or Alaska Native,Non-Hispanic,Native American,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1968,3/26/2018,2018,49.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1968,3/26/2018,2018,49.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/16/1968,3/26/2018,2018,49.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1949,3/26/2018,2018,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1950,3/30/2018,2018,68,White,Non-Hispanic,White,Male,21610,PCYC-1142-CA; Pro20160001587 : 20162015,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase II,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/9/1963,4/5/2018,2018,54.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1962,4/16/2018,2018,55.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1962,4/16/2018,2018,55.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1944,4/23/2018,2018,74,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1952,4/24/2018,2018,65.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1952,4/24/2018,2018,65.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/2011,4/26/2018,2018,6.6,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/7/1996,4/26/2018,2018,21.6,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/31/1972,4/30/2018,2018,45.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1972,4/30/2018,2018,45.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/2011,4/30/2018,2018,6.7,White,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/3/1961,4/30/2018,2018,56.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1961,4/30/2018,2018,56.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1949,4/30/2018,2018,68.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1949,4/30/2018,2018,68.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1951,5/1/2018,2018,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/17/1951,5/1/2018,2018,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1959,5/2/2018,2018,58.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1959,5/2/2018,2018,58.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1993,5/2/2018,2018,25.1,White,Hispanic or Latino,Hispanic/Latino,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1966,5/2/2018,2018,51.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1966,5/2/2018,2018,51.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1971,5/3/2018,2018,47.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1971,5/3/2018,2018,47.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/2015,5/3/2018,2018,2.6,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
11/22/1991,5/4/2018,2018,26.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1991,5/4/2018,2018,26.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/2006,5/4/2018,2018,11.4,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/1/1956,5/4/2018,2018,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1956,5/4/2018,2018,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/2006,5/4/2018,2018,11.4,White,Non-Hispanic,White,Female,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1940,5/7/2018,2018,77.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1940,5/7/2018,2018,77.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1956,5/7/2018,2018,62.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1956,5/7/2018,2018,62.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1968,5/8/2018,2018,50.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1956,5/9/2018,2018,62.4,White,Non-Hispanic,White,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/30/1935,5/9/2018,2018,82.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1935,5/9/2018,2018,82.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1952,5/9/2018,2018,65.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1952,5/9/2018,2018,65.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1942,5/10/2018,2018,76,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1942,5/10/2018,2018,76,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/2011,5/10/2018,2018,7,Asian,Non-Hispanic,Asian,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
2/5/1950,5/10/2018,2018,68.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1950,5/10/2018,2018,68.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1955,5/10/2018,2018,63.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1955,5/10/2018,2018,63.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1955,5/11/2018,2018,63.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1955,5/11/2018,2018,63.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1989,5/15/2018,2018,29.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1989,5/15/2018,2018,29.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1993,5/15/2018,2018,25.1,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/18/1955,5/15/2018,2018,62.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1955,5/15/2018,2018,62.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1936,5/15/2018,2018,82.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1952,5/16/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1952,5/16/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1959,5/17/2018,2018,59.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1959,5/17/2018,2018,59.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1984,5/17/2018,2018,34.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1984,5/17/2018,2018,34.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1949,5/21/2018,2018,68.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1949,5/21/2018,2018,68.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1932,5/21/2018,2018,86.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1932,5/21/2018,2018,86.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1944,5/22/2018,2018,73.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1944,5/22/2018,2018,73.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1958,5/22/2018,2018,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1958,5/22/2018,2018,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1941,5/22/2018,2018,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1941,5/22/2018,2018,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1952,5/22/2018,2018,66.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1952,5/22/2018,2018,66.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1960,5/22/2018,2018,58,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1960,5/22/2018,2018,58,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1954,5/23/2018,2018,63.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1954,5/23/2018,2018,63.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1950,5/23/2018,2018,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1950,5/23/2018,2018,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1963,5/23/2018,2018,54.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1963,5/23/2018,2018,54.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1981,5/29/2018,2018,37.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1981,5/29/2018,2018,37.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/2014,5/29/2018,2018,3.8,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/15/1944,5/30/2018,2018,74.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1948,6/1/2018,2018,69.9,White,Non-Hispanic,White,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/15/1953,6/1/2018,2018,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/2012,6/1/2018,2018,6.2,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/13/1963,6/4/2018,2018,55,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1976,6/5/2018,2018,42.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1956,6/5/2018,2018,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1962,6/5/2018,2018,55.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1938,6/5/2018,2018,80.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1955,6/6/2018,2018,62.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1946,6/6/2018,2018,71.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1976,6/6/2018,2018,42,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1959,6/6/2018,2018,59.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1956,6/7/2018,2018,62,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1946,6/7/2018,2018,72,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1956,6/7/2018,2018,62.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1948,6/7/2018,2018,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/8/1943,6/7/2018,2018,75.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1963,6/11/2018,2018,54.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1966,6/12/2018,2018,52.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1964,6/18/2018,2018,53.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1964,6/18/2018,2018,53.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1987,6/18/2018,2018,30.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1987,6/18/2018,2018,30.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1955,6/18/2018,2018,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1955,6/18/2018,2018,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/19/1950,6/19/2018,2018,67.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/19/1950,6/19/2018,2018,67.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/2015,6/19/2018,2018,2.5,White,Non-Hispanic,White,Male,111006,AALL08B1; NCI CIRB Pro2220100222,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1964,6/21/2018,2018,53.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1964,6/21/2018,2018,53.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1952,6/22/2018,2018,65.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1952,6/22/2018,2018,65.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1982,6/26/2018,2018,36,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1982,6/26/2018,2018,36,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1948,6/26/2018,2018,70.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1948,6/26/2018,2018,70.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1961,6/27/2018,2018,56.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1961,6/27/2018,2018,56.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1957,6/27/2018,2018,60.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1957,6/27/2018,2018,60.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1941,6/27/2018,2018,76.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1941,6/27/2018,2018,76.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1943,6/27/2018,2018,74.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1943,6/27/2018,2018,74.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1974,6/27/2018,2018,43.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1974,6/27/2018,2018,43.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1960,6/28/2018,2018,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1960,6/28/2018,2018,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1983,6/28/2018,2018,34.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1983,6/28/2018,2018,34.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1960,7/5/2018,2018,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1960,7/5/2018,2018,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1961,7/5/2018,2018,56.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1961,7/5/2018,2018,56.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1980,7/5/2018,2018,38.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1980,7/5/2018,2018,38.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1990,7/6/2018,2018,27.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1990,7/6/2018,2018,27.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1936,7/10/2018,2018,82,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1936,7/10/2018,2018,82,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1953,7/10/2018,2018,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1953,7/10/2018,2018,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1955,7/11/2018,2018,63.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1955,7/11/2018,2018,63.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1952,7/11/2018,2018,65.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1952,7/11/2018,2018,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1963,7/11/2018,2018,55,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1963,7/11/2018,2018,55,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1946,7/11/2018,2018,72,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1946,7/11/2018,2018,72,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1948,7/12/2018,2018,69.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1948,7/12/2018,2018,69.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1949,7/12/2018,2018,69.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1949,7/12/2018,2018,69.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1970,7/12/2018,2018,47.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1970,7/12/2018,2018,47.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1939,7/12/2018,2018,78.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1939,7/12/2018,2018,78.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1993,7/12/2018,2018,24.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1993,7/12/2018,2018,24.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1950,7/12/2018,2018,68.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1950,7/12/2018,2018,68.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/2000,7/13/2018,2018,18.2,White,Non-Hispanic,White,Female,111502,AALL1331; NCI CIRB Pro2019001968,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/8/1955,7/16/2018,2018,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1955,7/16/2018,2018,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1995,7/16/2018,2018,23.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1995,7/16/2018,2018,23.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1974,7/16/2018,2018,44,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/29/1974,7/16/2018,2018,44,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1961,7/17/2018,2018,56.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1961,7/17/2018,2018,56.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1932,7/17/2018,2018,86,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1932,7/17/2018,2018,86,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1961,7/18/2018,2018,57.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1961,7/18/2018,2018,57.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/2/1963,7/18/2018,2018,55.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1955,7/18/2018,2018,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1955,7/18/2018,2018,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1954,7/19/2018,2018,64.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1954,7/19/2018,2018,64.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1936,7/19/2018,2018,82.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1936,7/19/2018,2018,82.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1968,7/19/2018,2018,50,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1968,7/19/2018,2018,50,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1958,7/24/2018,2018,59.9,Asian,Non-Hispanic,Asian,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/13/1948,7/25/2018,2018,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1948,7/25/2018,2018,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1957,7/26/2018,2018,61.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1957,7/26/2018,2018,61.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1968,7/26/2018,2018,50,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1968,7/26/2018,2018,50,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1946,7/30/2018,2018,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1946,7/30/2018,2018,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1978,7/31/2018,2018,40.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1978,7/31/2018,2018,40.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1955,7/31/2018,2018,63.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1955,7/31/2018,2018,63.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1951,7/31/2018,2018,66.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1951,7/31/2018,2018,66.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1952,7/31/2018,2018,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1952,7/31/2018,2018,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1963,8/1/2018,2018,55,White,Non-Hispanic,White,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/1/1961,8/1/2018,2018,57.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1961,8/1/2018,2018,57.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1950,8/1/2018,2018,68.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1975,8/1/2018,2018,42.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1950,8/1/2018,2018,68.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1975,8/1/2018,2018,42.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1946,8/2/2018,2018,71.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1946,8/2/2018,2018,71.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1957,8/2/2018,2018,61.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1957,8/2/2018,2018,61.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1973,8/2/2018,2018,44.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1973,8/2/2018,2018,44.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1961,8/2/2018,2018,57.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1961,8/2/2018,2018,57.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1959,8/2/2018,2018,59.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1959,8/2/2018,2018,59.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1967,8/2/2018,2018,51.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1967,8/2/2018,2018,51.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1955,8/2/2018,2018,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1955,8/2/2018,2018,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/2015,8/3/2018,2018,3.2,White,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Acute Megakaryoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/28/2014,8/7/2018,2018,3.9,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/15/1945,8/8/2018,2018,73,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1945,8/8/2018,2018,73,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1987,8/8/2018,2018,30.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1987,8/8/2018,2018,30.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1938,8/9/2018,2018,80.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1938,8/9/2018,2018,80.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1934,8/9/2018,2018,84.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1934,8/9/2018,2018,84.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1949,8/9/2018,2018,69.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1949,8/9/2018,2018,69.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1950,8/9/2018,2018,68.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1950,8/9/2018,2018,68.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1949,8/9/2018,2018,68.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1949,8/9/2018,2018,68.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1966,8/10/2018,2018,52,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1966,8/10/2018,2018,52,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1977,8/10/2018,2018,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1977,8/10/2018,2018,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1998,8/13/2018,2018,20,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/7/2000,8/13/2018,2018,18.3,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/31/1964,8/14/2018,2018,54.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1964,8/14/2018,2018,54.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1950,8/14/2018,2018,68.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1950,8/14/2018,2018,68.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1973,8/14/2018,2018,44.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1973,8/14/2018,2018,44.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/2004,8/15/2018,2018,14.1,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/28/2004,8/17/2018,2018,14.1,White,Hispanic or Latino,Hispanic/Latino,Male,111507,ACCL1333; Pro20150002333,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Supportive Care,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/2/1949,8/20/2018,2018,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1949,8/20/2018,2018,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1953,8/20/2018,2018,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1953,8/20/2018,2018,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1997,8/21/2018,2018,21,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/11/1955,8/21/2018,2018,63.7,Black or African American,Non-Hispanic,Black,Male,21802,PCYC-1145-LT; WIRB # 20170394; Pro2018000743,Blood & Bone Marrow,Blood & Bone Marrow,"Leukemia, Nos",Leukemia,N/A,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
8/17/1997,8/23/2018,2018,21,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/30/1962,8/23/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1962,8/23/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1974,8/23/2018,2018,44.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1974,8/23/2018,2018,44.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1941,8/24/2018,2018,76.7,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/24/1958,8/27/2018,2018,60.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1958,8/27/2018,2018,60.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1963,8/27/2018,2018,55.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1963,8/27/2018,2018,55.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1951,8/28/2018,2018,66.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1951,8/28/2018,2018,66.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1963,8/28/2018,2018,55.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1963,8/28/2018,2018,55.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1940,8/29/2018,2018,77.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1940,8/29/2018,2018,77.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1976,8/29/2018,2018,42.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1976,8/29/2018,2018,42.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1949,8/29/2018,2018,69.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1949,8/29/2018,2018,69.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,8/30/2018,2018,,White,Hispanic or Latino,Hispanic/Latino,Female,21804,Pro2018001594,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia,Leukemia,Not Applicable,New Brunswick,Enrolled Patients
5/13/1954,8/30/2018,2018,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1954,8/30/2018,2018,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1946,8/31/2018,2018,71.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1946,8/31/2018,2018,71.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1950,8/31/2018,2018,68.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1966,8/31/2018,2018,52.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1966,8/31/2018,2018,52.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1999,9/6/2018,2018,18.9,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/22/1959,9/6/2018,2018,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1959,9/6/2018,2018,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1970,9/6/2018,2018,47.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1970,9/6/2018,2018,47.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/25/1974,9/7/2018,2018,44.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/25/1974,9/7/2018,2018,44.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1949,9/7/2018,2018,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1949,9/7/2018,2018,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1947,9/10/2018,2018,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1947,9/10/2018,2018,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1959,9/11/2018,2018,59.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1959,9/11/2018,2018,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1966,9/12/2018,2018,52,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1966,9/12/2018,2018,52,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1955,9/12/2018,2018,62.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1955,9/12/2018,2018,62.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1953,9/12/2018,2018,64.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1953,9/12/2018,2018,64.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1959,9/18/2018,2018,59.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1959,9/18/2018,2018,59.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1951,9/19/2018,2018,66.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1951,9/19/2018,2018,66.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1964,9/24/2018,2018,54.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1964,9/24/2018,2018,54.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1997,9/25/2018,2018,21.1,White,Hispanic or Latino,Hispanic/Latino,Male,111603,AALL1521; INCB 18424-269; WIRB 20161312 Pro20160000858,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase II,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/1/1999,9/26/2018,2018,19.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1999,9/26/2018,2018,19.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1990,9/26/2018,2018,27.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1990,9/26/2018,2018,27.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1973,9/27/2018,2018,45.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1973,9/27/2018,2018,45.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1942,9/28/2018,2018,76.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1942,9/28/2018,2018,76.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1964,9/28/2018,2018,54.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1964,9/28/2018,2018,54.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1954,9/28/2018,2018,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1947,10/2/2018,2018,71.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1947,10/2/2018,2018,71.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1945,10/2/2018,2018,73.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1945,10/2/2018,2018,73.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1952,10/2/2018,2018,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1952,10/2/2018,2018,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1999,10/3/2018,2018,19.4,White,Non-Hispanic,White,Female,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/25/1952,10/3/2018,2018,65.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/25/1952,10/3/2018,2018,65.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/25/1952,10/3/2018,2018,65.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1976,10/3/2018,2018,42.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1976,10/3/2018,2018,42.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1991,10/3/2018,2018,27.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1991,10/3/2018,2018,27.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1999,10/3/2018,2018,19.4,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/8/1952,10/4/2018,2018,66,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1952,10/4/2018,2018,66,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1945,10/5/2018,2018,73.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1945,10/5/2018,2018,73.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1975,10/8/2018,2018,43,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1975,10/8/2018,2018,43,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1950,10/8/2018,2018,68.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1950,10/8/2018,2018,68.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1970,10/9/2018,2018,47.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1970,10/9/2018,2018,47.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1949,10/10/2018,2018,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1949,10/10/2018,2018,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1949,10/10/2018,2018,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1949,10/10/2018,2018,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1954,10/10/2018,2018,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1954,10/10/2018,2018,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1936,10/10/2018,2018,82.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1936,10/10/2018,2018,82.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1939,10/11/2018,2018,79.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1939,10/11/2018,2018,79.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1946,10/11/2018,2018,72.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1946,10/11/2018,2018,72.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1953,10/11/2018,2018,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1953,10/11/2018,2018,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1948,10/11/2018,2018,70.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1948,10/11/2018,2018,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1992,10/12/2018,2018,26.3,White,Hispanic or Latino,Hispanic/Latino,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Monocytic Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/27/1971,10/15/2018,2018,47.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1971,10/15/2018,2018,47.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1941,10/15/2018,2018,77.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1941,10/15/2018,2018,77.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1999,10/16/2018,2018,19.4,White,Non-Hispanic,White,Female,111804,AALL1631; NCI CIRB Pro2018002060,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/2/1969,10/17/2018,2018,49.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1969,10/17/2018,2018,49.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1996,10/17/2018,2018,22.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/1996,10/17/2018,2018,22.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1957,10/17/2018,2018,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1957,10/17/2018,2018,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1964,10/17/2018,2018,54.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1964,10/17/2018,2018,54.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/2004,10/18/2018,2018,13.9,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/1/2004,10/18/2018,2018,13.9,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/17/1946,10/18/2018,2018,72.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1946,10/18/2018,2018,72.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1935,10/18/2018,2018,83.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1935,10/18/2018,2018,83.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/2004,10/19/2018,2018,13.9,White,Hispanic or Latino,Hispanic/Latino,Male,111507,ACCL1333; Pro20150002333,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Supportive Care,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
11/7/1941,10/23/2018,2018,77,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/27/1971,10/23/2018,2018,47.4,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/11/1992,10/23/2018,2018,26.3,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/11/1970,10/23/2018,2018,48.5,White,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/10/1969,10/23/2018,2018,49.6,Asian,Non-Hispanic,Asian,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/20/1972,10/23/2018,2018,46.3,Asian,Non-Hispanic,Asian,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/19/1963,10/23/2018,2018,55.3,Black or African American,Non-Hispanic,Black,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/16/1951,10/23/2018,2018,67.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1951,10/23/2018,2018,67.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/1956,10/23/2018,2018,62.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1956,10/23/2018,2018,62.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1951,10/23/2018,2018,67.2,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/14/1945,10/23/2018,2018,73.8,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
9/19/1966,10/23/2018,2018,52.1,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
11/14/1993,10/23/2018,2018,25,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
3/5/1967,10/23/2018,2018,51.7,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/17/1963,10/23/2018,2018,55.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/13/1957,10/23/2018,2018,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1957,10/23/2018,2018,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1979,10/23/2018,2018,39.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1979,10/23/2018,2018,39.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1953,10/23/2018,2018,65.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1953,10/23/2018,2018,65.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1969,10/23/2018,2018,48.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1969,10/23/2018,2018,48.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1949,10/25/2018,2018,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1949,10/25/2018,2018,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1946,10/25/2018,2018,72.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1946,10/25/2018,2018,72.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1955,10/25/2018,2018,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1955,10/25/2018,2018,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1953,10/25/2018,2018,65.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1953,10/25/2018,2018,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1967,10/26/2018,2018,51.5,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/6/1938,10/26/2018,2018,80.4,Asian,Non-Hispanic,Asian,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/18/1943,10/26/2018,2018,75.6,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/8/1964,10/26/2018,2018,54.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/20/1948,10/26/2018,2018,70.2,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/4/1957,10/26/2018,2018,61.3,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/8/1980,10/26/2018,2018,38.4,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
11/12/1956,10/29/2018,2018,62,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/19/1991,10/29/2018,2018,27.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/27/1952,10/29/2018,2018,66,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leuk. With Multilineage Dysplasia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
2/6/1956,10/29/2018,2018,62.8,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/6/1931,10/29/2018,2018,87.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/1/1942,10/29/2018,2018,76.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1952,10/29/2018,2018,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1952,10/29/2018,2018,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1948,10/30/2018,2018,70.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1948,10/30/2018,2018,70.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1942,10/30/2018,2018,76.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1965,10/30/2018,2018,53.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1965,10/30/2018,2018,53.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1991,10/30/2018,2018,27.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/30/1991,10/30/2018,2018,27.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1948,10/30/2018,2018,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1948,10/30/2018,2018,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1965,10/31/2018,2018,53.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1965,10/31/2018,2018,53.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1949,11/1/2018,2018,69,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1949,11/1/2018,2018,69,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1963,11/1/2018,2018,54.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1963,11/1/2018,2018,54.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1959,11/1/2018,2018,59.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1959,11/1/2018,2018,59.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/7/1950,11/1/2018,2018,68.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1950,11/1/2018,2018,68.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1988,11/2/2018,2018,30.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1988,11/2/2018,2018,30.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1966,11/2/2018,2018,51.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1966,11/2/2018,2018,51.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1985,11/5/2018,2018,33.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1985,11/5/2018,2018,33.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1948,11/5/2018,2018,70,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1948,11/5/2018,2018,70,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1949,11/6/2018,2018,69.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1949,11/6/2018,2018,69.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1956,11/6/2018,2018,62,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1956,11/6/2018,2018,62,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1975,11/8/2018,2018,42.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1975,11/8/2018,2018,42.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1946,11/8/2018,2018,72.9,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/31/1971,11/8/2018,2018,47.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1971,11/8/2018,2018,47.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1954,11/8/2018,2018,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1954,11/8/2018,2018,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1946,11/8/2018,2018,72.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1946,11/8/2018,2018,72.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1979,11/13/2018,2018,39.6,White,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/23/1970,11/13/2018,2018,48.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1970,11/13/2018,2018,48.3,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1954,11/13/2018,2018,64.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1954,11/13/2018,2018,64.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1972,11/14/2018,2018,46.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1957,11/14/2018,2018,61.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1957,11/14/2018,2018,61.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1949,11/14/2018,2018,69.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1949,11/14/2018,2018,69.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1939,11/14/2018,2018,79.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1939,11/14/2018,2018,79.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1961,11/15/2018,2018,57.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1961,11/15/2018,2018,57.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1952,11/15/2018,2018,66.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1987,11/20/2018,2018,31,White,Non-Hispanic,White,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/2/2014,11/20/2018,2018,4.2,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/6/1973,11/28/2018,2018,45.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1973,11/28/2018,2018,45.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1961,12/4/2018,2018,57.8,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/28/1964,12/4/2018,2018,54.4,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/15/1969,12/10/2018,2018,49.2,White,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/1/1949,12/10/2018,2018,69.2,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
9/17/1951,12/10/2018,2018,67.3,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/17/1946,12/11/2018,2018,72.5,Asian,Non-Hispanic,Asian,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/23/1950,12/11/2018,2018,68.3,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
11/17/1943,12/11/2018,2018,75.1,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
3/7/1981,12/14/2018,2018,37.8,White,Hispanic or Latino,Hispanic/Latino,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/31/1974,12/14/2018,2018,44.3,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
9/11/1947,12/14/2018,2018,71.3,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
9/25/1983,12/14/2018,2018,35.2,Black or African American,Non-Hispanic,Black,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/7/1936,12/14/2018,2018,82.4,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/4/1938,12/14/2018,2018,81,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
9/30/1951,12/14/2018,2018,67.3,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/18/1963,12/14/2018,2018,55.4,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
1/17/1985,12/17/2018,2018,33.9,Black or African American,Non-Hispanic,Black,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/10/1988,12/17/2018,2018,30.2,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Acute Basophilic Leukemia,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
5/18/1941,12/17/2018,2018,77.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1941,12/17/2018,2018,77.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1996,12/18/2018,2018,22.3,Black or African American,Non-Hispanic,Black,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/15/1948,12/18/2018,2018,70.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/28/1949,12/18/2018,2018,69.4,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
7/10/1952,12/19/2018,2018,66.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/20/1934,12/27/2018,2018,84.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1934,12/27/2018,2018,84.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1998,1/3/2019,2019,20.8,Asian,Non-Hispanic,Asian,Male,111506,AAML1331; NCI CIRB Pro2019000168,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Promyelocytic Leuk.,T(15;17)(Q22;Q11-12)",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/21/1960,1/7/2019,2019,58.8,Asian,Non-Hispanic,Asian,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/30/1957,1/7/2019,2019,61.4,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/23/2000,1/14/2019,2019,18.6,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/23/2000,1/15/2019,2019,18.6,White,Hispanic or Latino,Hispanic/Latino,Male,111106,AALL1131; NCI CIRB Pro2220120026,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
11/28/1942,1/18/2019,2019,76.2,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/15/1946,1/18/2019,2019,72.5,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/9/1963,1/18/2019,2019,55.5,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/11/1965,1/18/2019,2019,53.8,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/20/1934,1/18/2019,2019,84.5,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
11/30/1990,1/18/2019,2019,28.2,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/12/1998,1/23/2019,2019,20.5,Black or African American,Non-Hispanic,Black,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
4/11/1966,1/23/2019,2019,52.8,White,Non-Hispanic,White,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/6/1956,1/23/2019,2019,62.7,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
10/8/1982,1/29/2019,2019,36.3,Black or African American,Non-Hispanic,Black,Female,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
3/1/1956,1/29/2019,2019,63,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/26/1953,1/31/2019,2019,65.5,White,Hispanic or Latino,Hispanic/Latino,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
12/21/1937,1/31/2019,2019,81.2,White,Non-Hispanic,White,Male,11704,PT-112-102; Pro20170001542; 20172708,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/20/1947,2/8/2019,2019,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1947,2/8/2019,2019,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1961,2/8/2019,2019,57.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1961,2/8/2019,2019,57.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1950,2/11/2019,2019,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1950,2/11/2019,2019,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1944,2/13/2019,2019,74.4,Black or African American,Non-Hispanic,Black,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
12/21/1937,2/14/2019,2019,81.2,White,Non-Hispanic,White,Male,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/20/1947,2/15/2019,2019,71.7,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
8/11/1935,2/15/2019,2019,83.6,White,Non-Hispanic,White,Male,21501,Pro20150001893,Blood & Bone Marrow,Blood & Bone Marrow,,Leukemia,N/A,Other,Leukemia,Leukemia,Observational,New Brunswick,Enrolled Patients
6/23/2000,2/18/2019,2019,18.7,White,Hispanic or Latino,Hispanic/Latino,Male,111603,AALL1521; INCB 18424-269; WIRB 20161312 Pro20160000858,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase II,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/3/1960,2/19/2019,2019,58.3,White,Non-Hispanic,White,Female,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/31/1936,2/20/2019,2019,82.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1975,2/21/2019,2019,44,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1975,2/21/2019,2019,44,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1966,2/21/2019,2019,52.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1966,2/21/2019,2019,52.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1949,3/6/2019,2019,70.2,White,Hispanic or Latino,Hispanic/Latino,Male,21604,04-30; Pro20160000646 ; WIRB 20152744,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
9/8/2011,3/14/2019,2019,7.5,White,Non-Hispanic,White,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor T-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/14/1963,3/15/2019,2019,55.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1963,3/15/2019,2019,55.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1952,3/19/2019,2019,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1952,3/19/2019,2019,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1964,3/19/2019,2019,54.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1964,3/19/2019,2019,54.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/6/1948,3/27/2019,2019,71.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1948,3/27/2019,2019,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1966,4/5/2019,2019,53,White,Non-Hispanic,White,Female,21807,INCB 18424-MA-GD-301; Pro2018001833; WIRB20171533,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/13/1942,4/5/2019,2019,76.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1942,4/5/2019,2019,76.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1975,4/10/2019,2019,43.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1975,4/10/2019,2019,43.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1963,4/10/2019,2019,55.4,White,Non-Hispanic,White,Male,21902,EA9161; NCI CIRB Pro2019000285,Blood & Bone Marrow,Blood & Bone Marrow,"Lymphoid Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/17/1991,4/10/2019,2019,27.3,White,Non-Hispanic,White,Female,21807,INCB 18424-MA-GD-301; Pro2018001833; WIRB20171533,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/7/1996,4/10/2019,2019,22.5,White,Non-Hispanic,White,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/28/1979,4/25/2019,2019,40.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1979,4/25/2019,2019,40.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1950,4/29/2019,2019,69.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1945,4/29/2019,2019,73.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1945,4/29/2019,2019,73.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1949,4/29/2019,2019,70,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1949,4/29/2019,2019,70,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1966,4/30/2019,2019,52.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1966,4/30/2019,2019,52.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1962,4/30/2019,2019,57.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1962,4/30/2019,2019,57.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1977,5/3/2019,2019,41.4,White,Hispanic or Latino,Hispanic/Latino,Female,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/17/1964,5/3/2019,2019,54.4,White,Non-Hispanic,White,Female,21807,INCB 18424-MA-GD-301; Pro2018001833; WIRB20171533,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/15/1962,5/9/2019,2019,57.3,White,Non-Hispanic,White,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
5/18/2015,5/13/2019,2019,4,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/16/1968,5/17/2019,2019,50.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1947,5/21/2019,2019,71.7,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/16/1954,5/28/2019,2019,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1954,5/28/2019,2019,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1953,5/30/2019,2019,65.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1953,5/30/2019,2019,65.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1965,5/30/2019,2019,54.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1965,5/30/2019,2019,54.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1948,6/5/2019,2019,70.9,White,Non-Hispanic,White,Female,11819,54767414MMY3019; Pro2018002493; WIRB 20183053,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
11/4/1970,6/12/2019,2019,48.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1970,6/12/2019,2019,48.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1938,6/19/2019,2019,81.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1938,6/19/2019,2019,81.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1962,6/19/2019,2019,56.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1962,6/19/2019,2019,56.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1959,6/20/2019,2019,59.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1959,6/20/2019,2019,59.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1962,6/25/2019,2019,56.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1956,6/25/2019,2019,63.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1956,6/25/2019,2019,63.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1958,7/6/2019,2019,60.9,Asian,Non-Hispanic,Asian,Female,11704,PT-112-102; Pro20170001542; 20172708,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/3/1934,7/8/2019,2019,85.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1934,7/8/2019,2019,85.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1957,7/9/2019,2019,62,White,Non-Hispanic,White,Female,21809,PTC299-HEM-001-LEU; Pro2019000428,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
3/28/1956,7/10/2019,2019,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1956,7/10/2019,2019,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/2012,7/10/2019,2019,6.8,White,Non-Hispanic,White,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/4/1982,7/11/2019,2019,37,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/2016,7/12/2019,2019,2.7,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/15/1999,7/15/2019,2019,19.9,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Chronic Myeloid Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/26/2001,7/15/2019,2019,17.9,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Precursor Cell Lymphoblastic Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/13/1975,7/22/2019,2019,43.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1975,7/22/2019,2019,43.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/8/1960,7/22/2019,2019,59.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/8/1960,7/22/2019,2019,59.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/2018,7/24/2019,2019,0.8,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/11/1954,7/26/2019,2019,64.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1954,7/26/2019,2019,64.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1947,8/1/2019,2019,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1947,8/1/2019,2019,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1960,8/2/2019,2019,58.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1960,8/2/2019,2019,58.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1979,8/6/2019,2019,39.6,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1960,8/8/2019,2019,58.9,White,Hispanic or Latino,Hispanic/Latino,Female,21805,ARO-021; Pro2019000420; WIRB 20172249 ,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
1/5/1949,8/8/2019,2019,70.6,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1949,8/8/2019,2019,70.6,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/2012,8/10/2019,2019,6.9,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
4/11/1964,8/20/2019,2019,55.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1964,8/20/2019,2019,55.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1967,8/20/2019,2019,51.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1967,8/20/2019,2019,51.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1943,8/21/2019,2019,75.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1943,8/21/2019,2019,75.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/2002,8/23/2019,2019,17.2,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/13/2002,8/23/2019,2019,17.2,White,Hispanic or Latino,Hispanic/Latino,Male,111603,AALL1521; INCB 18424-269; WIRB 20161312 Pro20160000858,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase II,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/25/1979,9/3/2019,2019,40.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1979,9/3/2019,2019,40.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1937,9/3/2019,2019,81.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1937,9/3/2019,2019,81.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1970,9/5/2019,2019,48.8,American Indian or Alaska Native,Hispanic or Latino,Hispanic/Latino,Female,11505,E4412; NCI CIRB Pro2018002913,Blood & Bone Marrow,Blood & Bone Marrow,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/25/1972,9/6/2019,2019,47.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/25/1972,9/6/2019,2019,47.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/2008,9/10/2019,2019,10.9,White,Non-Hispanic,White,Male,111801, ADVL1722; NCI CIRB Pro2018000412,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,Phase II,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/29/1953,9/12/2019,2019,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1953,9/12/2019,2019,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1954,9/16/2019,2019,64.9,White,Non-Hispanic,White,Male,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/31/1937,9/17/2019,2019,82.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/2007,9/18/2019,2019,12.6,Asian,Non-Hispanic,Asian,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/7/2007,9/19/2019,2019,12.6,Asian,Non-Hispanic,Asian,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/31/1937,9/19/2019,2019,82.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1937,9/23/2019,2019,82.2,White,Non-Hispanic,White,Male,21908,CTL019B20031; Pro2019001694,Blood & Bone Marrow,Blood & Bone Marrow,"B lymphoblastic leukemia/lymphoma, NOS",Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/21/1960,9/25/2019,2019,59.2,White,Hispanic or Latino,Hispanic/Latino,Female,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/31/1988,9/27/2019,2019,31.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1963,9/30/2019,2019,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1963,9/30/2019,2019,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1992,10/1/2019,2019,27.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1992,10/1/2019,2019,27.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1942,10/1/2019,2019,77,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1942,10/1/2019,2019,77,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1973,10/3/2019,2019,45.9,Black or African American,Non-Hispanic,Black,Male,11505,E4412; NCI CIRB Pro2018002913,Blood & Bone Marrow,Blood & Bone Marrow,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/22/1958,10/4/2019,2019,61.2,Asian,Non-Hispanic,Asian,Male,21402,E1910; NCI CIRB Pro20140000293 old; Pro2019000696 new eIRB,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/21/1955,10/7/2019,2019,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1955,10/7/2019,2019,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1953,10/8/2019,2019,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1953,10/8/2019,2019,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/2004,10/9/2019,2019,15.4,White,Non-Hispanic,White,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
11/2/1954,10/10/2019,2019,65,White,Hispanic or Latino,Hispanic/Latino,Female,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/8/2010,10/10/2019,2019,9.6,Black or African American,Non-Hispanic,Black,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/21/1955,10/10/2019,2019,64.3,White,Non-Hispanic,White,Female,21902,EA9161; NCI CIRB Pro2019000285,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
5/3/2004,10/10/2019,2019,15.4,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/8/2010,10/11/2019,2019,9.6,Black or African American,Non-Hispanic,Black,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/9/1938,10/16/2019,2019,80.9,White,Non-Hispanic,White,Male,21901,A041702; NCI CIRB Pro2019000284,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
6/10/1965,10/18/2019,2019,54.4,White,Non-Hispanic,White,Female,11505,E4412; NCI CIRB Pro2018002913,Blood & Bone Marrow,Blood & Bone Marrow,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/14/1938,10/30/2019,2019,81.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1938,10/30/2019,2019,81.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1955,10/30/2019,2019,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1955,10/30/2019,2019,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1995,10/30/2019,2019,24.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1995,10/30/2019,2019,24.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1936,11/5/2019,2019,83.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/2015,11/8/2019,2019,4.4,White,Non-Hispanic,White,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/13/1959,11/12/2019,2019,60.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1959,11/12/2019,2019,60.6,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/13/1959,11/12/2019,2019,60.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1984,11/14/2019,2019,35.4,White,Hispanic or Latino,Hispanic/Latino,Male,21808,EA9152; NCI CIRB Pro2019001332,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase I/II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
8/7/1937,11/14/2019,2019,82.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1937,11/14/2019,2019,82.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/2006,11/15/2019,2019,13.6,White,Non-Hispanic,White,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
11/20/2014,11/19/2019,2019,5,White,Non-Hispanic,White,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/6/1961,11/25/2019,2019,58.9,Asian,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1961,11/25/2019,2019,58.9,Asian,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1955,11/26/2019,2019,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1955,11/26/2019,2019,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/2015,11/27/2019,2019,4.8,White,Non-Hispanic,White,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/31/2014,11/27/2019,2019,5.7,White,Non-Hispanic,White,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/22/1949,12/3/2019,2019,70.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1949,12/3/2019,2019,70.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1963,12/6/2019,2019,56.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1963,12/6/2019,2019,56.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/2/1955,12/10/2019,2019,64.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/2/1955,12/10/2019,2019,64.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1949,12/10/2019,2019,70.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1949,12/10/2019,2019,70.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1948,12/11/2019,2019,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1948,12/11/2019,2019,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1952,12/11/2019,2019,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1952,12/11/2019,2019,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/2014,12/12/2019,2019,5,White,Hispanic or Latino,Hispanic/Latino,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/7/1962,12/17/2019,2019,57.9,White,Non-Hispanic,White,Female,11811,Pro2018001700,Blood & Bone Marrow,Blood & Bone Marrow,"Malignant Lymphoma, Non-Hodgkin",Lymphoma / Myeloma,N/A,Basic Science,Lymphoma / Myeloma,Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1972,12/17/2019,2019,47.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1972,12/17/2019,2019,47.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1970,12/18/2019,2019,49.2,Black or African American,Non-Hispanic,Black,Female,21803,GC P#05.01.020; Pro2018001701;    WIRB 20181641,Blood & Bone Marrow,Blood & Bone Marrow,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
11/16/1950,12/19/2019,2019,69.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1950,12/19/2019,2019,69.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/6/1939,12/27/2019,2019,80.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/6/1939,12/27/2019,2019,80.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1972,12/27/2019,2019,47.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1972,12/27/2019,2019,47.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1953,1/2/2020,2020,66.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1953,1/2/2020,2020,66.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1957,1/7/2020,2020,63,White,Hispanic or Latino,Hispanic/Latino,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,B lymphoblastic leukemia/lymphoma with hyperdiploidy,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/10/1958,1/8/2020,2020,61.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1958,1/8/2020,2020,61.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1962,1/8/2020,2020,57.4,White,Non-Hispanic,White,Male,11811,Pro2018001700,Blood & Bone Marrow,Blood & Bone Marrow,"Malignant Lymphoma, Non-Hodgkin",Lymphoma / Myeloma,N/A,Basic Science,Lymphoma / Myeloma,Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1963,1/15/2020,2020,56.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1963,1/15/2020,2020,56.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/2015,1/18/2020,2020,4.3,Asian,Non-Hispanic,Asian,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/6/1938,1/21/2020,2020,81.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1938,1/21/2020,2020,81.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1968,1/21/2020,2020,52,Unknown,Non-Hispanic,Unknown,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1968,1/21/2020,2020,52,Unknown,Non-Hispanic,Unknown,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1962,1/21/2020,2020,58,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1962,1/21/2020,2020,58,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1960,1/21/2020,2020,59.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1960,1/21/2020,2020,59.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1958,1/27/2020,2020,61.5,White,Non-Hispanic,White,Male,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/12/1962,1/29/2020,2020,58.1,White,Non-Hispanic,White,Male,11506,GO29833; Pro20150002688; WIRB20152110,Blood & Bone Marrow,Blood & Bone Marrow,"Follicular Lymphoma, Grade 2",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/23/2009,1/31/2020,2020,10.8,White,Hispanic or Latino,Hispanic/Latino,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/7/1937,2/5/2020,2020,82.6,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/31/1981,2/7/2020,2020,38.9,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1981,2/7/2020,2020,38.9,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1965,2/11/2020,2020,54.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/1965,2/11/2020,2020,54.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1961,2/12/2020,2020,59.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1961,2/12/2020,2020,59.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1954,2/12/2020,2020,65.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1954,2/12/2020,2020,65.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1939,2/12/2020,2020,81,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1939,2/12/2020,2020,81,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1978,2/13/2020,2020,41.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1962,2/21/2020,2020,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1962,2/21/2020,2020,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1944,2/26/2020,2020,75.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1944,2/26/2020,2020,75.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1952,2/28/2020,2020,67.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1952,2/28/2020,2020,67.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1939,3/2/2020,2020,80.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1939,3/2/2020,2020,80.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1956,3/3/2020,2020,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/22/1956,3/3/2020,2020,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1949,3/3/2020,2020,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1949,3/3/2020,2020,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1946,3/5/2020,2020,73.4,White,Non-Hispanic,White,Female,21909,CMBG453B12201; WIRB 20190785        Pro2019002006,Blood & Bone Marrow,Blood & Bone Marrow,"Myelodysplastic Syndrome, Nos",Leukemia,Phase II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
2/14/1949,3/5/2020,2020,71.1,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Follicular Lymphoma, Grade 1",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/29/1949,3/9/2020,2020,71.2,Black or African American,Non-Hispanic,Black,Female,12002,,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,N/A,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/30/1955,3/12/2020,2020,64.2,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
11/20/2014,3/24/2020,2020,5.3,White,Non-Hispanic,White,Female,111917,AALL1931; JZP458-201; Pro2020000235,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,Phase II/III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
2/15/1953,3/27/2020,2020,67.2,White,Non-Hispanic,White,Female,11806, PrE0404 ; Pro2018000749,Blood & Bone Marrow,Blood & Bone Marrow,Mantle Cell Lymphoma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/22/2006,4/13/2020,2020,14,White,Non-Hispanic,White,Male,111917,AALL1931; JZP458-201; Pro2020000235,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,Phase II/III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
6/7/2010,4/24/2020,2020,9.9,White,Non-Hispanic,White,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/10/1979,4/27/2020,2020,41.1,White,Hispanic or Latino,Hispanic/Latino,Female,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/3/1987,5/22/2020,2020,32.5,White,Hispanic or Latino,Hispanic/Latino,Female,21808,EA9152; NCI CIRB Pro2019001332,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Leukemia,Phase I/II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/1/1962,5/24/2020,2020,57.9,Asian,Non-Hispanic,Asian,Male,12001,A051701; NCI CIRB Pro2020000230,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase II/III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/25/1956,5/26/2020,2020,64,White,Hispanic or Latino,Hispanic/Latino,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/2/2000,6/1/2020,2020,20.1,Asian,Non-Hispanic,Asian,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/10/1975,6/4/2020,2020,44.5,White,Hispanic or Latino,Hispanic/Latino,Male,11813,EA4151; NCI CIRB Pro2018001702,Blood & Bone Marrow,Blood & Bone Marrow,Mantle Cell Lymphoma,Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/17/1968,6/9/2020,2020,51.9,White,Non-Hispanic,White,Female,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
1/16/1950,6/11/2020,2020,70.4,White,Hispanic or Latino,Hispanic/Latino,Male,11104,10-CBA; Pro0220110164,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/10/2010,6/17/2020,2020,9.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,112006,Pro2020001471,Blood & Bone Marrow,Blood & Bone Marrow,"Langerhans cell histiocytosis, NOS",Pediatric Oncology,N/A,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/1/2008,6/29/2020,2020,11.8,Asian,Non-Hispanic,Asian,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/19/2019,7/2/2020,2020,1.3,Black or African American,Non-Hispanic,Black,Female,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/2/2000,7/7/2020,2020,20.2,Asian,Non-Hispanic,Asian,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"B lymphoblastic leukemia/lymphoma, NOS",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/30/1963,7/10/2020,2020,56.7,White,Hispanic or Latino,Hispanic/Latino,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/3/2012,7/10/2020,2020,8.2,Asian,Non-Hispanic,Asian,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"B lymphoblastic leukemia/lymphoma, NOS",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/30/1946,7/13/2020,2020,73.9,White,Non-Hispanic,White,Male,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
5/19/1962,7/20/2020,2020,58.2,Black or African American,Non-Hispanic,Black,Male,11909,68284528MMY2003; Pro2019001776,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/6/1980,7/20/2020,2020,40.3,White,Non-Hispanic,White,Female,12001,A051701; NCI CIRB Pro2020000230,Blood & Bone Marrow,Blood & Bone Marrow,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase II/III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/7/2010,7/24/2020,2020,10.1,White,Non-Hispanic,White,Female,111917,AALL1931; JZP458-201; Pro2020000235,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,Phase II/III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/24/1997,7/27/2020,2020,23,White,Non-Hispanic,White,Female,111911,AALL1732; NCI CIRB Pro2019002127,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Leukemia,Phase III,Treatment,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Leukemia; Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/28/1990,8/7/2020,2020,30,White,Hispanic or Latino,Hispanic/Latino,Male,11505,E4412; NCI CIRB Pro2018002913,Blood & Bone Marrow,Blood & Bone Marrow,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/28/1990,8/11/2020,2020,30.1,White,Hispanic or Latino,Hispanic/Latino,Male,171801,PICI0009; Pro2018002367 ,Blood & Bone Marrow,Blood & Bone Marrow,"Hodgkin Lymphoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1962,8/12/2020,2020,57.7,White,Non-Hispanic,White,Male,1813,Pro2018000576,Blood & Bone Marrow,Blood & Bone Marrow,,Lymphoma / Myeloma,N/A,Basic Science,Lymphoma / Myeloma,Lymphoma / Myeloma,Not Applicable,New Brunswick,Enrolled Patients
12/23/1962,8/12/2020,2020,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1962,8/12/2020,2020,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Blood & Bone Marrow,Blood & Bone Marrow,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1943,8/13/2020,2020,77,White,Non-Hispanic,White,Male,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Leukemia, Nos",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
8/28/1964,8/18/2020,2020,56,White,Non-Hispanic,White,Male,21902,EA9161; NCI CIRB Pro2019000285,Blood & Bone Marrow,Blood & Bone Marrow,"Lymphoid Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
6/22/1943,9/4/2020,2020,77.3,Black or African American,Non-Hispanic,Black,Male,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Leukemia, Nos",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
6/7/2010,9/21/2020,2020,10.3,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Lymphoblastic Leukemia, L2 Type, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/13/2005,9/22/2020,2020,15.7,Unknown,Non-Hispanic,Unknown,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/13/2005,9/23/2020,2020,15.7,Unknown,Non-Hispanic,Unknown,Female,112008,AAML1831; NCI CIRB Pro2020002226,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
12/16/1957,9/24/2020,2020,62.8,Black or African American,Non-Hispanic,Black,Male,11909,68284528MMY2003; Pro2019001776,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/16/1951,10/5/2020,2020,69,Black or African American,Non-Hispanic,Black,Female,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/30/1946,10/12/2020,2020,74.2,White,Non-Hispanic,White,Male,21809,PTC299-HEM-001-LEU; Pro2019000428,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
7/30/1957,10/16/2020,2020,63.3,Unknown,Hispanic or Latino,Hispanic/Latino,Female,21911,10246; NCI CIRB Pro2019002242,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Myeloid Leukemia, M6 Type",Leukemia,Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/13/2018,10/16/2020,2020,1.8,Unknown,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/6/1959,10/20/2020,2020,61.7,White,Non-Hispanic,White,Male,21903,017004; Pro2019000801,Blood & Bone Marrow,Blood & Bone Marrow,B-Cell Chr. Lymph. Leuk./Small Lymphocytic Lymphoma,Leukemia,Phase I/II,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
12/13/2018,10/22/2020,2020,1.9,Unknown,Hispanic or Latino,Hispanic/Latino,Female,112008,AAML1831; NCI CIRB Pro2020002226,Blood & Bone Marrow,Blood & Bone Marrow,Acute Myeloid Leukemia,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/25/2012,10/22/2020,2020,8,American Indian or Alaska Native,Non-Hispanic,Native American,Male,111805,16-001; Pro2018002186,Blood & Bone Marrow,Blood & Bone Marrow,"Acute Leukemia, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/10/1961,10/22/2020,2020,59.8,White,Non-Hispanic,White,Female,21902,EA9161; NCI CIRB Pro2019000285,Blood & Bone Marrow,Blood & Bone Marrow,"Lymphoid Leukemia, Nos",Leukemia,Phase III,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
1/6/1950,10/26/2020,2020,70.9,Black or African American,Non-Hispanic,Black,Female,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Blood & Bone Marrow,Blood & Bone Marrow,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/30/1998,4/5/2017,2017,18.6,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Bone & Cartilage,Bone & Cartilage,"Ml, Large B-Cell, Diffuse",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
2/3/1986,9/19/2017,2017,31.6,Asian,Non-Hispanic,Asian,Male,1610,001610  201209025; Pro20160000426,Bone & Cartilage,Bone & Cartilage,"Chondrosarcoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
3/5/1974,4/30/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Bone & Cartilage,Bone & Cartilage,Adenoid Cystic Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/9/1990,7/25/2018,2018,28,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Bone & Cartilage,Bone & Cartilage,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1990,7/25/2018,2018,28,White,Non-Hispanic,White,Male,1209,Pro2012002075,Bone & Cartilage,Bone & Cartilage,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/9/1990,7/25/2018,2018,28,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Bone & Cartilage,Bone & Cartilage,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/2005,10/16/2018,2018,13.6,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Bone & Cartilage,Bone & Cartilage,"Osteosarcoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/17/2003,7/24/2019,2019,16,Asian,Non-Hispanic,Asian,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Bone & Cartilage,Bone & Cartilage,Chondroblastic Osteosarcoma,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/21/2010,7/25/2019,2019,8.8,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Bone & Cartilage,Bone & Cartilage,"Osteosarcoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/9/1990,11/1/2019,2019,29.2,White,Non-Hispanic,White,Male,171701-Z1H,EAY131-Z1H; NCI CIRB Pro2018000037,Bone & Cartilage,Bone & Cartilage,,Precision Medicine,Phase II,Treatment,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
9/24/1957,2/11/2020,2020,62.4,White,Hispanic or Latino,Hispanic/Latino,Female,141804,10129; NCI CIRB Pro2018001815,Bone & Cartilage,Bone & Cartilage,"Chondrosarcoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
2/1/1949,2/11/2020,2020,71.1,White,Non-Hispanic,White,Female,141806,2012-ONC-102; Advarra # 00030215  Pro 2018002107  ,Bone & Cartilage,Bone & Cartilage,"Chondrosarcoma, Nos",CNS,Phase I/II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
5/13/1954,6/15/2020,2020,66.1,White,Non-Hispanic,White,Male,11818,R5458-ONC-1826; WIRB20182934;   Pro2018002381,Bone & Cartilage,Bone & Cartilage,Multiple Myeloma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/1/1949,9/11/2020,2020,71.7,White,Non-Hispanic,White,Female,141804,10129; NCI CIRB Pro2018001815,Bone & Cartilage,Bone & Cartilage,"Chondrosarcoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
5/14/2005,10/1/2020,2020,15.4,Black or African American,Non-Hispanic,Black,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Bone & Cartilage,Bone & Cartilage,"Hodgkin Lymphoma, Mixed Cellularity, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/19/1958,1/19/2017,2017,58.5,Black or African American,Non-Hispanic,Black,Female,41404,AGR-10576; Pro20150001297,Breast,Breast,"Carcinoma In Situ, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/7/1977,1/27/2017,2017,40,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1977,1/27/2017,2017,40,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/7/1977,1/27/2017,2017,40,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1981,1/30/2017,2017,35.9,White,Hispanic or Latino,Hispanic/Latino,Female,41505,PUMA-NER-6201; Pro20150001614-WIRB 20150243,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/22/1943,2/2/2017,2017,73.5,Black or African American,Non-Hispanic,Black,Female,41404,AGR-10576; Pro20150001297,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/27/1968,2/6/2017,2017,49,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/20/1979,2/14/2017,2017,37.5,White,Non-Hispanic,White,Female,51513,9782; NCI CIRB Pro20160000225,Breast,Breast,"Intraductal Papillary-Mucinous Carcinoma, Invasive",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/11/1945,2/15/2017,2017,71.7,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
11/11/1976,2/20/2017,2017,40.3,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/5/1954,2/20/2017,2017,63.2,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/23/1983,2/21/2017,2017,33.7,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,"Intraductal Carcinoma, Noninfiltrating, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/28/1966,2/23/2017,2017,50.8,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/7/1951,2/23/2017,2017,65.3,White,Non-Hispanic,White,Female,41404,AGR-10576; Pro20150001297,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/7/1958,2/24/2017,2017,59.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1958,2/24/2017,2017,59.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1971,2/27/2017,2017,45.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/15/1977,3/6/2017,2017,39.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1964,3/7/2017,2017,52.5,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/4/1967,3/16/2017,2017,49.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1954,3/20/2017,2017,62.4,White,Non-Hispanic,White,Female,51608,C16-380; Pro20160001213,Breast,Breast,"Carcinoma, Anaplastic Type, Nos",DT - Phase I,N/A,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Not Applicable,New Brunswick,Enrolled Patients
7/10/1960,3/21/2017,2017,56.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1969,3/27/2017,2017,47.8,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,"Adenocarcinoma, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/18/1984,3/27/2017,2017,33,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/1/1939,3/27/2017,2017,77.6,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,"Metaplastic Carcinoma, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/2/1969,3/30/2017,2017,47.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1959,4/4/2017,2017,57.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1967,4/14/2017,2017,50.1,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/28/1937,4/17/2017,2017,80.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/29/1960,4/21/2017,2017,56.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1960,4/21/2017,2017,56.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1966,4/21/2017,2017,50.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1971,4/21/2017,2017,45.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1971,4/21/2017,2017,45.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1968,4/24/2017,2017,48.6,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/3/1964,4/24/2017,2017,53,White,Non-Hispanic,White,Female,41505,PUMA-NER-6201; Pro20150001614-WIRB 20150243,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/11/1968,4/24/2017,2017,48.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/17/1973,4/25/2017,2017,43.6,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/28/1966,4/25/2017,2017,50.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1991,4/26/2017,2017,25.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1991,4/26/2017,2017,25.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1976,5/1/2017,2017,41.2,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/7/1963,5/5/2017,2017,54.2,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/11/1959,5/15/2017,2017,57.7,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,41505,PUMA-NER-6201; Pro20150001614-WIRB 20150243,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/15/1952,5/17/2017,2017,64.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1952,5/17/2017,2017,64.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1962,5/18/2017,2017,54.8,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/13/1980,5/22/2017,2017,36.7,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/13/1976,5/22/2017,2017,40.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1976,5/22/2017,2017,40.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/13/1976,5/22/2017,2017,40.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1941,5/23/2017,2017,75.6,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/17/1966,5/31/2017,2017,50.7,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Carcinoma In Situ, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/1/1957,6/2/2017,2017,60.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1957,6/2/2017,2017,60.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1972,6/9/2017,2017,45,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1972,6/9/2017,2017,45,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1946,6/9/2017,2017,70.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1946,6/9/2017,2017,70.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1941,6/9/2017,2017,75.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1941,6/9/2017,2017,75.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1953,6/16/2017,2017,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1953,6/16/2017,2017,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1971,6/20/2017,2017,45.7,White,Non-Hispanic,White,Female,51513,9782; NCI CIRB Pro20160000225,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/28/1948,6/23/2017,2017,69.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1948,6/23/2017,2017,69.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1984,6/26/2017,2017,33.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1984,6/26/2017,2017,33.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1949,6/29/2017,2017,68.1,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/17/1947,6/29/2017,2017,69.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/30/1950,6/29/2017,2017,67.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
8/14/1952,7/3/2017,2017,64.9,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/11/1976,7/7/2017,2017,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1976,7/7/2017,2017,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1957,7/10/2017,2017,60.4,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/2/1970,7/13/2017,2017,47.5,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/17/1971,7/13/2017,2017,46.3,Black or African American,Non-Hispanic,Black,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/13/1977,7/14/2017,2017,39.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1977,7/14/2017,2017,39.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1959,7/18/2017,2017,57.8,White,Non-Hispanic,White,Female,41314,NCI CIRB Pro2014004047; S1207,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/29/1960,7/27/2017,2017,57.4,Black or African American,Non-Hispanic,Black,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/16/1976,7/28/2017,2017,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1976,7/28/2017,2017,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1960,7/31/2017,2017,57.6,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/16/1951,8/3/2017,2017,66.5,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/12/1964,8/3/2017,2017,53.3,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/4/1955,8/4/2017,2017,62.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1955,8/4/2017,2017,62.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1979,8/7/2017,2017,38,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Breast,Breast,"Intraductal Papillary-Mucinous Carcinoma, Invasive",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/16/1956,8/8/2017,2017,61.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/23/1980,8/9/2017,2017,36.8,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/12/1946,8/15/2017,2017,71.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/29/1956,8/16/2017,2017,60.9,Black or African American,Non-Hispanic,Black,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Breast,Breast,Intraductal Papillary Adenocarcinoma With Invasion,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
8/5/1976,8/21/2017,2017,41.1,White,Non-Hispanic,White,Female,41505,PUMA-NER-6201; Pro20150001614-WIRB 20150243,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
1/1/1957,8/24/2017,2017,60.7,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/14/1961,8/25/2017,2017,56.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Lobular Carcinoma In Situ,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/26/1964,8/31/2017,2017,52.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1964,8/31/2017,2017,52.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1964,9/7/2017,2017,53.1,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/11/1976,9/8/2017,2017,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1976,9/8/2017,2017,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1941,9/15/2017,2017,75.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1941,9/15/2017,2017,75.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1960,9/18/2017,2017,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1960,9/18/2017,2017,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1951,9/19/2017,2017,65.8,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/12/1964,9/19/2017,2017,53.5,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,Breast,Breast,"Carcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
11/27/1971,9/28/2017,2017,45.9,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/5/1965,9/28/2017,2017,52.4,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,"Intraductal Carcinoma, Noninfiltrating, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/25/1968,9/29/2017,2017,49.4,White,Non-Hispanic,White,Female,51603,1966-001-00; 20160648,Breast,Breast,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/13/1948,10/5/2017,2017,69,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/18/1955,10/5/2017,2017,62.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/17/1952,10/6/2017,2017,65.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1952,10/6/2017,2017,65.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1955,10/9/2017,2017,62.2,White,Non-Hispanic,White,Female,41505,PUMA-NER-6201; Pro20150001614-WIRB 20150243,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/25/1968,10/9/2017,2017,49.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1968,10/9/2017,2017,49.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/25/1968,10/9/2017,2017,49.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1974,10/10/2017,2017,43.5,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/14/1930,10/10/2017,2017,87.4,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
3/16/1958,10/10/2017,2017,59.6,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/20/1975,10/10/2017,2017,42.7,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,"Carcinoma, Nos",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/14/1974,10/10/2017,2017,43.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/10/1955,10/11/2017,2017,62,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
11/5/1973,10/12/2017,2017,44,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/27/1968,10/12/2017,2017,49.7,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/12/1946,10/12/2017,2017,71.7,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/15/1955,10/12/2017,2017,62.8,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/6/1967,10/13/2017,2017,50.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1967,10/13/2017,2017,50.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1944,10/13/2017,2017,73.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1944,10/13/2017,2017,73.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1943,10/16/2017,2017,74.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1943,10/16/2017,2017,74.3,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/8/1943,10/16/2017,2017,74.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1961,10/16/2017,2017,55.9,White,Non-Hispanic,White,Female,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/6/1945,10/23/2017,2017,72.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1957,10/24/2017,2017,60.9,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/13/1947,10/24/2017,2017,70.5,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
8/7/1964,10/26/2017,2017,53.3,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/28/1962,10/26/2017,2017,55,Black or African American,Non-Hispanic,Black,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/10/1962,10/26/2017,2017,55.1,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/16/1941,10/26/2017,2017,76.7,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/19/1947,10/30/2017,2017,70.7,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
,11/2/2017,2017,,Black or African American,Non-Hispanic,Black,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/28/1968,11/3/2017,2017,49.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1968,11/3/2017,2017,49.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/3/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/21/1932,11/3/2017,2017,85.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1932,11/3/2017,2017,85.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1958,11/9/2017,2017,59.6,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/4/1943,11/9/2017,2017,74.3,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/22/1941,11/9/2017,2017,76.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/26/1945,11/9/2017,2017,71.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Carcinoma, Nos",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/12/1963,11/9/2017,2017,54.4,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/21/1945,11/9/2017,2017,72.6,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
8/5/1976,11/9/2017,2017,41.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/30/1950,11/9/2017,2017,67.2,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/23/1983,11/10/2017,2017,34.4,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
,11/15/2017,2017,,Asian,Non-Hispanic,Asian,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/3/1951,11/16/2017,2017,66,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/9/1976,11/17/2017,2017,41,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1976,11/17/2017,2017,41,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1965,11/20/2017,2017,52.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1965,11/20/2017,2017,52.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1963,11/21/2017,2017,54.5,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/17/1982,12/11/2017,2017,35.3,Black or African American,Non-Hispanic,Black,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/26/1946,12/13/2017,2017,71.4,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/7/1953,12/19/2017,2017,64.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/20/2017,2017,,Asian,Non-Hispanic,Asian,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/27/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/27/2017,2017,,Black or African American,Non-Hispanic,Black,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/29/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/29/2017,2017,,Unknown,Non-Hispanic,Unknown,Female,1714,Pro20170000634,Breast,Breast,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/1/1947,1/8/2018,2018,70.7,Asian; American Indian or Alaska Native,Non-Hispanic,Asian,Female,41601,MK-3475-355; Pro20160000941 WIRB 20161207,Breast,Breast,"Metaplastic Carcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/11/1976,1/8/2018,2018,41.9,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/11/1956,1/16/2018,2018,61.7,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,"Carcinoma, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
1/3/1970,1/16/2018,2018,48.1,White,Non-Hispanic,White,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/1/1946,2/2/2018,2018,71.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1946,2/2/2018,2018,71.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1946,2/2/2018,2018,71.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1946,2/2/2018,2018,71.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1949,2/9/2018,2018,69,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1949,2/9/2018,2018,69,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1971,2/12/2018,2018,46.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1971,2/12/2018,2018,46.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1981,2/13/2018,2018,36.2,White,Hispanic or Latino,Hispanic/Latino,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,"Adenocarcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/25/1960,2/16/2018,2018,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1960,2/16/2018,2018,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1953,2/16/2018,2018,64.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1953,2/16/2018,2018,64.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1950,2/19/2018,2018,67.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1950,2/19/2018,2018,67.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1953,2/23/2018,2018,64.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/22/1965,2/23/2018,2018,53,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Breast,Breast,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/20/1966,2/26/2018,2018,51.7,White,Non-Hispanic,White,Female,41601,MK-3475-355; Pro20160000941 WIRB 20161207,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/4/1972,2/27/2018,2018,45.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1988,3/1/2018,2018,29.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/10/1988,3/1/2018,2018,29.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/10/1988,3/1/2018,2018,29.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1947,3/5/2018,2018,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/30/1947,3/5/2018,2018,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1948,3/5/2018,2018,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1948,3/5/2018,2018,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1961,3/16/2018,2018,56.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1961,3/16/2018,2018,56.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1946,3/19/2018,2018,71.8,Black or African American,Non-Hispanic,Black,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/5/1977,3/19/2018,2018,40.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1977,3/19/2018,2018,40.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1975,3/19/2018,2018,42.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1975,3/19/2018,2018,42.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1946,3/20/2018,2018,72.2,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,"Neoplasm, Malignant",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/11/1956,3/20/2018,2018,61.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1956,3/20/2018,2018,61.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1962,3/20/2018,2018,56.2,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Neoplasm, Malignant",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/30/1959,3/20/2018,2018,58.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Neoplasm, Malignant",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/4/1948,3/20/2018,2018,69.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/2/1970,4/3/2018,2018,48.2,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/18/1975,4/3/2018,2018,43.2,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/18/1951,4/3/2018,2018,66.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
11/24/1978,4/3/2018,2018,39.4,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/12/1946,4/4/2018,2018,71.9,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/7/1972,4/6/2018,2018,46,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/12/1963,4/6/2018,2018,54.9,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
11/25/1981,4/13/2018,2018,36.4,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/17/1957,4/17/2018,2018,61,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,"Neoplasm, Malignant",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/28/1937,4/17/2018,2018,81.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Neoplasm, Malignant",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/19/1953,4/17/2018,2018,64.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/8/1964,4/20/2018,2018,53.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1964,4/20/2018,2018,53.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1992,4/20/2018,2018,25.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/2/1992,4/20/2018,2018,25.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1954,4/24/2018,2018,64.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/13/1963,4/26/2018,2018,54.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1963,4/26/2018,2018,54.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1949,5/1/2018,2018,69.3,White,Hispanic or Latino,Hispanic/Latino,Female,41601,MK-3475-355; Pro20160000941 WIRB 20161207,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
6/12/1979,5/1/2018,2018,38.9,White,Non-Hispanic,White,Female,41314,NCI CIRB Pro2014004047; S1207,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/18/1980,5/3/2018,2018,38.2,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/22/1966,5/8/2018,2018,52.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1966,5/8/2018,2018,52.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/22/1966,5/8/2018,2018,52.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1963,5/9/2018,2018,54.6,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/7/1972,5/10/2018,2018,46.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1972,5/10/2018,2018,46.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1972,5/10/2018,2018,46.4,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/16/1944,5/11/2018,2018,74,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1944,5/11/2018,2018,74,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1946,5/15/2018,2018,72,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1946,5/15/2018,2018,72,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1951,5/22/2018,2018,67.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/11/1975,5/23/2018,2018,42.7,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
2/8/1939,5/23/2018,2018,79.3,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/29/1950,5/23/2018,2018,68.4,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/7/1947,5/23/2018,2018,71,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/23/1943,5/30/2018,2018,74.7,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/30/1953,5/31/2018,2018,64.7,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
8/11/1943,5/31/2018,2018,74.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1955,6/1/2018,2018,63.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1957,6/5/2018,2018,60.7,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/1/1960,6/5/2018,2018,57.7,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/21/1947,6/5/2018,2018,71.1,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/28/1980,6/6/2018,2018,38.4,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,Mucinous Adenocarcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/6/1987,6/6/2018,2018,31.4,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
8/24/1961,6/6/2018,2018,56.8,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/12/1963,6/6/2018,2018,55.1,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
11/18/1948,6/6/2018,2018,69.6,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/17/1975,6/6/2018,2018,42.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/21/1966,6/12/2018,2018,51.7,White,Hispanic or Latino,Hispanic/Latino,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
6/23/1983,6/12/2018,2018,35,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/7/1954,6/12/2018,2018,64,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/25/1952,6/13/2018,2018,66.4,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/8/1964,6/13/2018,2018,53.5,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/23/1960,6/13/2018,2018,57.8,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/23/1956,6/13/2018,2018,62,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/30/1952,6/13/2018,2018,66.1,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
3/14/1970,6/13/2018,2018,48.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
11/23/1952,6/19/2018,2018,65.6,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/10/1976,6/28/2018,2018,41.6,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/2/1944,7/6/2018,2018,73.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1944,7/6/2018,2018,73.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1963,7/11/2018,2018,55.2,White,Non-Hispanic,White,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/13/1982,7/12/2018,2018,35.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/25/1964,7/12/2018,2018,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1964,7/12/2018,2018,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1949,7/13/2018,2018,68.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1949,7/13/2018,2018,68.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1969,7/17/2018,2018,48.9,Asian,Non-Hispanic,Asian,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/30/1973,7/18/2018,2018,45.2,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/8/1943,7/18/2018,2018,75.1,Black or African American,Non-Hispanic,Black,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
3/7/1948,7/18/2018,2018,70.4,Black or African American,Non-Hispanic,Black,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/13/1977,7/18/2018,2018,40.6,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/23/1975,7/20/2018,2018,43.2,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/11/1972,7/20/2018,2018,45.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/3/1956,7/23/2018,2018,62.1,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/15/1959,7/24/2018,2018,59.1,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/13/1955,7/24/2018,2018,63.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/10/1960,7/24/2018,2018,57.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Lobular Mixed With Other Types Of Carc.,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
1/2/1974,7/24/2018,2018,44.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/18/1958,7/27/2018,2018,60.5,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/7/1955,7/31/2018,2018,63.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1968,8/1/2018,2018,50.2,Asian,Non-Hispanic,Asian,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/5/1967,8/3/2018,2018,51.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1967,8/3/2018,2018,51.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1979,8/3/2018,2018,39,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1979,8/3/2018,2018,39,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1962,8/10/2018,2018,55.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/24/1954,8/13/2018,2018,64.1,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/18/1954,8/13/2018,2018,63.8,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
5/5/1975,8/14/2018,2018,43.3,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/6/1945,8/14/2018,2018,72.7,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/31/1950,8/15/2018,2018,68.1,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/12/1952,8/15/2018,2018,66.5,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
9/12/1964,8/17/2018,2018,54,Asian,Non-Hispanic,Asian,Female,1610,001610  201209025; Pro20160000426,Breast,Breast,"Duct Carcinoma In Situ, Solid Type",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
8/28/1951,8/22/2018,2018,67,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
7/25/1960,8/22/2018,2018,58.1,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
12/25/1981,8/22/2018,2018,36.7,White,Hispanic or Latino,Hispanic/Latino,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/19/1977,8/22/2018,2018,41.4,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/13/1963,8/22/2018,2018,54.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
10/5/1977,8/22/2018,2018,40.9,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
4/20/1963,8/22/2018,2018,55.4,White,Non-Hispanic,White,Female,40703,220070169,Breast,Breast,,Breast,N/A,Other,Breast,Breast,Observational,New Brunswick,Enrolled Patients
6/7/1931,8/27/2018,2018,87.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1931,8/27/2018,2018,87.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1969,8/27/2018,2018,49.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1969,8/27/2018,2018,49.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1935,8/28/2018,2018,83.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1935,8/28/2018,2018,83.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1972,8/30/2018,2018,45.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1972,8/30/2018,2018,45.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1950,8/31/2018,2018,68.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1949,9/4/2018,2018,69.3,White,Non-Hispanic,White,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/10/1950,9/7/2018,2018,68.1,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/11/1955,9/10/2018,2018,63.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1955,9/10/2018,2018,63.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1955,9/12/2018,2018,63.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/1/1986,9/19/2018,2018,32.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1954,9/19/2018,2018,64.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1954,9/19/2018,2018,64.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1962,9/19/2018,2018,55.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/31/1962,9/19/2018,2018,55.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1951,9/21/2018,2018,67.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1951,9/21/2018,2018,67.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1964,9/24/2018,2018,54.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1964,9/24/2018,2018,54.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1951,9/25/2018,2018,67.2,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,Lobular Carcinoma In Situ,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1959,9/26/2018,2018,59.5,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/24/1952,9/26/2018,2018,66.2,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/29/1928,10/1/2018,2018,90.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1928,10/1/2018,2018,90.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1966,10/3/2018,2018,52.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1966,10/3/2018,2018,52.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1976,10/15/2018,2018,42.1,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/1/1986,10/19/2018,2018,32.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1954,10/19/2018,2018,64.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1954,10/19/2018,2018,64.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1954,10/22/2018,2018,63.9,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Breast,Breast,Infiltrating Ductular Carcinoma,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1963,10/22/2018,2018,55.1,White,Non-Hispanic,White,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/5/1945,10/22/2018,2018,73.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1976,10/22/2018,2018,42.2,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1975,11/1/2018,2018,43,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1975,11/1/2018,2018,43,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1978,11/1/2018,2018,40.5,White,Non-Hispanic,White,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/7/1954,11/6/2018,2018,64,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/24/1954,11/6/2018,2018,64.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1954,11/6/2018,2018,64.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1963,11/6/2018,2018,55.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1963,11/6/2018,2018,55.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1973,11/6/2018,2018,45.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1964,11/7/2018,2018,54.4,White,Non-Hispanic,White,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/29/1960,11/8/2018,2018,58.7,Black or African American,Non-Hispanic,Black,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/25/1973,11/9/2018,2018,45.2,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1959,11/9/2018,2018,59.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1971,11/9/2018,2018,47.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1974,11/9/2018,2018,44.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1974,11/9/2018,2018,44.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/14/1974,11/9/2018,2018,44.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1973,11/9/2018,2018,45.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1966,11/9/2018,2018,52,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1969,11/13/2018,2018,49.2,Asian,Non-Hispanic,Asian,Female,41704,"AFT   05, ABCSG 42; PrE0109; Pro20170000885",Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/25/1981,11/14/2018,2018,37,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1981,11/14/2018,2018,37,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1958,11/20/2018,2018,60.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/25/1958,11/20/2018,2018,60.9,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/11/1976,11/20/2018,2018,42.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/5/1959,11/26/2018,2018,59,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1962,11/30/2018,2018,56.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1962,11/30/2018,2018,56.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1961,12/3/2018,2018,57.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1942,12/4/2018,2018,76.9,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/26/1959,12/6/2018,2018,59.2,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1986,12/6/2018,2018,32.5,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1977,12/6/2018,2018,41.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1959,12/6/2018,2018,59.2,White,Non-Hispanic,White,Female,131317,Pro2013003676,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1964,12/18/2018,2018,54.9,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/6/1957,12/20/2018,2018,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1957,12/20/2018,2018,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1950,12/27/2018,2018,68.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/25/1934,12/27/2018,2018,84.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1934,12/27/2018,2018,84.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1951,1/8/2019,2019,67.1,White,Non-Hispanic,White,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/13/1945,1/9/2019,2019,73.1,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/16/1949,1/10/2019,2019,69.6,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/29/1986,1/14/2019,2019,32.1,Asian,Non-Hispanic,Asian,Female,41801,NCI CIRB         Pro2018000097; S1418/BR006,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
6/1/1957,1/18/2019,2019,61.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1957,1/18/2019,2019,61.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1987,1/27/2019,2019,31.7,Black or African American,Non-Hispanic,Black,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Breast,Breast,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/17/1966,1/28/2019,2019,52.5,White,Non-Hispanic,White,Female,41808,IMMU-132-05; Pro2018001437-WIRB 20170229,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/7/1961,2/1/2019,2019,57.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1961,2/1/2019,2019,57.3,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1942,2/8/2019,2019,76.3,White,Non-Hispanic,White,Female,171701,EAY131; NCI CIRB Pro2018000037,Breast,Breast,,Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
5/29/1987,2/18/2019,2019,31.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1987,2/18/2019,2019,31.7,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/29/1987,2/18/2019,2019,31.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1961,2/22/2019,2019,57.5,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/3/1956,2/22/2019,2019,62.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1956,2/22/2019,2019,62.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1942,2/22/2019,2019,76.3,White,Non-Hispanic,White,Female,171701-K1,EAY131-K1; NCI CIRB Pro2018000037,Breast,Breast,,Precision Medicine,Phase II,Treatment,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
9/10/1962,2/27/2019,2019,56.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1962,2/27/2019,2019,56.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1966,3/8/2019,2019,52.4,White,Hispanic or Latino,Hispanic/Latino,Female,51513,9782; NCI CIRB Pro20160000225,Breast,Breast,"Intraductal Carcinoma, Noninfiltrating, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/16/1949,3/11/2019,2019,69.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1949,3/11/2019,2019,69.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1978,3/12/2019,2019,40.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1978,3/12/2019,2019,40.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1967,3/13/2019,2019,51.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1967,3/13/2019,2019,51.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1966,3/13/2019,2019,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1966,3/13/2019,2019,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1962,3/13/2019,2019,56.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1962,3/13/2019,2019,56.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1954,3/13/2019,2019,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1954,3/13/2019,2019,64.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1970,3/14/2019,2019,48.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1970,3/14/2019,2019,48.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1956,3/14/2019,2019,62.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1956,3/14/2019,2019,62.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1985,3/15/2019,2019,33.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1963,3/15/2019,2019,56.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1963,3/15/2019,2019,56.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1960,3/20/2019,2019,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1960,3/20/2019,2019,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1961,3/20/2019,2019,58.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1961,3/20/2019,2019,58.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1966,3/22/2019,2019,52.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1961,3/25/2019,2019,57.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1961,3/25/2019,2019,57.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/19/1963,3/27/2019,2019,55.3,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/16/1950,4/4/2019,2019,68.6,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/15/1949,4/8/2019,2019,69.9,White,Non-Hispanic,White,Female,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,Breast,Breast,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/14/1963,4/9/2019,2019,55.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1963,4/9/2019,2019,55.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1944,4/11/2019,2019,75.1,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/14/1970,4/12/2019,2019,48.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1970,4/12/2019,2019,48.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1975,4/12/2019,2019,43.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1975,4/12/2019,2019,43.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1977,4/12/2019,2019,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1977,4/12/2019,2019,41.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/11/1977,4/12/2019,2019,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1976,4/15/2019,2019,42.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1976,4/18/2019,2019,42.4,White,Non-Hispanic,White,Female,41801,NCI CIRB         Pro2018000097; S1418/BR006,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/27/1973,4/19/2019,2019,45.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1973,4/19/2019,2019,45.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1973,5/1/2019,2019,45.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1973,5/1/2019,2019,45.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1977,5/13/2019,2019,42.1,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Breast,Breast,"Adenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/7/1986,5/15/2019,2019,32.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1986,5/15/2019,2019,32.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1964,5/15/2019,2019,55.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1964,5/15/2019,2019,55.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1970,5/15/2019,2019,48.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1970,5/15/2019,2019,48.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1963,5/16/2019,2019,55.7,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/29/1963,5/20/2019,2019,56.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1973,5/22/2019,2019,45.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1973,5/22/2019,2019,45.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1949,5/23/2019,2019,69.7,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
8/10/1969,5/24/2019,2019,49.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1969,5/24/2019,2019,49.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1973,5/24/2019,2019,45.4,White,Non-Hispanic,White,Female,41806,A221505; NCI CIRB Pro2018000924,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/22/1970,5/24/2019,2019,48.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1970,5/24/2019,2019,48.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1943,5/28/2019,2019,75.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1943,5/28/2019,2019,75.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1976,6/3/2019,2019,42.7,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/20/1964,6/6/2019,2019,54.7,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/27/1982,6/12/2019,2019,36.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1982,6/12/2019,2019,36.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1935,6/12/2019,2019,83.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1935,6/12/2019,2019,83.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1973,6/12/2019,2019,46,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1973,6/12/2019,2019,46,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1974,6/13/2019,2019,45.1,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,51804,MK-3475-587-00; eIRB 2018001473  WIRB 20181257,Breast,Breast,"Adenocarcinoma, Nos",DT - Phase I,Phase III,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/25/1987,6/13/2019,2019,31.7,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/30/1944,6/19/2019,2019,75.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1944,6/19/2019,2019,75.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1965,6/19/2019,2019,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1965,6/19/2019,2019,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1962,6/25/2019,2019,56.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1961,6/26/2019,2019,58.1,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/22/1962,6/27/2019,2019,57.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1970,7/1/2019,2019,49,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1970,7/1/2019,2019,49,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1979,7/1/2019,2019,40,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1979,7/1/2019,2019,40,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1947,7/3/2019,2019,72.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1947,7/3/2019,2019,72.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1957,7/10/2019,2019,62.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1957,7/10/2019,2019,62.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1959,7/11/2019,2019,60.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1959,7/11/2019,2019,60.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1977,7/17/2019,2019,42.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1977,7/17/2019,2019,42.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1966,7/23/2019,2019,53.3,White,Non-Hispanic,White,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/15/1969,7/29/2019,2019,50,White,Non-Hispanic,White,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
1/18/1960,7/31/2019,2019,59.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1960,7/31/2019,2019,59.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1958,7/31/2019,2019,61.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1958,7/31/2019,2019,61.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1956,8/8/2019,2019,63.4,White,Non-Hispanic,White,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/30/1971,8/13/2019,2019,48.1,White,Non-Hispanic,White,Female,41803,A011502; NCI CIRB            Pro2018000125,Breast,Breast,"Intraductal Carcinoma, Noninfiltrating, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/3/1965,8/13/2019,2019,54.1,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/16/1958,8/13/2019,2019,61.5,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
6/13/1967,8/14/2019,2019,52.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1976,8/16/2019,2019,42.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1976,8/16/2019,2019,42.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1961,8/21/2019,2019,58.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1961,8/21/2019,2019,58.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1976,8/21/2019,2019,43.5,White,Non-Hispanic,White,Female,41808,IMMU-132-05; Pro2018001437-WIRB 20170229,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/23/1966,8/26/2019,2019,53,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/12/1964,8/30/2019,2019,55.2,White,Non-Hispanic,White,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/30/1954,8/30/2019,2019,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1954,8/30/2019,2019,64.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1987,9/5/2019,2019,31.9,Black or African American,Non-Hispanic,Black,Female,41808,IMMU-132-05; Pro2018001437-WIRB 20170229,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/28/1979,9/12/2019,2019,40.6,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/20/1978,9/19/2019,2019,41.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1978,9/19/2019,2019,41.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/20/1978,9/19/2019,2019,41.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1961,9/24/2019,2019,58.5,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/30/1963,9/26/2019,2019,56,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1963,9/26/2019,2019,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1962,9/27/2019,2019,57.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1962,9/27/2019,2019,57.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1973,10/2/2019,2019,46.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1967,10/7/2019,2019,52.4,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,Lobular Carcinoma In Situ,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/24/1980,10/7/2019,2019,39.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1980,10/7/2019,2019,39.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1945,10/7/2019,2019,74.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1945,10/7/2019,2019,74.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1960,10/9/2019,2019,59.8,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,"Intraductal Carcinoma, Noninfiltrating, Nos",Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/3/1956,10/9/2019,2019,63.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1956,10/9/2019,2019,63.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1979,10/11/2019,2019,39.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1979,10/11/2019,2019,39.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1965,10/11/2019,2019,54.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1965,10/11/2019,2019,54.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1943,10/14/2019,2019,76.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/17/1978,10/15/2019,2019,40.9,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/17/1978,10/16/2019,2019,40.9,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1978,10/16/2019,2019,40.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1967,10/21/2019,2019,52.7,White,Hispanic or Latino,Hispanic/Latino,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/12/1942,10/21/2019,2019,77.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1942,10/21/2019,2019,77.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1967,10/22/2019,2019,52.3,Black or African American,Non-Hispanic,Black,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/1/1961,10/23/2019,2019,58.2,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/31/1936,10/24/2019,2019,83,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1936,10/24/2019,2019,83,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1950,10/24/2019,2019,69,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/5/1982,11/5/2019,2019,37.4,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1982,11/5/2019,2019,37.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1955,11/7/2019,2019,64.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1955,11/7/2019,2019,64.4,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/14/1955,11/7/2019,2019,64.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1953,11/7/2019,2019,66.5,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/4/1950,11/8/2019,2019,69.7,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/13/1957,11/11/2019,2019,62,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1957,11/11/2019,2019,62,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1957,11/18/2019,2019,62.3,Asian,Non-Hispanic,Asian,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/1/1949,11/22/2019,2019,70.5,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1949,11/22/2019,2019,70.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1971,11/22/2019,2019,48.1,White,Non-Hispanic,White,Female,51804,MK-3475-587-00; eIRB 2018001473  WIRB 20181257,Breast,Breast,,DT - Phase I,Phase III,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/24/1970,11/25/2019,2019,49.5,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/3/1956,11/25/2019,2019,63.6,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/1/1949,11/26/2019,2019,70.5,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/6/1971,12/5/2019,2019,48.6,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1971,12/5/2019,2019,48.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1972,12/11/2019,2019,47,White,Hispanic or Latino,Hispanic/Latino,Male,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1972,12/11/2019,2019,47,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1966,12/11/2019,2019,53.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1966,12/11/2019,2019,53.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1940,12/13/2019,2019,79.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1940,12/13/2019,2019,79.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1948,12/18/2019,2019,71.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1948,12/18/2019,2019,71.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1985,12/20/2019,2019,35,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1985,12/20/2019,2019,35,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1987,12/20/2019,2019,32.5,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1987,12/20/2019,2019,32.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1948,12/26/2019,2019,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1948,12/26/2019,2019,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1971,1/3/2020,2020,48.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1971,1/3/2020,2020,48.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1980,1/6/2020,2020,39.9,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1980,1/6/2020,2020,39.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1970,1/6/2020,2020,49.4,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1970,1/6/2020,2020,49.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1956,1/6/2020,2020,63.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1956,1/6/2020,2020,63.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1962,1/7/2020,2020,57.1,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1962,1/7/2020,2020,57.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1936,1/8/2020,2020,83.2,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1968,1/9/2020,2020,51.3,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1972,1/9/2020,2020,47.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1972,1/9/2020,2020,47.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1968,1/9/2020,2020,51.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1946,1/10/2020,2020,73.1,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1946,1/10/2020,2020,73.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1966,1/13/2020,2020,54.1,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1966,1/13/2020,2020,54.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/3/1986,1/21/2020,2020,33.2,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1963,1/21/2020,2020,56.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1963,1/22/2020,2020,56.2,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1952,1/22/2020,2020,67.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1952,1/22/2020,2020,67.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1966,1/22/2020,2020,53.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1966,1/22/2020,2020,53.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1961,1/24/2020,2020,58.8,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1961,1/24/2020,2020,58.8,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1986,1/24/2020,2020,33.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1972,1/24/2020,2020,47.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1972,1/24/2020,2020,47.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1965,1/24/2020,2020,54.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1965,1/24/2020,2020,54.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1954,1/27/2020,2020,65.2,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1954,1/27/2020,2020,65.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1958,1/28/2020,2020,61.5,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1952,1/28/2020,2020,67.4,White,Non-Hispanic,White,Female,40807,Pro20170001671,Breast,Breast,,Breast,Phase II,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/31/1958,1/28/2020,2020,61.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1960,2/3/2020,2020,59.5,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1960,2/3/2020,2020,59.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1980,2/4/2020,2020,39.5,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1980,2/4/2020,2020,39.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1986,2/7/2020,2020,33.5,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1986,2/7/2020,2020,33.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1986,2/7/2020,2020,33.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1964,2/10/2020,2020,56.1,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1964,2/10/2020,2020,56.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1952,2/10/2020,2020,67.4,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1952,2/10/2020,2020,67.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1949,2/18/2020,2020,70.8,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1949,2/18/2020,2020,70.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1973,2/26/2020,2020,46.5,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1973,2/26/2020,2020,46.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1949,3/4/2020,2020,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1949,3/4/2020,2020,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1942,3/10/2020,2020,77.3,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1942,3/10/2020,2020,77.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1955,3/11/2020,2020,64.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1955,3/11/2020,2020,64.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1944,3/20/2020,2020,75.8,Black or African American,Non-Hispanic,Black,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/20/1978,4/3/2020,2020,41.9,White,Non-Hispanic,White,Female,41919,IMMU-132-09; Pro2019002061-WIRB 20191321,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/4/1971,4/9/2020,2020,49.1,Unknown,Non-Hispanic,Unknown,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/1/1978,4/13/2020,2020,41.6,Black or African American,Non-Hispanic,Black,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/6/1979,4/24/2020,2020,41.1,White,Non-Hispanic,White,Female,41921,CA209-7FL; Pro2019002424    WIRB 20192020,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/1/1981,5/1/2020,2020,38.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
11/10/1958,5/5/2020,2020,61.5,White,Non-Hispanic,White,Female,42004,EA1181; NCI CIRB Pro2020000354,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
2/4/1961,5/11/2020,2020,59.3,Black or African American,Non-Hispanic,Black,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/12/1967,5/27/2020,2020,52.7,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,"Infiltrating Duct Carcinoma, Nos",Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/8/1957,6/4/2020,2020,63,White,Non-Hispanic,White,Female,41705,BTCRC-BRE16-042; Pro20170001090,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/25/1981,6/9/2020,2020,38.7,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/3/1950,6/15/2020,2020,69.9,White,Non-Hispanic,White,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
10/3/1936,6/18/2020,2020,83.8,White,Non-Hispanic,White,Female,42004,EA1181; NCI CIRB Pro2020000354,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
12/29/1962,6/23/2020,2020,57.5,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/12/1955,7/10/2020,2020,64.8,White,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
11/24/1957,7/24/2020,2020,62.7,White,Non-Hispanic,White,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,"Lobular Carcinoma, Nos",Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/30/1949,8/6/2020,2020,71.2,White,Non-Hispanic,White,Female,52001,10302; NCI CIRB 10302   Pro2020000092,Breast,Breast,"Carcinoma, Nos",Breast,Phase II,Treatment,Breast; Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/2/1956,8/7/2020,2020,64.1,White,Non-Hispanic,White,Female,131901,19488,Breast,Breast,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/9/1959,8/10/2020,2020,61.5,White,Non-Hispanic,White,Female,42004,EA1181; NCI CIRB Pro2020000354,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/10/1969,8/11/2020,2020,51.1,White,Non-Hispanic,White,Female,42004,EA1181; NCI CIRB Pro2020000354,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/11/1948,8/18/2020,2020,72.2,White,Non-Hispanic,White,Female,42001,I-0012-196-08; INCMGA00012; Pro2020000268,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/23/1964,8/27/2020,2020,56.4,White,Hispanic or Latino,Hispanic/Latino,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Breast,Breast,"Carcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/3/1987,8/31/2020,2020,33.2,Black or African American,Non-Hispanic,Black,Female,131901,19488,Breast,Breast,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/3/1987,9/1/2020,2020,33.2,Black or African American,Non-Hispanic,Black,Female,42008,EAZ171; NCI CIRB Pro2020001050,Breast,Breast,Mucinous Adenocarcinoma,Breast,Phase II,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
8/30/1958,9/10/2020,2020,62.1,White,Non-Hispanic,White,Male,131901,19488,Breast,Breast,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/14/1988,9/14/2020,2020,31.8,White,Non-Hispanic,White,Female,131901,19488,Breast,Breast,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
5/3/1965,9/16/2020,2020,55.4,Unknown,Non-Hispanic,Unknown,Female,131901,19488,Breast,Breast,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
3/7/1962,9/16/2020,2020,58.6,Unknown,Unknown,Unknown,Female,42004,EA1181; NCI CIRB Pro2020000354,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
1/16/1966,9/17/2020,2020,54.7,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1966,9/17/2020,2020,54.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1962,9/21/2020,2020,58.6,Unknown,Unknown,Unknown,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1962,9/21/2020,2020,58.6,Unknown,Unknown,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1972,9/22/2020,2020,48.4,Unknown,Hispanic or Latino,Hispanic/Latino,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
5/24/1970,9/22/2020,2020,50.4,White,Non-Hispanic,White,Female,41806,A221505; NCI CIRB Pro2018000924,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/28/1993,9/23/2020,2020,27.2,Unknown,Non-Hispanic,Unknown,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1993,9/23/2020,2020,27.2,Unknown,Non-Hispanic,Unknown,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
7/28/1993,9/23/2020,2020,27.2,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1968,9/29/2020,2020,52.1,Asian,Non-Hispanic,Asian,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1968,9/29/2020,2020,52.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1972,10/2/2020,2020,47.9,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1972,10/2/2020,2020,47.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1971,10/8/2020,2020,48.8,Asian,Non-Hispanic,Asian,Female,41511,3510; PCS-1403-12804; Pro20150002738; RTOG 3510,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast; Radiation Oncology,Breast; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/25/1981,10/8/2020,2020,39.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1981,10/8/2020,2020,39.1,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/25/1981,10/8/2020,2020,39.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1948,10/12/2020,2020,72.5,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1964,10/13/2020,2020,56.3,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1989,10/13/2020,2020,31.7,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1953,10/13/2020,2020,67,White,Non-Hispanic,White,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1989,10/13/2020,2020,31.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1989,10/13/2020,2020,31.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1953,10/13/2020,2020,67,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1953,10/13/2020,2020,67,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1966,10/16/2020,2020,54.6,Asian,Non-Hispanic,Asian,Female,41401,Pro20140000477,Breast,Breast,Infiltrating Duct And Lobular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/9/1947,10/16/2020,2020,73.2,White,Non-Hispanic,White,Female,42001,I-0012-196-08; INCMGA00012; Pro2020000268,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase II,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
3/18/1956,10/20/2020,2020,64.6,Black or African American,Non-Hispanic,Black,Female,1839,1 R01 CA233662-01A1; Pro2018002623,Breast,Breast,,Breast,N/A,Basic Science,Breast,Breast; Lymphoma / Myeloma,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1956,10/20/2020,2020,64.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1975,10/20/2020,2020,45.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Breast,Breast,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1975,10/20/2020,2020,45.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Breast,Breast,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/31/1989,10/27/2020,2020,31.8,White,Non-Hispanic,White,Female,41921,CA209-7FL; Pro2019002424    WIRB 20192020,Breast,Breast,Infiltrating Ductular Carcinoma,Breast,Phase III,Treatment,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
4/5/2000,8/18/2017,2017,17.4,White,Non-Hispanic,White,Male,111705,Pro20170001111,Cerebellum,Cerebellum,,Pediatric Oncology,N/A,Treatment,Developmental Therapeutics-Phase I; Pediatric Oncology,Developmental Therapeutics-phase I; Pediatric Oncology,Not Applicable,New Brunswick,Enrolled Patients
2/6/1943,1/5/2017,2017,74,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1943,1/5/2017,2017,74,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/9/1961,2/8/2017,2017,55.8,White,Non-Hispanic,White,Female,51509,10467; Pro20150002013 WIRB 20151364; R2810-ONC-1423.02,Cervix Uteri,Cervix,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/18/1969,9/25/2017,2017,48.6,White,Non-Hispanic,White,Female,51710,10010; NCI CIRB Pro20170000771,Cervix Uteri,Cervix,,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
1/15/1964,10/3/2017,2017,53.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1964,10/3/2017,2017,53.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1936,11/7/2017,2017,81.3,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/3/1962,11/8/2017,2017,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1962,11/8/2017,2017,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/15/2017,2017,,Asian,Non-Hispanic,Asian,Female,1714,Pro20170000634,Cervix Uteri,Cervix,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/16/1960,11/17/2017,2017,57.6,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
,11/29/2017,2017,,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1714,Pro20170000634,Cervix Uteri,Cervix,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/21/1953,12/29/2017,2017,64.3,Black or African American,Non-Hispanic,Black,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/15/1958,1/23/2018,2018,59.6,Asian,Non-Hispanic,Asian,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/29/1972,1/25/2018,2018,45.2,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/13/1950,2/14/2018,2018,68,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1950,2/14/2018,2018,68,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1954,2/14/2018,2018,63.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1958,2/19/2018,2018,59.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1958,2/19/2018,2018,59.6,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/15/1958,2/19/2018,2018,59.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1955,2/23/2018,2018,63,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/2/1979,3/12/2018,2018,39.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1979,3/12/2018,2018,39.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1976,3/28/2018,2018,41.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1976,3/28/2018,2018,41.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1969,4/25/2018,2018,48.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1969,4/25/2018,2018,48.4,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/22/1969,4/25/2018,2018,48.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1939,6/7/2018,2018,78.9,White,Non-Hispanic,White,Female,51801,10132; NCI CIRB Pro2018000300,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/24/1957,10/22/2018,2018,61,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1960,11/20/2018,2018,58.3,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/22/1962,1/18/2019,2019,57,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1950,1/22/2019,2019,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1950,1/22/2019,2019,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1951,1/25/2019,2019,67.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1951,1/25/2019,2019,67.2,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/15/1951,1/25/2019,2019,67.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1951,2/22/2019,2019,67.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/23/1951,2/22/2019,2019,67.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1986,2/28/2019,2019,32.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1986,2/28/2019,2019,32.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1956,3/9/2019,2019,62.5,Unknown,Non-Hispanic,Unknown,Female,1209,Pro2012002075,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/10/1945,5/13/2019,2019,74.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/10/1945,5/13/2019,2019,74.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1955,5/15/2019,2019,63.7,White,Non-Hispanic,White,Female,51801,10132; NCI CIRB Pro2018000300,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/16/1976,6/6/2019,2019,42.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1976,6/6/2019,2019,42.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1976,7/25/2019,2019,43.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1981,8/1/2019,2019,38.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1981,8/1/2019,2019,38.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1970,8/8/2019,2019,49.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1970,8/8/2019,2019,49.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1953,1/24/2020,2020,66.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1953,1/24/2020,2020,66.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1974,1/28/2020,2020,45.2,White,Non-Hispanic,White,Female,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Cervix Uteri,Cervix,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/26/1955,2/7/2020,2020,64.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/18/1967,2/13/2020,2020,52.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/18/1967,2/13/2020,2020,52.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1948,3/4/2020,2020,71.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1948,3/4/2020,2020,71.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1956,3/6/2020,2020,63.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1956,3/6/2020,2020,63.5,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/12/1965,3/9/2020,2020,55.2,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1965,3/9/2020,2020,55.2,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1956,3/9/2020,2020,63.5,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Cervix Uteri,Cervix,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1975,1/9/2017,2017,41.3,Black or African American,Non-Hispanic,Black,Female,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/6/1966,1/12/2017,2017,50.8,Black or African American,Non-Hispanic,Black,Male,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/10/1956,1/12/2017,2017,60.6,White,Non-Hispanic,White,Female,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Colon & Rectum,Colon & Rectum,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/19/1954,1/25/2017,2017,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/19/1954,1/25/2017,2017,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1969,2/1/2017,2017,47.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1969,2/1/2017,2017,47.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1961,2/8/2017,2017,55.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1961,2/8/2017,2017,55.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1940,2/14/2017,2017,77.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1940,2/14/2017,2017,77.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1978,2/15/2017,2017,39.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1978,2/15/2017,2017,39.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1958,2/15/2017,2017,58.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1958,2/15/2017,2017,58.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1940,2/23/2017,2017,76.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1940,2/23/2017,2017,76.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1975,2/28/2017,2017,41.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1975,2/28/2017,2017,41.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1946,3/2/2017,2017,70.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1955,3/7/2017,2017,61.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1955,3/7/2017,2017,61.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1957,3/9/2017,2017,60,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1961,3/9/2017,2017,55.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1961,3/9/2017,2017,55.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1967,3/9/2017,2017,49.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1953,3/9/2017,2017,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1953,3/9/2017,2017,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1960,3/13/2017,2017,56.7,Black or African American,Non-Hispanic,Black,Male,51403,Pro20140000405,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/2/1940,3/21/2017,2017,76.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/2/1940,3/21/2017,2017,76.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/25/1969,3/22/2017,2017,48,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1969,3/22/2017,2017,48,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1955,3/23/2017,2017,61.5,White,Non-Hispanic,White,Female,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/15/1949,4/7/2017,2017,68.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1949,4/7/2017,2017,68.1,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/15/1949,4/7/2017,2017,68.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1938,4/20/2017,2017,78.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1938,4/20/2017,2017,78.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1936,4/26/2017,2017,80.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/29/1936,4/26/2017,2017,80.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1956,4/26/2017,2017,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1956,4/26/2017,2017,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1965,4/26/2017,2017,51.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1965,4/26/2017,2017,51.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1957,4/27/2017,2017,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1957,4/27/2017,2017,59.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1953,5/3/2017,2017,63.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1953,5/3/2017,2017,63.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1955,5/3/2017,2017,62.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1955,5/3/2017,2017,62.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1945,5/3/2017,2017,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/2/1945,5/3/2017,2017,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1954,5/9/2017,2017,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1954,5/9/2017,2017,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1954,5/16/2017,2017,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1954,5/16/2017,2017,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1955,5/17/2017,2017,61.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1926,5/17/2017,2017,91.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1926,5/17/2017,2017,91.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1976,5/17/2017,2017,40.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1976,5/17/2017,2017,40.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1953,5/24/2017,2017,64.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1966,5/31/2017,2017,51.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1938,6/7/2017,2017,78.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/2/1938,6/7/2017,2017,78.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1956,6/8/2017,2017,61.5,White,Non-Hispanic,White,Female,131604,20170000115,Colon & Rectum,Colon & Rectum,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/21/1941,6/20/2017,2017,76,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1941,6/20/2017,2017,76,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1962,6/22/2017,2017,54.7,White,Non-Hispanic,White,Male,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/12/1967,6/27/2017,2017,50,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1967,6/27/2017,2017,50,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1966,7/7/2017,2017,50.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1943,7/12/2017,2017,73.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1943,7/12/2017,2017,73.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1959,7/25/2017,2017,58.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1959,7/25/2017,2017,58.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1947,7/31/2017,2017,69.9,White,Non-Hispanic,White,Female,91306,9466; NCI CIRB Pro2018000540,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/19/1951,8/3/2017,2017,65.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/19/1951,8/3/2017,2017,65.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1966,8/9/2017,2017,51.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1966,8/9/2017,2017,51.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1952,8/15/2017,2017,65.4,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
8/29/1939,8/17/2017,2017,78,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1939,8/17/2017,2017,78,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1947,8/21/2017,2017,70,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1947,8/21/2017,2017,70,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1956,8/24/2017,2017,60.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1956,8/24/2017,2017,60.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1959,8/25/2017,2017,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1965,8/30/2017,2017,52,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1965,8/30/2017,2017,52,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1968,9/6/2017,2017,48.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1968,9/6/2017,2017,48.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1942,9/13/2017,2017,75.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1935,9/13/2017,2017,82.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1935,9/13/2017,2017,82.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1974,9/27/2017,2017,43.3,White,Non-Hispanic,White,Female,71706,10021; NCI CIRB Pro20170001183,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/9/1956,9/27/2017,2017,61,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1956,9/27/2017,2017,61,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1946,9/28/2017,2017,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1946,9/28/2017,2017,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1965,10/9/2017,2017,52.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1965,10/9/2017,2017,52.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1981,10/11/2017,2017,35.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1981,10/11/2017,2017,35.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1946,10/11/2017,2017,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1946,10/11/2017,2017,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1952,10/12/2017,2017,65.4,Black or African American,Non-Hispanic,Black,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
6/15/1974,10/12/2017,2017,43.4,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
12/8/1954,10/12/2017,2017,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1954,10/12/2017,2017,62.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/8/1954,10/12/2017,2017,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1954,10/13/2017,2017,62.9,White,Hispanic or Latino,Hispanic/Latino,Male,71706,10021; NCI CIRB Pro20170001183,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/13/1968,10/17/2017,2017,49.5,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/21/1965,10/17/2017,2017,52.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/1/1962,10/17/2017,2017,55.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1962,10/17/2017,2017,55.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1967,10/18/2017,2017,50.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1967,10/18/2017,2017,50.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1937,10/18/2017,2017,80,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1937,10/18/2017,2017,80,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1946,10/18/2017,2017,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1946,10/18/2017,2017,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1970,10/24/2017,2017,47.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1970,10/24/2017,2017,47.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1941,10/26/2017,2017,76.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/15/1974,10/31/2017,2017,43.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1974,10/31/2017,2017,43.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/15/1974,10/31/2017,2017,43.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1928,11/1/2017,2017,89.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1928,11/1/2017,2017,89.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/2/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/15/1960,11/2/2017,2017,57.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1960,11/2/2017,2017,57.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1949,11/3/2017,2017,68.3,White,Non-Hispanic,White,Male,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/3/1958,11/7/2017,2017,59.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1958,11/7/2017,2017,59.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1946,11/13/2017,2017,71.6,Asian,Non-Hispanic,Asian,Female,51708,MS100015-0019; WIRB 20171114 ,Colon & Rectum,Colon & Rectum,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/24/1959,11/16/2017,2017,58.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1967,11/21/2017,2017,50.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1967,11/21/2017,2017,50.7,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/3/1967,11/21/2017,2017,50.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1967,11/22/2017,2017,50.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1967,11/22/2017,2017,50.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1962,11/22/2017,2017,55.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1962,11/22/2017,2017,55.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1948,11/28/2017,2017,69.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1948,11/28/2017,2017,69.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1968,11/30/2017,2017,49.9,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Male,131604,20170000115,Colon & Rectum,Colon & Rectum,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/28/1953,12/5/2017,2017,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1953,12/5/2017,2017,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1944,12/6/2017,2017,73.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1944,12/6/2017,2017,73.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1959,12/6/2017,2017,58.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/7/1986,12/7/2017,2017,31.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1986,12/7/2017,2017,31.9,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/7/1986,12/7/2017,2017,31.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1939,12/7/2017,2017,78.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/2/1939,12/7/2017,2017,78.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1955,12/12/2017,2017,62.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1955,12/12/2017,2017,62.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1965,12/14/2017,2017,52.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1965,12/14/2017,2017,52.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/29/2017,2017,,Black or African American,Non-Hispanic,Black,Female,1714,Pro20170000634,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/12/1952,1/5/2018,2018,65.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1952,1/5/2018,2018,65.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1961,1/10/2018,2018,56.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1953,1/10/2018,2018,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1961,1/10/2018,2018,56.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1953,1/10/2018,2018,64.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1952,1/10/2018,2018,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1952,1/10/2018,2018,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1959,1/10/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1959,1/10/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1951,1/10/2018,2018,66.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1951,1/10/2018,2018,66.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1955,1/11/2018,2018,62.3,White,Non-Hispanic,White,Female,51602,Pro20160000270 WIRB20160671; RRx001-16-01,Colon & Rectum,Colon & Rectum,Mucinous Adenocarcinoma,Gastrointestinal,Phase I,Treatment,Developmental Therapeutics-Phase I; Gastrointestinal,Developmental Therapeutics-phase I; Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/26/1958,1/16/2018,2018,59.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1958,1/16/2018,2018,59.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1948,1/18/2018,2018,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1948,1/18/2018,2018,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/31/1969,1/18/2018,2018,48.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1969,1/18/2018,2018,48.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1945,1/18/2018,2018,73,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1945,1/18/2018,2018,73,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1954,1/25/2018,2018,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1954,1/25/2018,2018,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1948,1/30/2018,2018,69.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1948,1/30/2018,2018,69.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1959,1/31/2018,2018,58.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1959,1/31/2018,2018,58.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1967,1/31/2018,2018,50.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1967,1/31/2018,2018,50.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1947,1/31/2018,2018,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1947,1/31/2018,2018,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1961,1/31/2018,2018,56.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1961,1/31/2018,2018,56.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1942,2/6/2018,2018,75.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1942,2/6/2018,2018,75.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/21/1942,2/6/2018,2018,75.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1957,2/7/2018,2018,60.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1957,2/7/2018,2018,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1949,2/7/2018,2018,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1949,2/7/2018,2018,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1987,2/7/2018,2018,30.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/1/1987,2/7/2018,2018,30.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1944,2/7/2018,2018,73.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1944,2/7/2018,2018,73.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1940,2/8/2018,2018,77.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1940,2/8/2018,2018,77.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1967,2/14/2018,2018,51.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1967,2/14/2018,2018,51.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1947,2/21/2018,2018,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1947,2/21/2018,2018,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1943,2/22/2018,2018,75.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/4/1943,2/22/2018,2018,75.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1953,2/22/2018,2018,64.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/31/1953,2/22/2018,2018,64.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1945,3/2/2018,2018,73,Black or African American,Non-Hispanic,Black,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/3/1945,3/5/2018,2018,73.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1945,3/5/2018,2018,73.1,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/3/1945,3/5/2018,2018,73.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1946,3/8/2018,2018,71.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1946,3/8/2018,2018,71.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1968,3/14/2018,2018,49.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1968,3/14/2018,2018,49.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1947,3/28/2018,2018,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1947,3/28/2018,2018,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/14/1932,3/28/2018,2018,86.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1932,3/28/2018,2018,86.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1958,4/9/2018,2018,60.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1958,4/9/2018,2018,60.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/18/1958,4/9/2018,2018,60.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1947,4/18/2018,2018,71.1,White,Non-Hispanic,White,Male,51713,MK-3475-651; Pro20170001523  WIRB 20172151  3475-651,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/16/1972,4/20/2018,2018,45.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1972,4/20/2018,2018,45.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1958,4/24/2018,2018,60.2,White,Non-Hispanic,White,Male,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/31/1947,4/25/2018,2018,71.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1947,4/25/2018,2018,71.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1946,5/10/2018,2018,72.1,Asian,Non-Hispanic,Asian,Female,51602,Pro20160000270 WIRB20160671; RRx001-16-01,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase I,Treatment,Developmental Therapeutics-Phase I; Gastrointestinal,Developmental Therapeutics-phase I; Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/23/1958,5/10/2018,2018,59.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1958,5/10/2018,2018,59.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1966,5/11/2018,2018,52.2,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/21/1955,5/16/2018,2018,63.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1955,5/17/2018,2018,63.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1963,5/18/2018,2018,55.4,Asian,Non-Hispanic,Asian,Male,51602,Pro20160000270 WIRB20160671; RRx001-16-01,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase I,Treatment,Developmental Therapeutics-Phase I; Gastrointestinal,Developmental Therapeutics-phase I; Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/24/1957,5/18/2018,2018,60.4,Black or African American,Non-Hispanic,Black,Male,51713,MK-3475-651; Pro20170001523  WIRB 20172151  3475-651,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/15/1957,5/21/2018,2018,61.3,White,Non-Hispanic,White,Female,51513,9782; NCI CIRB Pro20160000225,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/9/1964,5/22/2018,2018,53.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1964,5/22/2018,2018,53.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/9/1964,5/22/2018,2018,53.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1965,5/23/2018,2018,52.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1965,5/23/2018,2018,52.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1974,5/30/2018,2018,44,White,Non-Hispanic,White,Female,171701,EAY131; NCI CIRB Pro2018000037,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
6/15/1974,5/31/2018,2018,44,White,Non-Hispanic,White,Female,171701-T,EAY131-T; NCI CIRB Pro2018000037,Colon & Rectum,Colon & Rectum,Adrenal Cortical Carcinoma,Gastrointestinal,Phase II,Treatment,Gastrointestinal; Precision Medicine Investigational Therapeutics,Gastrointestinal; Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
6/15/1961,6/5/2018,2018,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1960,6/11/2018,2018,58.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1930,6/13/2018,2018,88.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1935,6/13/2018,2018,83.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1964,6/21/2018,2018,53.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1964,6/21/2018,2018,53.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1961,6/26/2018,2018,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1961,6/26/2018,2018,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1948,6/28/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1948,6/28/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/3/1948,6/28/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1953,7/6/2018,2018,65.5,White,Non-Hispanic,White,Female,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
1/30/1965,7/11/2018,2018,53.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1965,7/11/2018,2018,53.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1938,7/11/2018,2018,79.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1938,7/11/2018,2018,79.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1969,7/17/2018,2018,49.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1969,7/17/2018,2018,49.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/3/1969,7/17/2018,2018,49.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1945,7/18/2018,2018,72.9,White,Non-Hispanic,White,Male,51704,ADXS-NEO-02; IBC # 17-025; Pro20170000374,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/1/1953,7/19/2018,2018,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1953,7/19/2018,2018,64.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1957,7/23/2018,2018,60.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1957,7/23/2018,2018,60.6,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/24/1957,7/23/2018,2018,60.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1965,7/24/2018,2018,53.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1965,7/24/2018,2018,53.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1961,7/24/2018,2018,57.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1946,7/27/2018,2018,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1946,7/27/2018,2018,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1957,7/31/2018,2018,61.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1957,7/31/2018,2018,61.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/15/1957,7/31/2018,2018,61.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1954,8/1/2018,2018,64.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1954,8/1/2018,2018,64.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1957,8/1/2018,2018,61.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/24/1957,8/1/2018,2018,61.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1953,8/6/2018,2018,65.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1953,8/6/2018,2018,65.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/14/1953,8/6/2018,2018,65.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1951,8/22/2018,2018,67.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1951,8/22/2018,2018,67.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1968,8/22/2018,2018,50.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1968,8/22/2018,2018,50.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1951,8/24/2018,2018,67,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/16/1959,8/28/2018,2018,59.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1959,8/28/2018,2018,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1966,8/31/2018,2018,52.5,White,Non-Hispanic,White,Female,51513,9782; NCI CIRB Pro20160000225,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/21/1953,9/10/2018,2018,65,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/25/1943,9/14/2018,2018,74.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1959,9/19/2018,2018,59.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1959,9/19/2018,2018,59.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1952,9/20/2018,2018,66,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1952,9/20/2018,2018,66,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1957,9/21/2018,2018,61.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/18/1978,9/24/2018,2018,40.7,White,Hispanic or Latino,Hispanic/Latino,Female,51713,MK-3475-651; Pro20170001523  WIRB 20172151  3475-651,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/11/1972,9/26/2018,2018,45.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1972,9/26/2018,2018,45.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/25/1956,9/26/2018,2018,62.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/25/1956,9/26/2018,2018,62.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1964,10/3/2018,2018,54.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1964,10/3/2018,2018,54.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1948,10/3/2018,2018,70.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1948,10/3/2018,2018,70.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1971,10/11/2018,2018,47.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1971,10/11/2018,2018,47.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1951,10/11/2018,2018,67.5,White,Non-Hispanic,White,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/19/1939,10/17/2018,2018,79,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1939,10/17/2018,2018,79,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1989,10/17/2018,2018,28.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1989,10/17/2018,2018,28.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1942,10/18/2018,2018,76.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1942,10/18/2018,2018,76.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1956,10/25/2018,2018,62.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1946,10/30/2018,2018,72,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1946,10/30/2018,2018,72,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1951,10/30/2018,2018,67.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1951,10/30/2018,2018,67.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1964,11/2/2018,2018,54,White,Hispanic or Latino,Hispanic/Latino,Female,51713,MK-3475-651; Pro20170001523  WIRB 20172151  3475-651,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/4/1972,11/6/2018,2018,46.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1942,11/7/2018,2018,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1942,11/7/2018,2018,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1977,11/16/2018,2018,41.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1977,11/16/2018,2018,41.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1948,11/20/2018,2018,70.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1948,11/20/2018,2018,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1963,11/21/2018,2018,55.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/25/1963,11/21/2018,2018,55.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1952,11/21/2018,2018,66.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1952,11/21/2018,2018,66.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1960,12/11/2018,2018,58.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/25/1960,12/11/2018,2018,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1938,12/20/2018,2018,80.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1951,12/20/2018,2018,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1951,12/20/2018,2018,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1947,12/20/2018,2018,71.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1947,12/20/2018,2018,71.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1967,12/28/2018,2018,51.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1967,12/28/2018,2018,51.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1961,12/28/2018,2018,58,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1961,12/28/2018,2018,58,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1960,12/28/2018,2018,58.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1960,12/28/2018,2018,58.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1945,12/28/2018,2018,73.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/23/1945,12/28/2018,2018,73.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1957,1/2/2019,2019,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1957,1/2/2019,2019,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1954,1/11/2019,2019,64.7,White,Non-Hispanic,White,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/22/1963,1/11/2019,2019,55.4,White,Non-Hispanic,White,Female,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
1/18/1935,1/16/2019,2019,84.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1935,1/16/2019,2019,84.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1935,1/22/2019,2019,83.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1935,1/22/2019,2019,83.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1952,1/23/2019,2019,66.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/12/1946,1/24/2019,2019,72.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1956,1/24/2019,2019,62.5,White,Non-Hispanic,White,Male,71822,NCI CIRB Pro2018002704; NRG-GI002,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/14/1946,1/25/2019,2019,72.7,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/2/1964,1/28/2019,2019,54.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/2/1964,1/28/2019,2019,54.2,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/2/1964,1/28/2019,2019,54.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1954,2/1/2019,2019,64.2,White,Hispanic or Latino,Hispanic/Latino,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/3/1969,2/1/2019,2019,49.3,White,Non-Hispanic,White,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/3/1976,2/13/2019,2019,42.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1976,2/13/2019,2019,42.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1951,2/14/2019,2019,67.8,White,Non-Hispanic,White,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/14/1956,2/15/2019,2019,62.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1956,2/15/2019,2019,62.5,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/14/1956,2/15/2019,2019,62.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1944,2/20/2019,2019,74.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1944,2/20/2019,2019,74.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1967,2/21/2019,2019,51.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1967,2/21/2019,2019,51.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1951,2/22/2019,2019,68.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1951,2/22/2019,2019,68.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/6/1954,2/26/2019,2019,65,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1954,2/26/2019,2019,65,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1961,2/27/2019,2019,58.1,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
7/12/1949,2/27/2019,2019,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1949,2/27/2019,2019,69.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/12/1949,2/27/2019,2019,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1947,2/28/2019,2019,71.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/1/1976,3/5/2019,2019,42.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1976,3/5/2019,2019,42.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1972,3/5/2019,2019,46.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/6/1958,3/6/2019,2019,61.2,White,Non-Hispanic,White,Female,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/10/1975,3/12/2019,2019,43.4,White,Non-Hispanic,White,Female,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/2/1964,3/13/2019,2019,54.3,White,Hispanic or Latino,Hispanic/Latino,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/10/1948,3/13/2019,2019,71.1,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/26/1956,3/19/2019,2019,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1956,3/19/2019,2019,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1951,3/20/2019,2019,68.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1951,3/20/2019,2019,68.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1966,3/21/2019,2019,52.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1966,3/21/2019,2019,52.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1963,3/22/2019,2019,56.1,White,Hispanic or Latino,Hispanic/Latino,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/5/1958,3/25/2019,2019,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1958,3/25/2019,2019,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1962,3/27/2019,2019,56.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1962,3/27/2019,2019,56.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1926,3/27/2019,2019,92.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1926,3/27/2019,2019,92.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1964,3/27/2019,2019,55,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1964,3/27/2019,2019,55,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1979,3/27/2019,2019,39.4,White; Black or African American; American Indian or Alaska Native,Non-Hispanic,Black,Female,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/19/1963,4/5/2019,2019,56.2,Asian,Non-Hispanic,Asian,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/25/1950,4/8/2019,2019,68.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1950,4/8/2019,2019,68.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1972,4/8/2019,2019,46.8,White,Non-Hispanic,White,Female,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/1/1933,4/10/2019,2019,86,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1933,4/10/2019,2019,86,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1963,4/10/2019,2019,55.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1963,4/10/2019,2019,55.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1957,4/15/2019,2019,61.3,Black or African American,Non-Hispanic,Black,Male,71812,AGICC 17CRC01/EXELIXIS IST56 ; Pro2018000862 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/28/1928,4/24/2019,2019,90.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1928,4/24/2019,2019,90.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1951,4/25/2019,2019,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1951,4/25/2019,2019,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1955,4/30/2019,2019,63.6,White,Non-Hispanic,White,Female,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Tubulovillous Adenoma,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/14/1946,5/1/2019,2019,72.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1946,5/1/2019,2019,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1966,5/1/2019,2019,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1966,5/1/2019,2019,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1930,5/2/2019,2019,88.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1966,5/3/2019,2019,52.8,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/21/1965,5/15/2019,2019,53.7,White,Non-Hispanic,White,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Acute Leukemia, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
7/6/1954,5/15/2019,2019,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1954,5/15/2019,2019,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1955,5/15/2019,2019,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1955,5/15/2019,2019,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1948,5/21/2019,2019,71.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1948,5/21/2019,2019,71.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1944,5/23/2019,2019,75.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1944,5/23/2019,2019,75.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1972,6/6/2019,2019,46.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/5/1972,6/6/2019,2019,46.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1940,6/7/2019,2019,79.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1940,6/7/2019,2019,79.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1959,6/13/2019,2019,60.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1959,6/13/2019,2019,60.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1932,6/13/2019,2019,86.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1932,6/13/2019,2019,86.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1947,6/19/2019,2019,71.9,White,Non-Hispanic,White,Male,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/22/1953,6/26/2019,2019,65.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1953,6/26/2019,2019,65.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1962,6/26/2019,2019,56.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1962,6/26/2019,2019,56.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1946,6/28/2019,2019,72.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1946,6/28/2019,2019,72.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1964,7/9/2019,2019,55.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1964,7/9/2019,2019,55.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1940,7/10/2019,2019,79.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1940,7/10/2019,2019,79.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1942,7/17/2019,2019,76.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1942,7/17/2019,2019,76.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1935,7/17/2019,2019,83.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1935,7/17/2019,2019,83.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1984,7/22/2019,2019,35,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1984,7/22/2019,2019,35,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1945,7/24/2019,2019,74.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1945,7/24/2019,2019,74.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/2/1961,7/24/2019,2019,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/2/1961,7/24/2019,2019,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1961,7/31/2019,2019,58.2,White,Non-Hispanic,White,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/20/1962,8/7/2019,2019,56.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1962,8/7/2019,2019,56.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1950,8/13/2019,2019,68.9,Asian,Non-Hispanic,Asian,Male,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/4/1954,8/14/2019,2019,65.2,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/14/1956,8/14/2019,2019,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1956,8/14/2019,2019,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1969,8/14/2019,2019,50.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1969,8/14/2019,2019,50.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1951,8/21/2019,2019,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1951,8/21/2019,2019,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1967,9/4/2019,2019,52.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1967,9/4/2019,2019,52.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1956,9/5/2019,2019,62.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1956,9/6/2019,2019,62.9,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
1/17/1965,9/11/2019,2019,54.7,White,Non-Hispanic,White,Female,51713,MK-3475-651; Pro20170001523  WIRB 20172151  3475-651,Colon & Rectum,Colon & Rectum,Signet Ring Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/25/1948,9/24/2019,2019,71.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/25/1948,9/24/2019,2019,71.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/25/1948,9/24/2019,2019,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1947,9/25/2019,2019,71.9,Asian,Non-Hispanic,Asian,Female,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
7/24/1956,9/26/2019,2019,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1956,9/26/2019,2019,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1964,10/2/2019,2019,55.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1964,10/2/2019,2019,55.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1948,10/4/2019,2019,71.2,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/10/1966,10/9/2019,2019,53.5,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/12/1970,10/9/2019,2019,48.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1970,10/9/2019,2019,48.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1943,10/23/2019,2019,76,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1943,10/23/2019,2019,76,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1971,10/28/2019,2019,48.8,White,Non-Hispanic,White,Male,71816,D419NC00001; WIRB 20160517                     Pro2018001877 ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/19/1939,11/1/2019,2019,80.6,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1986,11/8/2019,2019,33.8,Black or African American,Non-Hispanic,Black,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/25/1956,11/18/2019,2019,63.4,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/2/1946,11/25/2019,2019,73.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1946,11/25/2019,2019,73.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1968,12/4/2019,2019,51.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1968,12/4/2019,2019,51.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/9/1968,12/4/2019,2019,51.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1964,12/5/2019,2019,55.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1964,12/5/2019,2019,55.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1971,1/2/2020,2020,48.5,White,Non-Hispanic,White,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/3/1959,1/3/2020,2020,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1959,1/3/2020,2020,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1951,1/7/2020,2020,68.8,White,Non-Hispanic,White,Female,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/10/1972,1/9/2020,2020,47.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1972,1/9/2020,2020,47.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1967,1/9/2020,2020,52.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1967,1/9/2020,2020,52.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1946,1/16/2020,2020,73.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1946,1/16/2020,2020,73.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/26/1965,1/24/2020,2020,55,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/15/1939,1/27/2020,2020,80.8,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Intestinal Type",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/19/1947,1/27/2020,2020,72.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1947,1/27/2020,2020,72.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1951,1/28/2020,2020,68.6,White,Non-Hispanic,White,Female,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/21/1948,1/29/2020,2020,71.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/21/1948,1/29/2020,2020,71.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1966,1/31/2020,2020,53.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/10/1966,1/31/2020,2020,53.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1966,2/4/2020,2020,53.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1966,2/4/2020,2020,53.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1961,2/6/2020,2020,58.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1961,2/6/2020,2020,58.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1957,2/13/2020,2020,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1957,2/13/2020,2020,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1957,2/20/2020,2020,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1957,2/20/2020,2020,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1950,2/24/2020,2020,69.4,White,Non-Hispanic,White,Female,71915,NRG-GI005; Pro2020000123 NCI CIRB,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/22/1967,2/25/2020,2020,52.3,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1967,2/25/2020,2020,52.3,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1957,2/26/2020,2020,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1957,2/26/2020,2020,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1956,2/26/2020,2020,63.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1956,2/26/2020,2020,63.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1963,3/2/2020,2020,56.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1963,3/2/2020,2020,56.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1951,3/2/2020,2020,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1951,3/2/2020,2020,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1934,3/4/2020,2020,85.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1934,3/4/2020,2020,85.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1964,3/6/2020,2020,55.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1964,3/6/2020,2020,55.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1964,3/6/2020,2020,55.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1964,3/6/2020,2020,55.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1963,3/11/2020,2020,56.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1963,3/11/2020,2020,56.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1961,3/18/2020,2020,59.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1950,3/18/2020,2020,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1950,3/18/2020,2020,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1967,3/18/2020,2020,52.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1967,3/18/2020,2020,52.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1960,3/23/2020,2020,59.8,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/13/1962,3/24/2020,2020,58.1,Asian,Non-Hispanic,Asian,Male,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/19/1960,3/26/2020,2020,60.1,White,Non-Hispanic,White,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/11/1968,4/13/2020,2020,51.5,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/7/1966,4/13/2020,2020,54.1,White,Non-Hispanic,White,Male,71703,HCRN GI16-288; Pro20170000595,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/5/1952,5/11/2020,2020,67.6,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/23/1956,6/1/2020,2020,63.5,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/2/1952,6/16/2020,2020,68.1,Black or African American,Non-Hispanic,Black,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/16/1968,6/16/2020,2020,51.8,White,Non-Hispanic,White,Female,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/5/1991,6/30/2020,2020,28.8,White,Non-Hispanic,White,Male,71806,NCI CIRB Pro2018000449; S1613,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/2/1958,7/13/2020,2020,62.5,White,Non-Hispanic,White,Male,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/5/1972,7/28/2020,2020,47.9,Black or African American,Non-Hispanic,Black,Female,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
1/17/1965,7/31/2020,2020,55.6,White,Non-Hispanic,White,Female,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/17/1967,8/6/2020,2020,53.4,White,Non-Hispanic,White,Female,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/16/1977,8/11/2020,2020,43.2,Black or African American,Non-Hispanic,Black,Female,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/7/1952,8/18/2020,2020,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1952,8/18/2020,2020,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1977,9/3/2020,2020,43.3,Black or African American,Non-Hispanic,Black,Female,71914,I 444019; SITE00000014 Pro2019002848,Colon & Rectum,Colon & Rectum,,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/30/1958,9/10/2020,2020,62.1,Asian,Non-Hispanic,Asian,Female,131901,19488,Colon & Rectum,Colon & Rectum,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/22/1978,9/15/2020,2020,41.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1978,9/15/2020,2020,41.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1964,9/16/2020,2020,56.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1964,9/16/2020,2020,56.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1970,9/23/2020,2020,49.8,Asian,Unknown,Asian,Male,71910,Panit7156; WIRB 20192224    Pro2019001676,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/15/1947,10/5/2020,2020,73.2,White,Non-Hispanic,White,Male,72005,2019-013-GLOB1; 20200649   Pro2020001147             ,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/25/1949,10/9/2020,2020,71.5,Unknown,Non-Hispanic,Unknown,Male,71915,NRG-GI005; Pro2020000123 NCI CIRB,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/21/1967,10/14/2020,2020,53.6,White,Non-Hispanic,White,Female,71910,Panit7156; WIRB 20192224    Pro2019001676,Colon & Rectum,Colon & Rectum,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/23/1984,10/20/2020,2020,36.5,White,Non-Hispanic,White,Male,71801,1605017852; Pro2018001469,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
5/24/1938,10/21/2020,2020,82.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1966,10/23/2020,2020,54.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Colon & Rectum,Colon & Rectum,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1957,10/27/2020,2020,62.9,White,Non-Hispanic,White,Female,71818,IS0-CC-007; Pro00029368                 Pro2018002229,Colon & Rectum,Colon & Rectum,Adenocarcinoma In Situ,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
7/8/2010,4/5/2017,2017,6.7,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Connective/Soft Tissue,Connective/Soft Tissue,Ewing Sarcoma,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/31/1956,4/21/2017,2017,60.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1956,4/21/2017,2017,60.5,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/31/1956,4/21/2017,2017,60.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1950,8/10/2017,2017,66.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1950,8/10/2017,2017,66.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1963,9/28/2017,2017,54,White,Non-Hispanic,White,Female,51403,Pro20140000405,Connective/Soft Tissue,Connective/Soft Tissue,Neuroendocrine Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/15/2001,10/18/2017,2017,16.1,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Connective/Soft Tissue,Connective/Soft Tissue,Ewing Sarcoma,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
8/9/2001,10/27/2017,2017,16.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/23/1988,12/4/2017,2017,29.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1988,12/4/2017,2017,29.6,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/23/1988,12/4/2017,2017,29.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1997,12/6/2017,2017,20.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1997,12/6/2017,2017,20.5,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/28/1997,12/6/2017,2017,20.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1962,12/20/2017,2017,56,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1962,12/20/2017,2017,56,White,Non-Hispanic,White,Female,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/20/1962,12/20/2017,2017,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1969,12/20/2017,2017,48.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1969,12/20/2017,2017,48.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/9/1969,12/20/2017,2017,48.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/2002,1/18/2018,2018,15.7,Asian,Non-Hispanic,Asian,Male,111706,APEC1621SC; NCI CIRB Pro20170001553,Connective/Soft Tissue,Connective/Soft Tissue,Spindle Cell Carcinoma,Pediatric Oncology,N/A,Screening,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
11/6/1966,2/5/2018,2018,51.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1966,2/5/2018,2018,51.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1954,2/14/2018,2018,63.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/2002,2/23/2018,2018,15.9,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/30/1965,3/28/2018,2018,52.4,White,Non-Hispanic,White,Female,51707,20170000453,Connective/Soft Tissue,Connective/Soft Tissue,"Squamous Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/9/1993,4/4/2018,2018,25.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1993,4/4/2018,2018,25.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/9/1993,4/4/2018,2018,25.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/2011,5/29/2018,2018,6.8,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Connective/Soft Tissue,Connective/Soft Tissue,"Burkitt Lymphoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/14/1936,6/8/2018,2018,82,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1936,6/8/2018,2018,82,White,Non-Hispanic,White,Female,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/26/1947,7/11/2018,2018,71.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1947,7/11/2018,2018,71.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/6/1980,8/8/2018,2018,37.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/6/1980,8/8/2018,2018,37.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/6/1980,8/8/2018,2018,37.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/1953,10/31/2018,2018,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1953,10/31/2018,2018,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1978,11/1/2018,2018,40.8,White,Hispanic or Latino,Hispanic/Latino,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Connective/Soft Tissue,Connective/Soft Tissue,Spindle Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/28/1962,12/6/2018,2018,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1962,12/6/2018,2018,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1967,1/31/2019,2019,51.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1977,7/2/2019,2019,42.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1977,7/2/2019,2019,42.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1952,8/2/2019,2019,67.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/24/1950,10/3/2019,2019,68.9,Black or African American,Non-Hispanic,Black,Male,91901,PH-L19TNFDOX2-02/17; Pro 2019000676  WIRB 20181483,Connective/Soft Tissue,Connective/Soft Tissue,Kaposi Sarcoma,Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
11/24/1950,11/11/2019,2019,69,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/9/1941,11/18/2019,2019,78.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1941,11/18/2019,2019,78.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1954,8/12/2020,2020,65.9,White,Non-Hispanic,White,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Connective/Soft Tissue,Connective/Soft Tissue,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/1/1958,10/5/2020,2020,61.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1958,10/5/2020,2020,61.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Connective/Soft Tissue,Connective/Soft Tissue,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1958,1/3/2017,2017,59,White,Non-Hispanic,White,Female,51403,Pro20140000405,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/20/1958,2/7/2017,2017,59.1,White,Non-Hispanic,White,Female,51407,Pro20140000735,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/19/1953,2/27/2017,2017,64.2,Black or African American,Non-Hispanic,Black,Female,51403,Pro20140000405,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/7/1959,4/3/2017,2017,57.4,Black or African American,Non-Hispanic,Black,Female,90906,0220100066; Pro0220100066; 1R01CA149627-01; 8850,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/19/1953,4/10/2017,2017,64.3,Black or African American,Non-Hispanic,Black,Female,51407,Pro20140000735,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/25/1949,4/17/2017,2017,67.7,Asian,Non-Hispanic,Asian,Female,51403,Pro20140000405,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/6/1952,5/23/2017,2017,64.7,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Corpus Uteri,Uterus,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/4/1957,6/5/2017,2017,60.2,White,Non-Hispanic,White,Female,51403,Pro20140000405,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/19/1948,6/9/2017,2017,69.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1948,6/9/2017,2017,69.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1975,6/22/2017,2017,41.8,Black or African American,Non-Hispanic,Black,Female,51403,Pro20140000405,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/30/1959,9/8/2017,2017,58,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/15/1958,9/15/2017,2017,59.5,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/3/1954,11/22/2017,2017,63.3,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/24/1943,12/1/2017,2017,74.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/8/1959,1/9/2018,2018,59,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/28/1967,2/9/2018,2018,50.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1967,2/9/2018,2018,50.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1952,2/13/2018,2018,65.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1952,2/13/2018,2018,65.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/6/1952,2/13/2018,2018,65.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1950,6/5/2018,2018,68.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Corpus Uteri,Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1951,3/1/2019,2019,67.3,Black or African American,Non-Hispanic,Black,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,Corpus Uteri,Uterus,"Adenocarcinoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
1/19/1948,10/28/2019,2019,71.8,Black or African American,Non-Hispanic,Black,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Corpus Uteri,Uterus,"Papillary Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/20/1944,7/6/2020,2020,75.7,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,Corpus Uteri,Uterus,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
8/24/1951,3/22/2017,2017,65.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Endocrine gland, NOS","Endocrine gland, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1978,7/17/2019,2019,40.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Endocrine gland, NOS","Endocrine gland, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1978,7/17/2019,2019,40.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Endocrine gland, NOS","Endocrine gland, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1948,11/21/2019,2019,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Endocrine gland, NOS","Endocrine gland, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1948,11/21/2019,2019,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Endocrine gland, NOS","Endocrine gland, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1960,3/1/2017,2017,57.1,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1960,3/1/2017,2017,57.1,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1937,4/26/2017,2017,79.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1937,4/26/2017,2017,79.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1961,5/3/2017,2017,55.6,White,Non-Hispanic,White,Male,51513,9782; NCI CIRB Pro20160000225,Esophagus,Esophagus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/27/1937,8/2/2017,2017,80.3,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Esophagus,Esophagus,Mucinous Adenocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
3/16/1942,9/27/2017,2017,75.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1942,9/27/2017,2017,75.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1968,10/4/2017,2017,49.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1968,10/4/2017,2017,49.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1956,10/12/2017,2017,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1956,10/12/2017,2017,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1969,10/17/2017,2017,48.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1969,10/17/2017,2017,48.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1950,10/24/2017,2017,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1950,10/24/2017,2017,67.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/8/1950,10/24/2017,2017,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1957,12/20/2017,2017,60.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1957,12/20/2017,2017,60.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1941,2/1/2018,2018,76.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1941,2/1/2018,2018,76.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1965,2/22/2018,2018,52.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1965,2/22/2018,2018,52.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1956,2/27/2018,2018,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1956,2/27/2018,2018,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1947,3/14/2018,2018,70.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1947,3/14/2018,2018,70.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1971,3/28/2018,2018,46.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1971,3/28/2018,2018,46.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1947,3/29/2018,2018,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1947,3/29/2018,2018,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1965,4/11/2018,2018,53.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1965,4/11/2018,2018,53.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1957,4/18/2018,2018,61.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1957,4/18/2018,2018,61.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/2/1957,4/18/2018,2018,61.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1955,7/18/2018,2018,63,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1955,7/18/2018,2018,63,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1965,9/12/2018,2018,53.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1965,9/12/2018,2018,53.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/14/1953,10/18/2018,2018,65.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1953,10/18/2018,2018,65.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1943,10/24/2018,2018,75.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1943,10/24/2018,2018,75.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1954,11/15/2018,2018,64.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1954,11/15/2018,2018,64.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1959,12/6/2018,2018,59.9,White,Non-Hispanic,White,Male,131317,Pro2013003676,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/26/1942,1/7/2019,2019,76.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1942,1/7/2019,2019,76.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1963,1/23/2019,2019,55.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1963,1/23/2019,2019,55.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1953,2/8/2019,2019,65.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1953,2/8/2019,2019,65.4,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/1/1953,2/8/2019,2019,65.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1950,2/27/2019,2019,69.2,White,Non-Hispanic,White,Male,171701,EAY131; NCI CIRB Pro2018000037,Esophagus,Esophagus,"Squamous Cell Carcinoma, Nos",Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
1/10/1950,3/5/2019,2019,69.2,White,Non-Hispanic,White,Male,171701-T,EAY131-T; NCI CIRB Pro2018000037,Esophagus,Esophagus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal; Precision Medicine Investigational Therapeutics,Gastrointestinal; Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
9/27/1963,4/17/2019,2019,55.6,White; Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1963,4/17/2019,2019,55.6,White; Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1961,5/3/2019,2019,57.6,White,Non-Hispanic,White,Male,71903,EA2174; NCI CIRB Pro2019000449,Esophagus,Esophagus,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/14/1950,6/17/2019,2019,68.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1950,6/17/2019,2019,68.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1954,7/10/2019,2019,64.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1954,7/10/2019,2019,64.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1961,7/10/2019,2019,57.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1961,7/10/2019,2019,57.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1946,8/7/2019,2019,73.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1946,9/26/2019,2019,73.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/19/1946,10/2/2019,2019,73.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1946,10/2/2019,2019,73.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1966,10/15/2019,2019,53.4,White,Non-Hispanic,White,Female,71903,EA2174; NCI CIRB Pro2019000449,Esophagus,Esophagus,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/18/1959,11/27/2019,2019,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1959,11/27/2019,2019,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1950,12/11/2019,2019,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1950,12/11/2019,2019,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1964,12/24/2019,2019,55.3,White,Non-Hispanic,White,Male,71810,10066; NCI CIRB Pro2018000861,Esophagus,Esophagus,"Adenocarcinoma, Nos",Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/4/1943,1/8/2020,2020,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1943,1/8/2020,2020,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1942,2/17/2020,2020,78.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1942,2/17/2020,2020,78.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1963,4/16/2020,2020,56.6,White; Unknown,Hispanic or Latino,Hispanic/Latino,Male,71908,"CP-MGAH22-06; Pro00036725     	Pro2019002160",Esophagus,Esophagus,"Adenocarcinoma, Nos",Gastrointestinal,Phase II/III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/22/1970,7/1/2020,2020,49.8,White,Non-Hispanic,White,Male,71815,GI15-015; Pro2018001612,Esophagus,Esophagus,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/18/1949,8/18/2020,2020,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1949,8/18/2020,2020,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Esophagus,Esophagus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/2011,7/21/2019,2019,7.6,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,"Eye, Nos","Eye, Nos","Glioma, Malignant",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
12/7/1948,1/4/2017,2017,68.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1948,1/4/2017,2017,68.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1984,2/22/2017,2017,33.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1984,2/22/2017,2017,33.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1960,7/17/2017,2017,57,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1968,8/2/2017,2017,49.1,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Gallbladder,Gallbladder,Cholangiocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
6/12/1953,8/25/2017,2017,64.2,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/12/1974,9/12/2017,2017,43.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1974,9/12/2017,2017,43.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1952,9/22/2017,2017,64.9,White,Non-Hispanic,White,Female,51602,Pro20160000270 WIRB20160671; RRx001-16-01,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gastrointestinal,Developmental Therapeutics-phase I; Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/10/1953,10/25/2017,2017,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1953,10/25/2017,2017,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1953,11/6/2017,2017,64.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1953,11/6/2017,2017,64.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/12/1953,11/6/2017,2017,64.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1956,11/7/2017,2017,61.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1956,11/7/2017,2017,61.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1947,12/14/2017,2017,70.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1947,12/14/2017,2017,70.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1951,1/23/2018,2018,66.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1951,1/24/2018,2018,66.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1963,3/9/2018,2018,54.2,White,Non-Hispanic,White,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/8/1943,3/20/2018,2018,74.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1943,3/20/2018,2018,74.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1961,3/28/2018,2018,56.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1961,3/28/2018,2018,56.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1955,4/10/2018,2018,62.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1955,4/10/2018,2018,62.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1958,4/13/2018,2018,60.2,White,Non-Hispanic,White,Male,71804,10139; NCI CIRB Pro2018000356,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
3/24/1947,6/21/2018,2018,71.3,Black or African American,Non-Hispanic,Black,Female,71804,10139; NCI CIRB Pro2018000356,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/9/1956,7/5/2018,2018,62.3,White,Non-Hispanic,White,Female,71804,10139; NCI CIRB Pro2018000356,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/28/1945,8/2/2018,2018,72.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1945,8/2/2018,2018,72.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1961,8/3/2018,2018,57.5,White,Non-Hispanic,White,Female,71804,10139; NCI CIRB Pro2018000356,Gallbladder,Gallbladder,,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/1/1949,8/7/2018,2018,69.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/1/1949,8/7/2018,2018,69.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1982,8/14/2018,2018,36,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1982,8/14/2018,2018,36,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1951,9/7/2018,2018,67.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1951,9/7/2018,2018,67.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1959,1/29/2019,2019,59.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1959,1/29/2019,2019,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1972,2/5/2019,2019,46.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/7/1961,2/27/2019,2019,57.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1961,2/27/2019,2019,57.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1976,3/21/2019,2019,42.5,Asian,Non-Hispanic,Asian,Female,71821,NCI CIRB Pro2018002736; S1815,Gallbladder,Gallbladder,Cholangiocarcinoma,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/16/1948,4/3/2019,2019,71,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1948,4/3/2019,2019,71,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1964,4/24/2019,2019,55,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1964,4/24/2019,2019,55,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1958,5/2/2019,2019,61.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1934,7/30/2019,2019,85.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1934,7/30/2019,2019,85.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1953,11/12/2019,2019,66.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1946,4/8/2020,2020,73.9,Black or African American,Non-Hispanic,Black,Female,52002,10276; NCI CIRB Pro2019002815,Gallbladder,Gallbladder,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/20/1942,8/26/2020,2020,78.3,White,Non-Hispanic,White,Female,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Gallbladder,Gallbladder,Adenocarcinoma In Situ,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/3/1940,10/2/2020,2020,80.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1940,10/2/2020,2020,80.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Gallbladder,Gallbladder,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1968,9/13/2017,2017,49.7,Black or African American,Non-Hispanic,Black,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,"Gum, NOS","Gum, NOS","Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
3/5/1974,1/2/2018,2018,43.9,Black or African American,Non-Hispanic,Black,Female,51513,9782; NCI CIRB Pro20160000225,"Gum, NOS","Gum, NOS",Adenoid Cystic Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/3/1967,3/9/2018,2018,50.5,Black or African American,Non-Hispanic,Black,Female,51712,INCAGN 1949-201; WIRB 20171333                      Pro20170001199,"Gum, NOS","Gum, NOS",Adenoid Cystic Carcinoma,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/13/1962,10/13/2020,2020,58.1,White,Non-Hispanic,White,Male,31922,9950; NCI CIRB Pro2019002413,Hypopharynx,Head & Neck,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
11/15/1934,1/5/2017,2017,82.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1934,1/5/2017,2017,82.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1942,1/5/2017,2017,74.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1942,1/5/2017,2017,74.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1961,1/5/2017,2017,55.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1961,1/5/2017,2017,55.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1947,1/5/2017,2017,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1947,1/5/2017,2017,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1949,1/11/2017,2017,67.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1949,1/11/2017,2017,67.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1935,1/11/2017,2017,81.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1935,1/11/2017,2017,81.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1987,1/25/2017,2017,29.2,White,Hispanic or Latino,Hispanic/Latino,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/11/1949,1/25/2017,2017,67.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1949,1/25/2017,2017,67.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1967,1/30/2017,2017,49.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1967,1/30/2017,2017,49.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1972,2/2/2017,2017,44.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1972,2/3/2017,2017,44.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1940,2/3/2017,2017,76.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1940,2/3/2017,2017,76.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1969,2/8/2017,2017,47.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/22/1969,2/8/2017,2017,47.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/2014,2/8/2017,2017,2.6,White,Non-Hispanic,White,Male,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Neoplasm, Malignant",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1987,2/13/2017,2017,29.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1987,2/13/2017,2017,29.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1942,2/13/2017,2017,74.6,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/16/1962,2/22/2017,2017,54.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1962,2/22/2017,2017,54.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1964,3/1/2017,2017,53.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1964,3/1/2017,2017,53.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1952,3/3/2017,2017,64.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1952,3/3/2017,2017,64.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1942,3/3/2017,2017,74.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1942,3/3/2017,2017,74.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1953,3/3/2017,2017,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1953,3/3/2017,2017,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1937,3/6/2017,2017,79.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1937,3/6/2017,2017,79.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1984,3/8/2017,2017,32.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1984,3/8/2017,2017,32.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1941,3/9/2017,2017,76.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1941,3/9/2017,2017,76.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1950,3/9/2017,2017,66.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1950,3/9/2017,2017,66.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1942,3/10/2017,2017,74.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1960,3/13/2017,2017,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1960,3/13/2017,2017,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1950,3/22/2017,2017,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1950,3/22/2017,2017,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1971,3/22/2017,2017,45.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1941,3/27/2017,2017,76.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1941,3/27/2017,2017,76.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1975,3/28/2017,2017,41.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1975,3/28/2017,2017,41.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1962,3/30/2017,2017,54.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1962,3/30/2017,2017,54.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1952,4/3/2017,2017,65.1,White,Non-Hispanic,White,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/26/1952,4/3/2017,2017,65.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1952,4/3/2017,2017,65.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1938,4/4/2017,2017,78.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1938,4/4/2017,2017,78.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1958,4/19/2017,2017,58.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1958,4/19/2017,2017,58.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1950,4/20/2017,2017,66.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1950,4/20/2017,2017,66.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1946,4/20/2017,2017,71.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1946,4/20/2017,2017,71.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1950,4/24/2017,2017,66.5,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/18/1941,5/1/2017,2017,75.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1941,5/1/2017,2017,75.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1962,5/12/2017,2017,55.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/4/1962,5/12/2017,2017,55.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1950,5/18/2017,2017,67.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1950,5/18/2017,2017,67.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1971,5/19/2017,2017,46.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1971,5/19/2017,2017,46.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1933,5/22/2017,2017,83.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1933,5/22/2017,2017,83.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1963,6/1/2017,2017,53.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1963,6/1/2017,2017,53.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1950,6/7/2017,2017,66.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1964,6/7/2017,2017,52.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1938,6/9/2017,2017,79.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/10/1938,6/9/2017,2017,79.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1941,6/15/2017,2017,76,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1941,6/15/2017,2017,76,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1971,6/20/2017,2017,45.9,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/3/1953,6/22/2017,2017,63.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1953,6/22/2017,2017,63.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1969,6/27/2017,2017,48,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1969,6/27/2017,2017,48,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1980,6/29/2017,2017,36.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/21/1980,6/29/2017,2017,36.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1962,7/3/2017,2017,54.6,White,Non-Hispanic,White,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/7/1943,7/6/2017,2017,74.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1943,7/6/2017,2017,74.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1948,7/6/2017,2017,68.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1948,7/6/2017,2017,68.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1952,7/13/2017,2017,64.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1952,7/13/2017,2017,64.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1948,7/14/2017,2017,69.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1959,7/17/2017,2017,58.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1959,7/17/2017,2017,58.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1943,7/17/2017,2017,74.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1953,7/26/2017,2017,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1953,7/26/2017,2017,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1941,8/2/2017,2017,76,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1963,8/3/2017,2017,53.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1963,8/3/2017,2017,53.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/15/1951,8/4/2017,2017,65.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1950,8/10/2017,2017,67,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1950,8/10/2017,2017,67,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/19/1960,8/28/2017,2017,57.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1960,8/28/2017,2017,57.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1963,8/29/2017,2017,54.6,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/11/1943,9/1/2017,2017,74.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1947,9/1/2017,2017,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1952,9/11/2017,2017,65.2,White,Non-Hispanic,White,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/17/1970,9/11/2017,2017,47.5,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/17/1970,9/11/2017,2017,47.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1970,9/11/2017,2017,47.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1944,9/12/2017,2017,73.7,Black or African American,Non-Hispanic,Black,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/22/1965,9/18/2017,2017,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1965,9/18/2017,2017,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/19/1961,9/18/2017,2017,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1961,9/18/2017,2017,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1953,9/18/2017,2017,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1953,9/18/2017,2017,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1961,9/19/2017,2017,56.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1961,9/19/2017,2017,56.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1947,9/21/2017,2017,69.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1947,9/21/2017,2017,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1954,9/27/2017,2017,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1954,9/27/2017,2017,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1944,10/2/2017,2017,73.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1944,10/2/2017,2017,73.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1991,10/4/2017,2017,26.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1991,10/4/2017,2017,26.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1966,10/9/2017,2017,51.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1966,10/9/2017,2017,51.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1967,10/9/2017,2017,50.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1967,10/9/2017,2017,50.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1953,10/13/2017,2017,64.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1934,10/16/2017,2017,83.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1934,10/16/2017,2017,83.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1943,10/17/2017,2017,73.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1943,10/17/2017,2017,73.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1957,10/19/2017,2017,60.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1957,10/19/2017,2017,60.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1952,10/20/2017,2017,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1952,10/20/2017,2017,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1939,10/30/2017,2017,78.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/5/1942,10/30/2017,2017,75,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/5/1942,10/30/2017,2017,75,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1935,10/30/2017,2017,82.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1935,10/30/2017,2017,82.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1941,10/31/2017,2017,76,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1941,10/31/2017,2017,76,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1995,11/16/2017,2017,22.4,White,Hispanic or Latino,Hispanic/Latino,Male,111501,AEWS1221; NCI CIRB Pro2019000559,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Ewing Sarcoma,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,CINJ Oncology Group; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/3/1949,11/20/2017,2017,68.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1949,11/20/2017,2017,68.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1967,11/21/2017,2017,50.2,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/15/1959,11/22/2017,2017,58.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1959,11/22/2017,2017,58.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1963,11/30/2017,2017,54.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1957,12/4/2017,2017,60.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/19/1957,12/4/2017,2017,60.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1947,12/4/2017,2017,70.5,White,Unknown,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1947,12/4/2017,2017,70.5,White,Unknown,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1958,12/15/2017,2017,59.3,White,Hispanic or Latino,Hispanic/Latino,Female,51707,20170000453,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/21/2011,12/15/2017,2017,6,White,Non-Hispanic,White,Male,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1936,12/18/2017,2017,81.4,White,Non-Hispanic,White,Male,51707,20170000453,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/8/1948,12/18/2017,2017,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1948,12/18/2017,2017,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1955,12/27/2017,2017,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1955,12/27/2017,2017,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1957,1/9/2018,2018,60.9,Asian,Non-Hispanic,Asian,Female,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/11/1944,1/12/2018,2018,74,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1944,1/12/2018,2018,74,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1953,1/12/2018,2018,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1953,1/12/2018,2018,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1968,1/19/2018,2018,49.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1968,1/19/2018,2018,49.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1970,1/19/2018,2018,47.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1970,1/19/2018,2018,47.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1961,1/29/2018,2018,56.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1961,1/29/2018,2018,56.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1946,2/2/2018,2018,71.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1946,2/2/2018,2018,71.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1974,2/2/2018,2018,43.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1974,2/2/2018,2018,43.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1969,2/8/2018,2018,48.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1969,2/8/2018,2018,48.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1945,2/21/2018,2018,73,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1945,2/21/2018,2018,73,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1934,2/23/2018,2018,83.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1934,2/23/2018,2018,83.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1946,2/23/2018,2018,71.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/19/1946,2/23/2018,2018,71.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1941,2/26/2018,2018,76.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1941,2/26/2018,2018,76.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1953,2/28/2018,2018,64.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1953,2/28/2018,2018,64.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/3/1953,2/28/2018,2018,64.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1979,3/5/2018,2018,38.8,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/5/1975,3/6/2018,2018,42.7,White,Hispanic or Latino,Hispanic/Latino,Female,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Renal Cell Carcinoma, Chromophobe Type",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/17/1951,3/6/2018,2018,66.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/17/1951,3/6/2018,2018,66.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1940,3/19/2018,2018,78.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1940,3/19/2018,2018,78.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1961,3/19/2018,2018,57,White; Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1961,3/19/2018,2018,57,White; Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1948,3/20/2018,2018,69.6,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/15/1982,3/26/2018,2018,35.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1982,3/26/2018,2018,35.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1951,3/26/2018,2018,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1951,3/26/2018,2018,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1935,3/27/2018,2018,83,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/18/1987,3/30/2018,2018,30.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1987,3/30/2018,2018,30.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1967,3/30/2018,2018,50.3,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/20/1967,3/30/2018,2018,50.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1967,3/30/2018,2018,50.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1975,4/5/2018,2018,42.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1975,4/5/2018,2018,42.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1955,4/9/2018,2018,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1955,4/9/2018,2018,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1932,4/13/2018,2018,85.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1932,4/13/2018,2018,85.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1959,4/16/2018,2018,59.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1959,4/16/2018,2018,59.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1934,4/16/2018,2018,83.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1934,4/16/2018,2018,83.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1956,4/19/2018,2018,61.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1956,4/19/2018,2018,61.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1947,4/20/2018,2018,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1947,4/20/2018,2018,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1979,4/20/2018,2018,39,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1979,4/20/2018,2018,39,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/2013,4/26/2018,2018,4.5,Black or African American,Non-Hispanic,Black,Female,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1957,4/30/2018,2018,61.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1957,4/30/2018,2018,61.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1943,4/30/2018,2018,74.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1943,4/30/2018,2018,74.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1953,4/30/2018,2018,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1953,4/30/2018,2018,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1972,5/2/2018,2018,45.8,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/24/1929,5/3/2018,2018,88.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1929,5/3/2018,2018,88.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/1957,5/7/2018,2018,61.2,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/5/1948,5/10/2018,2018,69.8,Native Hawaiian or Other Pacific Islander; Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1948,5/10/2018,2018,69.8,Native Hawaiian or Other Pacific Islander; Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/2013,5/11/2018,2018,4.6,Black or African American,Non-Hispanic,Black,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/11/1957,5/17/2018,2018,61.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1957,5/17/2018,2018,61.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/2010,5/17/2018,2018,7.4,White,Non-Hispanic,White,Female,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/2010,5/22/2018,2018,7.4,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
6/24/1945,5/25/2018,2018,73,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1945,5/25/2018,2018,73,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1940,6/4/2018,2018,78.4,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/15/1969,6/8/2018,2018,48.8,Asian,Non-Hispanic,Asian,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/20/1957,6/8/2018,2018,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1968,6/11/2018,2018,49.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1937,6/11/2018,2018,80.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1944,6/13/2018,2018,73.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1948,6/14/2018,2018,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1948,6/14/2018,2018,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1968,6/15/2018,2018,49.7,Asian,Non-Hispanic,Asian,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/23/1948,6/15/2018,2018,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/23/1948,6/15/2018,2018,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/2014,6/18/2018,2018,4,White,Non-Hispanic,White,Male,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1958,6/22/2018,2018,60.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1958,6/22/2018,2018,60.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1957,6/26/2018,2018,61.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/27/2014,6/29/2018,2018,4,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
11/28/1942,7/5/2018,2018,75.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1942,7/5/2018,2018,75.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1952,7/9/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1952,7/9/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1971,7/9/2018,2018,46.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1971,7/9/2018,2018,46.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1972,7/9/2018,2018,46,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1972,7/9/2018,2018,46,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1964,7/9/2018,2018,54.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1964,7/9/2018,2018,54.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1958,7/10/2018,2018,60.4,White,Hispanic or Latino,Hispanic/Latino,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/27/1954,7/16/2018,2018,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1954,7/16/2018,2018,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1939,7/16/2018,2018,79.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1939,7/16/2018,2018,79.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1949,7/17/2018,2018,68.9,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/14/1956,7/19/2018,2018,62.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1956,7/19/2018,2018,62.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1957,7/19/2018,2018,61,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1957,7/19/2018,2018,61,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1936,7/19/2018,2018,81.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1936,7/19/2018,2018,81.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1949,7/19/2018,2018,68.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1949,7/19/2018,2018,68.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1978,7/20/2018,2018,39.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1978,7/20/2018,2018,39.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1968,7/23/2018,2018,49.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1950,7/30/2018,2018,67.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1950,7/30/2018,2018,67.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1952,8/1/2018,2018,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1952,8/1/2018,2018,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1957,8/9/2018,2018,61.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1957,8/9/2018,2018,61.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1950,8/17/2018,2018,68.1,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/19/1957,8/20/2018,2018,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/19/1957,8/20/2018,2018,60.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/1957,8/20/2018,2018,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1936,8/20/2018,2018,81.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1936,8/20/2018,2018,81.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1966,8/24/2018,2018,52.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1966,8/24/2018,2018,52.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1936,9/6/2018,2018,81.8,White,Non-Hispanic,White,Male,51707,20170000453,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/20/1944,9/12/2018,2018,74.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1944,9/12/2018,2018,74.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1962,9/17/2018,2018,56.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1962,9/17/2018,2018,56.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1962,9/19/2018,2018,56.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1962,9/19/2018,2018,56.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1948,9/27/2018,2018,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1948,9/27/2018,2018,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1951,9/28/2018,2018,67,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1951,9/28/2018,2018,67,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/26/1951,9/28/2018,2018,67,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1954,10/1/2018,2018,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1954,10/1/2018,2018,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1957,10/11/2018,2018,61.8,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/3/1955,10/12/2018,2018,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1955,10/12/2018,2018,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1958,10/15/2018,2018,60.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1958,10/15/2018,2018,60.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1969,10/15/2018,2018,49.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1969,10/15/2018,2018,49.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1943,10/29/2018,2018,75.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1943,10/29/2018,2018,75.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1949,10/29/2018,2018,69,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/5/1949,10/29/2018,2018,69,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1947,10/29/2018,2018,70.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1947,10/29/2018,2018,70.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1951,10/29/2018,2018,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1951,10/29/2018,2018,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1967,11/5/2018,2018,51,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1967,11/5/2018,2018,51,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1956,11/8/2018,2018,62.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1956,11/8/2018,2018,62.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1955,11/12/2018,2018,63.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1955,11/12/2018,2018,63.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1955,11/20/2018,2018,63.6,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/8/1950,11/26/2018,2018,68,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1950,11/26/2018,2018,68,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1967,12/3/2018,2018,51.3,Black or African American,Non-Hispanic,Black,Male,131317,Pro2013003676,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1953,12/4/2018,2018,65.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1953,12/4/2018,2018,65.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1979,12/6/2018,2018,39.6,White,Non-Hispanic,White,Male,131317,Pro2013003676,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1933,12/13/2018,2018,85.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1933,12/13/2018,2018,85.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1956,12/26/2018,2018,62.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1956,12/26/2018,2018,62.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1949,12/31/2018,2018,69.2,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/8/1937,12/31/2018,2018,81.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1937,12/31/2018,2018,81.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1943,1/2/2019,2019,75.6,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/8/1949,1/4/2019,2019,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1949,1/4/2019,2019,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1958,1/11/2019,2019,60.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1958,1/11/2019,2019,60.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1958,1/17/2019,2019,60.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1958,1/17/2019,2019,60.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1954,1/18/2019,2019,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1954,1/18/2019,2019,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1944,1/23/2019,2019,74.5,White,Non-Hispanic,White,Male,51707,20170000453,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Carcinoma In Situ, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/12/1967,1/28/2019,2019,52.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1967,1/28/2019,2019,52.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1988,1/28/2019,2019,30.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1988,1/28/2019,2019,30.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1947,1/30/2019,2019,72,White,Non-Hispanic,White,Male,51805,CA027-002; Pro2018001473; 20172711,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/26/1959,2/4/2019,2019,60.1,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Clear Cell Sarcoma Of Kidney,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/15/1972,2/7/2019,2019,47,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1972,2/7/2019,2019,47,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1977,2/11/2019,2019,41.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1977,2/11/2019,2019,41.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1968,2/11/2019,2019,51.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1968,2/11/2019,2019,51.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1956,2/21/2019,2019,62.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1944,2/21/2019,2019,74.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1944,2/21/2019,2019,74.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1970,2/21/2019,2019,48.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1970,2/21/2019,2019,48.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1961,2/25/2019,2019,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1961,2/25/2019,2019,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1961,2/25/2019,2019,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1961,2/25/2019,2019,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1958,2/25/2019,2019,60.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1958,2/25/2019,2019,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1943,2/26/2019,2019,75.9,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/24/1951,2/28/2019,2019,67.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1951,2/28/2019,2019,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1944,3/1/2019,2019,74.3,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/30/1947,3/1/2019,2019,71.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1947,3/1/2019,2019,71.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1932,3/4/2019,2019,86.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1932,3/4/2019,2019,86.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1981,3/8/2019,2019,37.5,White,Hispanic or Latino,Hispanic/Latino,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/12/1981,3/8/2019,2019,37.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/12/1981,3/8/2019,2019,37.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1947,3/8/2019,2019,71.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1947,3/8/2019,2019,71.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1944,3/12/2019,2019,74.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1944,3/12/2019,2019,74.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/29/1944,3/12/2019,2019,74.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1953,3/18/2019,2019,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1953,3/18/2019,2019,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1970,3/21/2019,2019,48.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1970,3/21/2019,2019,48.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/20/1967,3/22/2019,2019,52,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/20/1967,3/22/2019,2019,52,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1968,4/5/2019,2019,51,Black or African American,Non-Hispanic,Black,Male,81604,Pro20170000806,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Neoplasm, Malignant",Genitourinary,Early Phase I,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/4/1961,4/8/2019,2019,57.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1961,4/8/2019,2019,57.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1966,4/15/2019,2019,52.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1966,4/15/2019,2019,52.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1966,4/18/2019,2019,52.8,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/1/1942,4/25/2019,2019,76.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1942,4/25/2019,2019,76.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1957,4/29/2019,2019,62.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1957,4/29/2019,2019,62.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1962,4/29/2019,2019,56.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1962,4/29/2019,2019,56.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1954,4/29/2019,2019,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1954,4/29/2019,2019,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1950,4/29/2019,2019,68.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1950,4/29/2019,2019,68.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1972,5/2/2019,2019,46.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1972,5/2/2019,2019,46.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1933,5/2/2019,2019,85.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1933,5/2/2019,2019,85.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1946,5/8/2019,2019,73.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1946,5/8/2019,2019,73.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1964,5/13/2019,2019,54.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1964,5/13/2019,2019,54.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1948,5/16/2019,2019,71.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1950,5/17/2019,2019,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1950,5/17/2019,2019,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1966,5/24/2019,2019,53.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1966,5/24/2019,2019,53.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1946,5/29/2019,2019,72.7,White,Non-Hispanic,White,Male,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/25/1967,5/30/2019,2019,52,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1967,5/30/2019,2019,52,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1949,5/31/2019,2019,69.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1949,5/31/2019,2019,69.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1949,5/31/2019,2019,70.2,White,Non-Hispanic,White,Male,51808,Pro2018002377  WIRB20170992; XL184-021,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/8/1946,5/31/2019,2019,72.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1946,5/31/2019,2019,72.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1945,6/3/2019,2019,73.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1945,6/3/2019,2019,73.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1956,6/4/2019,2019,62.6,White,Non-Hispanic,White,Female,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Squamous Cell Carcinoma, Clear Cell Type",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/14/1956,6/7/2019,2019,63.4,Black or African American,Non-Hispanic,Black,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Renal Cell Carcinoma, Sarcomatoid",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/12/1985,6/7/2019,2019,33.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1985,6/7/2019,2019,33.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1947,6/10/2019,2019,72.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1947,6/10/2019,2019,72.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1954,6/10/2019,2019,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1954,6/10/2019,2019,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/2007,6/10/2019,2019,12.1,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/14/2010,6/11/2019,2019,8.7,Black or African American,Non-Hispanic,Black,Female,110607,AREN03B2; NCI CIRB Pro20170002008,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Nephroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1953,6/17/2019,2019,65.9,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/17/1949,6/20/2019,2019,70,White,Non-Hispanic,White,Male,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/6/1969,6/21/2019,2019,49.7,Black or African American,Non-Hispanic,Black,Male,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/9/1964,6/24/2019,2019,54.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1964,6/24/2019,2019,54.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1968,6/24/2019,2019,50.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1968,6/24/2019,2019,50.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1947,6/27/2019,2019,71.9,White,Non-Hispanic,White,Female,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/19/1950,6/28/2019,2019,69.1,White,Non-Hispanic,White,Male,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/22/1953,6/28/2019,2019,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1953,6/28/2019,2019,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1956,7/3/2019,2019,62.8,Black or African American,Non-Hispanic,Black,Male,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/19/1955,7/3/2019,2019,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1955,7/3/2019,2019,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1953,7/12/2019,2019,66.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1953,7/12/2019,2019,66.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1957,7/15/2019,2019,61.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1957,7/15/2019,2019,61.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/31/1933,7/15/2019,2019,86,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1933,7/15/2019,2019,86,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1950,7/15/2019,2019,69.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1950,7/15/2019,2019,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1967,7/18/2019,2019,52.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1967,7/18/2019,2019,52.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1944,7/18/2019,2019,74.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1953,7/19/2019,2019,66.1,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/28/1947,7/22/2019,2019,72.4,White,Non-Hispanic,White,Male,81604,Pro20170000806,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Neoplasm, Malignant",Genitourinary,Early Phase I,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/8/1970,7/22/2019,2019,49,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1970,7/22/2019,2019,49,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1950,7/26/2019,2019,68.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1950,7/29/2019,2019,68.9,White,Non-Hispanic,White,Female,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/29/1950,7/29/2019,2019,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1950,7/29/2019,2019,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1954,7/29/2019,2019,65.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1954,7/29/2019,2019,65.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1956,7/29/2019,2019,63.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/26/1956,7/29/2019,2019,63.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1965,8/1/2019,2019,54.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1965,8/1/2019,2019,54.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1954,8/5/2019,2019,65.6,White,Non-Hispanic,White,Male,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/7/1937,8/9/2019,2019,82.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1937,8/9/2019,2019,82.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1941,8/12/2019,2019,78.4,White,Non-Hispanic,White,Female,81803,MK-3475-564; Pro2018001099  WIRB20170553,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/30/1953,8/12/2019,2019,66.2,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Adenocarcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1960,8/19/2019,2019,59,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1960,8/19/2019,2019,59,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1936,8/19/2019,2019,82.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1936,8/19/2019,2019,82.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1953,8/22/2019,2019,66,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/5/1960,8/23/2019,2019,59.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1960,8/23/2019,2019,59.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1960,8/26/2019,2019,59,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/24/1967,8/26/2019,2019,52.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1967,8/26/2019,2019,52.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1961,8/26/2019,2019,58.6,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Transitional Cell Carcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1944,8/30/2019,2019,75.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1944,8/30/2019,2019,75.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1970,8/30/2019,2019,49,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1970,8/30/2019,2019,49,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1944,9/5/2019,2019,74.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1944,9/5/2019,2019,74.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1974,9/16/2019,2019,45.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1961,9/16/2019,2019,58.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1961,9/16/2019,2019,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1965,9/17/2019,2019,54.3,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Neoplasm, Malignant",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/15/1976,9/19/2019,2019,43.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1976,9/19/2019,2019,43.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1963,9/23/2019,2019,56.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1963,9/23/2019,2019,56.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1951,9/30/2019,2019,68.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/1/1951,9/30/2019,2019,68.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/11/1952,9/30/2019,2019,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1952,9/30/2019,2019,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1962,9/30/2019,2019,57.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1962,9/30/2019,2019,57.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1974,10/7/2019,2019,45.5,White,Hispanic or Latino,Hispanic/Latino,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/30/1946,10/7/2019,2019,73.1,White,Non-Hispanic,White,Male,51903,MS100070_0176; WIRB20183367 Pro2019000695,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/8/1954,10/7/2019,2019,65,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1954,10/7/2019,2019,65,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1969,10/9/2019,2019,50.3,White,Non-Hispanic,White,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/25/1962,10/13/2019,2019,57.1,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/17/1969,10/14/2019,2019,50.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1969,10/14/2019,2019,50.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1978,10/17/2019,2019,41.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1978,10/17/2019,2019,41.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1942,10/18/2019,2019,77.6,White,Non-Hispanic,White,Male,81604,Pro20170000806,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Early Phase I,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/28/1944,10/18/2019,2019,75.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1944,10/18/2019,2019,75.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1977,10/18/2019,2019,41.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1977,10/18/2019,2019,41.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1967,10/18/2019,2019,52.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1967,10/18/2019,2019,52.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1959,11/1/2019,2019,59.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1959,11/1/2019,2019,59.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1980,11/1/2019,2019,39.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1980,11/1/2019,2019,39.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1955,11/4/2019,2019,64.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1955,11/4/2019,2019,64.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1980,11/6/2019,2019,39.8,Asian,Non-Hispanic,Asian,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/23/1962,11/14/2019,2019,57.2,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/26/1936,11/14/2019,2019,83.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/26/1936,11/14/2019,2019,83.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1961,11/21/2019,2019,58.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1961,11/21/2019,2019,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1968,11/25/2019,2019,51.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1968,11/25/2019,2019,51.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/2/1972,11/25/2019,2019,47.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/2/1972,11/25/2019,2019,47.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1956,11/25/2019,2019,63.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1956,11/25/2019,2019,63.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1968,11/25/2019,2019,51.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1968,11/25/2019,2019,51.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1946,11/25/2019,2019,73.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1946,11/25/2019,2019,73.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1964,11/26/2019,2019,55.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1964,11/26/2019,2019,55.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1941,12/2/2019,2019,78.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1941,12/2/2019,2019,78.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1954,12/6/2019,2019,65.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1954,12/6/2019,2019,65.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/2/1972,12/9/2019,2019,47.6,White,Hispanic or Latino,Hispanic/Latino,Female,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/26/1954,12/13/2019,2019,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1954,12/13/2019,2019,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1942,12/16/2019,2019,77.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/12/1942,12/16/2019,2019,77.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1971,12/23/2019,2019,49,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1971,12/23/2019,2019,49,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1976,1/3/2020,2020,43.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1976,1/3/2020,2020,43.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1955,1/3/2020,2020,64.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1955,1/3/2020,2020,64.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1960,1/3/2020,2020,59.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1960,1/3/2020,2020,59.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1950,1/3/2020,2020,69.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1950,1/3/2020,2020,69.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1963,1/6/2020,2020,56.6,White,Non-Hispanic,White,Male,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Clear Cell Sarcoma Of Kidney,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/16/1976,1/6/2020,2020,43.3,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/16/1959,1/9/2020,2020,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1959,1/9/2020,2020,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1973,1/10/2020,2020,46.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1973,1/10/2020,2020,46.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1956,1/10/2020,2020,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1956,1/10/2020,2020,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/8/1950,1/13/2020,2020,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1950,1/13/2020,2020,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1966,1/13/2020,2020,53.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1966,1/13/2020,2020,53.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1953,1/13/2020,2020,66.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/19/1958,1/14/2020,2020,61.7,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/26/1960,1/17/2020,2020,59.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1960,1/17/2020,2020,59.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1936,2/3/2020,2020,83.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1936,2/3/2020,2020,83.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1955,2/7/2020,2020,64.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1955,2/7/2020,2020,64.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1949,2/7/2020,2020,70.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1949,2/7/2020,2020,70.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1936,2/18/2020,2020,83.7,White,Hispanic or Latino,Hispanic/Latino,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/29/1961,2/18/2020,2020,58.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/29/1961,2/18/2020,2020,58.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1955,2/24/2020,2020,64.4,Black or African American,Non-Hispanic,Black,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/6/1939,2/28/2020,2020,80.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1939,2/28/2020,2020,80.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1967,2/28/2020,2020,52.3,Asian,Non-Hispanic,Asian,Female,171801,PICI0009; Pro2018002367 ,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Renal Cell Carcinoma, Chromophobe Type",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1954,3/2/2020,2020,65.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1954,3/2/2020,2020,65.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1977,3/2/2020,2020,42.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1977,3/2/2020,2020,42.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1947,3/9/2020,2020,72.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1947,3/9/2020,2020,72.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1956,3/9/2020,2020,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1956,3/9/2020,2020,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1965,3/9/2020,2020,54.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1965,3/9/2020,2020,54.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1950,3/10/2020,2020,69.6,White,Non-Hispanic,White,Female,81910,A031704; CTEP A031704  Pro2019002933,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/28/1954,3/12/2020,2020,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1954,3/12/2020,2020,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1943,3/16/2020,2020,76.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1943,3/16/2020,2020,76.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1965,3/19/2020,2020,54.7,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/8/1972,4/9/2020,2020,48.1,Asian,Non-Hispanic,Asian,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/17/1952,4/29/2020,2020,67.7,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/30/1989,5/7/2020,2020,31.1,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/4/1948,5/26/2020,2020,72,White,Non-Hispanic,White,Female,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/26/1956,5/28/2020,2020,63.6,White,Non-Hispanic,White,Female,81801,BTCRC-GU16-043; BTCRC-GU16043; Pro2017000045,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/3/1941,7/2/2020,2020,78.9,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/30/1956,7/2/2020,2020,63.5,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/12/1954,7/17/2020,2020,65.7,White,Non-Hispanic,White,Male,51901,Pro2019000353 ; WIRB20191459; TTX-030-001,Kidney & Renal Pelvis,Kidney & Renal Pelvis,Renal Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/15/1963,8/31/2020,2020,57.3,White,Non-Hispanic,White,Female,81910,A031704; CTEP A031704  Pro2019002933,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/11/1962,9/2/2020,2020,58.2,White,Non-Hispanic,White,Female,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/31/1964,9/25/2020,2020,55.8,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/29/1966,9/25/2020,2020,54,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/9/1961,9/28/2020,2020,59.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1963,9/29/2020,2020,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1963,9/29/2020,2020,57.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/30/1963,9/29/2020,2020,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/9/1961,9/29/2020,2020,59.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1956,10/1/2020,2020,64.4,White,Non-Hispanic,White,Male,81407,Pro2013003918,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/9/1966,10/5/2020,2020,54.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/9/1966,10/5/2020,2020,54.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1956,10/5/2020,2020,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1956,10/5/2020,2020,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1946,10/7/2020,2020,74.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1946,10/7/2020,2020,74.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/30/1946,10/7/2020,2020,74.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1946,10/7/2020,2020,74.1,White,Non-Hispanic,White,Male,81909,KC180159; Pro2020000061,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1969,10/13/2020,2020,51.4,White,Non-Hispanic,White,Male,81610,EA8143; NCI CIRB          Pro20170000183,Kidney & Renal Pelvis,Kidney & Renal Pelvis,"Clear Cell Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/15/1963,10/13/2020,2020,57.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1963,10/13/2020,2020,57.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/15/1963,10/13/2020,2020,57.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1963,10/13/2020,2020,57.5,White,Non-Hispanic,White,Female,81909,KC180159; Pro2020000061,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1938,10/16/2020,2020,82.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1938,10/16/2020,2020,82.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1954,10/20/2020,2020,66.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/22/1954,10/20/2020,2020,66.8,White,Non-Hispanic,White,Male,81909,KC180159; Pro2020000061,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1939,10/20/2020,2020,81.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/2/1950,10/25/2020,2020,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/23/1962,10/26/2020,2020,58.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/23/1962,10/26/2020,2020,58.1,White,Non-Hispanic,White,Male,81909,KC180159; Pro2020000061,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/9/1952,10/26/2020,2020,68.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1948,10/26/2020,2020,72.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/8/1948,10/26/2020,2020,72.2,White,Non-Hispanic,White,Male,81909,KC180159; Pro2020000061,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1956,10/26/2020,2020,64.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Kidney & Renal Pelvis,Kidney & Renal Pelvis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1942,10/17/2017,2017,75.4,Asian,Non-Hispanic,Asian,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Larynx,Head & Neck,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
3/19/1959,10/17/2017,2017,58.6,Black or African American,Non-Hispanic,Black,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Larynx,Head & Neck,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
5/20/1958,4/10/2019,2019,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Larynx,Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1958,4/10/2019,2019,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Larynx,Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/2/1953,2/22/2019,2019,65.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,51707,20170000453,Lip,Head & Neck,Adenoid Cystic Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/15/1957,1/19/2017,2017,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1957,1/19/2017,2017,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1956,2/24/2017,2017,60.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1974,3/1/2017,2017,42.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1974,3/1/2017,2017,42.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1977,3/8/2017,2017,39.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/1/1977,3/8/2017,2017,39.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1966,3/22/2017,2017,51.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1964,3/28/2017,2017,52.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1964,3/28/2017,2017,52.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1962,3/29/2017,2017,54.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1938,3/29/2017,2017,79.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1938,3/29/2017,2017,79.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1962,3/30/2017,2017,54.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1959,4/3/2017,2017,57.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1965,4/19/2017,2017,51.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1965,4/19/2017,2017,51.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1970,4/26/2017,2017,46.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1970,4/26/2017,2017,46.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1968,4/26/2017,2017,48.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1968,4/26/2017,2017,48.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1987,5/23/2017,2017,30.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1987,5/23/2017,2017,30.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1957,5/23/2017,2017,60.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/19/1957,5/23/2017,2017,60.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1968,6/7/2017,2017,48.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1968,6/7/2017,2017,48.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1942,6/7/2017,2017,74.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/18/1970,6/20/2017,2017,47,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/18/1970,6/20/2017,2017,47,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1959,6/27/2017,2017,57.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1959,6/27/2017,2017,57.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1964,7/6/2017,2017,52.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1964,7/6/2017,2017,52.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1946,7/25/2017,2017,71.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1946,7/25/2017,2017,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1951,8/2/2017,2017,65.9,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Liver & Bile Duct,Liver & Bile Duct,Cholangiocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
10/1/1959,8/2/2017,2017,57.9,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Liver & Bile Duct,Liver & Bile Duct,"Hepatocellular Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
2/3/1962,8/2/2017,2017,55.5,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Liver & Bile Duct,Liver & Bile Duct,Cholangiocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
8/27/1969,8/15/2017,2017,48,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1969,8/15/2017,2017,48,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1975,8/29/2017,2017,41.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1975,8/29/2017,2017,41.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1954,9/26/2017,2017,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1954,9/26/2017,2017,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1956,10/1/2017,2017,61.8,White,Non-Hispanic,White,Male,131604,20170000115,Liver & Bile Duct,Liver & Bile Duct,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/3/1957,10/2/2017,2017,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1945,10/3/2017,2017,71.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1968,10/11/2017,2017,49.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1968,10/11/2017,2017,49.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1941,10/17/2017,2017,75.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1954,10/24/2017,2017,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1954,10/24/2017,2017,63.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/28/1954,10/24/2017,2017,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1948,12/21/2017,2017,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1948,12/21/2017,2017,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1960,1/3/2018,2018,57.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1960,1/3/2018,2018,57.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1963,1/9/2018,2018,54.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1963,1/9/2018,2018,54.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1946,2/9/2018,2018,72,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1946,2/9/2018,2018,72,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1963,2/15/2018,2018,55.1,White,Non-Hispanic,White,Male,51403,Pro20140000405,Liver & Bile Duct,Liver & Bile Duct,"Small Cell Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/22/1950,3/2/2018,2018,67.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1950,3/2/2018,2018,67.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1982,3/2/2018,2018,35.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1982,3/2/2018,2018,35.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1965,3/13/2018,2018,53,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1965,3/13/2018,2018,53,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1946,3/15/2018,2018,71.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1946,3/15/2018,2018,71.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/19/1943,3/30/2018,2018,74.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1943,3/30/2018,2018,74.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1950,4/3/2018,2018,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1950,4/3/2018,2018,67.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/9/1950,4/3/2018,2018,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1950,4/10/2018,2018,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1950,4/10/2018,2018,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1954,4/11/2018,2018,63.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1954,4/11/2018,2018,63.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1944,4/24/2018,2018,73.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1944,4/24/2018,2018,73.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1956,5/1/2018,2018,62.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1956,5/1/2018,2018,62.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1941,5/1/2018,2018,76.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1941,5/1/2018,2018,76.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1959,6/19/2018,2018,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1959,6/19/2018,2018,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1958,6/26/2018,2018,60,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1958,6/26/2018,2018,60,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1960,7/9/2018,2018,58.4,White,Non-Hispanic,White,Female,51803,NKTR-214; WIRB20170743  PRO2018000740,Liver & Bile Duct,Liver & Bile Duct,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/19/1941,7/10/2018,2018,77.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1941,7/10/2018,2018,77.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1954,7/19/2018,2018,64.1,White,Non-Hispanic,White,Male,71804,10139; NCI CIRB Pro2018000356,Liver & Bile Duct,Liver & Bile Duct,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/21/1934,7/26/2018,2018,84.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1934,7/26/2018,2018,84.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1940,7/26/2018,2018,77.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1940,7/26/2018,2018,77.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1953,7/31/2018,2018,65.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1953,7/31/2018,2018,65.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1936,7/31/2018,2018,82.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1936,7/31/2018,2018,82.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1954,8/14/2018,2018,64.6,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,Liver & Bile Duct,Liver & Bile Duct,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/22/1956,9/18/2018,2018,61.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1956,9/18/2018,2018,61.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1976,9/25/2018,2018,41.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1976,9/25/2018,2018,41.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1938,9/25/2018,2018,80.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1938,9/25/2018,2018,80.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1947,10/24/2018,2018,71.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1947,10/24/2018,2018,71.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1972,10/30/2018,2018,46.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1972,10/31/2018,2018,46.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1946,11/20/2018,2018,72.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1946,11/20/2018,2018,72.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1951,11/20/2018,2018,67.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1951,11/20/2018,2018,67.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1942,12/4/2018,2018,76,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1998,12/4/2018,2018,20.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1998,12/4/2018,2018,20.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1986,12/18/2018,2018,32.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1986,12/18/2018,2018,32.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1939,1/15/2019,2019,80.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1939,1/15/2019,2019,80.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1942,2/4/2019,2019,76.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1942,2/4/2019,2019,76.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1972,2/5/2019,2019,46.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1972,2/5/2019,2019,46.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1971,2/8/2019,2019,47.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1971,2/8/2019,2019,47.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1951,2/18/2019,2019,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1951,2/18/2019,2019,67.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/1/1951,2/18/2019,2019,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1945,2/22/2019,2019,73.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/17/1945,2/22/2019,2019,73.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1959,2/22/2019,2019,59.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1959,2/22/2019,2019,59.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1948,3/12/2019,2019,70.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1948,3/12/2019,2019,70.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1954,4/2/2019,2019,64.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1954,4/2/2019,2019,64.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1945,4/9/2019,2019,74,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1945,4/9/2019,2019,74,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1946,4/30/2019,2019,72.7,White,Non-Hispanic,White,Female,141804,10129; NCI CIRB Pro2018001815,Liver & Bile Duct,Liver & Bile Duct,"Adenocarcinoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
1/9/1963,5/14/2019,2019,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1963,5/14/2019,2019,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1938,5/21/2019,2019,81,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1938,5/21/2019,2019,81,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1947,5/21/2019,2019,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1947,5/21/2019,2019,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1947,5/23/2019,2019,71.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1947,5/23/2019,2019,71.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1938,5/23/2019,2019,80.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1938,5/23/2019,2019,80.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1969,6/4/2019,2019,49.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1969,6/4/2019,2019,49.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1948,6/24/2019,2019,70.8,White,Non-Hispanic,White,Male,71902,Pro 2019000554 Advarra SSU00079586; XL184-312,Liver & Bile Duct,Liver & Bile Duct,,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/15/1976,7/2/2019,2019,42.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1976,7/2/2019,2019,42.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1945,8/16/2019,2019,73.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1945,8/16/2019,2019,73.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1946,9/17/2019,2019,73.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1946,9/17/2019,2019,73.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1970,9/19/2019,2019,49.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1970,9/19/2019,2019,49.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1954,10/22/2019,2019,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1954,10/22/2019,2019,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1956,10/29/2019,2019,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1956,10/29/2019,2019,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1965,11/14/2019,2019,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1965,11/14/2019,2019,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1945,12/24/2019,2019,74.3,White,Non-Hispanic,White,Male,71902,Pro 2019000554 Advarra SSU00079586; XL184-312,Liver & Bile Duct,Liver & Bile Duct,Adenocarcinoma With Mixed Subtypes,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/28/1963,2/4/2020,2020,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1963,2/4/2020,2020,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1933,2/11/2020,2020,86.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1933,2/11/2020,2020,86.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1960,2/18/2020,2020,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1960,2/18/2020,2020,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1976,2/19/2020,2020,43.6,Black or African American,Non-Hispanic,Black,Female,71821,NCI CIRB Pro2018002736; S1815,Liver & Bile Duct,Liver & Bile Duct,"Adenocarcinoma, Nos",Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/24/1940,3/3/2020,2020,79.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1940,3/3/2020,2020,79.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Liver & Bile Duct,Liver & Bile Duct,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1950,4/8/2020,2020,70,White,Non-Hispanic,White,Male,52002,10276; NCI CIRB Pro2019002815,Liver & Bile Duct,Liver & Bile Duct,"Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/9/1964,8/3/2020,2020,55.7,White,Non-Hispanic,White,Male,71821,NCI CIRB Pro2018002736; S1815,Liver & Bile Duct,Liver & Bile Duct,Cholangiocarcinoma,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/9/1958,8/7/2020,2020,62.4,White,Non-Hispanic,White,Female,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Liver & Bile Duct,Liver & Bile Duct,Neuroendocrine Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/25/1958,8/17/2020,2020,62.1,White,Non-Hispanic,White,Female,71821,NCI CIRB Pro2018002736; S1815,Liver & Bile Duct,Liver & Bile Duct,,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
9/10/1997,9/17/2020,2020,23,White,Hispanic or Latino,Hispanic/Latino,Male,111806,AHEP1531; NCI CIRB Pro2018002841,Liver & Bile Duct,Liver & Bile Duct,Hepatoblastoma,Pediatric Oncology,Phase II/III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/2/1976,9/24/2020,2020,44.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,71821,NCI CIRB Pro2018002736; S1815,Liver & Bile Duct,Liver & Bile Duct,Cholangiocarcinoma,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/22/1945,10/1/2020,2020,75.7,Asian,Non-Hispanic,Asian,Female,71821,NCI CIRB Pro2018002736; S1815,Liver & Bile Duct,Liver & Bile Duct,Cholangiocarcinoma,Gastrointestinal,Phase III,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/11/1943,1/5/2017,2017,74,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1943,1/5/2017,2017,74,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/20/1939,1/9/2017,2017,77.4,Black or African American,Non-Hispanic,Black,Female,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/14/1951,1/17/2017,2017,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1951,1/17/2017,2017,65.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/14/1951,1/17/2017,2017,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1939,1/18/2017,2017,77.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1939,1/18/2017,2017,77.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/4/1939,1/18/2017,2017,77.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1969,1/30/2017,2017,48.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1969,1/30/2017,2017,48.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1952,1/30/2017,2017,64.9,White,Non-Hispanic,White,Female,31608,EA5142; NCI CIRB Pro20160000720,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
8/8/1943,1/30/2017,2017,73.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1943,1/30/2017,2017,73.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1942,2/20/2017,2017,75,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1942,2/20/2017,2017,75,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1954,2/22/2017,2017,62.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1954,2/22/2017,2017,62.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1955,2/27/2017,2017,61.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1955,2/27/2017,2017,61.5,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/30/1955,2/27/2017,2017,61.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1944,3/1/2017,2017,73,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1944,3/1/2017,2017,73,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/7/1944,3/1/2017,2017,73,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1952,3/8/2017,2017,64.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/3/1952,3/8/2017,2017,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1943,3/8/2017,2017,73.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1943,3/8/2017,2017,73.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/14/1943,3/8/2017,2017,73.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1952,3/9/2017,2017,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1945,4/3/2017,2017,71.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1945,4/3/2017,2017,72,White,Non-Hispanic,White,Female,31603,PrE0504; Pro20160000163,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/22/1955,4/24/2017,2017,61.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1955,4/24/2017,2017,61.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/5/1960,4/24/2017,2017,57.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1960,4/24/2017,2017,57.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1944,5/1/2017,2017,72.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1946,5/1/2017,2017,70.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1946,5/1/2017,2017,70.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1962,5/24/2017,2017,55.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1962,5/24/2017,2017,55.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1948,6/5/2017,2017,68.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1948,6/5/2017,2017,68.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1952,6/15/2017,2017,65.5,White,Non-Hispanic,White,Female,131604,20170000115,Lung and Bronchus,Lung and Bronchus,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/1955,6/19/2017,2017,62,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1955,6/19/2017,2017,62,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1951,6/19/2017,2017,65.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1951,6/19/2017,2017,65.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/6/1951,6/19/2017,2017,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/6/1972,6/26/2017,2017,45.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1972,6/26/2017,2017,45.1,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/6/1972,6/26/2017,2017,45.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1950,6/26/2017,2017,66.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1970,6/26/2017,2017,47.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1970,6/26/2017,2017,47.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1957,6/28/2017,2017,59.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/15/1957,6/28/2017,2017,59.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1940,6/28/2017,2017,77.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1940,6/28/2017,2017,77.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/30/1940,6/28/2017,2017,77.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1946,6/28/2017,2017,71.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1946,6/28/2017,2017,71.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/22/1946,6/28/2017,2017,71.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1953,7/3/2017,2017,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1953,7/3/2017,2017,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1968,7/10/2017,2017,49.6,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Male,131604,20170000115,Lung and Bronchus,Lung and Bronchus,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/10/1940,7/10/2017,2017,76.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1940,7/10/2017,2017,76.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1957,7/10/2017,2017,60,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1957,7/10/2017,2017,60,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1959,7/17/2017,2017,58.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1959,7/17/2017,2017,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1993,7/19/2017,2017,24.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1993,7/19/2017,2017,24.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/19/1993,7/19/2017,2017,24.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1955,7/21/2017,2017,61.9,White,Hispanic or Latino,Hispanic/Latino,Female,31610,9903; NCI CIRB Pro20160001439,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/6/1956,7/31/2017,2017,61.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1956,7/31/2017,2017,61.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1948,7/31/2017,2017,69.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1948,7/31/2017,2017,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1948,8/2/2017,2017,68.8,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
9/5/1935,8/7/2017,2017,82,White,Non-Hispanic,White,Male,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/12/1949,8/10/2017,2017,67.7,White,Non-Hispanic,White,Male,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
8/31/1951,8/28/2017,2017,66,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1951,8/28/2017,2017,66,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1962,8/28/2017,2017,54.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1962,8/28/2017,2017,54.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1968,9/5/2017,2017,49.7,White,Hispanic or Latino,Hispanic/Latino,Male,31701,M16-300; Pro20170000274-WIRB 20170636,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/10/1941,9/6/2017,2017,76.6,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
6/10/1937,9/6/2017,2017,80.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/10/1937,9/6/2017,2017,80.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1950,9/11/2017,2017,66.9,White,Non-Hispanic,White,Female,31603,PrE0504; Pro20160000163,Lung and Bronchus,Lung and Bronchus,"Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/3/1940,9/13/2017,2017,77,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1940,9/13/2017,2017,77,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1937,9/15/2017,2017,80.5,White,Non-Hispanic,White,Male,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/16/1970,9/18/2017,2017,47.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1970,9/18/2017,2017,47.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1952,9/18/2017,2017,64.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1952,9/18/2017,2017,64.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1950,9/18/2017,2017,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1943,9/18/2017,2017,74.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1943,9/18/2017,2017,74.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1945,9/22/2017,2017,72.5,White,Non-Hispanic,White,Female,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
9/9/1979,10/5/2017,2017,38.1,Asian,Non-Hispanic,Asian,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
11/28/1958,10/5/2017,2017,58.9,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,Neuroendocrine Carcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
4/29/1959,10/5/2017,2017,58.5,White,Non-Hispanic,White,Male,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,Adenosquamous Carcinoma,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1951,10/5/2017,2017,66,White,Non-Hispanic,White,Male,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1935,10/9/2017,2017,82,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1935,10/9/2017,2017,82,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1960,10/10/2017,2017,57.5,Black or African American,Non-Hispanic,Black,Female,31701,M16-300; Pro20170000274-WIRB 20170636,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/30/1956,10/12/2017,2017,61.5,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
3/6/1950,10/12/2017,2017,67.6,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,Mucinous Adenocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
11/27/1943,10/19/2017,2017,73.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1943,10/19/2017,2017,73.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1938,10/20/2017,2017,78.9,Asian,Non-Hispanic,Asian,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
7/16/1970,10/26/2017,2017,47.3,Black or African American,Non-Hispanic,Black,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
3/28/1947,10/30/2017,2017,70.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1947,10/30/2017,2017,70.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/2009,11/1/2017,2017,8.7,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/4/1965,11/1/2017,2017,52.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1965,11/1/2017,2017,52.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/4/1965,11/1/2017,2017,52.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1940,11/10/2017,2017,77.2,White,Non-Hispanic,White,Female,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/8/1928,11/13/2017,2017,89.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1928,11/13/2017,2017,89.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1935,11/14/2017,2017,82.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1935,11/14/2017,2017,82.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/15/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/30/1983,11/15/2017,2017,34.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1983,11/15/2017,2017,34.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/30/1983,11/15/2017,2017,34.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1951,11/17/2017,2017,66.1,White,Non-Hispanic,White,Male,31608,EA5142; NCI CIRB Pro20160000720,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/30/1694,11/17/2017,2017,,White,Non-Hispanic,White,Female,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/10/1950,11/17/2017,2017,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1950,11/17/2017,2017,67.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/10/1950,11/17/2017,2017,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1945,11/20/2017,2017,72.8,White,Non-Hispanic,White,Male,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1950,11/20/2017,2017,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1961,11/30/2017,2017,56.6,Black or African American,Non-Hispanic,Black,Female,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1968,12/4/2017,2017,49.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1968,12/4/2017,2017,49.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1945,12/4/2017,2017,72,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1968,12/4/2017,2017,49,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/1/1947,12/4/2017,2017,70.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1932,12/6/2017,2017,85.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1932,12/6/2017,2017,85.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/8/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/12/2017,2017,,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1714,Pro20170000634,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/12/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/30/1939,12/18/2017,2017,78.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1939,12/18/2017,2017,78.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/27/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/8/1968,1/12/2018,2018,49.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1968,1/12/2018,2018,49.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1944,1/29/2018,2018,73.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1944,1/29/2018,2018,73.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/6/1944,1/29/2018,2018,73.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1949,2/13/2018,2018,68.3,White,Hispanic or Latino,Hispanic/Latino,Male,31701,M16-300; Pro20170000274-WIRB 20170636,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/24/1944,2/13/2018,2018,74.1,White,Non-Hispanic,White,Male,51707,20170000453,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/23/1962,2/13/2018,2018,55.6,White,Non-Hispanic,White,Female,31701,M16-300; Pro20170000274-WIRB 20170636,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/15/1947,2/14/2018,2018,71,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/15/1947,2/14/2018,2018,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1947,2/14/2018,2018,70.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1947,2/14/2018,2018,70.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/29/1947,2/14/2018,2018,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1939,2/19/2018,2018,78.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1939,2/19/2018,2018,78.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/2/1939,2/19/2018,2018,78.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1952,2/19/2018,2018,65.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1952,2/19/2018,2018,65.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1935,2/23/2018,2018,82.4,White,Non-Hispanic,White,Male,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/1/1957,2/28/2018,2018,61,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1957,2/28/2018,2018,61,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/1/1957,2/28/2018,2018,61,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1970,3/6/2018,2018,47.7,Black or African American,Non-Hispanic,Black,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/1/1957,3/12/2018,2018,61,Black or African American,Non-Hispanic,Black,Female,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/9/1929,3/26/2018,2018,89.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/9/1929,3/26/2018,2018,89.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1965,4/4/2018,2018,53,White,Non-Hispanic,White,Male,31603,PrE0504; Pro20160000163,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Lung / Head and Neck,Developmental Therapeutics-phase I; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
5/20/1952,4/4/2018,2018,65.9,White,Non-Hispanic,White,Male,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/25/1963,4/9/2018,2018,54.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1963,4/9/2018,2018,54.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/8/1960,4/18/2018,2018,58.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/8/1960,4/18/2018,2018,58.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/8/1960,4/18/2018,2018,58.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1936,4/25/2018,2018,81.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1936,4/25/2018,2018,81.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/5/1936,4/25/2018,2018,81.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1947,4/30/2018,2018,71.2,White,Non-Hispanic,White,Male,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1952,4/30/2018,2018,66.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1952,4/30/2018,2018,66.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1949,5/9/2018,2018,68.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1949,5/9/2018,2018,68.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/12/1949,5/9/2018,2018,68.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1947,5/25/2018,2018,71.2,White,Non-Hispanic,White,Male,31608,EA5142; NCI CIRB Pro20160000720,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
6/22/1960,5/25/2018,2018,58,White,Non-Hispanic,White,Female,31507,MK-3475-218 / MISP 52658; Pro20150002247,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck; Radiation Oncology,Developmental Therapeutics-phase I; Lung / Head and Neck; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/9/1944,5/31/2018,2018,74.2,Asian,Non-Hispanic,Asian,Female,31801,B7461020; Pro2018000039-WIRB 20171374,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/15/1961,6/14/2018,2018,56.7,White,Hispanic or Latino,Hispanic/Latino,Female,31702,PrE0505; Pro20170000273,Lung and Bronchus,Lung and Bronchus,"Mesothelioma, Biphasic, Malignant",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
8/26/1934,6/18/2018,2018,83.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1934,6/18/2018,2018,83.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/19/1940,6/18/2018,2018,77.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/19/1940,6/18/2018,2018,77.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1944,6/27/2018,2018,74.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1944,6/27/2018,2018,74.4,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/1/1944,6/27/2018,2018,74.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1961,7/3/2018,2018,57.2,Black or African American,Non-Hispanic,Black,Female,31502,E4512; NCI CIRB Pro20150001767,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
5/18/1953,7/6/2018,2018,65.2,White,Non-Hispanic,White,Female,51707,20170000453,Lung and Bronchus,Lung and Bronchus,"Mesothelioma, Malignant",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/31/1974,7/9/2018,2018,43.9,Asian,Non-Hispanic,Asian,Male,31801,B7461020; Pro2018000039-WIRB 20171374,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/12/1942,7/11/2018,2018,76.4,White,Non-Hispanic,White,Male,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1967,7/17/2018,2018,50.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1967,7/17/2018,2018,50.8,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/3/1967,7/17/2018,2018,50.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1957,7/17/2018,2018,61.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1957,7/17/2018,2018,61.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1958,7/23/2018,2018,59.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1958,7/23/2018,2018,59.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1941,7/25/2018,2018,77,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1941,7/25/2018,2018,77,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/16/1941,7/25/2018,2018,77,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1954,7/25/2018,2018,64.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1954,7/25/2018,2018,64.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/7/1954,7/25/2018,2018,64.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1946,7/30/2018,2018,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1946,7/30/2018,2018,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1944,7/30/2018,2018,73.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1944,7/30/2018,2018,73.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1935,8/1/2018,2018,82.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1935,8/1/2018,2018,82.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1957,8/6/2018,2018,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1957,8/6/2018,2018,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1951,8/6/2018,2018,67.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/19/1951,8/6/2018,2018,67.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1939,8/6/2018,2018,79.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/27/1939,8/6/2018,2018,79.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/14/1952,8/8/2018,2018,66.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/12/1936,8/15/2018,2018,82.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1936,8/15/2018,2018,82.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/12/1936,8/15/2018,2018,82.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1962,8/20/2018,2018,56.2,White,Non-Hispanic,White,Male,31801,B7461020; Pro2018000039-WIRB 20171374,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,N/A,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
7/11/1967,9/6/2018,2018,51.2,Black or African American,Non-Hispanic,Black,Male,31801,B7461020; Pro2018000039-WIRB 20171374,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,N/A,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/9/1958,9/7/2018,2018,60.5,White,Non-Hispanic,White,Female,31805,BTCRC-LUN17-127; BTCTC-LUN17-127; Pro2018000959,Lung and Bronchus,Lung and Bronchus,Neuroendocrine Carcinoma,Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/19/1950,9/13/2018,2018,68.6,White,Non-Hispanic,White,Male,51707,20170000453,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/25/1958,9/21/2018,2018,60.6,White,Non-Hispanic,White,Female,51803,NKTR-214; WIRB20170743  PRO2018000740,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/28/1946,9/24/2018,2018,72.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1946,9/24/2018,2018,72.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1959,10/5/2018,2018,59.4,Black or African American,Non-Hispanic,Black,Female,51707,20170000453,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/28/1946,10/31/2018,2018,72.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/17/1943,11/5/2018,2018,75.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1943,11/5/2018,2018,75.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/17/1943,11/5/2018,2018,75.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1963,11/14/2018,2018,55.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1963,11/14/2018,2018,55.9,White,Hispanic or Latino,Hispanic/Latino,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/2/1963,11/14/2018,2018,55.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1970,11/14/2018,2018,48.1,Asian,Non-Hispanic,Asian,Female,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,Adenocarcinoma With Mixed Subtypes,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1934,11/14/2018,2018,84.3,White,Non-Hispanic,White,Female,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1931,11/21/2018,2018,87.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1931,11/21/2018,2018,87.8,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/8/1931,11/21/2018,2018,87.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1943,11/28/2018,2018,75.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1943,11/28/2018,2018,75.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/5/1943,11/28/2018,2018,75.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1949,11/28/2018,2018,69,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1949,11/28/2018,2018,69,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/27/1949,11/28/2018,2018,69,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1942,12/17/2018,2018,76.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1942,12/17/2018,2018,76.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1943,12/19/2018,2018,75.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/10/1943,12/19/2018,2018,75.7,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/10/1943,12/19/2018,2018,75.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1945,12/19/2018,2018,73.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1945,12/19/2018,2018,73.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/22/1945,12/19/2018,2018,73.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1956,1/9/2019,2019,62.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1956,1/9/2019,2019,62.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/24/1956,1/9/2019,2019,62.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1946,1/14/2019,2019,72.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1946,1/14/2019,2019,72.4,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/22/1946,1/14/2019,2019,72.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1963,1/15/2019,2019,55.9,Asian,Non-Hispanic,Asian,Male,71706,10021; NCI CIRB Pro20170001183,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
8/28/1946,1/15/2019,2019,72.4,White,Non-Hispanic,White,Female,31504,A151216; NCI CIRB                   Pro20150001769 ,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1968,1/16/2019,2019,50.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1968,1/16/2019,2019,50.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/20/1968,1/16/2019,2019,50.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1946,1/23/2019,2019,72.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1946,1/23/2019,2019,72.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/2/1946,1/23/2019,2019,72.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1949,1/28/2019,2019,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1949,1/28/2019,2019,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1962,1/30/2019,2019,56.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1962,1/30/2019,2019,56.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/7/1962,1/30/2019,2019,56.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1943,1/31/2019,2019,75.8,White,Non-Hispanic,White,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/18/1947,2/4/2019,2019,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1947,2/4/2019,2019,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1945,2/11/2019,2019,73.2,Black or African American,Non-Hispanic,Black,Male,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/24/1940,2/11/2019,2019,78.9,White,Non-Hispanic,White,Male,31805,BTCRC-LUN17-127; BTCTC-LUN17-127; Pro2018000959,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/12/1947,2/15/2019,2019,72.1,Asian,Non-Hispanic,Asian,Female,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/19/1950,2/15/2019,2019,69,White,Non-Hispanic,White,Male,51513,9782; NCI CIRB Pro20160000225,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/6/1942,2/18/2019,2019,76.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1942,2/18/2019,2019,76.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/6/1942,2/18/2019,2019,76.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1959,2/18/2019,2019,59.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1959,2/18/2019,2019,59.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1960,2/25/2019,2019,58.9,Black or African American,Non-Hispanic,Black,Male,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
12/27/1951,2/27/2019,2019,67.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1951,2/27/2019,2019,67.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/27/1951,2/27/2019,2019,67.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1962,3/4/2019,2019,57,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1962,3/4/2019,2019,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1952,3/11/2019,2019,66.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1952,3/11/2019,2019,66.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/30/1956,3/11/2019,2019,62.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1956,3/11/2019,2019,62.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1970,3/13/2019,2019,48.4,Asian,Non-Hispanic,Asian,Female,31502,E4512; NCI CIRB Pro20150001767,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
11/20/1942,3/13/2019,2019,76.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/13/1961,3/19/2019,2019,58,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1961,3/19/2019,2019,58,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1953,3/20/2019,2019,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1953,3/20/2019,2019,65.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/17/1953,3/20/2019,2019,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1947,3/20/2019,2019,72.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1947,3/20/2019,2019,72.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1960,3/25/2019,2019,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1960,3/25/2019,2019,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1974,3/27/2019,2019,45,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1974,3/27/2019,2019,45,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/4/1974,3/27/2019,2019,45,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1967,4/1/2019,2019,51.5,White,Hispanic or Latino,Hispanic/Latino,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
9/22/1946,4/8/2019,2019,72.6,Black or African American,Non-Hispanic,Black,Female,31703,BTCRC-LUN15-017; Pro20170000733,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
11/11/1945,4/8/2019,2019,73.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1945,4/8/2019,2019,73.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1939,4/10/2019,2019,79.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1939,4/10/2019,2019,79.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1965,5/6/2019,2019,53.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1965,5/6/2019,2019,53.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1948,5/8/2019,2019,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1948,5/8/2019,2019,70.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/4/1948,5/8/2019,2019,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1956,5/16/2019,2019,63.4,White,Non-Hispanic,White,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/6/1936,5/20/2019,2019,83.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1936,5/20/2019,2019,83.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1957,6/17/2019,2019,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1957,6/17/2019,2019,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1952,6/19/2019,2019,66.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/28/1952,6/19/2019,2019,66.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1949,6/19/2019,2019,69.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1949,6/19/2019,2019,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1956,6/20/2019,2019,62.7,Asian; American Indian or Alaska Native,Non-Hispanic,Asian,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/3/1956,6/20/2019,2019,62.7,Asian; American Indian or Alaska Native,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1943,7/1/2019,2019,76.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1943,7/1/2019,2019,76.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1963,7/1/2019,2019,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1963,7/1/2019,2019,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1956,7/3/2019,2019,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1956,7/3/2019,2019,62.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/14/1956,7/3/2019,2019,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1951,7/3/2019,2019,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/21/1951,7/3/2019,2019,67.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/21/1951,7/3/2019,2019,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1952,7/5/2019,2019,66.9,White,Non-Hispanic,White,Female,31807,MK-3475-799; Pro2018001680; WIRB 20181540  ,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
6/21/1989,7/8/2019,2019,30.1,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/17/1969,7/29/2019,2019,50.1,White,Hispanic or Latino,Hispanic/Latino,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/13/1961,7/29/2019,2019,58.3,White,Non-Hispanic,White,Female,31608,EA5142; NCI CIRB Pro20160000720,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
2/4/1950,7/31/2019,2019,69.5,Asian,Non-Hispanic,Asian,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/21/1951,7/31/2019,2019,67.8,White,Non-Hispanic,White,Male,31807,MK-3475-799; Pro2018001680; WIRB 20181540  ,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
12/6/1945,9/3/2019,2019,73.8,White,Non-Hispanic,White,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/8/1966,9/23/2019,2019,53.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1963,9/23/2019,2019,56.5,Black or African American,Non-Hispanic,Black,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/27/1952,9/23/2019,2019,67.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1952,9/23/2019,2019,67.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1968,9/27/2019,2019,51.1,White,Hispanic or Latino,Hispanic/Latino,Female,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
9/9/1946,9/29/2019,2019,73.1,Asian,Non-Hispanic,Asian,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/29/1953,9/30/2019,2019,65.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1953,9/30/2019,2019,65.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1957,9/30/2019,2019,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1957,9/30/2019,2019,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1936,10/2/2019,2019,83.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1936,10/2/2019,2019,83.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/3/1936,10/2/2019,2019,83.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1936,10/7/2019,2019,82.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1936,10/7/2019,2019,82.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1960,10/11/2019,2019,59.7,White,Hispanic or Latino,Hispanic/Latino,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/8/1963,10/30/2019,2019,56.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1963,10/30/2019,2019,56.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/8/1963,10/30/2019,2019,56.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1964,11/6/2019,2019,55,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1964,11/6/2019,2019,55,White,Non-Hispanic,White,Female,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/30/1964,11/6/2019,2019,55,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1971,11/25/2019,2019,48.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1971,11/25/2019,2019,48.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1955,12/2/2019,2019,64.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1955,12/2/2019,2019,64.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1953,12/20/2019,2019,66.6,White,Non-Hispanic,White,Female,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Lung and Bronchus,Lung and Bronchus,"Mesothelioma, Malignant",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/19/1949,1/3/2020,2020,70.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/6/1955,1/28/2020,2020,64.4,Asian,Non-Hispanic,Asian,Female,31901,BTCRC-LUN17-139; Pro2019000370,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
7/16/1954,2/3/2020,2020,65.6,Asian,Non-Hispanic,Asian,Male,31901,BTCRC-LUN17-139; Pro2019000370,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/28/1953,2/3/2020,2020,66.3,White,Non-Hispanic,White,Male,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
6/14/1957,2/12/2020,2020,62.7,White,Hispanic or Latino,Hispanic/Latino,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
9/11/1947,2/17/2020,2020,72.5,Black or African American,Non-Hispanic,Black,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
6/12/1949,2/17/2020,2020,70.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1949,2/17/2020,2020,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lung and Bronchus,Lung and Bronchus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1953,2/18/2020,2020,66.6,White,Non-Hispanic,White,Female,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
5/3/1936,2/21/2020,2020,83.9,White,Non-Hispanic,White,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Squamous Cell Carcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
5/3/1936,2/24/2020,2020,83.9,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,NTS / Lab Studies,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1947,3/3/2020,2020,72.9,Black or African American,Non-Hispanic,Black,Male,31807,MK-3475-799; Pro2018001680; WIRB 20181540  ,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/8/1946,3/3/2020,2020,74,White,Non-Hispanic,White,Female,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1941,3/6/2020,2020,78.6,Black or African American,Non-Hispanic,Black,Female,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1941,3/16/2020,2020,78.6,Black or African American,Non-Hispanic,Black,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
6/2/1945,3/16/2020,2020,74.8,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1946,4/6/2020,2020,74.1,White,Non-Hispanic,White,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/28/1953,4/16/2020,2020,66.5,White,Non-Hispanic,White,Male,31923,10266; NCI CIRB Pro2019002426,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/30/1970,4/21/2020,2020,49.5,White,Hispanic or Latino,Hispanic/Latino,Female,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
8/6/1957,6/4/2020,2020,62.9,White,Non-Hispanic,White,Female,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/24/1956,6/29/2020,2020,64.3,White,Non-Hispanic,White,Male,31921,NCI CIRB Pro2019002333; NRG-LU005,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Lung / Head and Neck,Phase II/III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
9/24/1948,7/6/2020,2020,71.8,White,Hispanic or Latino,Hispanic/Latino,Male,31901,BTCRC-LUN17-139; Pro2019000370,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
5/5/1938,7/17/2020,2020,82.3,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,Non-Small Cell Carcinoma,Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1938,7/27/2020,2020,82.3,White,Non-Hispanic,White,Male,31706,BTCRC-LUN16-081; Pro20170001835,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
3/22/1985,8/26/2020,2020,35.5,White,Non-Hispanic,White,Male,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
7/13/1955,9/1/2020,2020,65.2,Black or African American,Non-Hispanic,Black,Female,31917,MK3475-867-00; Pro2019001274-WIRB 20190703,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
10/30/1970,9/18/2020,2020,49.9,White,Hispanic or Latino,Hispanic/Latino,Female,31923,10266; NCI CIRB Pro2019002426,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/11/1977,9/21/2020,2020,43.7,Black or African American,Non-Hispanic,Black,Female,32003,20200319        Pro20200000762; MK7339-012,Lung and Bronchus,Lung and Bronchus,,Lung / Head and Neck,Phase III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/8/1963,9/21/2020,2020,57.5,White,Non-Hispanic,White,Female,171801,PICI0009; Pro2018002367 ,Lung and Bronchus,Lung and Bronchus,"Small Cell Carcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1953,9/25/2020,2020,67.5,White,Non-Hispanic,White,Male,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,Lung and Bronchus,Lung and Bronchus,Melanoma In Situ,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/5/1983,10/2/2020,2020,37.3,White,Non-Hispanic,White,Male,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Lung and Bronchus,Lung and Bronchus,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/16/1960,10/2/2020,2020,60.6,White,Non-Hispanic,White,Female,31912,Pro2019000923,Lung and Bronchus,Lung and Bronchus,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/11/2008,1/4/2017,2017,9,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Lymph Nodes,Lymph Nodes,"Rhabdomyosarcoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/15/1936,2/3/2017,2017,80.5,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/9/2000,4/5/2017,2017,16.8,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/14/1953,4/13/2017,2017,64.3,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/12/1984,5/2/2017,2017,33.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1984,5/2/2017,2017,33.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1945,5/19/2017,2017,72,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/15/1945,8/7/2017,2017,72.2,White,Non-Hispanic,White,Male,11701,"INCB 50465-202; Pro20170000425, WIRB 20162283",Lymph Nodes,Lymph Nodes,Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ,Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/29/1949,8/14/2017,2017,67.7,White,Non-Hispanic,White,Male,11506,GO29833; Pro20150002688; WIRB20152110,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 2",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/5/1981,8/31/2017,2017,36.5,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/22/1959,9/13/2017,2017,58.1,White,Non-Hispanic,White,Female,21701,CINJ 021701; Pro20170000304,Lymph Nodes,Lymph Nodes,"Malignant Lymphoma, Non-Hodgkin",Leukemia,Early Phase I,Treatment,Leukemia,Leukemia,Interventional,New Brunswick,Enrolled Patients
2/9/1973,10/4/2017,2017,44.7,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/30/1999,10/6/2017,2017,18.4,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
10/13/1958,10/16/2017,2017,59,White,Non-Hispanic,White,Male,11506,GO29833; Pro20150002688; WIRB20152110,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Nos",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/6/1948,10/23/2017,2017,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1948,10/23/2017,2017,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/2000,11/8/2017,2017,17.6,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
4/19/1941,3/14/2018,2018,77,White,Non-Hispanic,White,Female,11604,20150288; Pro20160001380 - WIRB 20162909,Lymph Nodes,Lymph Nodes,"Ml, Mixed Sm. And Lg. Cell, Diffuse",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/7/1991,4/13/2018,2018,26.4,White,Hispanic or Latino,Hispanic/Latino,Male,1610,001610  201209025; Pro20160000426,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
1/4/1936,6/21/2018,2018,82.5,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/2/1943,7/5/2018,2018,74.8,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/29/1955,7/11/2018,2018,63.2,White,Non-Hispanic,White,Female,11805, PrE0403 ; Pro2018000643,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 2",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/21/1956,7/18/2018,2018,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1956,7/18/2018,2018,62.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/21/1956,7/18/2018,2018,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1998,8/14/2018,2018,19.7,White,Hispanic or Latino,Hispanic/Latino,Female,1610,001610  201209025; Pro20160000426,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
6/20/1962,8/15/2018,2018,56.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1962,8/15/2018,2018,56.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1943,9/11/2018,2018,75.1,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Marginal Zone B-Cell Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/30/1962,9/18/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Female,11802,NU 14H09; Pro2018000332,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/30/1955,9/20/2018,2018,62.8,White,Non-Hispanic,White,Female,11802,NU 14H09; Pro2018000332,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/18/1966,10/1/2018,2018,52.2,White,Non-Hispanic,White,Female,11806, PrE0404 ; Pro2018000749,Lymph Nodes,Lymph Nodes,Mantle Cell Lymphoma,Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/21/1990,10/9/2018,2018,27.8,Asian,Non-Hispanic,Asian,Female,11803,NU 16H08; Pro2018000330,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nod. Scler., Cellular Phase",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/1/1949,11/7/2018,2018,69.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1949,11/7/2018,2018,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1983,12/20/2018,2018,35.2,White,Non-Hispanic,White,Male,11803,NU 16H08; Pro2018000330,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/28/2003,12/22/2018,2018,15.4,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Lymph Nodes,Lymph Nodes,"Marginal Zone B-Cell Lymphoma, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
2/17/1943,1/2/2019,2019,75.9,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/8/1964,2/8/2019,2019,54.6,Multiple (Summary Accrual Only),Hispanic or Latino,Hispanic/Latino,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/9/1968,2/8/2019,2019,50.9,White,Hispanic or Latino,Hispanic/Latino,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/7/1979,2/18/2019,2019,39.5,White,Non-Hispanic,White,Female,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/23/1999,2/21/2019,2019,19.8,White,Non-Hispanic,White,Male,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/4/1943,2/22/2019,2019,75.4,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/3/1948,3/6/2019,2019,70.6,Black or African American,Non-Hispanic,Black,Female,11506,GO29833; Pro20150002688; WIRB20152110,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/19/2002,3/14/2019,2019,16.7,Asian,Non-Hispanic,Asian,Female,111505,AHOD1331; NCI CIRB Pro2019000610,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/5/1969,3/14/2019,2019,49.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1969,3/14/2019,2019,49.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Lymph Nodes,Lymph Nodes,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1955,3/28/2019,2019,64.1,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 2",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/3/1951,4/11/2019,2019,68.3,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 3",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
2/3/1969,4/18/2019,2019,50.2,Asian,Non-Hispanic,Asian,Male,11902,ATA129-EAP-901; WIRB 20182393; Pro2019000321,Lymph Nodes,Lymph Nodes,"Burkitt Lymphoma, Nos",Lymphoma / Myeloma,N/A,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/27/1955,4/24/2019,2019,63.8,Black or African American,Non-Hispanic,Black,Female,11506,GO29833; Pro20150002688; WIRB20152110,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 3",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/11/1963,4/24/2019,2019,55.4,White,Non-Hispanic,White,Female,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/5/1981,4/26/2019,2019,38.2,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/11/1958,5/17/2019,2019,61,White,Non-Hispanic,White,Male,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/6/1951,5/17/2019,2019,68.2,White,Non-Hispanic,White,Female,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 2",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/27/1963,5/24/2019,2019,56.2,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse, Immunoblastic, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
11/1/1947,5/31/2019,2019,71.6,Asian,Non-Hispanic,Asian,Female,11819,54767414MMY3019; Pro2018002493; WIRB 20183053,Lymph Nodes,Lymph Nodes,Multiple Myeloma,Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
1/8/1980,6/7/2019,2019,39.4,Asian,Non-Hispanic,Asian,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
11/21/1966,6/10/2019,2019,52.6,White,Non-Hispanic,White,Male,11802,NU 14H09; Pro2018000332,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/19/1975,6/11/2019,2019,43.8,White,Hispanic or Latino,Hispanic/Latino,Male,11815,BTCRC-HEM15-028; Pro2018001816,Lymph Nodes,Lymph Nodes,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
7/16/1955,6/18/2019,2019,64,White,Hispanic or Latino,Hispanic/Latino,Female,11802,NU 14H09; Pro2018000332,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/25/1956,6/28/2019,2019,63.1,White,Non-Hispanic,White,Female,11805, PrE0403 ; Pro2018000643,Lymph Nodes,Lymph Nodes,"Follicular Lymphoma, Grade 3",Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
8/28/1987,7/15/2019,2019,31.9,Asian,Non-Hispanic,Asian,Female,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Lymphocytic Deplet., Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/9/1954,7/29/2019,2019,64.8,White,Non-Hispanic,White,Female,11802,NU 14H09; Pro2018000332,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
6/29/1976,9/6/2019,2019,43.2,White,Non-Hispanic,White,Male,11411,R1979-HM-1333; WIRB 20142456; 20140000898,Lymph Nodes,Lymph Nodes,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/17/2003,9/18/2019,2019,16.4,White,Non-Hispanic,White,Female,111907,NCI CIRB Pro2019002127; S1826,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Pediatric Oncology,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/6/1957,10/3/2019,2019,62.5,Black or African American,Non-Hispanic,Black,Female,11815,BTCRC-HEM15-028; Pro2018001816,Lymph Nodes,Lymph Nodes,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/15/1963,12/9/2019,2019,56.6,White,Non-Hispanic,White,Male,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
3/23/1987,2/4/2020,2020,32.9,Black or African American,Non-Hispanic,Black,Female,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/25/1982,3/23/2020,2020,37.9,White,Non-Hispanic,White,Female,11505,E4412; NCI CIRB Pro2018002913,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
4/14/1989,3/26/2020,2020,31,Unknown,Hispanic or Latino,Hispanic/Latino,Female,111907,NCI CIRB Pro2019002127; S1826,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/21/2007,4/3/2020,2020,12.5,Unknown,Hispanic or Latino,Hispanic/Latino,Male,111907,NCI CIRB Pro2019002127; S1826,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/8/2003,4/13/2020,2020,17.1,Unknown,Non-Hispanic,Unknown,Female,111907,NCI CIRB Pro2019002127; S1826,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/4/1998,5/29/2020,2020,22.2,Unknown,Non-Hispanic,Unknown,Male,111907,NCI CIRB Pro2019002127; S1826,Lymph Nodes,Lymph Nodes,"Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/2/1953,8/2/2017,2017,64.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,"Major salivary gland, NOS",Head & Neck,Adenoid Cystic Carcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
7/12/1989,9/6/2017,2017,28.2,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,"Major salivary gland, NOS",Head & Neck,Mucoepidermoid Carcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
5/2/1953,2/9/2018,2018,64.8,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,51712,INCAGN 1949-201; WIRB 20171333                      Pro20170001199,"Major salivary gland, NOS",Head & Neck,Adenoid Cystic Carcinoma,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/5/1974,5/1/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Major salivary gland, NOS",Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/5/1974,5/1/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,"Major salivary gland, NOS",Head & Neck,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/5/1974,5/1/2018,2018,44.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Major salivary gland, NOS",Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/2004,11/26/2019,2019,15,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,"Major salivary gland, NOS",Head & Neck,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/14/1948,2/18/2020,2020,71.3,White,Hispanic or Latino,Hispanic/Latino,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,"Major salivary gland, NOS",Head & Neck,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/8/2000,6/9/2017,2017,17.2,White,Non-Hispanic,White,Female,110721,ACCRN07; NCI CIRB Pro0220080053,"Mediastinum, NOS","Mediastinum, NOS",Mediastinal Large B-Cell Lymphoma,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/26/1937,1/29/2018,2018,80.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Mediastinum, NOS","Mediastinum, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1937,1/29/2018,2018,80.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Mediastinum, NOS","Mediastinum, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/2016,10/2/2018,2018,1.9,Asian,Non-Hispanic,Asian,Female,111509,APEC14B1; NCI CIRB Pro2019001948,"Mediastinum, NOS","Mediastinum, NOS","Langerhans cell histiocytosis, NOS",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/19/1997,11/9/2018,2018,21.2,Asian,Non-Hispanic,Asian,Female,111505,AHOD1331; NCI CIRB Pro2019000610,"Mediastinum, NOS","Mediastinum, NOS","Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/14/2017,5/6/2019,2019,1.6,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,"Mediastinum, NOS","Mediastinum, NOS","Pleomorphic Rhabdomyosarcoma, Adult Type",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/5/2013,5/10/2019,2019,6.2,White,Non-Hispanic,White,Female,110101,617; ANBL00B1; NCI CIRB Pro0220003367,"Mediastinum, NOS","Mediastinum, NOS","Neuroblastoma, Nos",Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/2017,5/21/2019,2019,1.6,White,Hispanic or Latino,Hispanic/Latino,Male,111604,ARST1431; NCI CIRB Pro20160001097,"Mediastinum, NOS","Mediastinum, NOS",Embryonal Rhabdomyosarcoma,Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
8/28/1982,8/27/2020,2020,38,Asian,Non-Hispanic,Asian,Male,111907,NCI CIRB Pro2019002127; S1826,"Mediastinum, NOS","Mediastinum, NOS","Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
5/14/2005,9/8/2020,2020,15.3,Black or African American,Non-Hispanic,Black,Male,111907,NCI CIRB Pro2019002127; S1826,"Mediastinum, NOS","Mediastinum, NOS","Hodgkin Lymphoma, Mixed Cellularity, Nos",Pediatric Oncology,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
3/1/2005,9/29/2020,2020,15.6,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,"Mediastinum, NOS","Mediastinum, NOS","Hodgkin Lymphoma, Nodular Sclerosis, Nos",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/21/1968,8/14/2018,2018,50.6,Asian,Non-Hispanic,Asian,Female,1610,001610  201209025; Pro20160000426,Meninges,Meninges,"Meningioma, Malignant",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
4/14/1939,8/14/2018,2018,79.4,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Meninges,Meninges,"Meningioma, Malignant",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
8/25/1999,5/22/2017,2017,17.8,Black or African American,Non-Hispanic,Black,Female,110721,ACCRN07; NCI CIRB Pro0220080053,Nasopharynx,Head & Neck,"Neoplasm, Malignant",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/6/1960,8/20/2018,2018,58.1,Black or African American,Non-Hispanic,Black,Male,1610,001610  201209025; Pro20160000426,Nasopharynx,Head & Neck,Lymphoepithelial Carcinoma,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
9/20/1963,10/5/2020,2020,57.1,Asian,Non-Hispanic,Asian,Female,31810,NCI CIRB Pro2018002656; NRG-HN001,Nasopharynx,Head & Neck,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase II/III,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
7/26/1957,1/10/2017,2017,59.5,Black or African American,Non-Hispanic,Black,Male,91501,NCI CIRB Pro20150001173; NRG-BN001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS; Radiation Oncology,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
5/20/1961,2/14/2017,2017,55.8,Black or African American,Non-Hispanic,Black,Male,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/26/1962,4/14/2017,2017,54.8,White,Non-Hispanic,White,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
11/30/1941,5/2/2017,2017,75.5,White,Non-Hispanic,White,Male,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/22/1960,5/22/2017,2017,56.7,White,Non-Hispanic,White,Male,51403,Pro20140000405,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/22/1977,5/25/2017,2017,40.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1963,5/30/2017,2017,54.1,White,Non-Hispanic,White,Male,141501,M13-813; RTOG 3508; WIRB 20151231,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II/III,Treatment,CNS; Radiation Oncology,CNS,Interventional,New Brunswick,Enrolled Patients
9/22/1960,6/28/2017,2017,56.8,White,Non-Hispanic,White,Male,51407,Pro20140000735,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/11/1950,8/7/2017,2017,67.3,White,Non-Hispanic,White,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/28/1962,8/7/2017,2017,54.6,White,Non-Hispanic,White,Male,51403,Pro20140000405,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/18/2001,8/9/2017,2017,15.7,Black or African American,Non-Hispanic,Black,Female,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS",Pineoblastoma,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
2/12/2003,8/9/2017,2017,14.5,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS",Pilocytic Astrocytoma,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
4/26/1940,8/14/2017,2017,77.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1940,8/14/2017,2017,77.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1989,8/15/2017,2017,28.4,White,Hispanic or Latino,Hispanic/Latino,Male,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
11/11/1974,9/11/2017,2017,42.9,White,Hispanic or Latino,Hispanic/Latino,Female,91501,NCI CIRB Pro20150001173; NRG-BN001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS; Radiation Oncology,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
6/21/1958,9/15/2017,2017,59.3,White,Non-Hispanic,White,Female,91501,NCI CIRB Pro20150001173; NRG-BN001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS; Radiation Oncology,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
4/5/2000,9/19/2017,2017,17.5,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS","Astrocytoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
2/4/1988,10/6/2017,2017,29.7,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS","Astrocytoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/5/1967,10/25/2017,2017,49.9,White,Non-Hispanic,White,Female,51403,Pro20140000405,"Nervous system, NOS","Nervous system, NOS","Neoplasm, Malignant",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/5/1949,12/11/2017,2017,68.3,White,Non-Hispanic,White,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/1/1950,12/19/2017,2017,67.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1950,12/19/2017,2017,67.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/1/1950,12/19/2017,2017,67.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1999,2/20/2018,2018,18.6,White,Hispanic or Latino,Hispanic/Latino,Male,111706,APEC1621SC; NCI CIRB Pro20170001553,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",Pediatric Oncology,N/A,Screening,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
10/28/1964,3/6/2018,2018,53.4,Asian,Non-Hispanic,Asian,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/22/1977,3/22/2018,2018,40.3,White,Non-Hispanic,White,Female,141801,10067; NCI CIRB Pro2018000083,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
4/12/1958,3/28/2018,2018,60,White,Non-Hispanic,White,Male,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/9/1999,4/2/2018,2018,18.7,White,Hispanic or Latino,Hispanic/Latino,Male,111706-H,APEC1621H; NCI CIRB Pro20170001553 ,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",Pediatric Oncology,Phase II,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/1/1955,4/12/2018,2018,63.1,White,Non-Hispanic,White,Male,91507,A071102; NCI CIRB Pro20160000412,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II/III,Treatment,CNS,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/2/1998,4/16/2018,2018,19.8,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS","Medulloblastoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
3/30/1951,5/16/2018,2018,67.2,White,Non-Hispanic,White,Male,141801,10067; NCI CIRB Pro2018000083,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
8/4/1960,6/12/2018,2018,57.9,White,Non-Hispanic,White,Male,141601,20170000440; 2401BT-002P,"Nervous system, NOS","Nervous system, NOS",Gliosarcoma,CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
8/28/1985,6/26/2018,2018,32.8,White,Non-Hispanic,White,Female,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
7/26/1957,6/28/2018,2018,61,Black or African American,Non-Hispanic,Black,Male,141801,10067; NCI CIRB Pro2018000083,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
10/24/1961,7/12/2018,2018,56.8,White,Hispanic or Latino,Hispanic/Latino,Male,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
1/12/1955,7/25/2018,2018,63.6,Black or African American,Non-Hispanic,Black,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/12/1955,7/27/2018,2018,63.6,Black or African American,Non-Hispanic,Black,Female,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
3/7/1960,8/10/2018,2018,58.5,White,Non-Hispanic,White,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
8/28/1985,8/14/2018,2018,33,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
3/7/1960,8/21/2018,2018,58.5,White,Non-Hispanic,White,Female,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
11/7/1952,9/6/2018,2018,65.9,White,Non-Hispanic,White,Male,141601,20170000440; 2401BT-002P,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
10/25/1937,9/24/2018,2018,81,White,Non-Hispanic,White,Male,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/16/1954,10/15/2018,2018,64.5,Asian,Non-Hispanic,Asian,Female,141701,2017000033,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
9/5/1949,10/25/2018,2018,69.2,White,Non-Hispanic,White,Female,141801,10067; NCI CIRB Pro2018000083,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
1/12/1940,11/2/2018,2018,78.9,Asian,Non-Hispanic,Asian,Female,51606,RRx001-17-02; WIRB20162458  Pro20160001123,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I; Radiation Oncology,CNS; Developmental Therapeutics-phase I; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/11/1961,11/12/2018,2018,57.8,White,Non-Hispanic,White,Female,141801,10067; NCI CIRB Pro2018000083,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
1/25/1954,11/29/2018,2018,64.9,White,Non-Hispanic,White,Female,91501,NCI CIRB Pro20150001173; NRG-BN001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS; Radiation Oncology,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
12/16/1983,12/10/2018,2018,35,White,Non-Hispanic,White,Male,141803,2018000508  IBC 18-014; GBM-001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I/II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
12/7/1964,12/19/2018,2018,54.1,White,Hispanic or Latino,Hispanic/Latino,Male,141803,2018000508  IBC 18-014; GBM-001,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase I/II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
1/26/1968,2/4/2019,2019,51.1,White,Non-Hispanic,White,Male,141805,2018002068  20182582 WIRB; CL-GBM-P01-US,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
12/19/1966,2/7/2019,2019,52.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/19/1966,2/7/2019,2019,52.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1953,2/13/2019,2019,65.4,White,Non-Hispanic,White,Male,141805,2018002068  20182582 WIRB; CL-GBM-P01-US,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
3/21/1948,3/13/2019,2019,71,White,Non-Hispanic,White,Male,141805,2018002068  20182582 WIRB; CL-GBM-P01-US,"Nervous system, NOS","Nervous system, NOS","Glioblastoma, Nos",CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
11/3/1968,3/18/2019,2019,50.4,White,Non-Hispanic,White,Male,141805,2018002068  20182582 WIRB; CL-GBM-P01-US,"Nervous system, NOS","Nervous system, NOS",,CNS,Phase II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
7/6/1983,8/5/2019,2019,36.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1983,8/5/2019,2019,36.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1977,8/13/2019,2019,41.8,White,Non-Hispanic,White,Male,141807,NCI CIRB Pro2018002173; NRG-BN003,"Nervous system, NOS","Nervous system, NOS","Meningioma, Malignant",CNS,Phase III,Treatment,CNS,CNS; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
8/27/1946,9/26/2019,2019,73.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1946,9/26/2019,2019,73.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1948,10/7/2019,2019,71,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1948,10/7/2019,2019,71,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1943,10/9/2019,2019,76.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1943,10/9/2019,2019,76.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Nervous system, NOS","Nervous system, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/2005,10/30/2019,2019,14.3,White,Non-Hispanic,White,Female,111706,APEC1621SC; NCI CIRB Pro20170001553,"Nervous system, NOS","Nervous system, NOS","Glioma, Malignant",Pediatric Oncology,N/A,Screening,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/24/1957,11/5/2019,2019,62.2,White,Hispanic or Latino,Hispanic/Latino,Female,141806,2012-ONC-102; Advarra # 00030215  Pro 2018002107  ,"Nervous system, NOS","Nervous system, NOS","Chondrosarcoma, Nos",CNS,Phase I/II,Treatment,CNS,CNS,Interventional,New Brunswick,Enrolled Patients
5/8/1965,9/6/2017,2017,52.4,White,Hispanic or Latino,Hispanic/Latino,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Oropharnyx,Head & Neck,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
5/29/1952,9/6/2017,2017,65.3,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Other and Ill-Defined Sites,Other and Ill-Defined Sites,"Squamous Cell Carcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
2/8/1988,8/23/2020,2020,32.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Other and Ill-Defined Sites,Other and Ill-Defined Sites,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1939,11/27/2018,2018,79.4,White,Non-Hispanic,White,Female,81802,BMS # CA209-9GC; HCRN GU16-287; Pro2018000875,Other and Unspecified Urinary Organs,Other and Unspecified Urinary Organs,"Papillary Carcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/12/1933,4/25/2019,2019,86.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other and Unspecified Urinary Organs,Other and Unspecified Urinary Organs,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1933,4/25/2019,2019,86.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Other and Unspecified Urinary Organs,Other and Unspecified Urinary Organs,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1958,11/3/2017,2017,59.7,White,Non-Hispanic,White,Male,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Other Digestive,Other Digestive,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/6/1941,9/10/2019,2019,78.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Other Digestive,Other Digestive,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1941,9/10/2019,2019,78.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Other Digestive,Other Digestive,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1949,5/21/2020,2020,71,White,Non-Hispanic,White,Male,52002,10276; NCI CIRB Pro2019002815,Other Digestive,Other Digestive,,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/22/1958,7/30/2020,2020,62.5,White,Non-Hispanic,White,Female,52002,10276; NCI CIRB Pro2019002815,Other Digestive,Other Digestive,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/28/1941,8/12/2020,2020,79.4,White,Hispanic or Latino,Hispanic/Latino,Female,52002,10276; NCI CIRB Pro2019002815,Other Digestive,Other Digestive,"Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/26/1958,9/25/2020,2020,62.1,White,Non-Hispanic,White,Female,52002,10276; NCI CIRB Pro2019002815,Other Digestive,Other Digestive,,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/6/1977,10/8/2020,2020,43.6,White,Non-Hispanic,White,Female,52002,10276; NCI CIRB Pro2019002815,Other Digestive,Other Digestive,"Synovial Sarcoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/20/1974,6/26/2017,2017,42.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1974,6/26/2017,2017,42.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1949,7/7/2017,2017,68.3,Black or African American,Non-Hispanic,Black,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Other Female Genital,Other Female Genital,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/15/1954,7/13/2017,2017,62.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1954,7/13/2017,2017,62.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/15/1961,9/1/2017,2017,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1961,9/1/2017,2017,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1928,10/12/2017,2017,89.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1928,10/12/2017,2017,89.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/20/2017,2017,,Asian,Non-Hispanic,Asian,Female,1714,Pro20170000634,Other Female Genital,Other Female Genital,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/11/1967,1/3/2018,2018,50.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1967,1/3/2018,2018,50.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/8/1962,6/19/2018,2018,55.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1962,6/19/2018,2018,55.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1957,1/11/2019,2019,61.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1957,1/11/2019,2019,61.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1966,10/11/2019,2019,53.3,Black or African American,Non-Hispanic,Black,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,Endometrioid Carcinoma,Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
1/26/1963,11/12/2019,2019,56.8,White,Non-Hispanic,White,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,,Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
5/18/1955,1/17/2020,2020,64.7,Black or African American,Non-Hispanic,Black,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,,Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/30/1955,1/29/2020,2020,64.3,White,Non-Hispanic,White,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,"Clear Cell Adenocarcinoma, Nos",Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
7/4/1969,3/2/2020,2020,50.7,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1969,3/2/2020,2020,50.7,Unknown,Non-Hispanic,Unknown,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1950,3/2/2020,2020,69.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1950,3/2/2020,2020,69.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Other Female Genital,Other Female Genital,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1951,3/13/2020,2020,69,Asian,Non-Hispanic,Asian,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,"Carcinoma, Undifferentiated Type, Nos",Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/31/1965,3/16/2020,2020,54.4,Black or African American,Non-Hispanic,Black,Female,101910,NCI CIRB Pro2019001900; NRG-GY018,Other Female Genital,Other Female Genital,,Gynecologic,Phase III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/15/1951,6/4/2020,2020,69.3,Asian,Non-Hispanic,Asian,Female,102003,NCI CIRB Pro2020000355; NRG-GY022,Other Female Genital,Other Female Genital,"Carcinoma, Undifferentiated Type, Nos",Gynecologic,N/A,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/31/1965,7/7/2020,2020,54.7,Black or African American,Non-Hispanic,Black,Female,102003,NCI CIRB Pro2020000355; NRG-GY022,Other Female Genital,Other Female Genital,,Gynecologic,N/A,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
8/10/1932,7/16/2020,2020,88,White,Non-Hispanic,White,Female,101913,10150; NCI CIRB Pro2019002682,Other Female Genital,Other Female Genital,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
2/6/1959,7/16/2020,2020,61.5,White,Non-Hispanic,White,Female,131901,19488,Other Female Genital,Other Female Genital,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/24/1984,9/13/2017,2017,32.7,Black or African American,Non-Hispanic,Black,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Other Nervous System,Other Nervous System,,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
10/3/2006,12/18/2018,2018,12.2,White,Hispanic or Latino,Hispanic/Latino,Female,111502,AALL1331; NCI CIRB Pro2019001968,Other Nervous System,Other Nervous System,Precursor B-Cell Lymphoblastic Leukemia,Pediatric Oncology,Phase III,Treatment,Leukemia; Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
9/14/1943,1/2/2020,2020,76.4,White,Non-Hispanic,White,Female,141701,2017000033,Other Nervous System,Other Nervous System,"Astrocytoma, Anaplastic",CNS,N/A,Other,CNS,CNS; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
9/6/2011,7/9/2020,2020,8.8,Asian,Non-Hispanic,Asian,Male,111914,ACNS1831; NCI CIRB Pro2020000068,Other Nervous System,Other Nervous System,"Glioblastoma, Nos",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
1/16/1979,1/3/2017,2017,38,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1952,1/20/2017,2017,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1952,1/20/2017,2017,64.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1941,1/25/2017,2017,75.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1941,1/25/2017,2017,75.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1946,2/3/2017,2017,70.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1946,2/3/2017,2017,70.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1944,2/6/2017,2017,72.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1944,2/6/2017,2017,72.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1951,2/7/2017,2017,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1951,2/7/2017,2017,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1965,2/14/2017,2017,51.6,White,Non-Hispanic,White,Female,51605,9825; NCI CIRB Pro20160000710,Ovary,Ovary,Papillary Serous Cystadenocarcinoma,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/19/1979,2/15/2017,2017,37.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1979,2/15/2017,2017,37.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1965,2/15/2017,2017,51.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1965,2/15/2017,2017,51.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1963,2/15/2017,2017,54.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1963,2/15/2017,2017,54.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1958,2/15/2017,2017,58.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/2/1958,2/15/2017,2017,58.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1965,2/16/2017,2017,51.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1965,2/16/2017,2017,51.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1961,2/16/2017,2017,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1961,2/16/2017,2017,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1943,2/17/2017,2017,73.9,Asian,Non-Hispanic,Asian,Female,51605,9825; NCI CIRB Pro20160000710,Ovary,Ovary,Papillary Serous Cystadenocarcinoma,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/4/1950,2/20/2017,2017,66.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/1/1973,2/21/2017,2017,43.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1973,2/21/2017,2017,43.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1952,2/22/2017,2017,64.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1952,2/22/2017,2017,64.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1943,2/27/2017,2017,73.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1943,2/27/2017,2017,73.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1958,3/1/2017,2017,59.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1958,3/1/2017,2017,59.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1954,3/1/2017,2017,63.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1954,3/1/2017,2017,63.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1961,3/2/2017,2017,55.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1961,3/2/2017,2017,55.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1955,3/2/2017,2017,61.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1953,3/17/2017,2017,63.6,White,Non-Hispanic,White,Female,51605,9825; NCI CIRB Pro20160000710,Ovary,Ovary,Papillary Serous Cystadenocarcinoma,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/27/1967,3/21/2017,2017,50,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1967,3/21/2017,2017,50,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1936,3/27/2017,2017,81,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1968,3/28/2017,2017,48.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1968,3/28/2017,2017,48.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1962,4/12/2017,2017,55.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1962,4/12/2017,2017,55.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1963,4/13/2017,2017,54.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1963,4/13/2017,2017,54.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1944,4/17/2017,2017,73,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1944,4/17/2017,2017,73,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1959,4/24/2017,2017,57.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1959,4/24/2017,2017,57.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1972,4/26/2017,2017,44.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1972,4/26/2017,2017,44.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1978,5/1/2017,2017,38.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1978,5/1/2017,2017,38.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1978,5/11/2017,2017,38.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1978,5/11/2017,2017,38.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1944,5/17/2017,2017,72.7,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Ovary,Ovary,"Clear Cell Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/20/1953,5/19/2017,2017,63.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1953,5/19/2017,2017,63.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1973,5/30/2017,2017,44.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1973,5/30/2017,2017,44.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/1/1962,5/31/2017,2017,55.2,White,Non-Hispanic,White,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
4/1/1962,6/8/2017,2017,55.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1962,6/8/2017,2017,55.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1958,6/9/2017,2017,59.2,White,Non-Hispanic,White,Female,51511,CC-486-CAGEN-001; Pro20150002014 WIRB 20141961,Ovary,Ovary,"Papillary Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/1/1946,6/15/2017,2017,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/1941,6/15/2017,2017,75.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1941,6/15/2017,2017,75.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/7/1941,6/15/2017,2017,75.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1978,6/19/2017,2017,38.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/3/1943,6/21/2017,2017,74.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1943,6/21/2017,2017,74.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1948,6/21/2017,2017,68.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1948,6/21/2017,2017,68.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/9/1964,6/22/2017,2017,53.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1964,6/22/2017,2017,53.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1954,6/22/2017,2017,62.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1954,6/22/2017,2017,62.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1940,6/28/2017,2017,77,White,Non-Hispanic,White,Female,51605,9825; NCI CIRB Pro20160000710,Ovary,Ovary,"Serous Cystadenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/20/1958,6/28/2017,2017,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1958,6/28/2017,2017,59.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/20/1958,6/28/2017,2017,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1968,7/13/2017,2017,49.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1968,7/13/2017,2017,49.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1958,7/13/2017,2017,59.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1958,7/13/2017,2017,59.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1952,7/24/2017,2017,65,White,Non-Hispanic,White,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/31/1958,7/31/2017,2017,59.4,Asian,Non-Hispanic,Asian,Female,51701,MDV3800-01; WIRB 20170546  20170000166,Ovary,Ovary,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/12/1965,8/17/2017,2017,52.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1965,8/17/2017,2017,52.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1958,8/25/2017,2017,59.4,Asian,Non-Hispanic,Asian,Female,51702,MDV3800-13; WIRB 20161496  Pro20170000233,Ovary,Ovary,,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/1/1953,9/6/2017,2017,64.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/1/1953,9/6/2017,2017,64.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1965,9/28/2017,2017,51.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1965,9/28/2017,2017,51.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1971,10/5/2017,2017,45.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/25/1971,10/5/2017,2017,45.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1960,10/5/2017,2017,57,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1949,10/9/2017,2017,68.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1949,10/9/2017,2017,68.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1954,10/9/2017,2017,63.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1954,10/9/2017,2017,63.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1971,10/10/2017,2017,46.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1971,10/10/2017,2017,46.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1972,10/10/2017,2017,44.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1972,10/10/2017,2017,44.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1958,10/10/2017,2017,59.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1958,10/10/2017,2017,59.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1955,10/17/2017,2017,62,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1955,10/17/2017,2017,62,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1944,10/17/2017,2017,73.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1944,10/17/2017,2017,73.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/18/1944,10/17/2017,2017,73.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1939,10/18/2017,2017,78.6,White,Non-Hispanic,White,Female,51511,CC-486-CAGEN-001; Pro20150002014 WIRB 20141961,Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/4/1941,10/18/2017,2017,75.9,White,Non-Hispanic,White,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
,11/2/2017,2017,,Black or African American,Non-Hispanic,Black,Female,1714,Pro20170000634,Ovary,Ovary,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/30/1959,11/6/2017,2017,58.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1959,11/6/2017,2017,58.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/30/1959,11/6/2017,2017,58.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1956,11/9/2017,2017,61.9,White,Non-Hispanic,White,Female,51707,20170000453,Ovary,Ovary,"Serous Cystadenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/31/1958,11/22/2017,2017,59.7,Asian,Non-Hispanic,Asian,Female,51511,CC-486-CAGEN-001; Pro20150002014 WIRB 20141961,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,Black or African American,Non-Hispanic,Black,Female,1714,Pro20170000634,Ovary,Ovary,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Ovary,Ovary,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/14/1985,12/6/2017,2017,32.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1985,12/6/2017,2017,32.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1974,12/13/2017,2017,43.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1974,12/13/2017,2017,43.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1946,12/14/2017,2017,71.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1946,12/14/2017,2017,71.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/20/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Ovary,Ovary,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/20/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Ovary,Ovary,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/10/1954,2/1/2018,2018,63.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1954,2/1/2018,2018,63.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/10/1954,2/1/2018,2018,63.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/19/1985,2/6/2018,2018,32.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1985,2/6/2018,2018,32.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1952,2/8/2018,2018,66,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1952,2/8/2018,2018,66,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1976,2/12/2018,2018,41.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/26/1976,2/12/2018,2018,41.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1972,2/15/2018,2018,45.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1972,2/15/2018,2018,45.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1961,2/19/2018,2018,56.8,White,Non-Hispanic,White,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
5/16/1961,3/5/2018,2018,56.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/13/1985,3/5/2018,2018,32.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1985,3/5/2018,2018,32.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1952,3/6/2018,2018,65.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1952,3/6/2018,2018,65.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/25/1952,3/6/2018,2018,65.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1947,3/13/2018,2018,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1947,3/13/2018,2018,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1975,3/14/2018,2018,42.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1975,3/14/2018,2018,42.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1942,3/15/2018,2018,75.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1942,3/15/2018,2018,75.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/5/1942,3/15/2018,2018,75.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1939,3/16/2018,2018,79,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Ovary,Ovary,Serous Surface Papillary Carcinoma,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/5/1942,3/23/2018,2018,75.9,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Ovary,Ovary,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/26/1959,3/27/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1959,3/27/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/14/1956,3/29/2018,2018,62,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1956,3/29/2018,2018,62,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1957,3/30/2018,2018,61.3,White,Non-Hispanic,White,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
8/10/1954,4/4/2018,2018,63.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1954,4/4/2018,2018,63.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1972,4/10/2018,2018,45.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1972,4/10/2018,2018,45.8,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/23/1972,4/10/2018,2018,45.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1958,4/13/2018,2018,60,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Ovary,Ovary,"Papillary Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/1/1969,4/16/2018,2018,48.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1969,4/16/2018,2018,48.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1939,4/16/2018,2018,79.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1939,4/16/2018,2018,79.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/29/1939,4/16/2018,2018,79.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1975,4/18/2018,2018,42.4,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/27/1979,4/18/2018,2018,38.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1979,4/18/2018,2018,38.6,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/27/1979,4/18/2018,2018,38.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1969,4/27/2018,2018,48.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1969,4/27/2018,2018,48.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1944,4/27/2018,2018,73.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1944,4/27/2018,2018,73.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1972,5/2/2018,2018,45.9,Black or African American,Non-Hispanic,Black,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/17/1956,5/14/2018,2018,62.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1956,5/14/2018,2018,62.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1988,6/19/2018,2018,29.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1988,6/19/2018,2018,29.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1941,8/2/2018,2018,77.4,White,Hispanic or Latino,Hispanic/Latino,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
2/20/1960,8/2/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/20/1960,8/2/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1941,8/6/2018,2018,77.4,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/28/1963,8/7/2018,2018,55.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1963,8/7/2018,2018,55.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/28/1963,8/7/2018,2018,55.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1958,8/16/2018,2018,60.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1958,8/16/2018,2018,60.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1960,9/21/2018,2018,58,White,Hispanic or Latino,Hispanic/Latino,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
1/26/1933,9/21/2018,2018,85.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1943,9/28/2018,2018,75.5,Asian,Non-Hispanic,Asian,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/2/1953,9/28/2018,2018,65.1,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/3/1943,10/23/2018,2018,75.6,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Ovary,Ovary,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/12/1955,11/6/2018,2018,63.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,"Clear Cell Adenocarcinoma, Nos",NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1977,11/9/2018,2018,41.7,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1932,11/9/2018,2018,86.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1959,11/9/2018,2018,59.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1972,11/19/2018,2018,46.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1972,11/19/2018,2018,46.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1958,11/26/2018,2018,60.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1961,11/30/2018,2018,57.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1955,12/3/2018,2018,63.5,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1985,12/6/2018,2018,33.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1955,12/6/2018,2018,64,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1960,12/6/2018,2018,58.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1958,12/24/2018,2018,60.7,White,Non-Hispanic,White,Female,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Ovary,Ovary,"Papillary Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/8/1971,12/27/2018,2018,47.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1971,12/27/2018,2018,47.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1971,1/18/2019,2019,47.1,Asian,Non-Hispanic,Asian,Female,51607,Pro20160001310 WIRB 20163000; SPL-006,Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I; Gynecologic,Interventional,New Brunswick,Enrolled Patients
12/26/1929,1/24/2019,2019,89.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1929,1/24/2019,2019,89.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1961,1/28/2019,2019,58.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1961,1/28/2019,2019,58.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1961,1/30/2019,2019,57.7,White,Non-Hispanic,White,Female,51802,10017; NCI CIRB 10017; Pro2018002126,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/9/1957,2/8/2019,2019,61.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1957,2/8/2019,2019,61.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1949,2/26/2019,2019,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1949,2/26/2019,2019,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1959,3/13/2019,2019,59.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1959,3/13/2019,2019,59.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1954,4/8/2019,2019,65.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1954,4/8/2019,2019,65.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1971,4/15/2019,2019,47.3,Asian,Non-Hispanic,Asian,Female,51802,10017; NCI CIRB 10017; Pro2018002126,Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Gynecologic,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/24/1966,5/21/2019,2019,53.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/24/1966,5/21/2019,2019,53.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1940,5/30/2019,2019,79,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1940,5/30/2019,2019,79,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1962,6/17/2019,2019,57.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1962,6/17/2019,2019,57.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1940,6/20/2019,2019,79.3,Black or African American,Non-Hispanic,Black,Female,101905,NCI CIRB Pro2019000670; NRG-GY005,Ovary,Ovary,Endometrioid Carcinoma,Gynecologic,Phase II/III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/30/1976,7/11/2019,2019,43.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1976,7/11/2019,2019,43.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1959,7/23/2019,2019,60.5,White,Hispanic or Latino,Hispanic/Latino,Female,51809,Debio 1347-201; WIRB:20183155  Pro2018002761,Ovary,Ovary,,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/11/1941,7/30/2019,2019,77.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1941,7/30/2019,2019,77.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1950,8/20/2019,2019,69.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1950,8/20/2019,2019,69.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1952,8/22/2019,2019,67.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1952,8/22/2019,2019,67.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1994,9/5/2019,2019,24.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1994,9/6/2019,2019,24.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1959,9/12/2019,2019,59.9,White,Non-Hispanic,White,Female,101905,NCI CIRB Pro2019000670; NRG-GY005,Ovary,Ovary,Serous Adenocarcinofibroma,Gynecologic,Phase II/III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
9/19/1942,9/13/2019,2019,77,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1942,9/13/2019,2019,77,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1963,9/17/2019,2019,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1963,9/17/2019,2019,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1949,9/20/2019,2019,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1949,9/20/2019,2019,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1957,9/27/2019,2019,61.9,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1944,10/3/2019,2019,75.6,White,Non-Hispanic,White,Female,51902,MK-7902-005-00; WIRB 20183068  Pro2018002863,Ovary,Ovary,,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/28/1971,10/18/2019,2019,48.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1984,10/22/2019,2019,35.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1984,10/22/2019,2019,35.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1949,12/18/2019,2019,70.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1949,12/18/2019,2019,70.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1971,12/18/2019,2019,48.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1963,12/31/2019,2019,56.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1963,12/31/2019,2019,56.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1932,1/14/2020,2020,87.5,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,Adenocarcinoma In Tubulovillous Adenoma,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/23/1984,1/24/2020,2020,35.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1984,1/24/2020,2020,35.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1965,2/6/2020,2020,54.6,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,Adenocarcinoma With Mixed Subtypes,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/16/1983,2/13/2020,2020,36.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1983,2/13/2020,2020,36.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Ovary,Ovary,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1950,2/21/2020,2020,69.3,Black or African American,Non-Hispanic,Black,Female,51912,9948; NCI CIRB Pro2019002530,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/29/1964,4/6/2020,2020,55.4,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/18/1938,7/15/2020,2020,82.3,Asian,Non-Hispanic,Asian,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/30/1960,7/17/2020,2020,60.1,White,Non-Hispanic,White,Female,101905,NCI CIRB Pro2019000670; NRG-GY005,Ovary,Ovary,,Gynecologic,Phase II/III,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/17/1970,8/31/2020,2020,49.9,Asian,Non-Hispanic,Asian,Female,131901,19488,Ovary,Ovary,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/13/1979,8/31/2020,2020,41.1,White,Non-Hispanic,White,Female,102005,NCI CIRB Pro2020001725; NRG-CC008,Ovary,Ovary,,Gynecologic,N/A,Prevention,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
5/5/1944,9/1/2020,2020,76.4,White,Non-Hispanic,White,Female,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/25/1955,9/15/2020,2020,65.1,White,Non-Hispanic,White,Female,131901,19488,Ovary,Ovary,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/27/1984,9/16/2020,2020,36.1,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131901,19488,Ovary,Ovary,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/2/1970,10/6/2020,2020,50,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,"Carcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/22/1979,10/27/2020,2020,41.6,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Ovary,Ovary,"Adenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/22/1942,1/4/2017,2017,74.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1942,1/4/2017,2017,74.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1963,1/18/2017,2017,54.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1963,1/18/2017,2017,54.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1970,1/19/2017,2017,46.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1970,1/19/2017,2017,46.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1958,1/26/2017,2017,58.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1958,1/26/2017,2017,58.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1958,2/28/2017,2017,58.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1958,2/28/2017,2017,58.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1938,3/2/2017,2017,78.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1938,3/2/2017,2017,78.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1939,3/7/2017,2017,78.2,White,Non-Hispanic,White,Male,31609,0761-014; Pro20160001000  WIRB#20160268,Pancreas,Pancreas,"Carcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
1/22/1957,3/8/2017,2017,60.2,White,Non-Hispanic,White,Male,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/28/1955,3/8/2017,2017,61.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1955,3/8/2017,2017,61.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1961,3/9/2017,2017,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1941,3/29/2017,2017,76.1,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/6/1971,3/29/2017,2017,45.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/6/1971,3/29/2017,2017,45.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/26/1958,3/30/2017,2017,58.4,White,Hispanic or Latino,Hispanic/Latino,Female,31609,0761-014; Pro20160001000  WIRB#20160268,Pancreas,Pancreas,"Adenocarcinoma, Nos",Lung / Head and Neck,Phase I/II,Treatment,Lung / Head and Neck,Lung / Head and Neck,Interventional,New Brunswick,Enrolled Patients
4/29/1932,3/30/2017,2017,85,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1932,3/30/2017,2017,85,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1936,4/5/2017,2017,80.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1936,4/5/2017,2017,80.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1941,4/19/2017,2017,75.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1941,4/19/2017,2017,75.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/2005,4/28/2017,2017,11.4,White,Non-Hispanic,White,Male,110721,ACCRN07; NCI CIRB Pro0220080053,Pancreas,Pancreas,Embryonal Rhabdomyosarcoma,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/15/1942,5/17/2017,2017,74.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1942,5/17/2017,2017,74.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1934,5/19/2017,2017,82.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1934,5/19/2017,2017,82.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/23/1947,5/30/2017,2017,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/23/1947,5/30/2017,2017,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1956,6/13/2017,2017,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1956,6/13/2017,2017,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1970,6/14/2017,2017,47.2,Black or African American,Non-Hispanic,Black,Female,51516,MK3475-158-02; Pro20150002542  WIRB 20152193,Pancreas,Pancreas,,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/9/1957,6/15/2017,2017,60.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/9/1957,6/15/2017,2017,60.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1932,6/27/2017,2017,85,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1932,6/27/2017,2017,85,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1951,6/27/2017,2017,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1951,6/27/2017,2017,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1939,7/5/2017,2017,77.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1939,7/5/2017,2017,77.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1945,7/5/2017,2017,72.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1945,7/5/2017,2017,72.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1957,7/6/2017,2017,60.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1957,7/6/2017,2017,60.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1949,7/11/2017,2017,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1949,7/11/2017,2017,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1957,8/1/2017,2017,60,White,Non-Hispanic,White,Female,51705,9149; NCI CIRB Pro20170000458,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/29/1961,8/3/2017,2017,55.6,White,Non-Hispanic,White,Male,51602,Pro20160000270 WIRB20160671; RRx001-16-01,Pancreas,Pancreas,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I; Gastrointestinal,Developmental Therapeutics-phase I; Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
1/17/1931,8/3/2017,2017,86.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1931,8/3/2017,2017,86.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1938,8/9/2017,2017,79.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1938,8/9/2017,2017,79.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1951,8/10/2017,2017,65.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1951,8/10/2017,2017,65.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1945,8/15/2017,2017,72.6,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Pancreas,Pancreas,Mucinous Adenocarcinoma,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
8/7/1947,9/14/2017,2017,70.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1947,9/14/2017,2017,70.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1978,9/27/2017,2017,38.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1978,9/27/2017,2017,38.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1936,9/27/2017,2017,80.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1936,9/27/2017,2017,80.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1949,9/28/2017,2017,68,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1949,9/29/2017,2017,68,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1938,10/17/2017,2017,79.7,White,Non-Hispanic,White,Female,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
7/31/1956,10/24/2017,2017,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1956,10/24/2017,2017,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1963,10/31/2017,2017,54.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1963,10/31/2017,2017,54.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/28/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Pancreas,Pancreas,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/16/1959,12/6/2017,2017,58.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1959,12/6/2017,2017,58.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1959,12/7/2017,2017,58.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/27/1959,12/7/2017,2017,58.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1946,12/7/2017,2017,72,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1946,12/7/2017,2017,72,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,12/8/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Pancreas,Pancreas,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/8/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Pancreas,Pancreas,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/18/1955,12/12/2017,2017,62.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1955,12/12/2017,2017,62.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1955,12/27/2017,2017,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1955,12/27/2017,2017,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1963,1/5/2018,2018,54.9,White,Non-Hispanic,White,Male,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/10/1963,1/8/2018,2018,54.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1963,1/8/2018,2018,54.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/10/1963,1/8/2018,2018,54.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1942,1/10/2018,2018,75.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1942,1/10/2018,2018,75.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1948,1/12/2018,2018,69.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1948,1/12/2018,2018,69.9,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/11/1948,1/12/2018,2018,69.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1947,1/16/2018,2018,70.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1947,1/16/2018,2018,70.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1949,1/23/2018,2018,68.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1949,1/23/2018,2018,68.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1946,1/25/2018,2018,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1946,1/25/2018,2018,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1969,2/13/2018,2018,48.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1969,2/13/2018,2018,48.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1959,2/14/2018,2018,58.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1959,2/14/2018,2018,58.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1938,2/23/2018,2018,79.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1938,2/23/2018,2018,79.6,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/9/1938,2/23/2018,2018,79.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1977,2/27/2018,2018,41,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1977,2/27/2018,2018,41,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1932,2/28/2018,2018,85.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1932,2/28/2018,2018,85.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1943,3/20/2018,2018,74.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1943,3/20/2018,2018,74.9,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/1/1943,3/20/2018,2018,74.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1963,3/26/2018,2018,55.1,White,Non-Hispanic,White,Male,51513,9782; NCI CIRB Pro20160000225,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/22/1957,4/26/2018,2018,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1957,4/26/2018,2018,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1983,5/1/2018,2018,35.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1983,5/1/2018,2018,35.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1925,5/1/2018,2018,93.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1925,5/1/2018,2018,93.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1946,5/1/2018,2018,71.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1946,5/1/2018,2018,71.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1925,5/7/2018,2018,93.3,White,Non-Hispanic,White,Male,71805,Pro2018000419,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1938,5/9/2018,2018,79.6,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1938,5/9/2018,2018,79.6,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1972,5/9/2018,2018,46.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1972,5/9/2018,2018,46.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1964,5/30/2018,2018,54.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1966,6/5/2018,2018,52.3,White,Non-Hispanic,White,Male,71805,Pro2018000419,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1966,6/5/2018,2018,52.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1962,6/19/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1962,6/19/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1957,6/25/2018,2018,61.3,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/4/1946,7/13/2018,2018,71.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1946,7/13/2018,2018,71.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/4/1946,7/13/2018,2018,71.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1948,7/17/2018,2018,70.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1948,7/17/2018,2018,70.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1945,7/18/2018,2018,72.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1945,7/18/2018,2018,72.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/11/1945,7/18/2018,2018,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1959,7/24/2018,2018,59.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1959,7/24/2018,2018,59.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/21/1966,7/31/2018,2018,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1948,8/14/2018,2018,70.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/9/1950,8/22/2018,2018,67.9,White,Non-Hispanic,White,Female,71802,1608018265; Pro2018000102; Yale HIC# 1608018265 ,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
2/26/1977,9/11/2018,2018,41.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1977,9/11/2018,2018,41.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1972,9/18/2018,2018,46,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/12/1972,9/18/2018,2018,46,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1954,9/21/2018,2018,64.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1954,9/21/2018,2018,64.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1951,9/27/2018,2018,67.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1951,9/27/2018,2018,67.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1931,9/27/2018,2018,87.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1931,9/27/2018,2018,87.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1946,10/4/2018,2018,72.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1946,10/4/2018,2018,72.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1958,10/4/2018,2018,60.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1958,10/4/2018,2018,60.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1948,10/9/2018,2018,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1948,10/9/2018,2018,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1954,10/9/2018,2018,63.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1954,10/9/2018,2018,63.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1960,10/10/2018,2018,58.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1960,10/10/2018,2018,58.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1939,10/10/2018,2018,78.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1939,10/10/2018,2018,78.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1939,10/22/2018,2018,78.9,White,Non-Hispanic,White,Male,71805,Pro2018000419,Pancreas,Pancreas,Adenocarcinoma In Situ,Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1955,11/9/2018,2018,63.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1943,11/13/2018,2018,75.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1943,11/13/2018,2018,75.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1960,11/14/2018,2018,58.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1960,11/14/2018,2018,58.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1944,11/14/2018,2018,74,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1944,11/14/2018,2018,74,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1939,11/19/2018,2018,79,White,Non-Hispanic,White,Male,71803,I5B-MC-JGDP(b); WIRB 20170768           Pro2018000144,Pancreas,Pancreas,Adenocarcinoma In Situ,Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
6/20/1938,11/30/2018,2018,80.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1958,12/3/2018,2018,60.7,White,Non-Hispanic,White,Female,71805,Pro2018000419,Pancreas,Pancreas,Adenocarcinoma In Situ,Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1929,12/3/2018,2018,89.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1929,12/3/2018,2018,89.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1932,12/10/2018,2018,86.5,White,Non-Hispanic,White,Female,71802,1608018265; Pro2018000102; Yale HIC# 1608018265 ,Pancreas,Pancreas,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
12/13/1944,12/13/2018,2018,74,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1944,12/13/2018,2018,74,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1951,12/17/2018,2018,67.5,White,Non-Hispanic,White,Male,51611,MGA012; WIRB 20170715 Pro20160001577,Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/6/1946,12/19/2018,2018,72.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1946,12/19/2018,2018,72.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1955,12/20/2018,2018,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1955,12/20/2018,2018,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1966,1/7/2019,2019,52.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1966,1/7/2019,2019,52.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/19/1966,1/7/2019,2019,52.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1966,1/14/2019,2019,52.3,White,Non-Hispanic,White,Male,71803,I5B-MC-JGDP(b); WIRB 20170768           Pro2018000144,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
11/30/1954,1/16/2019,2019,64.2,White,Non-Hispanic,White,Male,71803,I5B-MC-JGDP(b); WIRB 20170768           Pro2018000144,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
4/22/1940,1/23/2019,2019,78.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1940,1/23/2019,2019,78.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1953,1/30/2019,2019,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1953,1/30/2019,2019,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1962,1/31/2019,2019,56.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1962,1/31/2019,2019,56.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1939,2/15/2019,2019,79.5,White,Non-Hispanic,White,Female,51709,"CINJ 051709; MISP 54456, 3475-683; Pro20170001392",Pancreas,Pancreas,"Adenocarcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/14/1958,2/26/2019,2019,61.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1958,2/26/2019,2019,61.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1967,2/26/2019,2019,51.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1967,2/26/2019,2019,51.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1960,2/28/2019,2019,58.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1960,2/28/2019,2019,58.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1961,3/7/2019,2019,58,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1961,3/7/2019,2019,58,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1955,3/13/2019,2019,63.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1955,3/13/2019,2019,63.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1957,3/21/2019,2019,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/5/1957,3/21/2019,2019,61.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/23/1948,4/2/2019,2019,71.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/23/1948,4/2/2019,2019,71.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1947,4/4/2019,2019,71.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1947,4/4/2019,2019,71.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1945,4/9/2019,2019,73.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1945,4/9/2019,2019,73.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/1975,4/24/2019,2019,44.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/20/1975,4/24/2019,2019,44.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1963,4/25/2019,2019,56,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1963,4/25/2019,2019,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1957,5/6/2019,2019,61.7,White,Non-Hispanic,White,Male,71802,1608018265; Pro2018000102; Yale HIC# 1608018265 ,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
7/6/1967,5/10/2019,2019,51.9,White,Non-Hispanic,White,Female,71803,I5B-MC-JGDP(b); WIRB 20170768           Pro2018000144,Pancreas,Pancreas,"Adenocarcinoma, Nos",Gastrointestinal,Phase I/II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
8/12/1961,5/14/2019,2019,57.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1936,5/22/2019,2019,83,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1936,5/22/2019,2019,83,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1953,5/23/2019,2019,65.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1953,5/23/2019,2019,65.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1944,6/11/2019,2019,75.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1944,6/11/2019,2019,75.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1957,6/27/2019,2019,61.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1957,6/27/2019,2019,61.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1967,7/3/2019,2019,51.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1967,7/3/2019,2019,51.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1950,7/12/2019,2019,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1950,7/12/2019,2019,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1935,8/6/2019,2019,84.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1935,8/6/2019,2019,84.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/11/1942,8/14/2019,2019,77.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1942,8/14/2019,2019,77.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1957,8/27/2019,2019,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1957,8/27/2019,2019,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1952,9/3/2019,2019,67,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1952,9/3/2019,2019,67,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1952,10/3/2019,2019,67,White,Non-Hispanic,White,Male,71708,16-001; PCRT 16-001; Pro2018001893,Pancreas,Pancreas,Adenocarcinoma With Mixed Subtypes,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal,Interventional,New Brunswick,Enrolled Patients
10/14/1966,10/10/2019,2019,53,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1966,10/10/2019,2019,53,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1964,10/30/2019,2019,55.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1964,10/30/2019,2019,55.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1962,11/21/2019,2019,57.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1962,11/21/2019,2019,57.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1939,12/4/2019,2019,80.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1939,12/4/2019,2019,80.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1949,12/4/2019,2019,70.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1949,12/4/2019,2019,70.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1960,12/5/2019,2019,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1955,12/30/2019,2019,64.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1955,12/30/2019,2019,64.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1947,1/22/2020,2020,72.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1947,1/22/2020,2020,72.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/6/1943,1/28/2020,2020,77,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1965,2/18/2020,2020,54.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1965,2/18/2020,2020,54.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1961,2/24/2020,2020,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1961,2/24/2020,2020,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1974,2/25/2020,2020,45.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1949,3/11/2020,2020,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1942,3/17/2020,2020,78.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1942,3/17/2020,2020,78.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1949,3/18/2020,2020,70.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1949,3/18/2020,2020,70.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1957,9/23/2020,2020,63.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1957,9/23/2020,2020,63.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1956,9/30/2020,2020,64,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1956,9/30/2020,2020,64,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1937,10/7/2020,2020,83.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1937,10/7/2020,2020,83.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1949,10/22/2020,2020,71.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1963,10/23/2020,2020,57.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pancreas,Pancreas,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1934,9/21/2017,2017,83.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1934,9/21/2017,2017,83.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1951,9/21/2017,2017,66.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1951,9/21/2017,2017,66.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1985,11/9/2017,2017,32.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1985,11/9/2017,2017,32.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1965,11/9/2017,2017,52.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1965,11/9/2017,2017,52.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/1/1963,1/26/2018,2018,54.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1963,1/26/2018,2018,54.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1964,1/26/2018,2018,53.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1964,1/26/2018,2018,53.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1961,2/1/2018,2018,56.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1961,2/1/2018,2018,56.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1966,2/8/2018,2018,51.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1966,2/8/2018,2018,51.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1980,5/10/2018,2018,37.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1980,5/10/2018,2018,37.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1969,5/10/2018,2018,48.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1969,5/10/2018,2018,48.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1945,6/28/2018,2018,72.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1945,6/28/2018,2018,72.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1948,7/5/2018,2018,70.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1960,7/17/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1960,7/17/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1997,8/2/2018,2018,20.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1997,8/2/2018,2018,20.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1975,8/2/2018,2018,43.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1975,8/2/2018,2018,43.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1970,8/30/2018,2018,47.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1952,9/6/2018,2018,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/19/1952,9/6/2018,2018,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1961,9/18/2018,2018,57.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1961,9/18/2018,2018,57.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1973,9/25/2018,2018,44.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1973,9/25/2018,2018,44.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1963,11/1/2018,2018,55.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1963,11/1/2018,2018,55.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1964,11/1/2018,2018,54.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1964,11/1/2018,2018,54.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1960,11/1/2018,2018,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1960,11/1/2018,2018,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1943,11/15/2018,2018,75,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/2/1943,11/15/2018,2018,75,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1996,12/6/2018,2018,22.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1996,12/6/2018,2018,22.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1952,12/6/2018,2018,66.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1952,12/6/2018,2018,66.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1986,12/13/2018,2018,32.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1986,12/13/2018,2018,32.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1988,12/20/2018,2018,30.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/24/1988,12/20/2018,2018,30.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1958,12/20/2018,2018,60,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1958,12/20/2018,2018,60,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1950,1/10/2019,2019,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1950,1/10/2019,2019,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/14/1961,1/17/2019,2019,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1961,1/17/2019,2019,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1949,1/17/2019,2019,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1949,1/17/2019,2019,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1976,1/24/2019,2019,42.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1976,1/24/2019,2019,42.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/26/1936,1/24/2019,2019,82.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1936,1/24/2019,2019,82.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1956,2/14/2019,2019,62.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1956,2/14/2019,2019,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1985,2/21/2019,2019,34,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/4/1963,2/28/2019,2019,56.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/4/1963,2/28/2019,2019,56.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1957,3/21/2019,2019,62.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1957,3/21/2019,2019,62.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1942,4/11/2019,2019,77.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1942,4/11/2019,2019,77.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1950,4/18/2019,2019,68.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1950,4/18/2019,2019,68.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1961,5/2/2019,2019,58.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1961,5/2/2019,2019,58.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1971,5/2/2019,2019,47.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1971,5/2/2019,2019,47.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1984,5/9/2019,2019,34.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1984,5/9/2019,2019,34.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1954,5/9/2019,2019,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1954,5/9/2019,2019,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1946,6/6/2019,2019,73.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1946,6/6/2019,2019,73.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1948,6/27/2019,2019,70.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1948,6/27/2019,2019,70.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1965,7/11/2019,2019,53.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1965,7/11/2019,2019,53.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1954,8/1/2019,2019,65.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1954,8/1/2019,2019,65.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1961,9/19/2019,2019,58.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1961,9/19/2019,2019,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1953,9/19/2019,2019,66.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1953,9/19/2019,2019,66.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1965,9/19/2019,2019,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1965,9/19/2019,2019,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1969,9/26/2019,2019,49.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1969,9/26/2019,2019,49.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1950,9/26/2019,2019,69,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1950,9/26/2019,2019,69,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1961,9/26/2019,2019,58.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1961,9/26/2019,2019,58.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/6/1966,10/3/2019,2019,53.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1966,10/3/2019,2019,53.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1951,10/3/2019,2019,68,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1951,10/3/2019,2019,68,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1970,10/17/2019,2019,49,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1970,10/17/2019,2019,49,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1943,1/30/2020,2020,76.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1943,1/30/2020,2020,76.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Parathyroid Gland,Parathyroid Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1949,5/8/2017,2017,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1952,1/5/2018,2018,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1952,1/5/2018,2018,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/25/1952,5/21/2018,2018,66.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Penis,Penis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/11/1967,8/24/2018,2018,50.8,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Penis,Penis,"Squamous Cell Carcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/29/1961,11/1/2018,2018,57,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1961,11/1/2018,2018,57,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1964,12/6/2018,2018,54.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1951,3/14/2019,2019,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1951,3/14/2019,2019,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Penis,Penis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1954,4/26/2017,2017,63.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1954,4/26/2017,2017,63.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1973,5/23/2017,2017,44.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/11/1968,10/3/2017,2017,49.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/11/1968,10/3/2017,2017,49.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1956,10/19/2017,2017,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1956,10/19/2017,2017,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1962,11/29/2017,2017,55.3,White,Non-Hispanic,White,Female,51511,CC-486-CAGEN-001; Pro20150002014 WIRB 20141961,Peritoneum/Retro,Peritoneum/Retro,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
,12/22/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/17/1941,12/27/2017,2017,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1941,12/27/2017,2017,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1938,1/10/2018,2018,79.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1938,1/10/2018,2018,79.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1940,1/17/2018,2018,78.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1940,1/17/2018,2018,78.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1985,1/25/2018,2018,32.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1985,1/25/2018,2018,32.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1966,1/25/2018,2018,51.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1966,1/25/2018,2018,51.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/5/1966,1/25/2018,2018,51.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1954,2/21/2018,2018,63.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/29/1995,3/8/2018,2018,23.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1995,3/8/2018,2018,23.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/29/1995,3/8/2018,2018,23.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1955,3/19/2018,2018,62.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1955,3/19/2018,2018,62.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/14/1955,3/19/2018,2018,62.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1958,5/14/2018,2018,60.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1958,5/14/2018,2018,60.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/28/1958,5/14/2018,2018,60.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1967,7/18/2018,2018,50.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1967,7/18/2018,2018,50.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1946,7/25/2018,2018,72.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1946,7/25/2018,2018,72.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1960,8/29/2018,2018,58.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1960,8/29/2018,2018,58.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1950,9/5/2018,2018,68.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/9/1950,9/5/2018,2018,68.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/9/1950,9/5/2018,2018,68.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1962,9/26/2018,2018,55.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1962,9/26/2018,2018,55.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1952,10/24/2018,2018,66.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1952,10/24/2018,2018,66.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1950,11/9/2018,2018,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/5/1950,11/9/2018,2018,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1961,12/20/2018,2018,57.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1941,2/4/2019,2019,77.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1941,2/4/2019,2019,77.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1970,3/8/2019,2019,48.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1970,3/8/2019,2019,48.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1979,4/18/2019,2019,39.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1979,4/18/2019,2019,39.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1963,6/27/2019,2019,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1963,6/27/2019,2019,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1967,7/22/2019,2019,51.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1967,7/22/2019,2019,51.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1976,7/24/2019,2019,43.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1976,7/24/2019,2019,43.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1947,7/26/2019,2019,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1947,7/26/2019,2019,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1971,8/20/2019,2019,48,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1971,8/20/2019,2019,48,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1942,9/6/2019,2019,76.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1942,9/6/2019,2019,76.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1958,9/19/2019,2019,61.5,White,Non-Hispanic,White,Female,51903,MS100070_0176; WIRB20183367 Pro2019000695,Peritoneum/Retro,Peritoneum/Retro,"Papillary Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/30/1958,10/4/2019,2019,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1958,10/4/2019,2019,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1962,12/2/2019,2019,57.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1962,12/2/2019,2019,57.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1954,12/4/2019,2019,65.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1954,12/4/2019,2019,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1981,2/28/2020,2020,39.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1981,2/28/2020,2020,39.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1982,3/5/2020,2020,37.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1982,3/5/2020,2020,37.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1973,3/6/2020,2020,46.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1973,3/6/2020,2020,46.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1952,6/29/2020,2020,68,White,Non-Hispanic,White,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Peritoneum/Retro,Peritoneum/Retro,Fibromyxosarcoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/9/1951,10/9/2020,2020,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1951,10/9/2020,2020,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Peritoneum/Retro,Peritoneum/Retro,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1952,10/26/2020,2020,68.3,White,Non-Hispanic,White,Male,51906,MS201922-0001; Pro2019002535; WIRB 20200093,Peritoneum/Retro,Peritoneum/Retro,"Fibrosarcoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/4/1975,9/19/2017,2017,42,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Pharynx, NOS",Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1975,9/19/2017,2017,42,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,"Pharynx, NOS",Head & Neck,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1975,10/2/2017,2017,42,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,"Pharynx, NOS",Head & Neck,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/24/1945,8/7/2019,2019,74.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1945,8/7/2019,2019,74.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1945,8/14/2019,2019,73.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1945,8/14/2019,2019,73.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1967,8/14/2019,2019,51.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1967,8/14/2019,2019,51.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1993,8/29/2019,2019,26.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1993,8/29/2019,2019,26.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1952,9/4/2019,2019,66.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1952,9/4/2019,2019,66.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1943,9/4/2019,2019,76.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1943,9/4/2019,2019,76.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/2000,9/5/2019,2019,19.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/2000,9/5/2019,2019,19.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1991,10/3/2019,2019,27.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1991,10/3/2019,2019,27.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1994,11/13/2019,2019,25.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/2001,1/8/2020,2020,18.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1965,1/29/2020,2020,54.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1955,2/5/2020,2020,64.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1966,2/12/2020,2020,53.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1974,2/26/2020,2020,45.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1955,2/26/2020,2020,64.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1974,3/11/2020,2020,45.9,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1988,6/9/2020,2020,32.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Pituitary Gland,Pituitary Gland,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1992,7/12/2017,2017,24.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Placenta,Placenta,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1992,7/12/2017,2017,24.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Placenta,Placenta,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/2002,9/11/2017,2017,15.3,White,Hispanic or Latino,Hispanic/Latino,Female,1610,001610  201209025; Pro20160000426,"Pleura, NOS","Pleura, NOS",Pleuropulmonary Blastoma,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
7/14/1954,8/6/2018,2018,64.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Pleura, NOS","Pleura, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1954,8/6/2018,2018,64.1,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,"Pleura, NOS","Pleura, NOS",,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/14/1954,8/6/2018,2018,64.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,"Pleura, NOS","Pleura, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1946,5/7/2019,2019,72.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Pleura, NOS","Pleura, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1946,5/7/2019,2019,72.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Pleura, NOS","Pleura, NOS",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1955,1/3/2017,2017,61.8,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/27/1954,1/6/2017,2017,62.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1954,1/6/2017,2017,62.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1949,1/9/2017,2017,67.8,White,Non-Hispanic,White,Male,81403,20140001022,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Early Phase I,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/24/1949,1/13/2017,2017,67.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1949,1/13/2017,2017,67.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1955,1/13/2017,2017,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1955,1/13/2017,2017,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1958,1/20/2017,2017,58.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1958,1/20/2017,2017,58.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1958,1/20/2017,2017,58.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1958,1/20/2017,2017,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1947,1/23/2017,2017,69.9,White,Non-Hispanic,White,Male,81511,IBC # 16-001; Pro20150002758 ; UW14572,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/12/1942,1/27/2017,2017,74.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1942,1/27/2017,2017,74.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1939,1/31/2017,2017,77.4,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/11/1972,2/2/2017,2017,45.1,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/19/1955,2/3/2017,2017,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1955,2/3/2017,2017,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1947,2/3/2017,2017,69.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1947,2/3/2017,2017,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1963,2/3/2017,2017,53.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1963,2/3/2017,2017,53.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1958,2/3/2017,2017,59.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1958,2/3/2017,2017,59.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1957,2/3/2017,2017,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1957,2/3/2017,2017,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1942,2/6/2017,2017,74.6,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/27/1964,2/7/2017,2017,52.5,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/5/1942,2/7/2017,2017,74.8,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/16/1954,2/17/2017,2017,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1947,2/21/2017,2017,69.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1939,2/21/2017,2017,77.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1947,2/24/2017,2017,69.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1947,2/24/2017,2017,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1954,2/24/2017,2017,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1952,2/24/2017,2017,64.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1952,2/24/2017,2017,64.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1955,2/24/2017,2017,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/17/1955,2/24/2017,2017,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1966,2/24/2017,2017,50.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1966,2/24/2017,2017,50.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1947,2/27/2017,2017,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/1/1947,2/28/2017,2017,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1954,2/28/2017,2017,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1967,2/28/2017,2017,49.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1958,2/28/2017,2017,58.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1963,2/28/2017,2017,54,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1951,3/3/2017,2017,65.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1951,3/3/2017,2017,65.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1962,3/3/2017,2017,54.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/10/1962,3/3/2017,2017,54.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1952,3/3/2017,2017,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1952,3/3/2017,2017,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1947,3/3/2017,2017,69.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1952,3/3/2017,2017,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1952,3/3/2017,2017,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1950,3/3/2017,2017,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1950,3/3/2017,2017,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1957,3/3/2017,2017,59.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1957,3/3/2017,2017,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1950,3/6/2017,2017,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1942,3/8/2017,2017,74.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1932,3/9/2017,2017,85,White,Non-Hispanic,White,Male,81511,IBC # 16-001; Pro20150002758 ; UW14572,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/1/1963,3/10/2017,2017,54.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1963,3/10/2017,2017,54.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1949,3/10/2017,2017,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1949,3/10/2017,2017,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1949,3/16/2017,2017,68.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1949,3/16/2017,2017,68.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1968,3/17/2017,2017,48.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1968,3/17/2017,2017,48.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1958,3/17/2017,2017,58.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1958,3/17/2017,2017,58.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1954,3/17/2017,2017,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1954,3/17/2017,2017,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1954,3/21/2017,2017,62.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1957,3/21/2017,2017,59.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1945,3/21/2017,2017,71.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1954,3/24/2017,2017,62.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1954,3/24/2017,2017,62.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1956,3/24/2017,2017,60.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1956,3/24/2017,2017,60.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1944,3/24/2017,2017,73.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1944,3/24/2017,2017,73.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1947,3/27/2017,2017,70.2,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/25/1956,3/28/2017,2017,61,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1945,3/28/2017,2017,71.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1946,3/28/2017,2017,70.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1952,3/28/2017,2017,64.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1952,3/28/2017,2017,64.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1938,3/28/2017,2017,78.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1956,3/28/2017,2017,60.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1951,4/3/2017,2017,65.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1948,4/6/2017,2017,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1948,4/6/2017,2017,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/19/1955,4/6/2017,2017,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/19/1955,4/6/2017,2017,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/11/1953,4/7/2017,2017,63.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/11/1953,4/7/2017,2017,63.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1951,4/11/2017,2017,65.6,Black or African American,Non-Hispanic,Black,Male,81501,Pro20150001378,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/17/1952,4/12/2017,2017,64.9,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/29/1936,4/12/2017,2017,80.8,White,Non-Hispanic,White,Male,81511,IBC # 16-001; Pro20150002758 ; UW14572,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/13/1965,4/18/2017,2017,52.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1965,4/18/2017,2017,52.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1962,4/21/2017,2017,54.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1962,4/21/2017,2017,54.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1961,4/21/2017,2017,55.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1961,4/21/2017,2017,55.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1955,4/21/2017,2017,61.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1976,4/23/2017,2017,40.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1976,4/24/2017,2017,40.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1952,4/25/2017,2017,64.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1957,4/25/2017,2017,59.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1955,4/28/2017,2017,62.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1955,4/28/2017,2017,62.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1958,4/28/2017,2017,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1958,4/28/2017,2017,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1955,4/28/2017,2017,61.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1955,4/28/2017,2017,61.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1947,4/28/2017,2017,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1947,4/28/2017,2017,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1939,5/1/2017,2017,77.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1952,5/2/2017,2017,65.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1945,5/2/2017,2017,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1949,5/2/2017,2017,68.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1952,5/3/2017,2017,64.6,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/17/1961,5/5/2017,2017,56.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1961,5/5/2017,2017,56.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/23/1949,5/5/2017,2017,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/23/1949,5/5/2017,2017,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1956,5/5/2017,2017,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1956,5/5/2017,2017,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1958,5/15/2017,2017,58.9,White,Non-Hispanic,White,Male,81511,IBC # 16-001; Pro20150002758 ; UW14572,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/28/1959,5/19/2017,2017,58,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1959,5/19/2017,2017,58,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/14/1950,5/19/2017,2017,67.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/14/1950,5/19/2017,2017,67.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1951,5/19/2017,2017,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1951,5/19/2017,2017,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1956,5/23/2017,2017,60.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1949,5/23/2017,2017,67.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1949,5/23/2017,2017,67.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1940,5/24/2017,2017,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/2/1965,5/25/2017,2017,51.5,White; Black or African American; American Indian or Alaska Native,Hispanic or Latino,Hispanic/Latino,Male,81601,GT0918-US-1001; WIRB 20152501 Pro20160000994,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/20/1954,6/2/2017,2017,62.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1954,6/2/2017,2017,62.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1935,6/5/2017,2017,81.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1953,6/7/2017,2017,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1961,6/9/2017,2017,56.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1961,6/9/2017,2017,56.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/22/1949,6/9/2017,2017,67.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1949,6/9/2017,2017,67.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1953,6/9/2017,2017,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1953,6/9/2017,2017,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1947,6/12/2017,2017,69.6,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/10/1947,6/20/2017,2017,69.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1942,6/20/2017,2017,74.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1958,6/20/2017,2017,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1955,6/20/2017,2017,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1947,6/20/2017,2017,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1959,6/20/2017,2017,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1944,6/21/2017,2017,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1950,6/23/2017,2017,67.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1945,6/23/2017,2017,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1945,6/23/2017,2017,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1960,6/23/2017,2017,56.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1960,6/23/2017,2017,56.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1950,6/27/2017,2017,66.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1945,6/27/2017,2017,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1962,6/27/2017,2017,54.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1955,6/27/2017,2017,61.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1947,6/28/2017,2017,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1948,6/30/2017,2017,68.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1948,6/30/2017,2017,68.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1950,6/30/2017,2017,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1950,6/30/2017,2017,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1958,6/30/2017,2017,58.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1958,6/30/2017,2017,58.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1958,6/30/2017,2017,59,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1958,6/30/2017,2017,59,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1962,7/4/2017,2017,55.5,Black or African American,Non-Hispanic,Black,Male,131604,20170000115,Prostate,Prostate,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/2/1952,7/10/2017,2017,64.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1952,7/10/2017,2017,64.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1958,7/10/2017,2017,58.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1947,7/12/2017,2017,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1947,7/12/2017,2017,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1951,7/13/2017,2017,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1951,7/13/2017,2017,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1939,7/13/2017,2017,78.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1949,7/13/2017,2017,67.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1949,7/13/2017,2017,67.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1958,7/14/2017,2017,58.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1953,7/17/2017,2017,64.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1966,7/21/2017,2017,50.9,White,Hispanic or Latino,Hispanic/Latino,Male,81511,IBC # 16-001; Pro20150002758 ; UW14572,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I,Treatment,Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/6/1955,7/21/2017,2017,61.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1955,7/21/2017,2017,61.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1925,7/21/2017,2017,92.3,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/27/1940,7/26/2017,2017,76.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1940,7/26/2017,2017,76.6,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/27/1940,7/26/2017,2017,76.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1950,7/31/2017,2017,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1950,8/1/2017,2017,67.4,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/13/1932,8/2/2017,2017,85.4,White,Non-Hispanic,White,Male,81701,PCCTC #: c16-168; WIRB 20162894,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/10/1943,8/2/2017,2017,74.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1951,8/2/2017,2017,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1960,8/3/2017,2017,56.8,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/30/1955,8/4/2017,2017,61.8,Asian,Non-Hispanic,Asian,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/12/1955,8/4/2017,2017,62,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1955,8/4/2017,2017,62,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1956,8/4/2017,2017,61,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1956,8/4/2017,2017,61,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1958,8/7/2017,2017,59.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1958,8/7/2017,2017,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1936,8/10/2017,2017,80.8,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/5/1957,8/10/2017,2017,59.9,White,Non-Hispanic,White,Male,81501,Pro20150001378,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/26/1955,8/10/2017,2017,61.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1955,8/10/2017,2017,61.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1960,8/11/2017,2017,57.3,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/20/1961,8/11/2017,2017,55.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/20/1961,8/11/2017,2017,55.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1946,8/15/2017,2017,71.5,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/7/1956,8/18/2017,2017,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1956,8/18/2017,2017,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1949,8/18/2017,2017,68.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1949,8/18/2017,2017,68.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1945,9/8/2017,2017,71.8,Asian,Non-Hispanic,Asian,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
7/22/1968,9/8/2017,2017,49.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/22/1968,9/8/2017,2017,49.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1956,9/8/2017,2017,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1956,9/8/2017,2017,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1952,9/8/2017,2017,65.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/12/1952,9/8/2017,2017,65.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1958,9/8/2017,2017,59.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1958,9/8/2017,2017,59.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1968,9/8/2017,2017,49.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1968,9/8/2017,2017,49.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1948,9/8/2017,2017,68.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/17/1948,9/8/2017,2017,68.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1942,9/12/2017,2017,75,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1957,9/12/2017,2017,60.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1958,9/12/2017,2017,59.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1964,9/12/2017,2017,53.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1946,9/12/2017,2017,71.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1954,9/18/2017,2017,62.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/15/1937,9/18/2017,2017,80.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1953,9/20/2017,2017,64.1,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/11/1951,9/22/2017,2017,66,White,Non-Hispanic,White,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/24/1963,9/26/2017,2017,54.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1963,9/26/2017,2017,54.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1932,9/27/2017,2017,85.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1932,9/27/2017,2017,85.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/13/1932,9/27/2017,2017,85.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1959,9/29/2017,2017,58.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1959,9/29/2017,2017,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1962,9/29/2017,2017,55.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1962,9/29/2017,2017,55.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1950,9/29/2017,2017,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1950,9/29/2017,2017,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1967,10/4/2017,2017,50.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1967,10/4/2017,2017,50.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/18/1967,10/4/2017,2017,50.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1961,10/5/2017,2017,56.2,Black or African American,Non-Hispanic,Black,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/16/1961,10/6/2017,2017,56.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1961,10/6/2017,2017,56.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1961,10/6/2017,2017,56,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1961,10/6/2017,2017,56,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1957,10/6/2017,2017,59.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1957,10/6/2017,2017,59.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1943,10/6/2017,2017,73.9,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
6/27/1957,10/12/2017,2017,60.3,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/1/1948,10/12/2017,2017,69.6,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/3/1943,10/12/2017,2017,74.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1943,10/12/2017,2017,74.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1947,10/17/2017,2017,70.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1959,10/17/2017,2017,58.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1927,10/17/2017,2017,90.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1953,10/17/2017,2017,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1952,10/17/2017,2017,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1941,10/18/2017,2017,76.6,White,Non-Hispanic,White,Male,51403,Pro20140000405,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/2/1947,10/20/2017,2017,70.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/2/1947,10/20/2017,2017,70.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1958,10/20/2017,2017,59,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1958,10/20/2017,2017,59,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1947,10/20/2017,2017,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1947,10/20/2017,2017,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1958,10/20/2017,2017,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/22/1958,10/20/2017,2017,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/18/1948,10/25/2017,2017,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1962,10/27/2017,2017,55.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1962,10/27/2017,2017,55.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1953,10/27/2017,2017,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1953,10/27/2017,2017,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1952,10/30/2017,2017,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1952,10/30/2017,2017,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1941,10/30/2017,2017,76.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1941,10/30/2017,2017,76.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1942,11/7/2017,2017,75.2,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/10/1950,11/7/2017,2017,67.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/10/1950,11/7/2017,2017,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1951,11/7/2017,2017,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/20/1948,11/7/2017,2017,69.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1958,11/7/2017,2017,59.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1946,11/8/2017,2017,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1946,11/8/2017,2017,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1953,11/8/2017,2017,64.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1942,11/8/2017,2017,75.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1946,11/8/2017,2017,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1955,11/10/2017,2017,62.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1955,11/10/2017,2017,62.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1948,11/10/2017,2017,69.6,White,Non-Hispanic,White,Male,51408,14AVX-0014; Pro20150001392  IBC 15-028,Prostate,Prostate,"Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/30/1943,11/10/2017,2017,73.9,White,Non-Hispanic,White,Male,81501,Pro20150001378,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/29/1960,11/10/2017,2017,57.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1960,11/10/2017,2017,57.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/19/1950,11/10/2017,2017,67.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1950,11/10/2017,2017,67.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1957,11/10/2017,2017,60.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1957,11/10/2017,2017,60.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1936,11/14/2017,2017,81.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1956,11/17/2017,2017,61,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1956,11/17/2017,2017,61,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1959,11/17/2017,2017,58.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1959,11/17/2017,2017,58.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1958,11/27/2017,2017,59.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1946,11/28/2017,2017,71.3,Black or African American,Non-Hispanic,Black,Male,81601,GT0918-US-1001; WIRB 20152501 Pro20160000994,Prostate,Prostate,,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/24/1958,12/1/2017,2017,59.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1955,12/1/2017,2017,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1955,12/1/2017,2017,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1961,12/1/2017,2017,56.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1961,12/1/2017,2017,56.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1956,12/1/2017,2017,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1956,12/1/2017,2017,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1958,12/1/2017,2017,59.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1958,12/1/2017,2017,59.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1941,12/4/2017,2017,76.7,White,Non-Hispanic,White,Male,51407,Pro20140000735,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/9/1942,12/6/2017,2017,75,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1958,12/7/2017,2017,59.4,Black or African American,Non-Hispanic,Black,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,,Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/17/1951,12/8/2017,2017,66.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1951,12/8/2017,2017,66.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1953,12/8/2017,2017,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1953,12/8/2017,2017,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1956,12/13/2017,2017,61.3,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
1/31/1955,12/14/2017,2017,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1955,12/14/2017,2017,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1955,12/15/2017,2017,63,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1955,12/15/2017,2017,63,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1952,12/15/2017,2017,65.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1952,12/15/2017,2017,65.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1950,12/15/2017,2017,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1950,12/15/2017,2017,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1957,12/15/2017,2017,60.5,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
10/4/1943,12/19/2017,2017,74.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1946,12/19/2017,2017,71.1,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/28/1954,12/19/2017,2017,63.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1962,12/22/2017,2017,55.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1962,12/22/2017,2017,55.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1960,12/22/2017,2017,57.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1960,12/22/2017,2017,57.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1957,12/22/2017,2017,60.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1957,12/22/2017,2017,60.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1955,12/28/2017,2017,62.6,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/20/1959,12/29/2017,2017,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1959,12/29/2017,2017,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1940,1/3/2018,2018,77.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1940,1/3/2018,2018,77.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1971,1/4/2018,2018,46.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1971,1/4/2018,2018,46.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1946,1/5/2018,2018,71.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1946,1/5/2018,2018,71.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1954,1/5/2018,2018,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1954,1/5/2018,2018,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1955,1/8/2018,2018,62.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1944,1/12/2018,2018,74,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/10/1944,1/12/2018,2018,74,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1952,1/12/2018,2018,65.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1952,1/12/2018,2018,65.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1951,1/16/2018,2018,66.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1951,1/16/2018,2018,66.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1951,1/16/2018,2018,66.9,Black or African American,Non-Hispanic,Black,Male,1706,WIRB 20170327 / Pro20170000487,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1956,1/16/2018,2018,61.8,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/2/1952,1/19/2018,2018,65.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1952,1/19/2018,2018,65.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1955,1/19/2018,2018,62.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1955,1/19/2018,2018,62.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1957,1/19/2018,2018,60.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1957,1/19/2018,2018,60.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1965,1/19/2018,2018,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1965,1/19/2018,2018,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1947,1/22/2018,2018,70.2,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
7/6/1955,1/26/2018,2018,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1955,1/26/2018,2018,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1945,2/2/2018,2018,72.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1945,2/2/2018,2018,72.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1958,2/2/2018,2018,59.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1958,2/2/2018,2018,59.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1953,2/2/2018,2018,64.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1953,2/2/2018,2018,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1956,2/2/2018,2018,61.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1956,2/2/2018,2018,61.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1966,2/2/2018,2018,52,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1966,2/2/2018,2018,52,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/6/1945,2/5/2018,2018,72.7,White,Non-Hispanic,White,Male,81704,20171079      Pro20170001104; CO-338-052,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/21/1960,2/6/2018,2018,57.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1960,2/6/2018,2018,57.8,White,Non-Hispanic,White,Male,1706,WIRB 20170327 / Pro20170000487,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1953,2/8/2018,2018,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1953,2/8/2018,2018,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1954,2/15/2018,2018,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1954,2/15/2018,2018,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1956,2/15/2018,2018,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1951,2/16/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/10/1951,2/16/2018,2018,66.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1956,2/16/2018,2018,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1956,2/16/2018,2018,61.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1956,2/16/2018,2018,61.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1956,2/16/2018,2018,61.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1956,2/16/2018,2018,61.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1956,2/16/2018,2018,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1956,2/16/2018,2018,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1952,2/16/2018,2018,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1952,2/16/2018,2018,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1934,2/22/2018,2018,83.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1934,2/22/2018,2018,83.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1968,2/23/2018,2018,49.4,Black or African American,Non-Hispanic,Black,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/10/1945,2/23/2018,2018,72.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1945,2/23/2018,2018,72.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/15/1958,2/23/2018,2018,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1958,2/23/2018,2018,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1965,2/23/2018,2018,53,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1965,2/23/2018,2018,53,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1964,2/23/2018,2018,54,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1964,2/23/2018,2018,54,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1956,2/23/2018,2018,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1956,2/23/2018,2018,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1950,2/26/2018,2018,67.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1950,2/26/2018,2018,67.7,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/29/1950,2/26/2018,2018,67.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1946,3/1/2018,2018,71.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1946,3/1/2018,2018,71.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1968,3/2/2018,2018,50,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1968,3/2/2018,2018,50,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1960,3/2/2018,2018,57.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/9/1960,3/2/2018,2018,57.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/15/1951,3/2/2018,2018,66.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1951,3/2/2018,2018,66.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1951,3/2/2018,2018,66.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1951,3/2/2018,2018,66.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1960,3/2/2018,2018,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1960,3/2/2018,2018,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1957,3/5/2018,2018,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1957,3/5/2018,2018,60.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/17/1957,3/5/2018,2018,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1948,3/5/2018,2018,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1948,3/5/2018,2018,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1948,3/9/2018,2018,70.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1948,3/9/2018,2018,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/25/1964,3/13/2018,2018,54.1,White,Hispanic or Latino,Hispanic/Latino,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/15/1948,3/15/2018,2018,69.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1948,3/15/2018,2018,69.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1950,3/16/2018,2018,68.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1950,3/16/2018,2018,68.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1965,3/16/2018,2018,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1965,3/16/2018,2018,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1942,3/19/2018,2018,75.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/15/1951,3/20/2018,2018,66.9,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/29/1943,3/22/2018,2018,75.2,White,Non-Hispanic,White,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/25/1957,3/22/2018,2018,60.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1957,3/22/2018,2018,60.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1964,3/23/2018,2018,53.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1964,3/23/2018,2018,53.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1948,3/23/2018,2018,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1948,3/23/2018,2018,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1948,3/23/2018,2018,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1948,3/23/2018,2018,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1946,3/23/2018,2018,71.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1946,3/23/2018,2018,71.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1952,3/26/2018,2018,65.4,Black or African American,Non-Hispanic,Black,Male,81508,00046414; Pro20150001702,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/10/1948,3/26/2018,2018,70.3,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/13/1951,3/27/2018,2018,66.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1951,3/27/2018,2018,66.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1950,3/27/2018,2018,67.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1950,3/27/2018,2018,67.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/19/1950,3/27/2018,2018,67.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1949,3/29/2018,2018,69.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1949,3/29/2018,2018,69.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/4/1950,3/29/2018,2018,68.3,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/2/1947,3/29/2018,2018,70.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1952,3/30/2018,2018,65.9,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/4/1957,4/3/2018,2018,60.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/4/1957,4/3/2018,2018,60.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1963,4/5/2018,2018,54.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/9/1963,4/5/2018,2018,54.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1955,4/6/2018,2018,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1955,4/6/2018,2018,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1947,4/9/2018,2018,71.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1947,4/9/2018,2018,71.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1952,4/13/2018,2018,66.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1952,4/13/2018,2018,66.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1947,4/13/2018,2018,70.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1947,4/13/2018,2018,70.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1950,4/13/2018,2018,68.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1950,4/13/2018,2018,68.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1956,4/13/2018,2018,61.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1956,4/13/2018,2018,61.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1945,4/16/2018,2018,72.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1945,4/16/2018,2018,72.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/7/1944,4/17/2018,2018,74.1,White,Non-Hispanic,White,Male,81701,PCCTC #: c16-168; WIRB 20162894,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/15/1951,4/19/2018,2018,67.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1951,4/19/2018,2018,67.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/15/1951,4/19/2018,2018,67.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1968,4/27/2018,2018,50.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1968,4/27/2018,2018,50.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1958,4/27/2018,2018,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1958,4/27/2018,2018,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1953,5/1/2018,2018,64.9,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/3/1958,5/4/2018,2018,60.1,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/31/1951,5/4/2018,2018,67.3,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/22/1956,5/11/2018,2018,61.9,Black or African American,Non-Hispanic,Black,Male,1610,001610  201209025; Pro20160000426,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/2/1957,5/11/2018,2018,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/2/1957,5/11/2018,2018,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1944,5/16/2018,2018,74.3,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/22/1947,5/24/2018,2018,71.1,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/22/1959,5/25/2018,2018,58.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1959,5/25/2018,2018,58.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1955,5/25/2018,2018,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1955,5/25/2018,2018,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1948,5/25/2018,2018,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1948,5/25/2018,2018,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1947,5/25/2018,2018,70.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1947,5/25/2018,2018,70.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1961,5/25/2018,2018,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1961,5/25/2018,2018,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1962,5/25/2018,2018,55.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1962,5/25/2018,2018,55.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1948,6/1/2018,2018,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/25/1948,6/1/2018,2018,69.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/23/1961,6/5/2018,2018,57.4,White,Hispanic or Latino,Hispanic/Latino,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/6/1954,6/6/2018,2018,64.4,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/6/1953,6/8/2018,2018,64.9,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/25/1952,6/8/2018,2018,65.6,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/7/1949,6/15/2018,2018,69,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1949,6/15/2018,2018,69,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/7/1949,6/15/2018,2018,69,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1958,6/22/2018,2018,59.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1958,6/22/2018,2018,59.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/25/1946,6/22/2018,2018,72.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1946,6/22/2018,2018,72.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1951,6/22/2018,2018,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1951,6/22/2018,2018,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1944,6/22/2018,2018,73.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1944,6/22/2018,2018,73.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1953,6/29/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1953,6/29/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1959,6/29/2018,2018,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1959,6/29/2018,2018,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1953,6/29/2018,2018,65.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1953,6/29/2018,2018,65.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1953,7/5/2018,2018,64.8,White,Hispanic or Latino,Hispanic/Latino,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/4/1950,7/8/2018,2018,68.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1957,7/10/2018,2018,61.1,White,Hispanic or Latino,Hispanic/Latino,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/23/1954,7/11/2018,2018,63.7,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/8/1956,7/12/2018,2018,62.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1956,7/12/2018,2018,62.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1955,7/12/2018,2018,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1949,7/13/2018,2018,68.6,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/29/1955,7/13/2018,2018,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1961,7/13/2018,2018,57.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1961,7/13/2018,2018,57.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/4/1950,7/13/2018,2018,68.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1946,7/19/2018,2018,72.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1946,7/19/2018,2018,72.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1953,7/19/2018,2018,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1957,7/19/2018,2018,60.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1957,7/19/2018,2018,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1963,7/19/2018,2018,54.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1964,7/20/2018,2018,53.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1964,7/20/2018,2018,53.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1953,7/20/2018,2018,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1953,7/20/2018,2018,65.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1953,7/20/2018,2018,65.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1961,7/27/2018,2018,57,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1961,7/27/2018,2018,57,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1953,8/3/2018,2018,65.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1953,8/3/2018,2018,65.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1952,8/3/2018,2018,66.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1952,8/3/2018,2018,66.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1962,8/3/2018,2018,56.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1962,8/3/2018,2018,56.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/25/1956,8/10/2018,2018,62.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1956,8/10/2018,2018,62.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1952,8/10/2018,2018,66.3,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/3/1958,8/16/2018,2018,60.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1958,8/16/2018,2018,60.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/6/1944,8/16/2018,2018,74.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/6/1944,8/16/2018,2018,74.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/22/1947,8/17/2018,2018,71.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/22/1947,8/17/2018,2018,71.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1960,8/17/2018,2018,58,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1960,8/17/2018,2018,58,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1970,8/24/2018,2018,48.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1970,8/24/2018,2018,48.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1953,8/24/2018,2018,64.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1953,8/24/2018,2018,64.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1955,8/31/2018,2018,63.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1955,8/31/2018,2018,63.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1959,9/10/2018,2018,59.1,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/27/1954,9/11/2018,2018,64.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1954,9/11/2018,2018,64.6,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/27/1954,9/11/2018,2018,64.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1950,9/12/2018,2018,68.3,White,Hispanic or Latino,Hispanic/Latino,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/25/1944,9/13/2018,2018,74.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/30/1944,9/14/2018,2018,73.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1944,9/14/2018,2018,73.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1948,9/14/2018,2018,70.1,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1948,9/14/2018,2018,70.1,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1966,9/14/2018,2018,52,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1966,9/14/2018,2018,52,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1948,9/14/2018,2018,69.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1948,9/14/2018,2018,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1943,9/14/2018,2018,74.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1960,9/17/2018,2018,58.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/25/1951,9/21/2018,2018,67.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1951,9/21/2018,2018,67.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1941,9/26/2018,2018,77,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/13/1948,9/28/2018,2018,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1948,9/28/2018,2018,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1954,9/28/2018,2018,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1955,9/28/2018,2018,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1955,9/28/2018,2018,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1972,10/12/2018,2018,46.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1972,10/12/2018,2018,46.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/23/1958,10/16/2018,2018,60.7,Black or African American,Non-Hispanic,Black,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,Adenocarcinoid Tumor,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/8/1961,10/18/2018,2018,57.3,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/14/1956,10/26/2018,2018,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1956,10/26/2018,2018,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1945,10/29/2018,2018,73.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1945,10/29/2018,2018,73.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/13/1945,10/29/2018,2018,73.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1954,11/1/2018,2018,64.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1954,11/1/2018,2018,64.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1953,11/2/2018,2018,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1953,11/2/2018,2018,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1954,11/2/2018,2018,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1954,11/2/2018,2018,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1952,11/2/2018,2018,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1952,11/2/2018,2018,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1948,11/6/2018,2018,69.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1948,11/6/2018,2018,69.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1952,11/6/2018,2018,66.5,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/11/1962,11/9/2018,2018,56.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1962,11/9/2018,2018,56.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1966,11/9/2018,2018,52.2,White,Hispanic or Latino,Hispanic/Latino,Male,131317,Pro2013003676,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/9/1960,11/9/2018,2018,58.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/9/1960,11/9/2018,2018,58.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1959,11/9/2018,2018,59.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1959,11/9/2018,2018,59.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1962,11/9/2018,2018,56.3,Black or African American,Non-Hispanic,Black,Male,131317,Pro2013003676,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1943,11/9/2018,2018,75,White,Non-Hispanic,White,Male,131317,Pro2013003676,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1952,11/9/2018,2018,66.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1952,11/9/2018,2018,66.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1956,11/9/2018,2018,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1956,11/9/2018,2018,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1951,11/9/2018,2018,67.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1951,11/9/2018,2018,67.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1951,11/12/2018,2018,67.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1951,11/12/2018,2018,67.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1955,11/15/2018,2018,63.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1955,11/15/2018,2018,63.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1955,11/15/2018,2018,63.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1959,11/16/2018,2018,59.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1959,11/16/2018,2018,59.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1951,11/16/2018,2018,67.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1951,11/16/2018,2018,67.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1954,11/19/2018,2018,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1954,11/19/2018,2018,64.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/13/1954,11/19/2018,2018,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1962,11/19/2018,2018,56.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1962,11/19/2018,2018,56.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1961,11/26/2018,2018,57.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1961,11/26/2018,2018,57.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/8/1961,11/26/2018,2018,57.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1946,11/26/2018,2018,72.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1946,11/26/2018,2018,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/14/1946,11/30/2018,2018,72.7,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/23/1954,11/30/2018,2018,64.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1954,11/30/2018,2018,64.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1950,11/30/2018,2018,68.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1950,11/30/2018,2018,68.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1965,11/30/2018,2018,53.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1965,11/30/2018,2018,53.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1953,12/3/2018,2018,65.7,White,Non-Hispanic,White,Male,131317,Pro2013003676,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1956,12/6/2018,2018,62.7,Asian,Non-Hispanic,Asian,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/23/1942,12/6/2018,2018,76.4,White,Non-Hispanic,White,Male,131317,Pro2013003676,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1956,12/7/2018,2018,62.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1956,12/7/2018,2018,62.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1973,12/11/2018,2018,45.4,Black or African American,Non-Hispanic,Black,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/30/1952,12/11/2018,2018,66.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1952,12/11/2018,2018,66.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1951,12/12/2018,2018,67.6,Asian,Non-Hispanic,Asian,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/23/1945,12/14/2018,2018,73.6,White,Hispanic or Latino,Hispanic/Latino,Male,81806,NCI CIRB Pro2018002695; NRG-GU006,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/11/1957,12/18/2018,2018,61.9,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/29/1961,12/21/2018,2018,57.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/29/1961,12/21/2018,2018,57.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1956,12/21/2018,2018,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1956,12/21/2018,2018,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1959,12/21/2018,2018,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1959,12/21/2018,2018,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1943,12/28/2018,2018,75.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1943,12/28/2018,2018,75.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1959,12/28/2018,2018,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1959,12/28/2018,2018,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1955,12/28/2018,2018,63.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1955,12/28/2018,2018,63.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/23/1958,1/4/2019,2019,60.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/23/1958,1/4/2019,2019,60.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1955,1/8/2019,2019,63.2,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/18/1949,1/9/2019,2019,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1949,1/9/2019,2019,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1962,1/17/2019,2019,56.4,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/5/1962,1/17/2019,2019,56.4,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1956,1/18/2019,2019,62.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1956,1/18/2019,2019,62.3,Black or African American,Non-Hispanic,Black,Male,1209,Pro2012002075,Prostate,Prostate,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/1/1956,1/18/2019,2019,62.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1959,1/18/2019,2019,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1959,1/18/2019,2019,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1958,1/22/2019,2019,60.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1958,1/22/2019,2019,60.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1953,1/31/2019,2019,66,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1953,1/31/2019,2019,66,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1974,2/1/2019,2019,44.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1974,2/1/2019,2019,44.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1953,2/1/2019,2019,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1953,2/1/2019,2019,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1946,2/4/2019,2019,72.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1946,2/4/2019,2019,72.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1958,2/4/2019,2019,60.6,White,Non-Hispanic,White,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/24/1960,2/8/2019,2019,58.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/24/1960,2/8/2019,2019,58.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/22/1956,2/8/2019,2019,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1956,2/8/2019,2019,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1966,2/8/2019,2019,52.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1966,2/8/2019,2019,52.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1949,2/11/2019,2019,69.6,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/2/1954,2/12/2019,2019,65.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1954,2/12/2019,2019,65.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1960,2/12/2019,2019,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1960,2/12/2019,2019,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1956,2/15/2019,2019,62.6,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1956,2/15/2019,2019,62.6,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1955,2/15/2019,2019,64.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1955,2/15/2019,2019,64.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1965,2/15/2019,2019,53.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1965,2/15/2019,2019,53.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1950,2/22/2019,2019,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1950,2/22/2019,2019,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1964,2/22/2019,2019,54.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1964,2/22/2019,2019,54.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1949,2/27/2019,2019,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1949,2/27/2019,2019,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1964,2/28/2019,2019,54.2,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,Adenocarcinoma In Situ,Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/6/1944,2/28/2019,2019,74.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1944,2/28/2019,2019,74.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1966,3/1/2019,2019,53,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1966,3/1/2019,2019,53,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1956,3/7/2019,2019,63,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1956,3/7/2019,2019,63,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1952,3/8/2019,2019,67.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1952,3/8/2019,2019,67.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1973,3/8/2019,2019,45.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1973,3/8/2019,2019,45.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1962,3/8/2019,2019,56.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1962,3/8/2019,2019,56.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1954,3/8/2019,2019,64.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1954,3/8/2019,2019,64.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1950,3/11/2019,2019,69,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,Adenocarcinoma In Situ,Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/26/1960,3/14/2019,2019,59.1,American Indian or Alaska Native,Non-Hispanic,Native American,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1960,3/14/2019,2019,59.1,American Indian or Alaska Native,Non-Hispanic,Native American,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1947,3/15/2019,2019,71.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1947,3/15/2019,2019,71.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1961,3/15/2019,2019,57.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1961,3/15/2019,2019,57.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1961,3/15/2019,2019,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1961,3/15/2019,2019,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1949,3/25/2019,2019,69.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1949,3/25/2019,2019,69.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1958,3/27/2019,2019,61,White,Hispanic or Latino,Hispanic/Latino,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/7/1956,3/29/2019,2019,62.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1956,3/29/2019,2019,62.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1943,3/29/2019,2019,75.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1943,3/29/2019,2019,75.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1961,3/29/2019,2019,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1961,3/29/2019,2019,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1940,4/2/2019,2019,78.8,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/10/1954,4/2/2019,2019,64.9,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/26/1971,4/3/2019,2019,47.7,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,Adenocarcinoma In Situ,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/22/1960,4/3/2019,2019,59.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1960,4/3/2019,2019,59.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1950,4/5/2019,2019,68.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1950,4/5/2019,2019,68.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1957,4/5/2019,2019,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/21/1957,4/5/2019,2019,61.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/30/1963,4/5/2019,2019,55.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1963,4/5/2019,2019,55.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1948,4/5/2019,2019,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1948,4/5/2019,2019,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1956,4/8/2019,2019,62.4,White,Non-Hispanic,White,Male,81808,9785-CL-0123; WIRB 20161768 Pro2018002569,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/18/1950,4/8/2019,2019,68.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1950,4/8/2019,2019,68.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/29/1966,4/11/2019,2019,52.9,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/2/1952,4/23/2019,2019,67.2,White,Non-Hispanic,White,Male,81806,NCI CIRB Pro2018002695; NRG-GU006,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/16/1957,4/25/2019,2019,62,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1956,4/26/2019,2019,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1956,4/26/2019,2019,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1949,4/26/2019,2019,69.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1949,4/26/2019,2019,69.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1954,4/26/2019,2019,64.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1954,4/26/2019,2019,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1954,4/26/2019,2019,64.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/10/1954,4/26/2019,2019,64.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/4/1949,4/26/2019,2019,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/4/1949,4/26/2019,2019,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1944,4/30/2019,2019,75.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1944,4/30/2019,2019,75.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1958,5/2/2019,2019,61.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/22/1947,5/3/2019,2019,71.7,White,Non-Hispanic,White,Male,81808,9785-CL-0123; WIRB 20161768 Pro2018002569,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/12/1964,5/10/2019,2019,55.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1964,5/10/2019,2019,55.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1960,5/10/2019,2019,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1960,5/10/2019,2019,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1958,5/10/2019,2019,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1958,5/10/2019,2019,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1967,5/10/2019,2019,52.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1967,5/10/2019,2019,52.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1959,5/13/2019,2019,60.2,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,Adenocarcinoma In Situ,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/7/1947,5/14/2019,2019,72.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1947,5/14/2019,2019,72.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1969,5/14/2019,2019,50.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1969,5/14/2019,2019,50.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1967,5/17/2019,2019,51.6,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1967,5/17/2019,2019,51.6,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/22/1946,5/17/2019,2019,73.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1946,5/17/2019,2019,73.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1952,5/17/2019,2019,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1952,5/17/2019,2019,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1947,5/20/2019,2019,72,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1947,5/20/2019,2019,72,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1950,5/24/2019,2019,69.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1950,5/24/2019,2019,69.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1961,5/24/2019,2019,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1961,5/24/2019,2019,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1949,5/24/2019,2019,69.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1949,5/24/2019,2019,69.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1961,5/24/2019,2019,57.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1961,5/24/2019,2019,57.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1957,5/31/2019,2019,61.8,Black or African American,Non-Hispanic,Black,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/20/1952,5/31/2019,2019,67.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/20/1952,5/31/2019,2019,67.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1949,6/4/2019,2019,70.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1949,6/4/2019,2019,70.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1946,6/10/2019,2019,72.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1946,6/10/2019,2019,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1951,6/14/2019,2019,68.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1951,6/14/2019,2019,68.3,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/10/1951,6/14/2019,2019,68.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/10/1951,6/14/2019,2019,68.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1944,6/14/2019,2019,74.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1944,6/14/2019,2019,74.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1952,6/14/2019,2019,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1952,6/14/2019,2019,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1940,6/21/2019,2019,79,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1940,6/21/2019,2019,79,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1954,6/21/2019,2019,64.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1954,6/21/2019,2019,64.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1947,6/21/2019,2019,71.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1947,6/21/2019,2019,71.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1958,6/21/2019,2019,61.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1958,6/21/2019,2019,61.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1953,6/28/2019,2019,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1953,6/28/2019,2019,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1974,6/28/2019,2019,45.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1974,6/28/2019,2019,45.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1962,7/1/2019,2019,56.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1953,7/12/2019,2019,66,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1953,7/12/2019,2019,66,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1951,7/12/2019,2019,67.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1951,7/12/2019,2019,67.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1968,7/12/2019,2019,51,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/29/1968,7/12/2019,2019,51,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1948,7/12/2019,2019,70.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1948,7/12/2019,2019,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1957,7/15/2019,2019,62.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1957,7/15/2019,2019,62.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1953,7/16/2019,2019,66.4,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/1/1967,7/26/2019,2019,52.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1967,7/26/2019,2019,52.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1971,7/26/2019,2019,48,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1971,7/26/2019,2019,48,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1949,7/26/2019,2019,69.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1949,7/26/2019,2019,69.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/19/1955,7/26/2019,2019,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1955,7/26/2019,2019,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1957,7/26/2019,2019,62,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1957,7/26/2019,2019,62,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1960,8/2/2019,2019,59.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1960,8/2/2019,2019,59.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1958,8/2/2019,2019,60.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1958,8/2/2019,2019,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1961,8/2/2019,2019,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1961,8/2/2019,2019,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1956,8/6/2019,2019,63,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/15/1947,8/9/2019,2019,71.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1947,8/9/2019,2019,71.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1957,8/9/2019,2019,62,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1957,8/9/2019,2019,62,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1947,8/9/2019,2019,71.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1947,8/9/2019,2019,71.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1946,8/9/2019,2019,73.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1946,8/9/2019,2019,73.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1962,8/16/2019,2019,57.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1962,8/16/2019,2019,57.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1964,8/16/2019,2019,55.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1964,8/16/2019,2019,55.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1951,8/16/2019,2019,68.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1951,8/16/2019,2019,68.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1959,8/16/2019,2019,60.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1959,8/16/2019,2019,60.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1938,8/21/2019,2019,81.6,White,Non-Hispanic,White,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/29/1957,8/23/2019,2019,61.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1957,8/23/2019,2019,61.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1958,8/26/2019,2019,61.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1958,8/26/2019,2019,61.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1953,8/27/2019,2019,66.7,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/16/1953,8/29/2019,2019,66.6,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
1/16/1953,8/30/2019,2019,66.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1953,8/30/2019,2019,66.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1950,9/3/2019,2019,69.4,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/3/1949,9/6/2019,2019,70.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1949,9/6/2019,2019,70.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1953,9/6/2019,2019,66.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1953,9/6/2019,2019,66.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1964,9/12/2019,2019,55.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1964,9/12/2019,2019,55.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1955,9/20/2019,2019,64.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1955,9/20/2019,2019,64.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1950,9/20/2019,2019,69.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/10/1950,9/20/2019,2019,69.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1950,9/20/2019,2019,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/3/1950,9/20/2019,2019,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1940,9/20/2019,2019,79.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1940,9/20/2019,2019,79.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1960,9/20/2019,2019,59,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1960,9/20/2019,2019,59,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1945,9/24/2019,2019,74.2,Black or African American,Non-Hispanic,Black,Male,81611,MK-3475-365; WIRB 20162487       Pro20170000333,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/7/1965,9/27/2019,2019,54,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/7/1965,10/4/2019,2019,54,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1965,10/4/2019,2019,54,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1955,10/4/2019,2019,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1955,10/4/2019,2019,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1962,10/4/2019,2019,57,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1962,10/4/2019,2019,57,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1962,10/8/2019,2019,57,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/15/1959,10/10/2019,2019,59.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1959,10/10/2019,2019,59.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1959,10/11/2019,2019,60.3,White,Non-Hispanic,White,Male,81510,11-497; Pro20150002215,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase III,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/28/1966,10/18/2019,2019,53.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/28/1966,10/18/2019,2019,53.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1959,10/18/2019,2019,59.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1959,10/18/2019,2019,59.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1966,10/22/2019,2019,53.7,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/29/1956,10/22/2019,2019,63.5,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/18/1959,10/22/2019,2019,59.9,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/30/1958,10/25/2019,2019,61,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1958,10/25/2019,2019,61,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1955,10/25/2019,2019,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1955,10/25/2019,2019,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1953,10/25/2019,2019,66.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1953,10/25/2019,2019,66.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1954,11/1/2019,2019,65.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1954,11/1/2019,2019,65.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1957,11/1/2019,2019,62.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1957,11/1/2019,2019,62.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1962,11/5/2019,2019,57.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1961,11/8/2019,2019,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/25/1961,11/8/2019,2019,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1954,11/15/2019,2019,65,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1954,11/15/2019,2019,65,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1947,11/22/2019,2019,72.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1954,11/22/2019,2019,65.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1954,11/22/2019,2019,65.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/6/1958,11/22/2019,2019,61.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/6/1958,11/22/2019,2019,61.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1957,11/22/2019,2019,62.5,Unknown,Non-Hispanic,Unknown,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1957,11/22/2019,2019,62.5,Unknown,Non-Hispanic,Unknown,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1956,11/22/2019,2019,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1956,11/22/2019,2019,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1951,11/22/2019,2019,68.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1951,11/22/2019,2019,68.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1966,11/22/2019,2019,53.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1966,11/22/2019,2019,53.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1958,11/22/2019,2019,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1958,11/22/2019,2019,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1951,12/5/2019,2019,68.6,White,Non-Hispanic,White,Male,81907,10191; NCI CIRB Pro2019002071,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/23/1970,12/6/2019,2019,49.2,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1970,12/6/2019,2019,49.2,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1959,12/6/2019,2019,60.4,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/11/1960,12/6/2019,2019,59.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1960,12/6/2019,2019,59.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1958,12/6/2019,2019,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/26/1958,12/6/2019,2019,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1959,12/6/2019,2019,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1959,12/6/2019,2019,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1945,12/11/2019,2019,74.6,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/27/1952,12/13/2019,2019,67.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1952,12/13/2019,2019,67.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/4/1967,12/13/2019,2019,53,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/4/1967,12/13/2019,2019,53,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1971,12/13/2019,2019,48.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/11/1971,12/13/2019,2019,48.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/20/1962,12/20/2019,2019,57.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1964,12/23/2019,2019,55.4,White,Non-Hispanic,White,Male,81806,NCI CIRB Pro2018002695; NRG-GU006,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/4/1966,12/27/2019,2019,53.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1966,12/27/2019,2019,53.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1962,12/27/2019,2019,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1962,12/27/2019,2019,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1956,1/3/2020,2020,63.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1956,1/3/2020,2020,63.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1965,1/3/2020,2020,54.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1965,1/3/2020,2020,54.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1955,1/3/2020,2020,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/30/1955,1/3/2020,2020,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1955,1/3/2020,2020,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1955,1/3/2020,2020,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1959,1/3/2020,2020,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1959,1/3/2020,2020,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1947,1/6/2020,2020,72.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1959,1/10/2020,2020,60.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1959,1/10/2020,2020,60.4,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1956,1/10/2020,2020,63.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1956,1/10/2020,2020,63.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1957,1/10/2020,2020,62.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1957,1/10/2020,2020,62.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1965,1/17/2020,2020,54.4,Unknown,Non-Hispanic,Unknown,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1965,1/17/2020,2020,54.4,Unknown,Non-Hispanic,Unknown,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1957,1/17/2020,2020,62.2,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/4/1966,1/17/2020,2020,53.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1966,1/17/2020,2020,53.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1953,1/17/2020,2020,67.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1953,1/17/2020,2020,67.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1964,1/17/2020,2020,55.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1964,1/17/2020,2020,55.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1952,1/17/2020,2020,67.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1952,1/17/2020,2020,67.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1942,1/17/2020,2020,77.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/26/1942,1/17/2020,2020,77.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1959,1/23/2020,2020,60.6,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/24/1954,1/24/2020,2020,65.1,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/18/1963,1/24/2020,2020,56.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1963,1/24/2020,2020,56.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1954,1/24/2020,2020,65.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1954,1/24/2020,2020,65.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/29/1956,1/24/2020,2020,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1956,1/24/2020,2020,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1950,1/24/2020,2020,69.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1950,1/24/2020,2020,69.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/9/1951,1/29/2020,2020,68.8,White,Non-Hispanic,White,Male,81908,10096; NCI CIRB Pro2019001978,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/11/1958,2/7/2020,2020,61.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1958,2/7/2020,2020,61.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1967,2/7/2020,2020,53,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/6/1961,2/7/2020,2020,58.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1961,2/7/2020,2020,58.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1947,2/7/2020,2020,72.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1947,2/7/2020,2020,72.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1952,2/10/2020,2020,68.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1952,2/10/2020,2020,68.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1954,2/12/2020,2020,65.4,Black or African American,Non-Hispanic,Black,Male,81805,Pro2018002793,Prostate,Prostate,"Adenocarcinoma, Nos",Radiation Oncology,Phase II,Treatment,Genitourinary; Radiation Oncology,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/30/1956,2/13/2020,2020,63.6,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/18/1951,2/14/2020,2020,68.6,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1951,2/14/2020,2020,68.6,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1952,2/14/2020,2020,68.1,Asian,Non-Hispanic,Asian,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Prostate,Prostate,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/16/1961,2/14/2020,2020,58.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1961,2/14/2020,2020,58.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1961,2/14/2020,2020,58.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1961,2/14/2020,2020,58.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1950,2/21/2020,2020,70.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1950,2/21/2020,2020,70.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1954,2/21/2020,2020,65.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1954,2/21/2020,2020,65.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1962,2/21/2020,2020,58.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1962,2/21/2020,2020,58.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1962,2/21/2020,2020,57.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1962,2/21/2020,2020,57.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1948,2/26/2020,2020,71.4,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/14/1964,2/28/2020,2020,55.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1964,2/28/2020,2020,55.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1941,2/28/2020,2020,79,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Neoplasm, Malignant",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/27/1949,2/28/2020,2020,71,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1949,2/28/2020,2020,71,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1959,3/4/2020,2020,60.2,Unknown,Hispanic or Latino,Hispanic/Latino,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/27/1959,3/6/2020,2020,60.2,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1959,3/6/2020,2020,60.2,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1970,3/6/2020,2020,49.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/24/1970,3/6/2020,2020,49.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1945,3/6/2020,2020,74.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1945,3/6/2020,2020,74.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1949,3/6/2020,2020,70.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1949,3/6/2020,2020,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/1949,3/6/2020,2020,70.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1949,3/6/2020,2020,70.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1964,3/9/2020,2020,55.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1962,3/13/2020,2020,57.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1962,3/13/2020,2020,57.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1956,3/13/2020,2020,63.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1956,3/13/2020,2020,63.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/4/1961,3/13/2020,2020,58.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1961,3/13/2020,2020,58.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1947,3/13/2020,2020,73,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1947,3/13/2020,2020,73,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1951,5/12/2020,2020,69.1,White,Non-Hispanic,White,Male,81908,10096; NCI CIRB Pro2019001978,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase I/II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
4/1/1956,6/1/2020,2020,64.2,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
3/2/1948,6/2/2020,2020,72.3,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,,Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/11/1942,6/11/2020,2020,78,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/2/1946,7/2/2020,2020,73.6,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,Adenocarcinoma In Situ,Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
11/1/1952,7/24/2020,2020,67.8,Asian,Non-Hispanic,Asian,Male,82003,NCI CIRB Pro2020001336; NRG-GU008,Prostate,Prostate,Acinar Cell Carcinoma,Genitourinary,Phase III,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/13/1955,8/5/2020,2020,65.3,Black or African American,Non-Hispanic,Black,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/5/1959,8/11/2020,2020,61.2,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/9/1968,8/17/2020,2020,51.9,Black or African American,Non-Hispanic,Black,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
5/20/1953,8/20/2020,2020,67.3,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/17/1956,8/21/2020,2020,64.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1956,8/21/2020,2020,64.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1956,9/14/2020,2020,64.2,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,Prostate,Prostate,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/19/1947,9/16/2020,2020,73.2,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/11/1943,9/24/2020,2020,76.8,White,Non-Hispanic,White,Male,81807,COMPARE; Pro2018002795,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,N/A,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/15/1960,9/25/2020,2020,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1960,9/25/2020,2020,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/7/1968,10/6/2020,2020,52.7,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/18/1950,10/13/2020,2020,70.2,White,Non-Hispanic,White,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/3/1953,10/13/2020,2020,67.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1953,10/13/2020,2020,67.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Prostate,Prostate,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1936,10/19/2020,2020,84.3,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Prostate,Prostate,"Adenocarcinoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1953,10/21/2020,2020,67.2,White,Non-Hispanic,White,Male,81707,CINJ 081707; WIRB 20180243,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/23/1963,10/22/2020,2020,57.1,Unknown,Hispanic or Latino,Hispanic/Latino,Male,81603,56021927PCR2004; Pro20160000563,Prostate,Prostate,"Adenocarcinoma, Nos",Genitourinary,Phase II,Treatment,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/20/1942,1/4/2017,2017,74.1,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/18/1960,1/5/2017,2017,56.8,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/30/1946,1/19/2017,2017,71,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/31/1963,1/19/2017,2017,53.1,White,Non-Hispanic,White,Female,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
4/19/1946,1/23/2017,2017,70.8,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/31/1936,1/23/2017,2017,80.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/31/1936,1/23/2017,2017,80.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/31/1936,1/23/2017,2017,80.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1953,2/2/2017,2017,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1953,2/2/2017,2017,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/8/1946,2/10/2017,2017,70.4,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/8/1946,2/15/2017,2017,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1946,2/15/2017,2017,70.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/8/1946,2/15/2017,2017,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1948,2/23/2017,2017,68.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1948,2/23/2017,2017,68.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/15/1948,2/23/2017,2017,68.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1963,3/3/2017,2017,53.2,White,Non-Hispanic,White,Female,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/19/1942,3/10/2017,2017,74.7,White,Non-Hispanic,White,Male,131523,PRO20160000036,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/18/1964,3/15/2017,2017,52.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131523,PRO20160000036,Skin,Skin,,Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
10/23/1943,3/16/2017,2017,73.4,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/7/1948,3/16/2017,2017,68.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/2/1941,3/17/2017,2017,75.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/12/1947,3/18/2017,2017,70.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/16/1955,3/18/2017,2017,61.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/3/1946,3/21/2017,2017,71.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/6/1939,3/24/2017,2017,77.9,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/16/1979,3/24/2017,2017,38.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/19/1945,3/28/2017,2017,72.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Nodular Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/9/1950,3/29/2017,2017,67.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/1991,3/30/2017,2017,25.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/16/1938,3/31/2017,2017,78.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/3/1955,3/31/2017,2017,62.3,White,Non-Hispanic,White,Female,131523,PRO20160000036,Skin,Skin,,Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/29/1964,3/31/2017,2017,52.3,White,Non-Hispanic,White,Female,131523,PRO20160000036,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/30/1953,4/4/2017,2017,63.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/5/1942,4/6/2017,2017,75.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/13/1963,4/10/2017,2017,53.5,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/1/1951,4/12/2017,2017,65.9,Black or African American,Non-Hispanic,Black,Male,51517,Pro20150002605 WIRB 20152735; RRx001-22-01,Skin,Skin,"Malignant Melanoma, Nos",CNS,Phase I,Treatment,CNS; Developmental Therapeutics-Phase I,CNS; Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/18/1956,4/12/2017,2017,60.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1956,4/12/2017,2017,60.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1958,4/13/2017,2017,59.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/18/1950,4/13/2017,2017,67,White,Non-Hispanic,White,Male,131523,PRO20160000036,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/28/1962,4/13/2017,2017,54.7,White,Non-Hispanic,White,Female,131523,PRO20160000036,Skin,Skin,,Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/22/1945,4/13/2017,2017,71.4,White,Non-Hispanic,White,Male,131523,PRO20160000036,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/20/1981,4/14/2017,2017,35.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1963,4/14/2017,2017,53.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/7/1961,4/19/2017,2017,56,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/8/1958,4/20/2017,2017,59.1,White,Non-Hispanic,White,Male,131523,PRO20160000036,Skin,Skin,,Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/18/1972,4/22/2017,2017,44.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/9/1966,4/25/2017,2017,50.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/17/1952,4/26/2017,2017,64.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/26/1936,4/26/2017,2017,80.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/12/1944,4/26/2017,2017,73.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/1/1973,4/27/2017,2017,43.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/4/1950,4/27/2017,2017,66.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/26/1948,5/2/2017,2017,68.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1969,5/2/2017,2017,47.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/3/1946,5/3/2017,2017,70.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/26/1962,5/3/2017,2017,54.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/19/1958,5/3/2017,2017,58.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/3/1933,5/3/2017,2017,83.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/4/1969,5/3/2017,2017,48.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/22/1954,5/4/2017,2017,62.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/22/1935,5/5/2017,2017,82,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/28/1946,5/8/2017,2017,70.8,White,Non-Hispanic,White,Female,131523,PRO20160000036,Skin,Skin,"Sq. Cell Carcinoma, Keratinizing, Nos",Population Science,N/A,Other,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
10/30/1956,5/10/2017,2017,60.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/18/1933,5/16/2017,2017,84,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/22/1962,5/16/2017,2017,54.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/22/1946,5/16/2017,2017,70.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/3/1973,5/19/2017,2017,43.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/16/1943,5/20/2017,2017,74.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/12/1945,5/23/2017,2017,71.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/26/1948,5/23/2017,2017,68.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/9/1990,5/23/2017,2017,27.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/4/1973,5/23/2017,2017,43.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1973,5/23/2017,2017,43.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1973,5/23/2017,2017,43.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1973,5/23/2017,2017,43.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1932,5/23/2017,2017,84.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1932,5/23/2017,2017,84.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1938,5/24/2017,2017,78.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/2024,5/24/2017,2017,-7.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/21/1971,5/24/2017,2017,46.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/24/1956,5/24/2017,2017,60.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/11/1961,5/25/2017,2017,55.8,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/28/1956,5/26/2017,2017,61,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/24/1954,5/26/2017,2017,62.6,White,Non-Hispanic,White,Female,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/8/1948,5/27/2017,2017,69.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/26/1961,5/30/2017,2017,55.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/13/1996,5/30/2017,2017,20.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/25/1961,5/30/2017,2017,56.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/25/1961,5/30/2017,2017,56.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1935,5/30/2017,2017,82.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1935,5/30/2017,2017,82.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1964,5/31/2017,2017,53.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/16/1955,5/31/2017,2017,62.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/17/1951,5/31/2017,2017,66,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/30/1970,5/31/2017,2017,46.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/24/1952,5/31/2017,2017,65.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/6/1949,6/1/2017,2017,67.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/25/1949,6/1/2017,2017,68.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/22/1943,6/2/2017,2017,73.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/4/1942,6/2/2017,2017,74.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/24/1941,6/5/2017,2017,76.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/11/1951,6/9/2017,2017,66.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/4/1950,6/9/2017,2017,67.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/31/1945,6/13/2017,2017,72.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/24/1963,6/13/2017,2017,54.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/7/1928,6/13/2017,2017,88.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/23/1947,6/13/2017,2017,69.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/7/1958,6/13/2017,2017,58.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/27/1953,6/14/2017,2017,63.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/16/1951,6/14/2017,2017,65.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/22/1959,6/14/2017,2017,57.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/24/1930,6/14/2017,2017,87.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/9/1968,6/17/2017,2017,48.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/13/1957,6/19/2017,2017,60.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/13/1957,6/19/2017,2017,60.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/13/1957,6/19/2017,2017,60.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1957,6/20/2017,2017,60.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/22/1981,6/20/2017,2017,36.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1981,6/20/2017,2017,36.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1973,6/20/2017,2017,43.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1973,6/20/2017,2017,43.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1980,6/21/2017,2017,36.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1980,6/21/2017,2017,36.6,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/6/1980,6/21/2017,2017,36.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1965,6/21/2017,2017,52.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/30/1981,6/21/2017,2017,36,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/4/1953,6/21/2017,2017,64,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/6/1938,6/23/2017,2017,78.8,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/26/1947,6/26/2017,2017,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1947,6/26/2017,2017,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1929,6/26/2017,2017,87.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1981,6/26/2017,2017,36.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1981,6/26/2017,2017,36.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1968,6/27/2017,2017,48.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1925,6/27/2017,2017,92.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1925,6/27/2017,2017,92.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/11/1983,6/27/2017,2017,33.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/11/1983,6/27/2017,2017,33.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/23/1929,6/27/2017,2017,87.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1964,6/28/2017,2017,52.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/15/1957,6/28/2017,2017,60.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/7/1969,6/28/2017,2017,48,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/3/1951,6/28/2017,2017,65.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1948,6/29/2017,2017,69.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/8/1942,6/30/2017,2017,74.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/4/1955,6/30/2017,2017,61.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/6/1938,6/30/2017,2017,79.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1944,6/30/2017,2017,72.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/9/1943,6/30/2017,2017,73.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1947,7/3/2017,2017,70.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/19/1953,7/5/2017,2017,63.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/3/1966,7/5/2017,2017,51.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/5/1941,7/6/2017,2017,76,White,Hispanic or Latino,Hispanic/Latino,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/18/1975,7/6/2017,2017,41.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/24/1944,7/7/2017,2017,73.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/3/1949,7/7/2017,2017,67.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/4/1966,7/7/2017,2017,51.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/24/1955,7/7/2017,2017,62.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/31/1941,7/10/2017,2017,76.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/7/1950,7/11/2017,2017,67.2,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Skin,Skin,"Sarcoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/20/1955,7/11/2017,2017,62.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/16/1971,7/12/2017,2017,46.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/30/1979,7/13/2017,2017,37.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/17/1957,7/13/2017,2017,59.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/7/1945,7/13/2017,2017,72.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/23/1961,7/14/2017,2017,56.2,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/1/1951,7/17/2017,2017,66.6,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,131604,20170000115,Skin,Skin,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/15/1963,7/18/2017,2017,54.3,White,Hispanic or Latino,Hispanic/Latino,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/23/1944,7/19/2017,2017,73,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/30/1959,7/19/2017,2017,57.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/19/1948,7/19/2017,2017,69.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/14/1945,7/19/2017,2017,72.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/19/1964,7/20/2017,2017,53.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/9/1958,7/20/2017,2017,58.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/24/1979,7/20/2017,2017,38.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/4/1947,7/21/2017,2017,69.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Desmoplastic Melanoma, Malignant",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/1/1959,7/21/2017,2017,57.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/7/1982,7/21/2017,2017,35.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/9/1967,7/24/2017,2017,50.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/21/1947,7/24/2017,2017,70.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/2/1959,7/24/2017,2017,58.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/21/1948,7/25/2017,2017,68.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/10/1949,7/25/2017,2017,67.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1949,7/25/2017,2017,67.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1948,7/25/2017,2017,69.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1948,7/25/2017,2017,69.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1955,7/26/2017,2017,61.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/16/1970,7/26/2017,2017,47.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/24/1939,7/26/2017,2017,78.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1945,7/27/2017,2017,72.2,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/31/1962,7/27/2017,2017,55.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/26/1957,7/31/2017,2017,60.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/18/1956,7/31/2017,2017,60.9,White,Non-Hispanic,White,Female,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/28/1950,8/1/2017,2017,67,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1950,8/1/2017,2017,67,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1960,8/1/2017,2017,56.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/21/1960,8/1/2017,2017,56.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1939,8/1/2017,2017,77.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1939,8/1/2017,2017,77.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1956,8/1/2017,2017,60.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1956,8/1/2017,2017,60.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1938,8/3/2017,2017,78.7,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
11/14/1973,8/3/2017,2017,43.7,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/10/1955,8/7/2017,2017,62.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1960,8/7/2017,2017,56.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/15/1951,8/7/2017,2017,66.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/4/1948,8/7/2017,2017,69.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/2/1947,8/8/2017,2017,70.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/29/1940,8/8/2017,2017,77.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1940,8/8/2017,2017,77.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1938,8/8/2017,2017,78.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1938,8/8/2017,2017,78.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1954,8/10/2017,2017,63.3,White,Non-Hispanic,White,Female,51705,9149; NCI CIRB Pro20170000458,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/29/1945,8/10/2017,2017,71.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/3/1961,8/10/2017,2017,56.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/16/1963,8/10/2017,2017,54.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/25/1956,8/10/2017,2017,61.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/11/1960,8/10/2017,2017,57,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/16/1942,8/11/2017,2017,75.3,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/30/1972,8/11/2017,2017,44.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/5/1933,8/11/2017,2017,83.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1951,8/11/2017,2017,66,White,Non-Hispanic,White,Female,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
9/26/1949,8/14/2017,2017,67.9,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/10/1973,8/14/2017,2017,44.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/26/1951,8/15/2017,2017,66.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/26/1951,8/15/2017,2017,66.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/13/1966,8/15/2017,2017,51.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1966,8/15/2017,2017,51.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1953,8/17/2017,2017,64,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/1/2031,8/21/2017,2017,-14,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/17/1951,8/22/2017,2017,65.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/16/1971,8/22/2017,2017,46,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/12/1983,8/22/2017,2017,34.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/23/1951,8/22/2017,2017,66.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/4/1937,8/22/2017,2017,80.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/20/1952,8/22/2017,2017,65.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/4/1935,8/22/2017,2017,82.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/4/1935,8/22/2017,2017,82.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1932,8/22/2017,2017,85.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1932,8/22/2017,2017,85.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1967,8/22/2017,2017,50,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1967,8/22/2017,2017,50,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1963,8/22/2017,2017,53.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1963,8/22/2017,2017,53.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1927,8/22/2017,2017,90.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1927,8/22/2017,2017,90.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/10/1963,8/23/2017,2017,54.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/13/1954,8/23/2017,2017,63.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/4/1951,8/23/2017,2017,66.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1968,8/23/2017,2017,48.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/25/1956,8/24/2017,2017,61.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/11/1966,8/24/2017,2017,51.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/4/1964,8/24/2017,2017,53.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/26/1962,8/24/2017,2017,54.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/23/1970,8/28/2017,2017,47.4,White,Hispanic or Latino,Hispanic/Latino,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/20/1934,8/28/2017,2017,83.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/9/1951,8/28/2017,2017,65.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/21/1961,8/28/2017,2017,56.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/8/1943,8/29/2017,2017,74.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1951,8/29/2017,2017,66,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/4/1959,8/29/2017,2017,58.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1959,8/29/2017,2017,58.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1953,8/29/2017,2017,63.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/5/1953,8/29/2017,2017,63.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1950,8/31/2017,2017,67.4,White,Non-Hispanic,White,Male,91604,NCI CIRB Pro20160001158; S1404,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/17/1949,9/1/2017,2017,67.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/7/1956,9/5/2017,2017,60.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1956,9/5/2017,2017,60.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1956,9/5/2017,2017,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1956,9/5/2017,2017,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1947,9/5/2017,2017,70.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1947,9/5/2017,2017,70.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1942,9/6/2017,2017,75.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/4/1955,9/6/2017,2017,62.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/31/1947,9/6/2017,2017,70.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/17/1953,9/6/2017,2017,64.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/17/1993,9/7/2017,2017,24.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/1/1948,9/7/2017,2017,69.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/22/1954,9/7/2017,2017,62.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/24/1960,9/7/2017,2017,57.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/9/1964,9/7/2017,2017,52.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Nodular Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/21/1937,9/7/2017,2017,79.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/5/1948,9/7/2017,2017,69.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/12/1942,9/8/2017,2017,74.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/3/1954,9/8/2017,2017,63.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/5/2025,9/8/2017,2017,-7.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/29/1936,9/8/2017,2017,81.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/21/1981,9/8/2017,2017,36.4,White,Non-Hispanic,White,Female,91602,IIT15PLK03; MK-3475-354 / 52510; Pro20160000394,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma; Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
6/11/1953,9/8/2017,2017,64.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/1/1945,9/8/2017,2017,72.2,White,Unknown,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/26/1974,9/12/2017,2017,43.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/17/1966,9/12/2017,2017,51.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/20/1944,9/12/2017,2017,73,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/7/1965,9/12/2017,2017,52.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/21/1957,9/12/2017,2017,59.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1957,9/12/2017,2017,59.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1950,9/12/2017,2017,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1950,9/12/2017,2017,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1960,9/12/2017,2017,57.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1960,9/12/2017,2017,57.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1962,9/15/2017,2017,54.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/19/1953,9/18/2017,2017,64.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/23/1961,9/19/2017,2017,55.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1961,9/19/2017,2017,55.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1961,9/19/2017,2017,56.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1961,9/19/2017,2017,56.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1973,9/20/2017,2017,44.6,White,Hispanic or Latino,Hispanic/Latino,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/7/1932,9/21/2017,2017,84.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/6/1950,9/22/2017,2017,67.1,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/23/1947,9/22/2017,2017,70.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/14/1950,9/22/2017,2017,67.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/11/1941,9/26/2017,2017,76.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/20/1956,9/26/2017,2017,61.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1956,9/26/2017,2017,61.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1949,9/26/2017,2017,68.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1949,9/26/2017,2017,68.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/14/1960,9/26/2017,2017,57.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/14/1960,9/26/2017,2017,57.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1946,9/27/2017,2017,71.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/22/1926,9/27/2017,2017,91,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,Merkel Cell Carcinoma,Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/17/1963,9/27/2017,2017,54.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/24/1980,9/27/2017,2017,37,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/31/1958,9/28/2017,2017,59.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/3/1957,9/28/2017,2017,60,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/13/1963,9/28/2017,2017,54,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/13/1940,9/28/2017,2017,77.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/1/1947,9/28/2017,2017,70.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/3/1969,9/28/2017,2017,48.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/14/1980,9/28/2017,2017,37.7,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/28/1941,9/28/2017,2017,75.9,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/10/1957,9/29/2017,2017,60.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/24/1942,9/29/2017,2017,75.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/16/1947,9/29/2017,2017,70.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Spindle Cell Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/13/1946,9/29/2017,2017,70.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/14/1973,10/1/2017,2017,43.9,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/17/1932,10/2/2017,2017,85,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/8/1948,10/2/2017,2017,69.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1948,10/2/2017,2017,69.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/8/1948,10/2/2017,2017,69.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1932,10/2/2017,2017,85.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/19/1959,10/3/2017,2017,58.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1959,10/3/2017,2017,58.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1992,10/3/2017,2017,25.5,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/2/1941,10/4/2017,2017,76.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/21/1962,10/5/2017,2017,54.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/24/1945,10/5/2017,2017,72.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Acral Lentiginous Melanoma, Malig.",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/25/1958,10/10/2017,2017,59.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1958,10/10/2017,2017,59.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1952,10/11/2017,2017,65.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/12/1966,10/13/2017,2017,51.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1940,10/13/2017,2017,77.4,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/27/1991,10/16/2017,2017,26.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1944,10/16/2017,2017,73.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/2/1945,10/16/2017,2017,72.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/18/1960,10/17/2017,2017,57.6,White,Non-Hispanic,White,Male,51707,20170000453,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/15/1958,10/17/2017,2017,59.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/10/1958,10/17/2017,2017,59.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1958,10/17/2017,2017,59.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1942,10/17/2017,2017,75.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1942,10/17/2017,2017,75.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1952,10/17/2017,2017,65.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/26/1961,10/17/2017,2017,56.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/6/1989,10/18/2017,2017,28.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/23/1947,10/18/2017,2017,70,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/11/1960,10/19/2017,2017,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1950,10/19/2017,2017,67.2,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/9/1948,10/19/2017,2017,69.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/15/1952,10/19/2017,2017,65.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/14/1958,10/19/2017,2017,59.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/17/1936,10/20/2017,2017,81.4,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/5/1941,10/20/2017,2017,76.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/23/1948,10/23/2017,2017,69.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/12/1954,10/23/2017,2017,62.9,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1957,10/23/2017,2017,60.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/20/1965,10/24/2017,2017,52.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/28/1923,10/24/2017,2017,94.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/28/1923,10/24/2017,2017,94.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1957,10/24/2017,2017,60.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1957,10/24/2017,2017,60.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1960,10/24/2017,2017,57.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1960,10/24/2017,2017,57.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/1971,10/24/2017,2017,46,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/1971,10/24/2017,2017,46,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1947,10/25/2017,2017,70,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1966,10/26/2017,2017,51.5,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/23/1957,10/30/2017,2017,60.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/6/1949,10/31/2017,2017,68.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1949,10/31/2017,2017,68.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/29/1931,10/31/2017,2017,86.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/22/1938,10/31/2017,2017,79,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/13/1959,10/31/2017,2017,58.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1959,10/31/2017,2017,58.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1951,10/31/2017,2017,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1951,10/31/2017,2017,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1999,10/31/2017,2017,18.4,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Acral Lentiginous Melanoma, Malig.",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/30/1949,11/1/2017,2017,68.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/9/1951,11/1/2017,2017,66.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/10/1953,11/2/2017,2017,64,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/28/1944,11/3/2017,2017,73.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/9/1964,11/3/2017,2017,53.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/13/1958,11/3/2017,2017,59.5,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1957,11/6/2017,2017,60.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/18/1949,11/6/2017,2017,68.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/12/1942,11/6/2017,2017,75.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/24/1948,11/7/2017,2017,69.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Spindle Cell Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/1/1937,11/7/2017,2017,80,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1937,11/7/2017,2017,80,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1970,11/7/2017,2017,47.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1970,11/7/2017,2017,47.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/2/1960,11/7/2017,2017,57.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/2/1960,11/7/2017,2017,57.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1955,11/9/2017,2017,62.5,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/7/1943,11/9/2017,2017,74.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/6/1968,11/13/2017,2017,49.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/17/1973,11/13/2017,2017,44.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/9/1937,11/14/2017,2017,80.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/22/1950,11/14/2017,2017,67.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1950,11/14/2017,2017,67.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1944,11/14/2017,2017,73.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1944,11/14/2017,2017,73.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/17/1938,11/14/2017,2017,79.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/17/1938,11/14/2017,2017,79.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/21/1983,11/14/2017,2017,34.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/13/1959,11/15/2017,2017,58.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/16/1974,11/16/2017,2017,43.6,White,Non-Hispanic,White,Male,91602,IIT15PLK03; MK-3475-354 / 52510; Pro20160000394,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma; Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
3/1/1963,11/16/2017,2017,54.8,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/5/1933,11/17/2017,2017,84.9,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/8/1970,11/17/2017,2017,47.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/27/1941,11/17/2017,2017,76.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/11/1967,11/17/2017,2017,50.9,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/27/1945,11/20/2017,2017,72.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/10/1957,11/20/2017,2017,60.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1957,11/20/2017,2017,60.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/10/1957,11/20/2017,2017,60.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1954,11/20/2017,2017,63.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1954,11/20/2017,2017,63.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/24/1954,11/20/2017,2017,63.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1962,11/21/2017,2017,55.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/20/1959,11/21/2017,2017,58.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/17/1957,11/21/2017,2017,60.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/7/1975,11/21/2017,2017,42.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1951,11/28/2017,2017,66.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/26/1941,11/28/2017,2017,76.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1941,11/28/2017,2017,76.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1953,11/28/2017,2017,64.5,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/2/1966,11/29/2017,2017,51.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/4/1957,11/30/2017,2017,60.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/1/1986,12/1/2017,2017,31.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/24/1946,12/1/2017,2017,71.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/11/1961,12/1/2017,2017,56.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/27/1975,12/1/2017,2017,42.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/27/1975,12/1/2017,2017,42.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1960,12/1/2017,2017,57.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1960,12/1/2017,2017,57.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1980,12/4/2017,2017,37.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/26/1944,12/4/2017,2017,73.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/29/1952,12/4/2017,2017,65.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/2/1975,12/4/2017,2017,43,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/31/1943,12/4/2017,2017,74.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/12/1958,12/4/2017,2017,59.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/5/1963,12/5/2017,2017,54.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/5/1963,12/5/2017,2017,54.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1969,12/7/2017,2017,48.2,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/11/1927,12/7/2017,2017,90.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/15/1966,12/7/2017,2017,51.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/21/1941,12/7/2017,2017,76.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/18/1942,12/8/2017,2017,75.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/28/1936,12/8/2017,2017,81.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/27/1977,12/8/2017,2017,40.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/14/1942,12/10/2017,2017,75.3,White,Non-Hispanic,White,Female,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/17/1954,12/11/2017,2017,63.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/28/1979,12/13/2017,2017,38.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/3/1951,12/13/2017,2017,66.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1948,12/13/2017,2017,69.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1936,12/14/2017,2017,81.4,White,Non-Hispanic,White,Female,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
9/18/1930,12/14/2017,2017,87.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Spindle Cell Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
,12/14/2017,2017,,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/7/1975,12/15/2017,2017,42.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/26/1926,12/15/2017,2017,91.9,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/16/1990,12/19/2017,2017,27.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/30/1952,12/19/2017,2017,65.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1952,12/19/2017,2017,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1942,12/19/2017,2017,75.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/14/1938,12/21/2017,2017,79.1,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/21/1992,12/21/2017,2017,25.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/4/1956,12/22/2017,2017,61.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/5/1955,1/2/2018,2018,62.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/23/1980,1/2/2018,2018,37.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/23/1980,1/2/2018,2018,37.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1940,1/2/2018,2018,77.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1940,1/2/2018,2018,77.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1983,1/4/2018,2018,34.8,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/26/1948,1/8/2018,2018,69.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/3/1971,1/9/2018,2018,47,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1987,1/9/2018,2018,30.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/10/1956,1/9/2018,2018,61.9,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/24/1937,1/9/2018,2018,80.6,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/23/1949,1/11/2018,2018,68.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/3/1959,1/11/2018,2018,58.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/5/1944,1/11/2018,2018,73.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/18/1962,1/12/2018,2018,55.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/30/1949,1/12/2018,2018,68.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/10/1956,1/16/2018,2018,61.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/25/1963,1/16/2018,2018,54.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/15/1957,1/16/2018,2018,60.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1957,1/16/2018,2018,60.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/2/1943,1/16/2018,2018,74.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/2/1943,1/16/2018,2018,74.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/27/1942,1/16/2018,2018,75.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/27/1942,1/16/2018,2018,75.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1951,1/16/2018,2018,66.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/12/1951,1/16/2018,2018,66.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1994,1/16/2018,2018,23.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/10/1957,1/17/2018,2018,60.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/4/1965,1/18/2018,2018,52.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/16/1952,1/18/2018,2018,65.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/9/1984,1/19/2018,2018,33.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/18/1956,1/19/2018,2018,61.4,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/27/1983,1/22/2018,2018,35,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1950,1/22/2018,2018,67.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/12/1953,1/22/2018,2018,64.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1941,1/22/2018,2018,76.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/21/1962,1/22/2018,2018,55.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/1/1964,1/22/2018,2018,53.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/25/1929,1/23/2018,2018,88.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/4/1953,1/23/2018,2018,64.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/14/1971,1/23/2018,2018,46.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1971,1/23/2018,2018,46.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1972,1/23/2018,2018,45.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1972,1/23/2018,2018,45.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1950,1/24/2018,2018,68,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/2/1947,1/24/2018,2018,70.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/19/1962,1/24/2018,2018,55.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/14/1941,1/25/2018,2018,76.2,Unknown,Hispanic or Latino,Hispanic/Latino,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/11/1958,1/25/2018,2018,59.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/13/1955,1/25/2018,2018,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1955,1/25/2018,2018,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1933,1/26/2018,2018,84.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Nodular Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/4/1953,1/26/2018,2018,64.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/18/1972,1/29/2018,2018,45.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/20/1935,1/30/2018,2018,82.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/21/1959,1/30/2018,2018,59,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/27/1943,1/30/2018,2018,74.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1943,1/30/2018,2018,74.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1962,1/31/2018,2018,56,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/22/1958,1/31/2018,2018,59.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/25/1961,2/5/2018,2018,57,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/6/1960,2/5/2018,2018,57.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/1/1940,2/6/2018,2018,78,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1947,2/6/2018,2018,70.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/19/1960,2/6/2018,2018,57.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/3/1964,2/6/2018,2018,54,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/9/1947,2/6/2018,2018,70.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/17/1956,2/6/2018,2018,61.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1956,2/6/2018,2018,61.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1933,2/6/2018,2018,84.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1933,2/6/2018,2018,84.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/8/1954,2/9/2018,2018,63.7,White,Non-Hispanic,White,Female,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/3/1982,2/9/2018,2018,36,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/13/1955,2/9/2018,2018,62.4,Unknown,Unknown,Unknown,U,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/8/1962,2/12/2018,2018,55.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/11/1936,2/12/2018,2018,81.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/16/1968,2/19/2018,2018,50.1,White,Hispanic or Latino,Hispanic/Latino,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/13/1958,2/19/2018,2018,60,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/22/1981,2/19/2018,2018,36.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/17/1951,2/19/2018,2018,66.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/28/1952,2/20/2018,2018,65.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/23/1963,2/20/2018,2018,54.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/1931,2/21/2018,2018,86.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/30/1945,2/21/2018,2018,72.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/9/1955,2/22/2018,2018,62.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/11/1959,2/23/2018,2018,58.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/10/1956,2/26/2018,2018,61.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/18/1964,2/26/2018,2018,53.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/1/1955,2/27/2018,2018,62.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/29/1969,2/27/2018,2018,49.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/29/1969,2/27/2018,2018,49.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/3/1923,2/27/2018,2018,94.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1923,2/27/2018,2018,94.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1958,2/27/2018,2018,59.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/28/1951,3/1/2018,2018,67,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/17/1974,3/6/2018,2018,43.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1974,3/6/2018,2018,43.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1955,3/6/2018,2018,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1955,3/6/2018,2018,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1936,3/6/2018,2018,81.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/19/1936,3/6/2018,2018,81.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1969,3/12/2018,2018,48.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/25/1969,3/12/2018,2018,48.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/25/1969,3/12/2018,2018,48.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1942,3/12/2018,2018,75.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1942,3/12/2018,2018,75.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/20/1942,3/12/2018,2018,75.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/21/1960,3/13/2018,2018,57.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/24/1936,3/13/2018,2018,81.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/25/1996,3/13/2018,2018,21.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/9/1980,3/14/2018,2018,38,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/6/1972,3/14/2018,2018,46,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,"Papillary Adenocarcinoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/19/1966,3/14/2018,2018,51.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/9/1960,3/14/2018,2018,57.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/8/1951,3/14/2018,2018,66.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/23/1961,3/15/2018,2018,57.2,White,Non-Hispanic,White,Female,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma In Situ, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/17/1930,3/15/2018,2018,87.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/16/1967,3/15/2018,2018,50.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/18/1968,3/19/2018,2018,49.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/12/1944,3/20/2018,2018,73.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/28/1942,3/20/2018,2018,75.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/15/1976,3/20/2018,2018,42,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1976,3/20/2018,2018,42,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1941,3/20/2018,2018,76.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/25/1941,3/20/2018,2018,76.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/31/1946,3/20/2018,2018,71.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/31/1946,3/20/2018,2018,71.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1954,3/23/2018,2018,63.5,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,"Cutaneous T-Cell Lymphoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/25/1973,3/23/2018,2018,44.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/27/1994,3/26/2018,2018,23.4,Unknown,Non-Hispanic,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/25/1944,3/27/2018,2018,73.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/22/1953,3/27/2018,2018,64.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1953,3/27/2018,2018,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1931,3/29/2018,2018,86.8,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/6/1960,3/30/2018,2018,57.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/24/1937,3/30/2018,2018,81.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/30/1963,4/2/2018,2018,54.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1950,4/2/2018,2018,67.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/2/1963,4/2/2018,2018,54.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/21/1940,4/2/2018,2018,78,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/5/1979,4/3/2018,2018,39.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1979,4/3/2018,2018,39.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1946,4/3/2018,2018,71.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/1/1956,4/3/2018,2018,62.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1956,4/3/2018,2018,62.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1953,4/4/2018,2018,64.8,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/30/1941,4/4/2018,2018,76.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/29/1939,4/5/2018,2018,78.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/18/1954,4/6/2018,2018,63.9,White,Non-Hispanic,White,Female,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/7/1952,4/6/2018,2018,66.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/29/1965,4/10/2018,2018,52.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/15/1958,4/10/2018,2018,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1958,4/10/2018,2018,59.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1977,4/12/2018,2018,40.9,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/6/1969,4/13/2018,2018,48.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/8/1958,4/19/2018,2018,59.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1958,4/19/2018,2018,59.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/8/1958,4/19/2018,2018,59.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/6/1946,4/30/2018,2018,72.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/31/1963,5/10/2018,2018,54.4,White,Non-Hispanic,White,Female,51707,20170000453,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/16/1947,5/14/2018,2018,71,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/8/1954,5/14/2018,2018,64,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1954,5/14/2018,2018,64,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/8/1954,5/14/2018,2018,64,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/8/1936,5/15/2018,2018,81.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/8/1936,5/15/2018,2018,81.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/8/1936,5/15/2018,2018,81.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1959,5/22/2018,2018,59.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/5/1953,5/22/2018,2018,64.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/21/1964,5/22/2018,2018,54.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/17/1945,5/22/2018,2018,73.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Lentigo Maligna,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/8/1980,5/22/2018,2018,37.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/5/1949,5/23/2018,2018,68.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,Superficial Spreading Melanoma,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/25/1969,5/23/2018,2018,49,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/27/1961,5/24/2018,2018,57.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/15/1960,5/29/2018,2018,58.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/7/1965,5/29/2018,2018,52.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1960,5/29/2018,2018,57.8,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/23/1933,5/30/2018,2018,85.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/7/1964,5/30/2018,2018,54,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,Melanoma In Situ,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/26/1947,6/1/2018,2018,71.2,White,Non-Hispanic,White,Female,91602,IIT15PLK03; MK-3475-354 / 52510; Pro20160000394,Skin,Skin,"Malignant Melanoma, Regressing",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma; Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
11/2/1960,6/4/2018,2018,57.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/28/1954,6/22/2018,2018,64.3,White,Non-Hispanic,White,Female,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,"Cutaneous T-Cell Lymphoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/3/1981,6/29/2018,2018,36.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/3/1981,6/29/2018,2018,36.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1965,7/10/2018,2018,53.1,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,Merkel Cell Carcinoma,Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/5/1954,7/13/2018,2018,64.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/10/1939,7/18/2018,2018,79.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/8/1958,7/23/2018,2018,59.7,White,Non-Hispanic,White,Male,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/31/1963,7/23/2018,2018,54.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/31/1963,7/23/2018,2018,54.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/31/1963,7/23/2018,2018,54.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1945,7/23/2018,2018,72.7,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/3/1954,7/23/2018,2018,64.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/16/1944,7/24/2018,2018,74.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1944,7/24/2018,2018,74.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1944,7/24/2018,2018,74.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1944,7/24/2018,2018,74.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1975,7/25/2018,2018,43.5,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/8/1936,7/26/2018,2018,82,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/7/1944,7/26/2018,2018,74.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1944,7/26/2018,2018,74.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/7/1944,7/26/2018,2018,74.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1944,7/27/2018,2018,74.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1944,7/27/2018,2018,74.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/29/1944,7/27/2018,2018,74.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1943,7/27/2018,2018,74.8,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/6/1954,7/31/2018,2018,64,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/10/1966,7/31/2018,2018,52.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1966,7/31/2018,2018,52.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1954,7/31/2018,2018,64.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/22/1961,8/1/2018,2018,57.3,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/31/1944,8/1/2018,2018,74.6,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/4/1955,8/6/2018,2018,63,White,Non-Hispanic,White,Male,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,Sebaceous Adenocarcinoma,Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/8/1955,8/7/2018,2018,63.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/24/1956,8/10/2018,2018,62.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/24/1956,8/10/2018,2018,62.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1967,8/17/2018,2018,51.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,Skin,Skin,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/2/1943,8/22/2018,2018,75,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1943,8/22/2018,2018,75,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1958,9/10/2018,2018,59.9,White,Non-Hispanic,White,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/9/1960,9/10/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1960,9/10/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1931,9/11/2018,2018,87.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1931,9/11/2018,2018,87.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/18/1931,9/11/2018,2018,87.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1963,9/27/2018,2018,55.6,White,Non-Hispanic,White,Male,91801,17P.641; 2018000554,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/9/1956,11/6/2018,2018,62.8,White,Non-Hispanic,White,Male,131317,Pro2013003676,Skin,Skin,"Malignant Melanoma, Nos",NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1956,11/9/2018,2018,62.1,White,Non-Hispanic,White,Male,131317,Pro2013003676,Skin,Skin,"Malignant Melanoma, Nos",NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1950,12/5/2018,2018,68.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/24/1950,12/5/2018,2018,68.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1960,12/5/2018,2018,58.8,White,Non-Hispanic,White,Female,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/12/1970,12/10/2018,2018,48.4,Asian,Non-Hispanic,Asian,Male,51510,Pro20150001984; VLA-011,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/14/1946,12/11/2018,2018,72.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1946,12/11/2018,2018,72.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1949,12/13/2018,2018,70,White,Non-Hispanic,White,Male,91503,Pro20150001535; UPCC 02614,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase I/II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/11/1934,12/26/2018,2018,85,White,Non-Hispanic,White,Male,51804,MK-3475-587-00; eIRB 2018001473  WIRB 20181257,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase III,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/30/1965,12/26/2018,2018,53.6,White,Non-Hispanic,White,Male,51804,MK-3475-587-00; eIRB 2018001473  WIRB 20181257,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase III,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/21/1968,12/31/2018,2018,50.2,White,Hispanic or Latino,Hispanic/Latino,Female,91701,10057; NCI CIRB Pro20170000882 IBC 17-043,Skin,Skin,"Cutaneous T-Cell Lymphoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/16/1942,1/14/2019,2019,76.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1942,1/14/2019,2019,76.7,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/16/1942,1/14/2019,2019,76.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1946,1/14/2019,2019,72.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1946,1/14/2019,2019,72.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/6/1946,1/14/2019,2019,72.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1960,1/18/2019,2019,58.3,White,Non-Hispanic,White,Female,91306,9466; NCI CIRB Pro2018000540,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/21/1974,1/28/2019,2019,44.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1974,1/28/2019,2019,44.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1948,2/1/2019,2019,70.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1948,2/1/2019,2019,70.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1954,2/4/2019,2019,64.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/6/1954,2/4/2019,2019,64.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/6/1954,2/4/2019,2019,64.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1948,2/4/2019,2019,70.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/17/1938,2/4/2019,2019,80.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/6/1954,2/5/2019,2019,64.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1954,2/5/2019,2019,64.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/25/1969,2/11/2019,2019,49.3,White,Non-Hispanic,White,Male,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/10/1942,2/11/2019,2019,76.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1942,2/11/2019,2019,76.5,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/10/1942,2/11/2019,2019,76.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1970,2/21/2019,2019,48.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/12/1970,2/21/2019,2019,48.6,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/12/1970,2/21/2019,2019,48.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1973,2/22/2019,2019,45.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/19/1945,2/26/2019,2019,74.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1945,2/26/2019,2019,74.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1960,3/1/2019,2019,59,White,Non-Hispanic,White,Female,51805,CA027-002; Pro2018001473; 20172711,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/28/1935,3/4/2019,2019,83.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1935,3/4/2019,2019,83.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1959,3/6/2019,2019,60.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1959,3/6/2019,2019,60.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1949,3/8/2019,2019,70.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1949,3/8/2019,2019,70.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1953,3/15/2019,2019,66,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1953,3/15/2019,2019,66,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1934,3/22/2019,2019,84.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1934,3/22/2019,2019,84.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/28/1934,3/22/2019,2019,84.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1946,4/19/2019,2019,72.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/26/1946,4/19/2019,2019,72.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/17/1942,4/22/2019,2019,76.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/17/1942,4/22/2019,2019,76.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1970,4/26/2019,2019,48.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1970,4/26/2019,2019,48.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1973,4/26/2019,2019,46.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1973,4/26/2019,2019,46.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1943,5/14/2019,2019,75.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1943,5/14/2019,2019,75.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/2/1956,5/15/2019,2019,62.7,White,Non-Hispanic,White,Male,91801,17P.641; 2018000554,Skin,Skin,"Desmoplastic Melanoma, Malignant",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/17/1943,5/28/2019,2019,76.3,White,Non-Hispanic,White,Male,91801,17P.641; 2018000554,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/15/1974,6/4/2019,2019,45.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1974,6/4/2019,2019,45.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1964,6/10/2019,2019,55.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1964,6/10/2019,2019,55.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1970,6/11/2019,2019,48.9,Asian,Non-Hispanic,Asian,Male,91902,NCI CIRB Pro2019000625; S1616,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/26/1957,6/24/2019,2019,62.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1957,6/24/2019,2019,62.4,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/26/1957,6/24/2019,2019,62.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1937,7/5/2019,2019,81.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1937,7/5/2019,2019,81.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1968,7/5/2019,2019,51.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1968,7/5/2019,2019,51.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1940,7/15/2019,2019,79.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/26/1940,7/15/2019,2019,79.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/26/1940,7/15/2019,2019,79.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1951,7/19/2019,2019,68.3,White,Non-Hispanic,White,Female,91306,9466; NCI CIRB Pro2018000540,Skin,Skin,Nodular Melanoma,DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I; Melanoma / Sarcoma,Developmental Therapeutics-phase I; Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/24/1940,7/30/2019,2019,78.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1940,7/30/2019,2019,78.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/24/1940,7/30/2019,2019,78.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1955,8/13/2019,2019,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1955,8/13/2019,2019,64,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/4/1955,8/13/2019,2019,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/6/1954,8/21/2019,2019,65.1,White,Non-Hispanic,White,Male,51807,INCMGA 0012-102; WIRB 20181261  Pro2018001928,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/23/1928,8/22/2019,2019,90.7,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/13/1949,9/20/2019,2019,70,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1949,9/20/2019,2019,70,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1959,9/24/2019,2019,60.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1959,9/24/2019,2019,60.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1940,10/23/2019,2019,79.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/9/1960,10/24/2019,2019,59.7,White,Non-Hispanic,White,Female,51901,Pro2019000353 ; WIRB20191459; TTX-030-001,Skin,Skin,Nodular Melanoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/4/1955,10/25/2019,2019,64.4,White,Non-Hispanic,White,Male,91801,17P.641; 2018000554,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
4/7/1949,10/25/2019,2019,70.6,White,Non-Hispanic,White,Female,91801,17P.641; 2018000554,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
4/17/1943,10/25/2019,2019,76.6,White,Non-Hispanic,White,Male,171801,PICI0009; Pro2018002367 ,Skin,Skin,"Malignant Melanoma, Nos",Precision Medicine,N/A,Basic Science,Not tumor specific / Laboratory studies; Precision Medicine Investigational Therapeutics,CINJ Oncology Group; Precision Medicine Investigational Therapeutics,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1941,10/30/2019,2019,78.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1941,10/30/2019,2019,78.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1936,12/6/2019,2019,83.3,White,Non-Hispanic,White,Male,91303,Pro20140000555,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Early Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/22/1960,12/18/2019,2019,59,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1949,1/16/2020,2020,70.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/6/1949,1/16/2020,2020,70.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/27/1944,1/21/2020,2020,75.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/27/1944,1/21/2020,2020,75.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/9/1960,2/7/2020,2020,60,White,Non-Hispanic,White,Female,51907,CA022001; WIRB20170464   Pro2019001473,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
9/14/1942,2/18/2020,2020,77.5,White,Non-Hispanic,White,Female,51907,CA022001; WIRB20170464   Pro2019001473,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/6/1958,3/4/2020,2020,62,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/6/1958,3/4/2020,2020,62,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Skin,Skin,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1947,3/16/2020,2020,72.8,White,Non-Hispanic,White,Male,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,Skin,Skin,"Malignant Melanoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/6/1958,3/31/2020,2020,62,White,Non-Hispanic,White,Male,91909,2019002150; EA6174,Skin,Skin,,Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
1/1/1947,4/13/2020,2020,73.3,White,Non-Hispanic,White,Male,51908,INCB 86550-102; WIRB20182238;  Pro2019001545,Skin,Skin,Angiomyosarcoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/10/1959,4/17/2020,2020,60.9,White,Non-Hispanic,White,Male,91804,20167004; Pro2018002628,Skin,Skin,"Squamous Cell Carcinoma, Nos",Melanoma / Sarcoma,Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/9/1960,5/11/2020,2020,60.2,White,Non-Hispanic,White,Female,1209,Pro2012002075,Skin,Skin,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/17/1938,6/5/2020,2020,81.9,Black or African American,Non-Hispanic,Black,Male,91804,20167004; Pro2018002628,Skin,Skin,,Melanoma / Sarcoma,Phase I,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/2/1957,6/5/2020,2020,62.7,White,Non-Hispanic,White,Male,91906,Pro2019001626   IBC 19-047; V937-011-0002,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/16/1938,7/27/2020,2020,81.8,White,Non-Hispanic,White,Female,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/4/1962,7/28/2020,2020,58,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/6/1951,8/26/2020,2020,68.8,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/2/1935,9/9/2020,2020,85.4,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/18/1952,9/25/2020,2020,68,White,Non-Hispanic,White,Male,91906,Pro2019001626   IBC 19-047; V937-011-0002,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase II,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/21/1959,10/10/2020,2020,61.6,White,Non-Hispanic,White,Female,91907,2019002380; WIRB 20180594; PH-L19IL2TNF-01/18,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/10/1944,10/13/2020,2020,76.2,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/8/1966,10/14/2020,2020,54.4,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
10/27/1950,10/21/2020,2020,70,Unknown,Hispanic or Latino,Hispanic/Latino,Female,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
3/8/1974,10/26/2020,2020,46.7,White,Non-Hispanic,White,Female,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/27/1951,10/27/2020,2020,69.4,White,Non-Hispanic,White,Male,91908,02.18 MelMarT-II ; Pro2019002254,Skin,Skin,"Malignant Melanoma, Nos",Melanoma / Sarcoma,Phase III,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
2/16/1946,3/22/2017,2017,71.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1946,3/22/2017,2017,71.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/6/1977,3/28/2017,2017,40.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1977,3/28/2017,2017,40.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1978,4/5/2017,2017,39,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/10/1978,4/5/2017,2017,39,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1956,4/12/2017,2017,60.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/27/1956,4/12/2017,2017,60.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1973,4/13/2017,2017,44.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/7/1973,4/13/2017,2017,44.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1961,4/13/2017,2017,55.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1961,4/13/2017,2017,55.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1955,5/9/2017,2017,61.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1955,5/9/2017,2017,61.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/4/1955,5/9/2017,2017,61.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1979,5/23/2017,2017,37.5,White; Black or African American; American Indian or Alaska Native,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1979,5/23/2017,2017,37.5,White; Black or African American; American Indian or Alaska Native,Non-Hispanic,Black,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1970,7/5/2017,2017,47.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1970,7/5/2017,2017,47.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1962,7/11/2017,2017,55,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1962,7/11/2017,2017,55,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1972,8/2/2017,2017,44.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1961,8/22/2017,2017,55.8,Black or African American,Non-Hispanic,Black,Male,51513,9782; NCI CIRB Pro20160000225,Small Intestine,Small Intestine,Signet Ring Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/23/1979,10/12/2017,2017,37.9,White; Black or African American; American Indian or Alaska Native,Non-Hispanic,Black,Female,1209,Pro2012002075,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/26/1949,10/25/2017,2017,68.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1952,6/13/2018,2018,65.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1966,8/23/2018,2018,52.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1966,8/23/2018,2018,52.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1952,8/24/2018,2018,65.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1968,5/7/2019,2019,51.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/27/1968,5/7/2019,2019,51.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/20/1953,5/21/2019,2019,65.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1953,5/21/2019,2019,65.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1929,8/22/2019,2019,90.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1929,8/22/2019,2019,90.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1956,11/15/2019,2019,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1956,11/15/2019,2019,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1952,3/4/2020,2020,67.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/25/1952,3/4/2020,2020,67.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Small Intestine,Small Intestine,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1951,4/13/2017,2017,65.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/25/1951,4/13/2017,2017,65.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1959,5/24/2018,2018,58.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1959,5/24/2018,2018,58.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/10/1991,7/11/2018,2018,26.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/10/1991,7/11/2018,2018,26.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/6/1953,11/6/2018,2018,65,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/6/1953,11/6/2018,2018,65,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1944,8/21/2019,2019,75.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1944,8/21/2019,2019,75.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Spleen,Spleen,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1937,12/11/2019,2019,82.4,White,Non-Hispanic,White,Male,11816,ADCT-402-104; Pro2018001927; WIRB20182622,Spleen,Spleen,"Ml, Large B-Cell, Diffuse",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
10/22/1952,1/19/2017,2017,64.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1952,1/19/2017,2017,64.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/18/1979,2/21/2017,2017,37.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/18/1979,2/21/2017,2017,37.7,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/18/1979,2/21/2017,2017,37.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1943,2/28/2017,2017,73.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1943,2/28/2017,2017,73.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/9/1962,3/1/2017,2017,54.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1962,3/1/2017,2017,54.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1941,4/5/2017,2017,76.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1941,4/5/2017,2017,76.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1954,4/13/2017,2017,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1954,4/13/2017,2017,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1965,5/24/2017,2017,51.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/20/1965,5/24/2017,2017,51.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1958,6/8/2017,2017,58.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1956,6/13/2017,2017,60.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1956,6/13/2017,2017,60.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/27/1958,6/21/2017,2017,59.4,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1988,7/5/2017,2017,29.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1988,7/5/2017,2017,29.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1944,7/12/2017,2017,73.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1961,7/12/2017,2017,56,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1961,7/12/2017,2017,56,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1961,8/9/2017,2017,56.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1961,8/9/2017,2017,56.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1938,9/6/2017,2017,79.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1938,9/6/2017,2017,79.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1933,9/6/2017,2017,84.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1933,9/6/2017,2017,84.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/20/1965,9/13/2017,2017,52.2,White,Non-Hispanic,White,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
10/30/1937,9/15/2017,2017,79.9,White,Non-Hispanic,White,Male,51515,D1345C00003; Pro20150002369 WIRB 20151856 ,Stomach,Stomach,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/23/1950,10/5/2017,2017,66.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1950,10/5/2017,2017,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1946,10/5/2017,2017,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1946,10/5/2017,2017,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1929,10/10/2017,2017,88,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1929,10/10/2017,2017,88,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/31/1976,10/18/2017,2017,41.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/31/1976,10/18/2017,2017,41.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1948,10/19/2017,2017,69.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/7/1948,10/19/2017,2017,69.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1929,10/25/2017,2017,88.1,White,Non-Hispanic,White,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
9/14/1974,10/26/2017,2017,43.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1974,10/26/2017,2017,43.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1974,10/27/2017,2017,43.1,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/14/1938,11/9/2017,2017,79.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1938,11/9/2017,2017,79.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1934,12/20/2017,2017,83.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1934,12/20/2017,2017,83.5,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1943,12/21/2017,2017,74.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1943,12/21/2017,2017,74.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/15/1951,12/27/2017,2017,66.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/15/1951,12/27/2017,2017,66.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1984,1/5/2018,2018,34,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1984,1/5/2018,2018,34,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/14/1936,1/11/2018,2018,81.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/14/1936,1/11/2018,2018,81.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1946,1/30/2018,2018,71.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1946,1/30/2018,2018,71.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/29/1946,1/30/2018,2018,71.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1975,2/1/2018,2018,42.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1975,2/1/2018,2018,42.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1948,2/8/2018,2018,70.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1948,2/8/2018,2018,70.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1950,2/22/2018,2018,67.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1950,2/22/2018,2018,67.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/17/1958,3/6/2018,2018,60,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/17/1958,3/6/2018,2018,60,White,Non-Hispanic,White,Male,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/17/1958,3/6/2018,2018,60,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1939,3/8/2018,2018,78.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1939,3/8/2018,2018,78.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1934,3/19/2018,2018,83.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1934,3/19/2018,2018,83.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1961,3/27/2018,2018,56.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1961,3/27/2018,2018,56.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1938,3/28/2018,2018,80.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1938,3/28/2018,2018,80.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1945,4/25/2018,2018,72.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1945,4/25/2018,2018,72.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1943,5/16/2018,2018,74.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/27/1943,5/16/2018,2018,74.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1974,5/24/2018,2018,44.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1974,5/24/2018,2018,44.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1970,6/6/2018,2018,47.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1983,6/14/2018,2018,35.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1983,6/14/2018,2018,35.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1955,6/14/2018,2018,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1955,6/14/2018,2018,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1946,6/28/2018,2018,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/28/1946,6/28/2018,2018,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/23/1953,7/11/2018,2018,65.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/23/1953,7/11/2018,2018,65.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1954,7/19/2018,2018,64.3,White,Non-Hispanic,White,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/23/1943,7/31/2018,2018,75.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1943,7/31/2018,2018,75.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/30/1973,8/1/2018,2018,45,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/30/1973,8/1/2018,2018,45,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/26/1936,8/22/2018,2018,82.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1936,8/22/2018,2018,82.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1970,8/31/2018,2018,47.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1949,9/5/2018,2018,69.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1949,9/5/2018,2018,69.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/30/1938,9/12/2018,2018,80.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/30/1938,9/12/2018,2018,80.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1944,9/20/2018,2018,73.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1944,9/20/2018,2018,73.9,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/2010,9/26/2018,2018,8.4,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/18/1938,10/4/2018,2018,79.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1938,10/4/2018,2018,79.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/26/1964,11/8/2018,2018,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/26/1964,11/8/2018,2018,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1943,11/15/2018,2018,75,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1972,11/15/2018,2018,46.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/15/1972,11/15/2018,2018,46.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1957,12/20/2018,2018,61.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1957,12/20/2018,2018,61.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1958,1/9/2019,2019,61,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1958,1/9/2019,2019,61,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1947,2/7/2019,2019,71.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1955,2/14/2019,2019,63.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1955,2/14/2019,2019,63.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1956,3/1/2019,2019,62.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1956,3/1/2019,2019,62.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1988,3/8/2019,2019,30.9,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/15/1961,3/14/2019,2019,57.9,White,Non-Hispanic,White,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,Adenocarcinoma In Situ,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/22/1988,3/21/2019,2019,31.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/22/1988,3/21/2019,2019,31.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1951,3/27/2019,2019,67.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1951,3/27/2019,2019,67.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1971,4/5/2019,2019,48.2,White,Non-Hispanic,White,Female,51808,Pro2018002377  WIRB20170992; XL184-021,Stomach,Stomach,Signet Ring Cell Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/30/1955,4/17/2019,2019,63.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1955,4/17/2019,2019,63.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1955,4/18/2019,2019,64,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1955,4/18/2019,2019,64,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1952,4/25/2019,2019,67.1,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/10/1952,4/25/2019,2019,67.1,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1999,4/30/2019,2019,19.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1999,4/30/2019,2019,19.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1959,5/8/2019,2019,60.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1959,5/8/2019,2019,60.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1954,5/9/2019,2019,65.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1954,5/9/2019,2019,65.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1962,5/22/2019,2019,57.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1962,5/22/2019,2019,57.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/1952,6/4/2019,2019,67.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/20/1952,6/4/2019,2019,67.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1944,6/28/2019,2019,75.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1944,6/28/2019,2019,75.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1947,7/11/2019,2019,71.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1947,7/11/2019,2019,71.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1944,7/24/2019,2019,75.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1944,7/24/2019,2019,75.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1975,7/25/2019,2019,44,White,Hispanic or Latino,Hispanic/Latino,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,Signet Ring Cell Carcinoma,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
7/18/1956,8/8/2019,2019,63.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1956,8/8/2019,2019,63.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1946,8/27/2019,2019,73.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/13/1946,8/27/2019,2019,73.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1975,9/10/2019,2019,44.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1969,9/12/2019,2019,49.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1969,9/12/2019,2019,49.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1972,10/23/2019,2019,47.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1972,10/23/2019,2019,47.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1953,10/31/2019,2019,66,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1953,10/31/2019,2019,66,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1939,11/21/2019,2019,80.4,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1953,11/21/2019,2019,66.7,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1953,11/21/2019,2019,66.7,Unknown,Non-Hispanic,Unknown,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1953,12/2/2019,2019,66.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1953,12/2/2019,2019,66.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/17/1956,12/4/2019,2019,63.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/17/1956,12/4/2019,2019,63.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1950,12/10/2019,2019,69.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1950,12/10/2019,2019,69.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1977,12/11/2019,2019,42,American Indian or Alaska Native,Non-Hispanic,Native American,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1977,12/11/2019,2019,42,American Indian or Alaska Native,Non-Hispanic,Native American,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1952,12/20/2019,2019,67,Black or African American,Non-Hispanic,Black,Female,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Intestinal Type",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/10/1947,12/20/2019,2019,72.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1947,12/20/2019,2019,72.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1942,1/3/2020,2020,77.3,White,Non-Hispanic,White,Female,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/14/1961,1/7/2020,2020,58.1,White,Non-Hispanic,White,Female,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
12/14/1961,1/7/2020,2020,58.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1961,1/7/2020,2020,58.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/13/1962,1/8/2020,2020,57.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/13/1962,1/8/2020,2020,57.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/3/1934,1/9/2020,2020,85.8,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/3/1934,1/9/2020,2020,85.8,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1953,1/9/2020,2020,67,Asian,Non-Hispanic,Asian,Female,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,Mixed Cell Adenocarcinoma,Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
10/14/1986,1/10/2020,2020,33.3,White,Hispanic or Latino,Hispanic/Latino,Female,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
8/24/1945,1/15/2020,2020,74.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1945,1/15/2020,2020,74.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1966,1/21/2020,2020,53.8,White,Non-Hispanic,White,Female,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
5/2/1958,1/21/2020,2020,61.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/2/1958,1/21/2020,2020,61.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1966,1/21/2020,2020,53.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1966,1/21/2020,2020,53.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,Stomach,Stomach,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/26/1952,1/30/2020,2020,67.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1952,1/30/2020,2020,67.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1951,2/7/2020,2020,68.2,White,Non-Hispanic,White,Female,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/23/1975,2/14/2020,2020,44.7,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1975,2/14/2020,2020,44.7,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1948,2/20/2020,2020,71.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1948,2/20/2020,2020,71.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1962,2/26/2020,2020,57.7,White,Non-Hispanic,White,Male,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
6/6/1969,3/17/2020,2020,50.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/6/1969,3/17/2020,2020,50.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Stomach,Stomach,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/25/1952,4/20/2020,2020,68,White,Non-Hispanic,White,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
11/18/1949,5/15/2020,2020,70.5,Black or African American,Non-Hispanic,Black,Male,91911,DCC-2618-99-001; WIRB 20193182,Stomach,Stomach,Gastrointestinal Stromal Sarcoma,Melanoma / Sarcoma,N/A,Treatment,Melanoma / Sarcoma,Melanoma / Sarcoma,Interventional,New Brunswick,Enrolled Patients
7/23/1950,6/5/2020,2020,69.9,White,Non-Hispanic,White,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
3/26/1937,8/18/2020,2020,83.5,White,Non-Hispanic,White,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
1/1/1937,10/15/2020,2020,83.8,Black or African American,Non-Hispanic,Black,Male,71702,"MK-3475-535, MISP 54309; Pro20170000375 ",Stomach,Stomach,"Adenocarcinoma, Nos",Gastrointestinal,Phase II,Treatment,Gastrointestinal,Gastrointestinal; Radiation Oncology,Interventional,New Brunswick,Enrolled Patients
2/2/1964,3/27/2017,2017,53.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1964,3/27/2017,2017,53.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1993,3/30/2017,2017,24.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1993,3/30/2017,2017,24.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1994,4/6/2017,2017,23.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1994,4/6/2017,2017,23.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1986,5/18/2017,2017,30.4,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1986,5/18/2017,2017,30.4,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1976,6/15/2017,2017,41.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1976,6/15/2017,2017,41.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1969,7/6/2017,2017,47.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1969,7/6/2017,2017,47.7,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/2002,7/26/2017,2017,14.8,White,Non-Hispanic,White,Male,1209,Pro2012002075,Testis,Testis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/1/1971,8/4/2017,2017,46,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1971,8/4/2017,2017,46,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1993,8/9/2017,2017,24.5,White,Non-Hispanic,White,Male,51512,9681; NCI CIRB Pro20160000332,Testis,Testis,"Germ Cell Tumor, Nonseminomatous",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
10/6/1985,8/14/2017,2017,31.9,White; Black or African American; American Indian or Alaska Native,Hispanic or Latino,Hispanic/Latino,Male,51512,9681; NCI CIRB Pro20160000332,Testis,Testis,"Embryonal Carcinoma, Nos",Genitourinary,Phase I,Treatment,Developmental Therapeutics-Phase I; Genitourinary,Developmental Therapeutics-phase I; Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/4/1975,8/28/2017,2017,42.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/4/1975,8/28/2017,2017,42.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1994,9/21/2017,2017,23.3,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1994,9/21/2017,2017,23.3,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1986,9/21/2017,2017,31.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1986,9/21/2017,2017,31.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1978,10/9/2017,2017,39.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1978,10/9/2017,2017,39.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1980,10/19/2017,2017,37.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1980,10/19/2017,2017,37.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1974,12/11/2017,2017,43.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1974,12/11/2017,2017,43.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1986,2/7/2018,2018,31.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1986,2/7/2018,2018,31.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/2001,6/11/2018,2018,17,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Testis,Testis,Mixed Germ Cell Tumor,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
10/8/2001,8/29/2018,2018,16.9,Asian,Non-Hispanic,Asian,Male,111702,AGCT1531; NCI CIRB Pro20170000973,Testis,Testis,"Germ Cell Tumor, Nonseminomatous",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
4/29/1990,11/15/2018,2018,28.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/29/1990,11/15/2018,2018,28.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1972,11/19/2018,2018,46.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1972,11/19/2018,2018,46.5,White,Hispanic or Latino,Hispanic/Latino,Male,1209,Pro2012002075,Testis,Testis,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/7/1995,1/3/2019,2019,23.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1995,1/3/2019,2019,23.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1976,1/24/2019,2019,43.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1976,1/24/2019,2019,43.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/24/1995,3/4/2019,2019,23.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/24/1995,3/4/2019,2019,23.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/2002,3/14/2019,2019,16.5,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,Testis,Testis,"Germ Cell Tumor, Nonseminomatous",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
11/7/1981,3/22/2019,2019,37.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1981,3/22/2019,2019,37.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/2002,4/1/2019,2019,16.6,White,Hispanic or Latino,Hispanic/Latino,Male,111702,AGCT1531; NCI CIRB Pro20170000973,Testis,Testis,"Germ Cell Tumor, Nonseminomatous",Pediatric Oncology,Phase III,Treatment,Pediatric Oncology,Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/22/1983,4/4/2019,2019,35.7,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1990,4/8/2019,2019,29.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/6/1990,4/8/2019,2019,29.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/2/1990,6/10/2019,2019,29.5,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/2/1990,6/10/2019,2019,29.5,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/19/2000,6/20/2019,2019,18.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/19/2000,6/20/2019,2019,18.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1994,9/23/2019,2019,24.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1994,9/23/2019,2019,24.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1984,9/30/2019,2019,35.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1984,9/30/2019,2019,35.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1993,11/15/2019,2019,26,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1993,11/15/2019,2019,26,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1992,12/18/2019,2019,27.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1992,12/18/2019,2019,27.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1995,2/10/2020,2020,24.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1995,2/10/2020,2020,24.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Testis,Testis,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1988,9/16/2020,2020,32,White,Non-Hispanic,White,Male,131901,19488,Testis,Testis,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/14/1990,10/14/2020,2020,30.2,White,Non-Hispanic,White,Male,82004,NCI CIRB Pro2020002170; S1823,Testis,Testis,"Seminoma, Nos",Genitourinary,N/A,Health Services Research,Genitourinary,Genitourinary,Observational,New Brunswick,Enrolled Patients
10/30/1982,8/9/2017,2017,34.8,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,Thymus,Thymus,"Thymoma, Type B2, Malignant",Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/27/1936,2/20/2017,2017,80.2,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1936,2/20/2017,2017,80.2,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/27/1936,2/21/2017,2017,80.2,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1940,3/23/2017,2017,76.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/10/1940,3/23/2017,2017,76.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1967,3/23/2017,2017,49.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1967,3/23/2017,2017,49.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1965,3/29/2017,2017,52.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/4/1965,3/29/2017,2017,52.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/4/1965,3/29/2017,2017,52.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/11/1978,3/30/2017,2017,39.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/11/1978,3/30/2017,2017,39.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1960,3/30/2017,2017,56.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1960,3/30/2017,2017,56.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1975,4/6/2017,2017,41.3,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1975,4/6/2017,2017,41.3,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1937,4/6/2017,2017,80.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1937,4/6/2017,2017,80.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1983,4/6/2017,2017,33.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/16/1983,4/6/2017,2017,33.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1940,4/26/2017,2017,76.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/22/1961,4/26/2017,2017,56,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1950,4/26/2017,2017,66.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1953,5/1/2017,2017,63.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1967,5/11/2017,2017,50,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1967,5/11/2017,2017,50,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1969,5/18/2017,2017,48.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/15/1969,5/18/2017,2017,48.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1982,6/14/2017,2017,35.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1982,6/14/2017,2017,35.4,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/5/1982,6/14/2017,2017,35.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1974,6/14/2017,2017,43.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1974,6/14/2017,2017,43.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/16/1974,6/14/2017,2017,43.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/1964,6/15/2017,2017,53.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/3/1964,6/15/2017,2017,53.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1958,6/22/2017,2017,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1958,6/22/2017,2017,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1979,7/6/2017,2017,38.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1979,7/6/2017,2017,38.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1985,7/13/2017,2017,32.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1985,7/13/2017,2017,32.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1947,7/17/2017,2017,69.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1953,8/10/2017,2017,64,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1953,8/10/2017,2017,64,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1958,8/16/2017,2017,59.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1958,8/16/2017,2017,59.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/19/1971,8/17/2017,2017,46.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/19/1971,8/17/2017,2017,46.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1954,8/30/2017,2017,63.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1954,8/30/2017,2017,63.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1956,8/31/2017,2017,61.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1956,8/31/2017,2017,61.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1964,9/14/2017,2017,53.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1964,9/14/2017,2017,53.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1960,9/14/2017,2017,57.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1960,9/14/2017,2017,57.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1993,9/21/2017,2017,24.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1993,9/21/2017,2017,24.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1985,9/25/2017,2017,32.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1977,9/28/2017,2017,39.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1977,9/28/2017,2017,39.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/3/1978,10/12/2017,2017,39.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/3/1978,10/12/2017,2017,39.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1955,10/12/2017,2017,62.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/19/1955,10/12/2017,2017,62.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/23/1960,10/19/2017,2017,56.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/23/1960,10/19/2017,2017,56.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1968,10/30/2017,2017,49.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1963,11/1/2017,2017,54.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/10/1963,11/1/2017,2017,54.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/10/1963,11/1/2017,2017,54.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/8/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Thyroid,Thyroid,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/26/1958,11/9/2017,2017,59.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1958,11/9/2017,2017,59.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/1/1972,11/16/2017,2017,45.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/1/1972,11/16/2017,2017,45.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1954,11/27/2017,2017,63.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/9/1989,11/29/2017,2017,28.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/9/1989,11/29/2017,2017,28.8,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/9/1989,11/29/2017,2017,28.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/11/1992,11/29/2017,2017,25.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/11/1992,11/29/2017,2017,25.1,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/11/1992,11/29/2017,2017,25.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1957,11/30/2017,2017,60,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1957,11/30/2017,2017,60,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/20/1956,11/30/2017,2017,61.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/20/1956,11/30/2017,2017,61.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/5/1964,11/30/2017,2017,53.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1964,11/30/2017,2017,53.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/17/1943,12/5/2017,2017,74.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1943,12/5/2017,2017,74.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1986,12/7/2017,2017,31.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/12/1986,12/7/2017,2017,31.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1942,12/14/2017,2017,75.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1942,12/14/2017,2017,75.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1979,12/14/2017,2017,38.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/28/1979,12/14/2017,2017,38.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1980,12/19/2017,2017,37.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1980,12/19/2017,2017,37.4,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/20/1980,12/19/2017,2017,37.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1972,12/19/2017,2017,45.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/19/1972,12/19/2017,2017,45.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1953,12/21/2017,2017,64.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1953,12/21/2017,2017,64.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/12/1985,12/21/2017,2017,32.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1947,12/21/2017,2017,70.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1929,12/21/2017,2017,88.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1929,12/21/2017,2017,88.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/29/1929,12/21/2017,2017,88.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/8/1986,1/4/2018,2018,32,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/8/1986,1/4/2018,2018,32,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1988,1/4/2018,2018,29.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1988,1/4/2018,2018,29.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1971,1/25/2018,2018,46.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1971,1/25/2018,2018,46.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1995,1/25/2018,2018,22.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1995,1/25/2018,2018,22.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1975,1/30/2018,2018,42.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1975,1/30/2018,2018,42.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1985,2/1/2018,2018,32.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1985,2/1/2018,2018,32.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1970,2/1/2018,2018,47.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1970,2/1/2018,2018,47.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1986,2/1/2018,2018,31.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1986,2/1/2018,2018,31.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1954,2/1/2018,2018,63.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/30/1954,2/1/2018,2018,63.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1970,2/1/2018,2018,47.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1970,2/1/2018,2018,47.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1974,2/8/2018,2018,43.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1974,2/8/2018,2018,43.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/1/1958,2/9/2018,2018,60.1,Asian,Non-Hispanic,Asian,Female,51703,Pro20170000246-WIRB 20162082 ; SCRX001-006,Thyroid,Thyroid,"Medullary Carcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/1/1957,2/9/2018,2018,61.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/1/1957,2/9/2018,2018,61.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1973,2/12/2018,2018,44.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/7/1968,2/15/2018,2018,49.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/7/1968,2/15/2018,2018,49.3,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1968,2/15/2018,2018,49.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/17/1968,2/15/2018,2018,49.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1956,2/15/2018,2018,61.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1956,2/15/2018,2018,61.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1946,2/15/2018,2018,71.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1946,2/15/2018,2018,71.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1965,2/21/2018,2018,52.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/18/1965,2/21/2018,2018,52.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/18/1965,2/21/2018,2018,52.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1948,3/1/2018,2018,69.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1948,3/1/2018,2018,69.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/5/1964,3/1/2018,2018,53.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/5/1964,3/1/2018,2018,53.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/1/1958,3/5/2018,2018,60.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/1/1958,3/5/2018,2018,60.1,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/1/1958,3/5/2018,2018,60.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1980,3/16/2018,2018,38,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/9/1980,3/16/2018,2018,38,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/9/1980,3/16/2018,2018,38,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/16/1939,3/29/2018,2018,79,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/16/1939,3/29/2018,2018,79,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1986,4/5/2018,2018,32.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/30/1986,4/5/2018,2018,32.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1960,4/5/2018,2018,57.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1960,4/5/2018,2018,57.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1965,4/12/2018,2018,52.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1965,4/12/2018,2018,52.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1969,4/12/2018,2018,49.3,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1969,4/12/2018,2018,49.3,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/23/1977,4/12/2018,2018,40.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/23/1977,4/12/2018,2018,40.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/10/1969,4/12/2018,2018,49.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/10/1969,4/12/2018,2018,49.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/24/1942,4/19/2018,2018,75.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/24/1942,4/19/2018,2018,75.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1951,4/19/2018,2018,66.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1951,4/19/2018,2018,66.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1984,4/19/2018,2018,33.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1984,4/19/2018,2018,33.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/5/1962,4/19/2018,2018,56.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1962,4/19/2018,2018,56.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1991,4/19/2018,2018,27.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1991,4/19/2018,2018,27.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1966,4/19/2018,2018,51.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1966,4/19/2018,2018,51.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1945,4/25/2018,2018,73.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1945,4/25/2018,2018,73.2,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/13/1945,4/25/2018,2018,73.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1950,4/26/2018,2018,67.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1950,4/26/2018,2018,67.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1977,5/10/2018,2018,41,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/18/1977,5/10/2018,2018,41,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1960,5/10/2018,2018,57.8,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1960,5/10/2018,2018,57.8,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/20/1962,5/10/2018,2018,55.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/20/1962,5/10/2018,2018,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1960,5/10/2018,2018,58.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/15/1960,5/10/2018,2018,58.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1952,5/17/2018,2018,65.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1952,5/17/2018,2018,65.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1967,5/24/2018,2018,50.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1967,5/24/2018,2018,50.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1983,5/24/2018,2018,35.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1983,5/24/2018,2018,35.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1976,6/7/2018,2018,41.5,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/17/1995,6/7/2018,2018,22.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1961,6/7/2018,2018,56.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1976,6/14/2018,2018,42.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1976,6/14/2018,2018,42.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/17/1977,6/14/2018,2018,41.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1977,6/14/2018,2018,41.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1990,6/14/2018,2018,27.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/17/1990,6/14/2018,2018,27.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/2/1957,6/14/2018,2018,61,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/2/1957,6/14/2018,2018,61,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1991,6/14/2018,2018,26.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1955,6/14/2018,2018,62.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/19/1955,6/14/2018,2018,62.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1945,6/14/2018,2018,72.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1965,6/14/2018,2018,53,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1965,6/14/2018,2018,53,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1950,6/14/2018,2018,68,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1950,6/14/2018,2018,68,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1991,6/15/2018,2018,26.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1945,6/15/2018,2018,72.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/28/1990,6/28/2018,2018,27.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1992,7/5/2018,2018,25.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/13/1992,7/5/2018,2018,25.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1982,7/5/2018,2018,36,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1982,7/5/2018,2018,36,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1953,7/5/2018,2018,64.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1953,7/5/2018,2018,64.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/26/1948,7/5/2018,2018,70.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1973,7/5/2018,2018,44.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/9/1973,7/5/2018,2018,44.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1981,7/19/2018,2018,37.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1981,7/19/2018,2018,37.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/26/1963,7/19/2018,2018,54.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1983,8/1/2018,2018,35.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1983,8/1/2018,2018,35.1,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/25/1983,8/1/2018,2018,35.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/10/1935,8/1/2018,2018,82.9,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/20/1975,8/2/2018,2018,43.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1975,8/2/2018,2018,43.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1957,8/2/2018,2018,61.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1957,8/2/2018,2018,61.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1951,8/2/2018,2018,67.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1951,8/2/2018,2018,67.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1985,8/2/2018,2018,32.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1985,8/2/2018,2018,32.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1948,8/9/2018,2018,69.7,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1948,8/9/2018,2018,69.7,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1959,8/9/2018,2018,59.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1959,8/9/2018,2018,59.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1976,8/9/2018,2018,41.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1976,8/9/2018,2018,41.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/5/1965,8/9/2018,2018,53,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/5/1965,8/9/2018,2018,53,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1975,8/9/2018,2018,43.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/16/1975,8/9/2018,2018,43.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1992,8/15/2018,2018,25.9,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/21/1964,8/16/2018,2018,54.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1964,8/16/2018,2018,54.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1980,8/16/2018,2018,38.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1980,8/16/2018,2018,38.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1970,8/16/2018,2018,47.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1970,8/16/2018,2018,47.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1983,8/16/2018,2018,35.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1983,8/16/2018,2018,35.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/16/1985,8/16/2018,2018,32.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/16/1985,8/16/2018,2018,32.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1949,8/16/2018,2018,69.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1949,8/16/2018,2018,69.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1946,8/16/2018,2018,71.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1946,8/16/2018,2018,71.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1960,8/16/2018,2018,58.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1960,8/16/2018,2018,58.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1959,8/20/2018,2018,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/8/1959,8/20/2018,2018,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1983,8/23/2018,2018,35.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1983,8/23/2018,2018,35.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1970,8/30/2018,2018,47.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1975,9/6/2018,2018,43.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1975,9/6/2018,2018,43.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/3/1961,9/6/2018,2018,57.1,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/3/1961,9/6/2018,2018,57.1,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1998,9/6/2018,2018,20.6,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1998,9/6/2018,2018,20.6,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1996,9/6/2018,2018,21.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1996,9/6/2018,2018,21.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1948,9/7/2018,2018,70.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1948,9/7/2018,2018,70.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1956,9/12/2018,2018,61.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1956,9/12/2018,2018,61.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/26/1956,9/12/2018,2018,61.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1980,9/13/2018,2018,37.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/21/1980,9/13/2018,2018,37.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/24/1957,9/13/2018,2018,60.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/24/1957,9/13/2018,2018,60.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/6/1992,9/13/2018,2018,25.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/6/1992,9/13/2018,2018,25.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1966,9/18/2018,2018,52.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1966,9/18/2018,2018,52.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/30/1969,9/25/2018,2018,49,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/30/1969,9/25/2018,2018,49,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/28/1960,9/25/2018,2018,58.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1960,9/25/2018,2018,58.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1959,9/25/2018,2018,58.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1959,9/25/2018,2018,58.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/3/1981,9/27/2018,2018,37.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1981,9/27/2018,2018,37.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/21/1961,10/2/2018,2018,57.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/21/1961,10/2/2018,2018,57.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1980,10/11/2018,2018,38.5,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1980,10/11/2018,2018,38.5,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1945,10/11/2018,2018,73.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1945,10/11/2018,2018,73.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/3/1963,10/11/2018,2018,55.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/3/1963,10/11/2018,2018,55.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/30/1976,10/18/2018,2018,42.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/30/1976,10/18/2018,2018,42.2,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1955,10/18/2018,2018,63,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1955,10/18/2018,2018,63,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1993,10/18/2018,2018,25.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1993,10/18/2018,2018,25.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1958,11/1/2018,2018,60.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1958,11/1/2018,2018,60.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1962,11/1/2018,2018,56.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1962,11/1/2018,2018,56.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/11/1954,11/1/2018,2018,64.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/11/1954,11/1/2018,2018,64.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1966,11/8/2018,2018,52.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1966,11/8/2018,2018,52.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1948,12/6/2018,2018,70.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1948,12/6/2018,2018,70.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/18/1951,12/6/2018,2018,67,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/18/1951,12/6/2018,2018,67,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/5/1972,12/6/2018,2018,46.4,White,Non-Hispanic,White,Male,131317,Pro2013003676,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1960,12/20/2018,2018,58.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1960,12/20/2018,2018,58.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1963,12/20/2018,2018,55.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1963,12/20/2018,2018,55.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1952,12/20/2018,2018,66.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/18/1952,12/20/2018,2018,66.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1969,12/20/2018,2018,49,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1969,12/20/2018,2018,49,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/13/1983,1/3/2019,2019,35.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/13/1983,1/3/2019,2019,35.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1981,1/24/2019,2019,37.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/29/1981,1/24/2019,2019,37.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/24/1973,1/24/2019,2019,45.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/24/1973,1/24/2019,2019,45.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1993,2/7/2019,2019,25.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1993,2/7/2019,2019,25.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/18/1987,2/14/2019,2019,32,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/18/1987,2/14/2019,2019,32,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1980,2/21/2019,2019,38.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1980,2/21/2019,2019,38.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/22/1962,2/21/2019,2019,56.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/22/1962,2/21/2019,2019,56.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/5/1960,2/21/2019,2019,58.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/5/1960,2/21/2019,2019,58.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1940,2/21/2019,2019,79,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1985,2/21/2019,2019,34,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1983,2/21/2019,2019,35.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1983,2/21/2019,2019,35.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/16/1947,2/21/2019,2019,71.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1940,2/22/2019,2019,79,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1970,2/28/2019,2019,48.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1970,2/28/2019,2019,48.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1955,2/28/2019,2019,63.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1955,2/28/2019,2019,63.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/18/1975,2/28/2019,2019,43.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/18/1975,2/28/2019,2019,43.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1976,2/28/2019,2019,42.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1976,2/28/2019,2019,42.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1976,3/6/2019,2019,42.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1976,3/6/2019,2019,42.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/25/1976,3/6/2019,2019,42.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1948,3/7/2019,2019,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1948,3/7/2019,2019,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/4/1977,3/7/2019,2019,41.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/4/1977,3/7/2019,2019,41.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1954,3/14/2019,2019,64.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1938,3/14/2019,2019,80.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1938,3/14/2019,2019,80.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/27/1947,3/14/2019,2019,71.5,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/27/1947,3/14/2019,2019,71.5,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1962,3/14/2019,2019,56.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1962,3/14/2019,2019,56.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/20/1964,3/20/2019,2019,54.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1964,3/20/2019,2019,54.5,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/20/1964,3/20/2019,2019,54.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1978,3/21/2019,2019,41.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1975,3/21/2019,2019,43.9,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/19/1975,3/21/2019,2019,43.9,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/9/1977,3/21/2019,2019,42,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1977,3/21/2019,2019,42,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1971,3/28/2019,2019,48.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1971,3/28/2019,2019,48.2,White,Hispanic or Latino,Hispanic/Latino,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/2/1971,3/28/2019,2019,48.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1965,3/28/2019,2019,53.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1965,3/28/2019,2019,53.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/4/1987,3/28/2019,2019,32,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1987,3/28/2019,2019,32,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1984,4/4/2019,2019,34.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1984,4/4/2019,2019,34.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/21/1943,4/4/2019,2019,75.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/21/1943,4/4/2019,2019,75.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1970,4/4/2019,2019,49.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1970,4/4/2019,2019,49.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1957,4/4/2019,2019,62.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1957,4/4/2019,2019,62.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1949,4/4/2019,2019,70,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/5/1949,4/4/2019,2019,70,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/13/1971,4/4/2019,2019,47.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/13/1971,4/4/2019,2019,47.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1963,4/4/2019,2019,56.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1963,4/4/2019,2019,56.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1958,4/18/2019,2019,60.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/13/1958,4/18/2019,2019,60.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1950,4/18/2019,2019,68.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1950,4/18/2019,2019,68.6,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1954,4/18/2019,2019,64.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1954,4/18/2019,2019,64.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1970,4/18/2019,2019,49.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/2/1970,4/18/2019,2019,49.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1945,4/18/2019,2019,74.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/3/1945,4/18/2019,2019,74.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1953,4/18/2019,2019,66.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1953,4/18/2019,2019,66.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1980,4/18/2019,2019,38.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1980,4/18/2019,2019,38.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/9/1954,4/25/2019,2019,64.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1961,4/25/2019,2019,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/2/1961,4/25/2019,2019,57.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1954,4/25/2019,2019,64.6,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1954,4/25/2019,2019,64.6,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1948,4/25/2019,2019,71.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1948,4/25/2019,2019,71.1,White,Non-Hispanic,White,Female,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/21/1948,4/25/2019,2019,71.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1948,4/25/2019,2019,70.8,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/12/1948,4/25/2019,2019,70.8,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1970,4/29/2019,2019,48.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/7/1970,4/29/2019,2019,48.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1966,5/2/2019,2019,53.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/28/1966,5/2/2019,2019,53.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/7/1949,5/2/2019,2019,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/7/1949,5/2/2019,2019,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1953,5/2/2019,2019,65.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1953,5/2/2019,2019,65.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1948,5/9/2019,2019,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/16/1948,5/9/2019,2019,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1981,5/9/2019,2019,37.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/26/1981,5/9/2019,2019,37.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1935,5/9/2019,2019,83.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1935,5/9/2019,2019,83.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1971,5/16/2019,2019,47.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1971,5/16/2019,2019,47.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1967,5/16/2019,2019,52.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1967,5/16/2019,2019,52.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1972,5/16/2019,2019,47.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1972,5/16/2019,2019,47.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1958,5/16/2019,2019,60.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1958,5/16/2019,2019,60.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1937,5/29/2019,2019,82.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1937,5/29/2019,2019,82.3,White,Non-Hispanic,White,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/18/1937,5/29/2019,2019,82.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1950,5/30/2019,2019,68.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/1/1950,5/30/2019,2019,68.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1965,5/30/2019,2019,53.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/17/1965,5/30/2019,2019,53.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1983,5/30/2019,2019,35.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1983,5/30/2019,2019,35.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1952,5/30/2019,2019,66.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1952,5/30/2019,2019,66.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1977,6/6/2019,2019,41.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/15/1977,6/6/2019,2019,41.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1962,6/6/2019,2019,56.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1962,6/6/2019,2019,56.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/16/1954,6/6/2019,2019,65.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/16/1954,6/6/2019,2019,65.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1950,6/6/2019,2019,68.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1950,6/6/2019,2019,68.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1989,6/13/2019,2019,29.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1989,6/13/2019,2019,29.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1984,6/20/2019,2019,35.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/27/1984,6/20/2019,2019,35.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1964,6/27/2019,2019,55,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1964,6/27/2019,2019,55,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1966,6/27/2019,2019,53.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1966,6/27/2019,2019,53.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/22/1964,6/27/2019,2019,54.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/22/1964,6/27/2019,2019,54.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1959,7/11/2019,2019,59.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1959,7/11/2019,2019,59.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/30/1966,7/11/2019,2019,52.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/30/1966,7/11/2019,2019,52.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1976,7/11/2019,2019,43.4,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1976,7/11/2019,2019,43.4,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1967,7/11/2019,2019,52.1,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1967,7/11/2019,2019,52.1,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1977,7/18/2019,2019,41.7,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/5/1977,7/18/2019,2019,41.7,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1964,7/18/2019,2019,54.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1964,7/18/2019,2019,54.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1959,8/1/2019,2019,59.9,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1959,8/1/2019,2019,59.9,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/1/1963,8/1/2019,2019,56.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/1/1963,8/1/2019,2019,56.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/15/1971,8/1/2019,2019,48.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/15/1971,8/1/2019,2019,48.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1982,8/1/2019,2019,37.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1982,8/1/2019,2019,37.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1953,8/1/2019,2019,66,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1953,8/1/2019,2019,66,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/10/1942,8/8/2019,2019,77.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/10/1942,8/8/2019,2019,77.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1982,8/15/2019,2019,37.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1947,8/15/2019,2019,72.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1947,8/15/2019,2019,72.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1949,8/15/2019,2019,69.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1949,8/15/2019,2019,69.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1983,8/15/2019,2019,36.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/21/1983,8/15/2019,2019,36.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1963,8/15/2019,2019,55.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1963,8/15/2019,2019,55.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1993,8/15/2019,2019,26.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1993,8/15/2019,2019,26.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/13/1970,8/22/2019,2019,48.8,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/13/1970,8/22/2019,2019,48.8,Asian,Non-Hispanic,Asian,Male,1209,Pro2012002075,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/13/1970,8/22/2019,2019,48.8,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1978,9/5/2019,2019,41.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1978,9/5/2019,2019,41.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1953,9/5/2019,2019,66.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1953,9/5/2019,2019,66.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1962,9/5/2019,2019,56.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1962,9/5/2019,2019,56.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/2/1951,9/12/2019,2019,68.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1965,9/12/2019,2019,54.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1965,9/12/2019,2019,54.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/8/1969,9/12/2019,2019,50.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/8/1969,9/12/2019,2019,50.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/23/1977,9/12/2019,2019,41.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/23/1977,9/12/2019,2019,41.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/1977,9/19/2019,2019,42.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1987,9/19/2019,2019,32.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1987,9/19/2019,2019,32.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/18/1964,10/3/2019,2019,54.9,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/18/1964,10/3/2019,2019,54.9,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1986,10/3/2019,2019,32.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/1/1986,10/3/2019,2019,32.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1983,10/7/2019,2019,36.7,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1983,10/7/2019,2019,36.7,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/21/1988,10/10/2019,2019,31.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/21/1988,10/10/2019,2019,31.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1967,10/10/2019,2019,52.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1967,10/10/2019,2019,52.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/2/1958,10/10/2019,2019,61.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/2/1958,10/10/2019,2019,61.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1936,10/10/2019,2019,83.3,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/27/1936,10/10/2019,2019,83.3,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/1/1960,10/17/2019,2019,59.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/1/1960,10/17/2019,2019,59.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/28/1969,11/7/2019,2019,50,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/28/1969,11/7/2019,2019,50,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/14/1956,11/7/2019,2019,63.7,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1956,11/7/2019,2019,63.7,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1972,11/7/2019,2019,47.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1972,11/7/2019,2019,47.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1986,11/7/2019,2019,33.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1986,11/7/2019,2019,33.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1962,11/7/2019,2019,57.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/20/1962,11/7/2019,2019,57.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1953,11/14/2019,2019,66.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1953,11/14/2019,2019,66.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1967,11/21/2019,2019,52,Black or African American,Non-Hispanic,Black,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1967,11/21/2019,2019,52,Black or African American,Non-Hispanic,Black,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1980,11/21/2019,2019,39.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/29/1980,11/21/2019,2019,39.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1984,12/12/2019,2019,35.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/11/1984,12/12/2019,2019,35.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1966,12/19/2019,2019,53.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1981,12/19/2019,2019,38.9,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/28/1981,12/19/2019,2019,38.9,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/29/1972,12/19/2019,2019,47.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/29/1972,12/19/2019,2019,47.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1945,1/2/2020,2020,74.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/1945,1/2/2020,2020,74.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/5/1955,1/9/2020,2020,64.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/5/1955,1/9/2020,2020,64.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1950,1/9/2020,2020,70.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1950,1/9/2020,2020,70.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1962,1/16/2020,2020,57.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/30/1962,1/16/2020,2020,57.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1954,1/16/2020,2020,65.6,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/23/1954,1/16/2020,2020,65.6,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1962,1/23/2020,2020,57.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/19/1966,1/23/2020,2020,53.6,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1949,1/23/2020,2020,71,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/22/1949,1/23/2020,2020,71,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/4/1979,1/23/2020,2020,40.4,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/4/1979,1/23/2020,2020,40.4,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1948,1/30/2020,2020,71.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1948,1/30/2020,2020,71.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1971,1/31/2020,2020,48.4,Black or African American,Non-Hispanic,Black,Female,51901,Pro2019000353 ; WIRB20191459; TTX-030-001,Thyroid,Thyroid,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
12/20/1980,2/6/2020,2020,39.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1980,2/6/2020,2020,39.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1967,2/13/2020,2020,52.2,White,Hispanic or Latino,Hispanic/Latino,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1967,2/13/2020,2020,52.2,White,Hispanic or Latino,Hispanic/Latino,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1989,2/13/2020,2020,30.2,Asian,Non-Hispanic,Asian,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1989,2/13/2020,2020,30.2,Asian,Non-Hispanic,Asian,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1970,2/13/2020,2020,49.2,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1970,2/13/2020,2020,49.2,White,Non-Hispanic,White,Male,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1979,2/13/2020,2020,41.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/18/1979,2/13/2020,2020,41.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1953,2/13/2020,2020,66.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1953,2/13/2020,2020,66.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/23/1979,2/20/2020,2020,41.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1979,2/20/2020,2020,41.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1961,2/20/2020,2020,58.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1961,2/20/2020,2020,58.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1988,3/5/2020,2020,31.4,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1988,3/5/2020,2020,31.4,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1958,3/5/2020,2020,62.1,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1958,3/5/2020,2020,62.1,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1967,3/5/2020,2020,52.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1964,3/5/2020,2020,55.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1987,3/5/2020,2020,33.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/23/1987,3/5/2020,2020,33.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/15/1961,3/11/2020,2020,58.6,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/15/1961,3/11/2020,2020,58.6,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1978,3/12/2020,2020,41.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1978,3/12/2020,2020,41.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1967,10/21/2020,2020,53.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1964,10/21/2020,2020,55.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Thyroid,Thyroid,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1971,1/4/2017,2017,45.2,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1989,1/6/2017,2017,27.2,White,Unknown,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1955,1/9/2017,2017,61.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/15/1950,1/9/2017,2017,66.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/12/1975,1/10/2017,2017,41.6,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1979,1/11/2017,2017,37.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/27/1969,1/11/2017,2017,47.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1975,1/12/2017,2017,42,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1961,1/18/2017,2017,56.1,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/28/1961,1/19/2017,2017,55.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/26/1963,1/19/2017,2017,53.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1970,1/20/2017,2017,47.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/2/1974,1/20/2017,2017,43,Unknown,Unknown,Unknown,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1948,1/23/2017,2017,68.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1956,1/25/2017,2017,60.6,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/21/1941,1/25/2017,2017,75.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/20/1975,1/26/2017,2017,42,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1977,1/26/2017,2017,39.6,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1952,1/26/2017,2017,65.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1950,1/26/2017,2017,66.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1958,1/31/2017,2017,59.1,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1961,2/1/2017,2017,55.4,Asian,Non-Hispanic,Asian,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1972,2/1/2017,2017,44.7,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1961,2/2/2017,2017,56.1,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/3/2017,2/3/2017,2017,0,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1951,2/3/2017,2017,65.3,Unknown,Non-Hispanic,Unknown,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/25/1971,2/8/2017,2017,45.2,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1967,2/13/2017,2017,49.2,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/26/1958,2/13/2017,2017,58.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1977,2/13/2017,2017,40.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/28/1966,2/14/2017,2017,50.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/30/1960,2/15/2017,2017,56.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1957,2/16/2017,2017,59.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1988,2/16/2017,2017,28.5,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1970,2/22/2017,2017,46.5,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1941,2/22/2017,2017,76,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1967,2/24/2017,2017,49.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1989,2/24/2017,2017,27.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/26/1970,2/27/2017,2017,46.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/21/1959,2/27/2017,2017,57.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1970,2/28/2017,2017,47,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/31/1973,3/1/2017,2017,43.2,Asian,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1985,3/2/2017,2017,31.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1978,3/3/2017,2017,38.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/9/1963,3/3/2017,2017,53.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1984,3/6/2017,2017,32.9,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/30/1972,3/8/2017,2017,44.4,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1974,3/8/2017,2017,42.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1965,3/10/2017,2017,51.9,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1966,3/10/2017,2017,50.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/6/1944,3/15/2017,2017,72.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1957,3/17/2017,2017,59.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/18/1969,3/22/2017,2017,47.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/17/1993,3/29/2017,2017,23.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1955,3/31/2017,2017,62.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1967,4/3/2017,2017,49.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/13/1968,4/3/2017,2017,48.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1978,4/4/2017,2017,39.2,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/13/1949,4/5/2017,2017,67.7,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/28/1955,4/5/2017,2017,61.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/4/1990,4/5/2017,2017,26.5,Unknown,Unknown,Unknown,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/3/1970,4/6/2017,2017,47.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/7/1973,4/11/2017,2017,44.3,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1948,4/11/2017,2017,68.9,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/1/1980,4/17/2017,2017,36.6,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/31/1970,4/17/2017,2017,46.7,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1962,4/19/2017,2017,55.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1981,4/20/2017,2017,35.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1962,4/20/2017,2017,54.8,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1969,4/21/2017,2017,47.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1976,4/24/2017,2017,41.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1963,4/27/2017,2017,54.3,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/29/1967,4/28/2017,2017,49.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1969,5/2/2017,2017,48.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/11/1971,5/2/2017,2017,46.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/25/1981,5/4/2017,2017,35.5,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/5/1975,5/4/2017,2017,42,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1951,5/10/2017,2017,66.1,Unknown,Unknown,Unknown,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1956,5/11/2017,2017,60.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/28/1941,5/18/2017,2017,76.2,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1954,5/18/2017,2017,62.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1965,5/18/2017,2017,51.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1971,5/19/2017,2017,46.4,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1985,5/23/2017,2017,32.1,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1966,5/25/2017,2017,50.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1998,5/31/2017,2017,18.9,Unknown,Non-Hispanic,Unknown,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/18/1966,6/1/2017,2017,51.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/29/1954,6/2/2017,2017,63.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1960,6/8/2017,2017,57.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/7/1986,6/14/2017,2017,31.4,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/10/1978,6/14/2017,2017,38.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/16/1993,6/15/2017,2017,23.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1983,6/16/2017,2017,34.2,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1948,6/16/2017,2017,68.7,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/2017,6/21/2017,2017,0,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1945,7/5/2017,2017,71.8,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1971,7/7/2017,2017,46.2,Unknown,Non-Hispanic,Unknown,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/18/1987,7/11/2017,2017,29.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1966,7/14/2017,2017,51.3,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1980,7/18/2017,2017,36.8,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/18/1993,7/21/2017,2017,24.2,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/13/1967,8/1/2017,2017,50.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/27/1981,8/1/2017,2017,36.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1950,8/2/2017,2017,67.1,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/20/1987,8/9/2017,2017,29.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1973,8/14/2017,2017,43.8,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1964,8/16/2017,2017,53,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/6/1975,8/16/2017,2017,42,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1968,8/23/2017,2017,48.8,White,Hispanic or Latino,Hispanic/Latino,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1954,8/23/2017,2017,63.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1969,9/5/2017,2017,48,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1963,9/5/2017,2017,54.5,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/14/1949,9/6/2017,2017,68,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/9/1988,9/12/2017,2017,29.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/24/1970,9/13/2017,2017,47,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1993,9/18/2017,2017,23.8,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/28/1948,9/19/2017,2017,68.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/16/1951,9/29/2017,2017,66.3,White,Non-Hispanic,White,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/23/1931,10/4/2017,2017,86.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1948,10/5/2017,2017,68.9,Unknown,Non-Hispanic,Unknown,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/15/1947,10/13/2017,2017,70.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/5/1973,10/18/2017,2017,44,White,Hispanic or Latino,Hispanic/Latino,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/25/1985,10/20/2017,2017,32.1,Unknown,Hispanic or Latino,Hispanic/Latino,Male,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1961,10/25/2017,2017,56.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1946,11/1/2017,2017,71.7,Black or African American,Non-Hispanic,Black,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1986,11/1/2017,2017,31.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1966,11/3/2017,2017,51.6,Asian,Non-Hispanic,Asian,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/2/1960,11/3/2017,2017,57.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/12/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Male,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/13/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Female,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/13/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/13/2017,2017,,Unknown,Unknown,Unknown,U,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/20/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/20/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/20/2017,2017,,Unknown,Unknown,Unknown,U,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/22/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/22/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/22/2017,2017,,Unknown,Unknown,Unknown,U,1714,Pro20170000634,Unknown primary site,Unknown primary site,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/6/1954,2/14/2018,2018,63.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1954,2/14/2018,2018,63.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Unknown primary site,Unknown primary site,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/20/1957,10/19/2018,2018,61,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,Unknown primary site,Unknown primary site,Neuroendocrine Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
8/5/1957,9/25/2019,2019,62.2,White,Non-Hispanic,White,Male,11813,EA4151; NCI CIRB Pro2018001702,Unknown primary site,Unknown primary site,Mantle Cell Lymphoma,Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/24/1990,9/9/2020,2020,30,White,Non-Hispanic,White,Female,111907,NCI CIRB Pro2019002127; S1826,Unknown primary site,Unknown primary site,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase III,Treatment,Lymphoma / Myeloma; Pediatric Oncology,Lymphoma / Myeloma; Pediatric Oncology,Interventional,New Brunswick,Enrolled Patients
7/6/1969,1/12/2017,2017,47.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1969,1/12/2017,2017,47.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1964,1/24/2017,2017,52.8,White,Non-Hispanic,White,Female,51513,9782; NCI CIRB Pro20160000225,"Uterus, Nos",Uterus,"Leiomyosarcoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/30/1951,2/3/2017,2017,65.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1951,2/3/2017,2017,65.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1963,2/3/2017,2017,53.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1963,2/3/2017,2017,53.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/8/1963,2/3/2017,2017,53.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1955,2/13/2017,2017,61.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1949,2/13/2017,2017,67.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/17/1949,2/13/2017,2017,67.9,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/17/1949,2/13/2017,2017,67.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1957,3/9/2017,2017,59.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/12/1957,3/9/2017,2017,59.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/27/1959,3/20/2017,2017,57.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/4/1955,3/23/2017,2017,62.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/4/1955,3/23/2017,2017,62.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1969,3/24/2017,2017,47.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/1/1969,3/24/2017,2017,47.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/9/1946,3/24/2017,2017,70.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/9/1946,3/24/2017,2017,70.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1947,4/13/2017,2017,70.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1947,4/13/2017,2017,70.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1971,4/14/2017,2017,45.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1971,4/14/2017,2017,45.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1969,4/21/2017,2017,47.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1969,4/21/2017,2017,47.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1974,4/28/2017,2017,42.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1974,4/28/2017,2017,42.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1951,5/1/2017,2017,66,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1966,5/18/2017,2017,51.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1966,5/18/2017,2017,51.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/25/1949,6/16/2017,2017,67.9,Asian,Non-Hispanic,Asian,Female,51611,MGA012; WIRB 20170715 Pro20160001577,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/29/1947,6/16/2017,2017,70.3,White,Non-Hispanic,White,Female,51611,MGA012; WIRB 20170715 Pro20160001577,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/12/1957,7/1/2017,2017,59.8,Asian,Non-Hispanic,Asian,Female,51705,9149; NCI CIRB Pro20170000458,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
3/24/1932,7/11/2017,2017,85.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1932,7/11/2017,2017,85.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/11/1946,7/13/2017,2017,70.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/11/1946,7/13/2017,2017,70.6,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1953,7/31/2017,2017,64.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1953,7/31/2017,2017,64.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/21/1943,7/31/2017,2017,74.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/21/1943,7/31/2017,2017,74.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1970,9/15/2017,2017,47.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1970,9/15/2017,2017,47.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/14/1951,9/18/2017,2017,66.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/14/1951,9/18/2017,2017,66.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1971,9/27/2017,2017,46,White,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/11/1956,10/3/2017,2017,61.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/11/1956,10/3/2017,2017,61.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/19/1998,10/3/2017,2017,19.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/19/1998,10/3/2017,2017,19.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1946,10/3/2017,2017,71.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/27/1946,10/3/2017,2017,71.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/17/1983,10/3/2017,2017,34.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1983,10/3/2017,2017,34.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1943,10/10/2017,2017,74.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/22/1943,10/10/2017,2017,74.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1971,10/12/2017,2017,46.1,White,Hispanic or Latino,Hispanic/Latino,Female,51611,MGA012; WIRB 20170715 Pro20160001577,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
6/8/1962,11/15/2017,2017,55.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/8/1962,11/15/2017,2017,55.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1936,11/17/2017,2017,81,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1936,11/17/2017,2017,81,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/30/1972,11/30/2017,2017,45.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/30/1972,11/30/2017,2017,45.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/18/1969,12/4/2017,2017,48.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/18/1969,12/4/2017,2017,48.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1949,12/4/2017,2017,68,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/17/1958,12/11/2017,2017,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/17/1958,12/11/2017,2017,59.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1952,12/14/2017,2017,65.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/3/1952,12/14/2017,2017,65.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/1/1969,12/19/2017,2017,48.1,White,Non-Hispanic,White,Female,51511,CC-486-CAGEN-001; Pro20150002014 WIRB 20141961,"Uterus, Nos",Uterus,"Leiomyosarcoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
,12/22/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,"Uterus, Nos",Uterus,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/27/1946,1/5/2018,2018,71.9,White,Non-Hispanic,White,Female,51403,Pro20140000405,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/6/1966,1/30/2018,2018,51.3,White,Non-Hispanic,White,Female,51612,INCAGN 1949-101; Pro20160001575  WIRB 20170437,"Uterus, Nos",Uterus,"Leiomyosarcoma, Nos",DT - Phase I,Phase I/II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/4/1956,2/1/2018,2018,61.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1956,2/1/2018,2018,61.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/1/1949,2/2/2018,2018,68.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/1/1949,2/2/2018,2018,68.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1972,2/8/2018,2018,45.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1972,2/8/2018,2018,45.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/16/1944,2/15/2018,2018,74.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/16/1944,2/15/2018,2018,74.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/20/1949,2/16/2018,2018,69,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/20/1949,2/16/2018,2018,69,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1958,2/26/2018,2018,59.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1958,2/26/2018,2018,59.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/13/1949,2/26/2018,2018,69.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/13/1949,2/26/2018,2018,69.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/27/1946,2/27/2018,2018,72,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/3/1968,2/28/2018,2018,49.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/3/1968,2/28/2018,2018,49.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/10/1950,3/2/2018,2018,67.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/10/1950,3/2/2018,2018,67.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/23/1947,3/5/2018,2018,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1947,3/5/2018,2018,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/6/1961,3/5/2018,2018,57.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/6/1961,3/5/2018,2018,57.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/8/1964,3/6/2018,2018,53.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/8/1964,3/6/2018,2018,53.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/23/1937,3/6/2018,2018,80.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/23/1937,3/6/2018,2018,80.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/15/1965,3/9/2018,2018,52.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/15/1965,3/9/2018,2018,52.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/17/1948,3/12/2018,2018,69.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/17/1948,3/12/2018,2018,69.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1958,3/12/2018,2018,60.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1958,3/12/2018,2018,60.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1947,3/15/2018,2018,71,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1947,3/15/2018,2018,71,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1949,3/15/2018,2018,69.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1949,3/15/2018,2018,69.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1964,3/16/2018,2018,53.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1964,3/16/2018,2018,53.9,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/8/1964,3/16/2018,2018,53.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/20/1956,3/23/2018,2018,61.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/20/1956,3/23/2018,2018,61.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/7/1964,3/27/2018,2018,53.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/7/1964,3/27/2018,2018,53.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/12/1978,3/27/2018,2018,39.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/19/1949,3/27/2018,2018,68.6,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/18/1952,4/9/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1952,4/9/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/18/1952,4/9/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/12/1974,4/10/2018,2018,44.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/12/1974,4/10/2018,2018,44.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/12/1967,4/10/2018,2018,51,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/12/1967,4/10/2018,2018,51,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1950,4/12/2018,2018,68.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/19/1950,4/12/2018,2018,68.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/6/1952,4/13/2018,2018,65.6,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/18/1952,4/19/2018,2018,65.5,Black or African American,Non-Hispanic,Black,Female,51403,Pro20140000405,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
2/21/1994,5/15/2018,2018,24.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/21/1994,5/16/2018,2018,24.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/30/1961,5/16/2018,2018,56.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/30/1961,5/16/2018,2018,56.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/24/1947,5/21/2018,2018,71,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,Adenocarcinoma In Situ,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
7/2/1956,5/23/2018,2018,61.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/2/1956,5/23/2018,2018,61.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1948,5/23/2018,2018,70,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/14/1948,5/23/2018,2018,70,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/14/1948,5/23/2018,2018,70,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1940,5/31/2018,2018,77.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1952,6/1/2018,2018,65.7,Black or African American,Non-Hispanic,Black,Female,51407,Pro20140000735,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/26/1964,6/8/2018,2018,54.4,White,Hispanic or Latino,Hispanic/Latino,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
10/15/1955,6/11/2018,2018,62.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1951,6/12/2018,2018,66.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1953,6/15/2018,2018,64.6,Black or African American,Non-Hispanic,Black,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
6/3/1969,6/25/2018,2018,49.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/3/1969,6/25/2018,2018,49.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1955,7/5/2018,2018,63.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1955,7/5/2018,2018,63.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1961,7/5/2018,2018,56.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1963,7/9/2018,2018,55.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/26/1963,7/9/2018,2018,55.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/22/1961,7/9/2018,2018,56.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1958,7/16/2018,2018,60.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/1/1958,7/16/2018,2018,60.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/5/1947,8/15/2018,2018,71.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/5/1947,8/15/2018,2018,71.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1948,8/21/2018,2018,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/22/1948,8/21/2018,2018,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1954,8/27/2018,2018,63.9,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Carcinosarcoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
1/9/1946,8/30/2018,2018,72.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1946,8/30/2018,2018,72.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/31/1966,9/17/2018,2018,52.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/31/1966,9/17/2018,2018,52.7,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/31/1966,9/17/2018,2018,52.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/4/1948,9/20/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1948,9/20/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/4/1948,9/20/2018,2018,69.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/21/1944,9/26/2018,2018,74.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/21/1944,9/26/2018,2018,74.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1965,9/28/2018,2018,53.4,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1965,9/28/2018,2018,53.4,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1952,10/9/2018,2018,66,Black or African American,Non-Hispanic,Black,Female,51806,10104; NCI CIRB Pro2018001771,"Uterus, Nos",Uterus,"Endometrioid Adenocarcinoma, Ciliated Cell Variant",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/25/1953,10/10/2018,2018,64.9,Black or African American,Non-Hispanic,Black,Female,51806,10104; NCI CIRB Pro2018001771,"Uterus, Nos",Uterus,"Endometrioid Adenocarcinoma, Ciliated Cell Variant",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/24/1957,10/22/2018,2018,61,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/24/1957,10/22/2018,2018,61,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/15/1951,10/31/2018,2018,66.9,Black or African American,Non-Hispanic,Black,Female,51806,10104; NCI CIRB Pro2018001771,"Uterus, Nos",Uterus,"Endometrioid Adenocarcinoma, Secretory Variant",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/13/1964,11/1/2018,2018,54.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/13/1964,11/1/2018,2018,54.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1954,11/7/2018,2018,64.6,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1955,11/7/2018,2018,63.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/14/1955,11/7/2018,2018,63.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1958,11/9/2018,2018,60.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1958,11/9/2018,2018,60.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1951,11/9/2018,2018,67.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1951,11/9/2018,2018,67.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/28/1948,11/12/2018,2018,70.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/28/1948,11/12/2018,2018,70.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1984,11/15/2018,2018,34.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/31/1984,11/15/2018,2018,34.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/16/1953,11/19/2018,2018,65.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/16/1953,11/19/2018,2018,65.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/13/1975,11/26/2018,2018,43.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/13/1975,11/26/2018,2018,43.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1954,11/26/2018,2018,64.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1955,11/27/2018,2018,63.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1955,11/27/2018,2018,63.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1950,11/28/2018,2018,68.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1940,11/28/2018,2018,78.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1940,11/28/2018,2018,78.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1942,11/28/2018,2018,76.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1942,11/28/2018,2018,76.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1950,11/30/2018,2018,68.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1952,11/30/2018,2018,66.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/27/1949,12/6/2018,2018,69.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1955,12/6/2018,2018,63.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/3/1980,12/11/2018,2018,38.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1980,12/11/2018,2018,38.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/12/1992,12/17/2018,2018,26,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/12/1992,12/17/2018,2018,26,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1961,12/20/2018,2018,57.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1963,12/31/2018,2018,55.3,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/25/1963,12/31/2018,2018,55.3,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1955,1/2/2019,2019,63.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1955,1/2/2019,2019,63.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1971,1/3/2019,2019,47.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1971,1/3/2019,2019,47.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1960,1/7/2019,2019,58.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/7/1960,1/7/2019,2019,58.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1952,1/22/2019,2019,66.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1952,1/22/2019,2019,66.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1954,1/28/2019,2019,64.7,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1954,1/28/2019,2019,64.7,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1937,1/28/2019,2019,81.9,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1937,1/28/2019,2019,81.9,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/29/1957,1/28/2019,2019,61.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1957,1/28/2019,2019,61.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1968,1/30/2019,2019,50.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1968,1/30/2019,2019,50.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/16/1963,1/31/2019,2019,55.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/16/1963,1/31/2019,2019,55.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/15/1961,2/5/2019,2019,57.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/15/1961,2/5/2019,2019,57.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/28/1951,2/5/2019,2019,67.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/28/1951,2/5/2019,2019,67.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/16/1973,2/7/2019,2019,45.3,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/16/1973,2/7/2019,2019,45.3,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/7/1946,2/8/2019,2019,72.6,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
2/9/1952,2/18/2019,2019,67.1,Black or African American,Non-Hispanic,Black,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
4/4/1975,2/25/2019,2019,43.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/4/1975,2/25/2019,2019,43.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/1/1949,2/27/2019,2019,69.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/1/1949,2/27/2019,2019,69.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/14/1965,3/4/2019,2019,54.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/14/1965,3/4/2019,2019,54.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/9/1959,3/6/2019,2019,60.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/9/1959,3/6/2019,2019,60.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1948,3/7/2019,2019,70.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/30/1948,3/7/2019,2019,70.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/15/1955,3/7/2019,2019,63.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/15/1955,3/7/2019,2019,63.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/21/1946,3/11/2019,2019,72.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/21/1946,3/11/2019,2019,72.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/27/1950,3/11/2019,2019,69,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/27/1950,3/11/2019,2019,69,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1987,3/12/2019,2019,32,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/26/1987,3/12/2019,2019,32,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/15/1920,3/13/2019,2019,99.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/15/1920,3/13/2019,2019,99.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/29/1971,3/15/2019,2019,47.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/29/1971,3/15/2019,2019,47.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1957,3/18/2019,2019,61.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1957,3/18/2019,2019,61.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/28/1957,3/22/2019,2019,61.5,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/28/1957,3/22/2019,2019,61.5,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/4/1947,3/22/2019,2019,71.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/4/1947,3/22/2019,2019,71.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/12/1961,4/2/2019,2019,57.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/12/1961,4/2/2019,2019,57.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/19/1969,4/5/2019,2019,49.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/19/1969,4/5/2019,2019,49.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/18/1948,4/5/2019,2019,71,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/18/1948,4/5/2019,2019,71,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/19/1962,4/8/2019,2019,57,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1965,4/8/2019,2019,53.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/15/1965,4/8/2019,2019,53.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/25/1961,4/9/2019,2019,57.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/25/1961,4/9/2019,2019,57.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/29/1958,4/15/2019,2019,60.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1959,4/15/2019,2019,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/17/1959,4/15/2019,2019,59.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/12/1979,4/15/2019,2019,40.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/12/1979,4/15/2019,2019,40.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1952,4/22/2019,2019,66.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1952,4/22/2019,2019,66.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/25/1945,4/26/2019,2019,73.8,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/25/1945,4/26/2019,2019,73.8,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/20/1966,4/30/2019,2019,52.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1958,4/30/2019,2019,60.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1958,4/30/2019,2019,60.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/20/1961,4/30/2019,2019,58.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/20/1961,4/30/2019,2019,58.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/26/1948,5/3/2019,2019,71.2,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/26/1948,5/3/2019,2019,71.2,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/5/1959,5/6/2019,2019,59.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/5/1959,5/6/2019,2019,59.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/19/1946,5/7/2019,2019,73.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/19/1946,5/7/2019,2019,73.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/23/1968,5/9/2019,2019,50.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1968,5/9/2019,2019,50.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/19/1950,5/10/2019,2019,69.4,Black or African American,Non-Hispanic,Black,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Endometrioid Adenocarcinoma, Secretory Variant",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/23/1980,5/15/2019,2019,39.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/23/1980,5/15/2019,2019,39.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/7/1976,5/16/2019,2019,42.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1933,5/16/2019,2019,86,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1933,5/16/2019,2019,86,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/8/1954,6/3/2019,2019,65.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/8/1954,6/3/2019,2019,65.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/25/1965,6/5/2019,2019,54.2,White,Non-Hispanic,White,Female,51808,Pro2018002377  WIRB20170992; XL184-021,"Uterus, Nos",Uterus,Endometrioid Carcinoma,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
11/25/1948,6/11/2019,2019,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/25/1948,6/11/2019,2019,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1947,6/11/2019,2019,71.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/12/1947,6/11/2019,2019,71.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/11/1942,6/12/2019,2019,77.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/11/1942,6/12/2019,2019,77.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/9/1951,6/13/2019,2019,67.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1951,6/13/2019,2019,67.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/22/1951,6/18/2019,2019,67.7,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/22/1951,6/18/2019,2019,67.7,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/14/1963,6/20/2019,2019,56,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/14/1963,6/20/2019,2019,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/8/1948,6/24/2019,2019,71.4,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/8/1948,6/24/2019,2019,71.4,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/7/1953,6/24/2019,2019,66,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/7/1953,6/24/2019,2019,66,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1945,7/3/2019,2019,74.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1945,7/3/2019,2019,74.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/26/1966,7/5/2019,2019,53.3,Black or African American,Non-Hispanic,Black,Female,51808,Pro2018002377  WIRB20170992; XL184-021,"Uterus, Nos",Uterus,"Carcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/5/1945,7/11/2019,2019,74.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1945,7/11/2019,2019,74.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/8/1979,7/11/2019,2019,39.9,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/8/1979,7/11/2019,2019,39.9,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1940,7/12/2019,2019,79.2,White,Non-Hispanic,White,Female,51808,Pro2018002377  WIRB20170992; XL184-021,"Uterus, Nos",Uterus,"Endometrioid Adenocarcinoma, Secretory Variant",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
7/23/1947,7/15/2019,2019,72,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/23/1947,7/15/2019,2019,72,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1973,7/15/2019,2019,46,White,Non-Hispanic,White,Male,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/9/1973,7/15/2019,2019,46,White,Non-Hispanic,White,Male,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1960,7/23/2019,2019,59.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1950,7/24/2019,2019,68.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/20/1950,7/24/2019,2019,68.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/21/1946,7/24/2019,2019,73.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/21/1946,7/24/2019,2019,73.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/24/1973,7/25/2019,2019,46.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1949,7/25/2019,2019,70,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/16/1949,7/25/2019,2019,70,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/10/1966,7/30/2019,2019,53.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/10/1966,7/30/2019,2019,53.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/31/1966,8/1/2019,2019,53.4,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/31/1966,8/1/2019,2019,53.4,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/4/1951,8/2/2019,2019,67.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/4/1951,8/2/2019,2019,67.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/7/1947,8/8/2019,2019,72.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/7/1947,8/8/2019,2019,72.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/13/1949,8/12/2019,2019,69.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/13/1949,8/12/2019,2019,69.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/23/1955,8/28/2019,2019,64.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/23/1955,8/28/2019,2019,64.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/12/1947,8/28/2019,2019,72.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/12/1947,8/28/2019,2019,72.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/1/1955,8/30/2019,2019,64.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/1/1955,8/30/2019,2019,64.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1988,9/5/2019,2019,30.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1988,9/5/2019,2019,30.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/8/1960,9/10/2019,2019,58.8,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/8/1960,9/10/2019,2019,58.8,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/22/1950,9/11/2019,2019,69.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/22/1950,9/11/2019,2019,69.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/6/1944,9/23/2019,2019,75.3,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/6/1944,9/23/2019,2019,75.3,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1957,10/3/2019,2019,61.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1957,10/3/2019,2019,61.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/4/1956,10/8/2019,2019,63.6,Asian,Non-Hispanic,Asian,Female,51808,Pro2018002377  WIRB20170992; XL184-021,"Uterus, Nos",Uterus,"Adenocarcinoma, Nos",DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
1/25/1936,10/9/2019,2019,83.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/25/1936,10/9/2019,2019,83.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/8/1949,10/10/2019,2019,70.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/8/1949,10/10/2019,2019,70.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/3/1941,10/11/2019,2019,78.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/3/1941,10/11/2019,2019,78.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/1/1940,10/15/2019,2019,79.5,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
3/3/1958,10/16/2019,2019,61.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/3/1958,10/16/2019,2019,61.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/8/1935,10/16/2019,2019,84.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/8/1935,10/16/2019,2019,84.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/16/1955,10/18/2019,2019,64.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1967,10/21/2019,2019,52.6,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/29/1967,10/21/2019,2019,52.6,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/12/1963,10/24/2019,2019,56.2,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1980,10/24/2019,2019,39.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1980,10/24/2019,2019,39.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1964,10/24/2019,2019,55,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1964,10/24/2019,2019,55,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/13/1970,11/6/2019,2019,49.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1953,11/7/2019,2019,66.1,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/6/1953,11/7/2019,2019,66.1,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/14/1965,11/7/2019,2019,54.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/14/1965,11/7/2019,2019,54.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/8/1952,11/7/2019,2019,67.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/8/1952,11/7/2019,2019,67.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/9/1951,11/8/2019,2019,68.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/9/1951,11/8/2019,2019,68.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/1959,11/14/2019,2019,60.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/7/1959,11/14/2019,2019,60.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/25/1953,11/18/2019,2019,66.6,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/25/1953,11/18/2019,2019,66.6,Unknown,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1943,11/20/2019,2019,76.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1943,11/20/2019,2019,76.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/17/1942,11/22/2019,2019,77,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/17/1942,11/22/2019,2019,77,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/18/1963,11/26/2019,2019,56.1,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/18/1963,11/26/2019,2019,56.1,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/27/1959,11/27/2019,2019,60,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/27/1959,11/27/2019,2019,60,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/10/1959,11/27/2019,2019,60.7,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/10/1959,11/27/2019,2019,60.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/7/1960,12/4/2019,2019,59.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/7/1960,12/4/2019,2019,59.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/11/1952,12/5/2019,2019,67.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/11/1952,12/5/2019,2019,67.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/28/1967,12/5/2019,2019,52,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/28/1967,12/5/2019,2019,52,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/14/1965,12/10/2019,2019,54,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/14/1965,12/10/2019,2019,54,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/29/1974,12/13/2019,2019,45.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/29/1974,12/13/2019,2019,45.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/14/1953,12/13/2019,2019,66.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/14/1953,12/13/2019,2019,66.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/24/1951,12/17/2019,2019,68.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/24/1951,12/17/2019,2019,68.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/19/1954,12/18/2019,2019,65,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/16/1955,12/18/2019,2019,64.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/24/1959,12/30/2019,2019,60.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/24/1959,12/30/2019,2019,60.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/2/1953,12/31/2019,2019,66.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/2/1953,12/31/2019,2019,66.9,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/4/1964,1/6/2020,2020,56,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/4/1964,1/6/2020,2020,56,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/18/1943,1/17/2020,2020,76.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
6/18/1943,1/17/2020,2020,76.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/3/1959,1/23/2020,2020,60.3,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,Serous Surface Papillary Carcinoma,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
9/14/1963,1/24/2020,2020,56.4,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/14/1963,1/24/2020,2020,56.4,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1935,1/24/2020,2020,84.5,Unknown,Non-Hispanic,Unknown,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1935,1/24/2020,2020,84.5,Unknown,Non-Hispanic,Unknown,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/26/1946,1/24/2020,2020,73.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/26/1946,1/24/2020,2020,73.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/26/1955,2/7/2020,2020,64.7,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/24/1959,2/13/2020,2020,60.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/24/1959,2/13/2020,2020,60.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/2/1959,2/28/2020,2020,60.5,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
9/2/1959,2/28/2020,2020,60.5,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Uterus, Nos",Uterus,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/16/1946,3/31/2020,2020,73.9,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,"Carcinosarcoma, Nos",Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
6/1/1949,4/1/2020,2020,70.9,White,Non-Hispanic,White,Female,101702,ONC012; Pro20170001628-WIRB 20172407 ,"Uterus, Nos",Uterus,,Gynecologic,Phase II,Treatment,Gynecologic,Gynecologic,Interventional,New Brunswick,Enrolled Patients
4/25/1953,9/15/2020,2020,67.4,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131901,19488,"Uterus, Nos",Uterus,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/26/1967,4/23/2018,2018,50.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,Vagina,Vagina,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
7/26/1967,4/23/2018,2018,50.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,Vagina,Vagina,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/20/1971,10/22/2018,2018,47.5,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Vagina,Vagina,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/20/1971,10/22/2018,2018,47.5,White,Hispanic or Latino,Hispanic/Latino,Female,1502,14690; 20150001762,Vagina,Vagina,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/1/1955,10/19/2020,2020,65.7,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,Vagina,Vagina,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/1/1955,10/19/2020,2020,65.7,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,1209,Pro2012002075,Vagina,Vagina,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/24/1946,10/11/2017,2017,71.8,Asian,Non-Hispanic,Asian,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/24/1946,10/11/2017,2017,71.8,Asian,Non-Hispanic,Asian,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1960,10/13/2017,2017,57.4,Black or African American,Non-Hispanic,Black,Female,51516,MK3475-158-02; Pro20150002542  WIRB 20152193,"Vulva, Nos","Vulva, Nos","Sq. Cell Carcinoma, Keratinizing, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
10/5/1928,11/20/2017,2017,89.2,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/5/1928,11/20/2017,2017,89.2,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/24/1940,3/23/2018,2018,78.1,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
2/24/1940,3/23/2018,2018,78.1,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/29/1955,4/12/2018,2018,62.7,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Female,51516,MK3475-158-02; Pro20150002542  WIRB 20152193,"Vulva, Nos","Vulva, Nos","Squamous Cell Carcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
4/7/1929,6/25/2018,2018,89.3,Black or African American,Non-Hispanic,Black,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/7/1929,6/25/2018,2018,89.3,Black or African American,Non-Hispanic,Black,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1959,9/25/2018,2018,59.4,White,Non-Hispanic,White,Female,51516,MK3475-158-02; Pro20150002542  WIRB 20152193,"Vulva, Nos","Vulva, Nos",,DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/17/1966,12/20/2018,2018,52.6,White,Non-Hispanic,White,Female,51516,MK3475-158-02; Pro20150002542  WIRB 20152193,"Vulva, Nos","Vulva, Nos","Squamous Cell Carcinoma, Nos",DT - Phase I,Phase II,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/17/1966,2/11/2019,2019,52.8,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
5/17/1966,2/11/2019,2019,52.8,White,Non-Hispanic,White,Female,1209,Pro2012002075,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/17/1966,2/11/2019,2019,52.8,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1952,6/6/2019,2019,67.2,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/2/1952,6/6/2019,2019,67.2,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/20/1945,6/18/2019,2019,73.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
12/20/1945,6/18/2019,2019,73.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/3/1972,10/7/2019,2019,46.9,White,Hispanic or Latino,Hispanic/Latino,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1948,10/16/2019,2019,71.6,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
4/9/1948,10/16/2019,2019,71.6,White,Non-Hispanic,White,Female,1502,14690; 20150001762,"Vulva, Nos","Vulva, Nos",,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/13/1965,3/22/2017,2017,51.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
,3/26/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Male,131323,"1K07, CA174728-01; Pro2013003658",,,,Population Science,N/A,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,3/26/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Male,131323,"1K07, CA174728-01; Pro2013003658",,,,Population Science,N/A,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,3/28/2017,2017,,White,Non-Hispanic,White,Male,131323,"1K07, CA174728-01; Pro2013003658",,,,Population Science,N/A,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,4/8/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Female,131323,"1K07, CA174728-01; Pro2013003658",,,,Population Science,N/A,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,4/12/2017,2017,,Black or African American,Non-Hispanic,Black,Female,131323,"1K07, CA174728-01; Pro2013003658",,,,Population Science,N/A,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,5/30/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,5/30/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,5/31/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/5/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/1/1959,6/8/2017,2017,58.5,White,Non-Hispanic,White,Male,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/1/1948,6/16/2017,2017,69.5,White,Non-Hispanic,White,Male,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/17/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/17/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/17/2017,2017,,White; Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/17/2017,2017,,White,Unknown,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/19/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/19/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/20/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/20/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,6/26/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/18/1968,6/27/2017,2017,48.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
,7/3/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/1/1968,7/4/2017,2017,49.5,Black or African American,Non-Hispanic,Black,Female,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,7/7/2017,2017,,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/1/1970,7/10/2017,2017,47.6,White,Non-Hispanic,White,Female,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
6/7/1946,7/10/2017,2017,71.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
,7/11/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,7/13/2017,2017,,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/28/1940,7/14/2017,2017,77,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/1/1959,7/17/2017,2017,58.6,Black or African American,Non-Hispanic,Black,Female,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/7/2017,2017,,White,Hispanic or Latino,Hispanic/Latino,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/11/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/13/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/2/1972,8/14/2017,2017,45.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
,8/17/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/19/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/22/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/26/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/26/2017,2017,,White,Unknown,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,8/29/2017,2017,,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,9/12/2017,2017,,White,Non-Hispanic,White,U,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,9/19/2017,2017,,White,Unknown,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,9/26/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/1/1958,9/27/2017,2017,59.5,White,Hispanic or Latino,Hispanic/Latino,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
1/1/1959,10/1/2017,2017,58.8,White,Non-Hispanic,White,Female,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,10/2/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,10/13/2017,2017,,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,10/13/2017,2017,,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,10/15/2017,2017,,Unknown,Unknown,Unknown,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/10/1928,10/17/2017,2017,89.5,White,Hispanic or Latino,Hispanic/Latino,Male,71701,16.12.US.HCN; Pro20170000485; WIRB 20171420,,,,Gastrointestinal,Early Phase I,Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Gastrointestinal; Lung / Head and Neck; Radiation Oncology; Supportive Care,Interventional,New Brunswick,Enrolled Patients
,10/17/2017,2017,,Unknown,Unknown,Unknown,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,11/3/2017,2017,,White,Unknown,White,U,1714,Pro20170000634,,,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/19/1954,11/14/2017,2017,62.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/14/1994,11/17/2017,2017,23.9,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,,,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,,,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,11/29/2017,2017,,White,Non-Hispanic,White,Female,1714,Pro20170000634,,,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/1/1981,11/30/2017,2017,36.9,Native Hawaiian or Other Pacific Islander,Hispanic or Latino,Hispanic/Latino,Female,131604,20170000115,,,,Population Science,Early Phase I,Other,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
,12/1/2017,2017,,White,Non-Hispanic,White,Male,1714,Pro20170000634,,,,NTS / Lab Studies,Early Phase I,Supportive Care,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
,12/5/2017,2017,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,12/5/2017,2017,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,12/5/2017,2017,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,12/5/2017,2017,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
9/7/1942,12/14/2017,2017,75.3,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
4/30/1968,12/22/2017,2017,49.7,Asian,Non-Hispanic,Asian,Male,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/27/1991,12/28/2017,2017,26.9,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/14/1993,1/19/2018,2018,24.2,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/20/1958,1/23/2018,2018,59.8,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
6/25/1981,1/24/2018,2018,36.6,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
4/21/1988,1/31/2018,2018,29.8,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/1991,2/8/2018,2018,26.6,Unknown,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/8/2018,2/8/2018,2018,0,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/21/1992,2/9/2018,2018,25.3,White,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/12/1993,2/15/2018,2018,24.2,White,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/5/1997,2/16/2018,2018,21.1,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/19/1991,3/6/2018,2018,26.9,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/10/1996,3/8/2018,2018,21.4,Black or African American,Non-Hispanic,Black,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/10/1988,3/19/2018,2018,29.5,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/6/1990,3/27/2018,2018,28.1,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/23/1988,4/30/2018,2018,30,Black or African American,Non-Hispanic,Black,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/31/2018,5/3/2018,2018,0.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/19/1947,5/3/2018,2018,71.1,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/6/1945,5/8/2018,2018,72.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/16/1954,5/10/2018,2018,63.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/9/1952,5/10/2018,2018,65.6,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/15/1962,5/10/2018,2018,55.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/1/1991,5/11/2018,2018,26.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/22/1947,5/11/2018,2018,71,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/29/1940,5/14/2018,2018,78.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/21/1944,5/16/2018,2018,74.3,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/13/1958,5/18/2018,2018,59.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/22/1970,5/21/2018,2018,47.6,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/5/1949,5/22/2018,2018,68.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/17/1954,5/23/2018,2018,64.2,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/6/1997,5/23/2018,2018,20.9,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/4/1967,5/24/2018,2018,51.4,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/16/1942,5/24/2018,2018,75.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/27/1968,5/24/2018,2018,49.5,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/13/1946,5/24/2018,2018,72.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/21/1938,5/24/2018,2018,80.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/4/2012,5/29/2018,2018,6.1,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,"Synovial Sarcoma, Biphasic",Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/15/1969,5/29/2018,2018,48.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/14/1969,5/31/2018,2018,49.4,Unknown,Non-Hispanic,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/26/1947,5/31/2018,2018,70.5,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1943,6/1/2018,2018,74.8,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/21/1961,6/4/2018,2018,56.5,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/31/1938,6/4/2018,2018,80.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/17/1944,6/5/2018,2018,74.1,Unknown,Non-Hispanic,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/25/1952,6/5/2018,2018,66.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/2/1943,6/5/2018,2018,75.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/7/1962,6/6/2018,2018,56.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/2/1945,6/7/2018,2018,73.3,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/14/1941,6/7/2018,2018,77.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/30/1969,6/7/2018,2018,49,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/20/1948,6/7/2018,2018,70.2,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/25/1954,6/7/2018,2018,63.7,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/22/1944,6/7/2018,2018,74.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/6/1947,6/7/2018,2018,71.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/11/1957,6/8/2018,2018,60.7,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/24/1964,6/8/2018,2018,54.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/2/1975,6/8/2018,2018,43.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/31/1945,6/8/2018,2018,73.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/2/1947,6/12/2018,2018,71,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/17/1971,6/13/2018,2018,46.9,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/27/1967,6/13/2018,2018,51,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/27/1955,6/13/2018,2018,62.8,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/21/1962,6/13/2018,2018,56.3,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/20/1954,6/13/2018,2018,64.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/2/1946,6/14/2018,2018,71.7,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/15/1967,6/14/2018,2018,51,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/16/1955,6/14/2018,2018,62.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/3/1946,6/14/2018,2018,72,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/4/1965,6/14/2018,2018,53.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/4/1965,6/14/2018,2018,53.5,White,Non-Hispanic,White,Female,1502,14690; 20150001762,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/11/1951,6/15/2018,2018,67,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/7/1948,6/18/2018,2018,70.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/18/2018,6/18/2018,2018,0,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/2/1969,6/19/2018,2018,48.6,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/11/1946,6/19/2018,2018,72.2,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/13/1957,6/20/2018,2018,61.1,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/10/1958,6/20/2018,2018,60.5,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
3/12/1949,6/20/2018,2018,69.3,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
9/27/1949,6/20/2018,2018,68.8,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/31/1949,6/20/2018,2018,69.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
12/24/1993,6/21/2018,2018,24.5,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/29/1951,6/21/2018,2018,66.6,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/23/1947,6/22/2018,2018,71.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/14/1946,6/25/2018,2018,72,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/7/1948,6/26/2018,2018,70,White,Non-Hispanic,White,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
2/17/1961,6/26/2018,2018,57.4,White,Non-Hispanic,White,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/10/1940,6/26/2018,2018,78,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/20/1969,6/27/2018,2018,49.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/5/1951,6/27/2018,2018,67.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/21/1963,6/28/2018,2018,55.1,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
,6/29/2018,2018,,Black or African American,Non-Hispanic,Black,Female,131404,20150001595; R21CA191431,,,,Breast,N/A,Supportive Care,Breast,Breast,Interventional,New Brunswick,Enrolled Patients
6/21/2000,7/2/2018,2018,18,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/22/1950,7/2/2018,2018,68.4,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/22/1958,7/5/2018,2018,59.9,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
7/21/1954,7/5/2018,2018,64,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
4/2/1947,7/5/2018,2018,71.3,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
1/16/1962,7/6/2018,2018,56.5,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
6/14/1955,7/9/2018,2018,63.1,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
5/3/1963,7/10/2018,2018,55.2,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
8/21/1967,7/10/2018,2018,50.9,Unknown,Unknown,Unknown,Female,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
10/21/1953,7/11/2018,2018,64.8,Unknown,Unknown,Unknown,Male,131403,Pro2014000095; R01CA171666,,,,Melanoma / Sarcoma,N/A,Other,Melanoma / Sarcoma,Melanoma / Sarcoma; Population Science,Interventional,New Brunswick,Enrolled Patients
11/22/1991,7/13/2018,2018,26.7,White,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/7/1995,7/13/2018,2018,23.4,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/11/1992,8/15/2018,2018,26.1,White,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/4/1997,8/21/2018,2018,21.2,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/31/1961,8/22/2018,2018,56.7,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/6/1948,8/27/2018,2018,70.4,Asian,Non-Hispanic,Asian,Female,1209,Pro2012002075,,,,NTS / Lab Studies,N/A,Diagnostic,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/15/1960,9/5/2018,2018,57.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
7/30/1967,9/5/2018,2018,51.1,Black or African American,Non-Hispanic,Black,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
2/9/1969,9/5/2018,2018,49.6,White,Non-Hispanic,White,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/5/1947,9/6/2018,2018,70.8,White,Non-Hispanic,White,Female,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
8/9/1990,9/19/2018,2018,28.1,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/17/1997,9/20/2018,2018,21.1,White,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/18/1958,9/26/2018,2018,59.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
6/9/1988,10/2/2018,2018,30.3,Asian,Non-Hispanic,Asian,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/6/1945,10/2/2018,2018,72.9,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
6/22/1994,10/5/2018,2018,24.3,Asian,Non-Hispanic,Asian,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
9/7/1996,10/5/2018,2018,22.1,Black or African American,Non-Hispanic,Black,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/7/1995,10/16/2018,2018,23.5,Unknown,Non-Hispanic,Unknown,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/27/1954,10/29/2018,2018,64.3,White,Non-Hispanic,White,Female,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
5/17/1997,10/30/2018,2018,21.5,Unknown,Hispanic or Latino,Hispanic/Latino,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
12/21/1990,10/31/2018,2018,27.9,Asian,Non-Hispanic,Asian,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/20/1959,11/6/2018,2018,59.4,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/18/1984,11/6/2018,2018,34.3,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/15/1985,11/6/2018,2018,33.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/12/1963,11/6/2018,2018,55.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/28/1959,11/6/2018,2018,59.6,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/1/1951,11/7/2018,2018,67.1,Asian,Non-Hispanic,Asian,Male,1610,001610  201209025; Pro20160000426,,,,Radiation Oncology,N/A,Other,Radiation Oncology,Not tumor specific / Laboratory studies; Radiation Oncology,Observational,New Brunswick,Enrolled Patients
10/22/1999,11/8/2018,2018,19.1,White,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/18/1955,11/9/2018,2018,63.8,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/4/1989,11/9/2018,2018,29.9,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/10/1999,11/19/2018,2018,19.5,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/30/1991,11/19/2018,2018,27.3,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/22/1986,11/26/2018,2018,32.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/31/1993,11/30/2018,2018,25.5,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/11/1974,12/6/2018,2018,44.7,White,Non-Hispanic,White,Female,131317,Pro2013003676,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1951,12/7/2018,2018,67.5,White,Non-Hispanic,White,Male,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/4/1995,12/26/2018,2018,23.5,White,Non-Hispanic,White,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/20/1995,1/9/2019,2019,23.2,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/22/1962,2/1/2019,2019,56.6,Black or African American,Non-Hispanic,Black,Female,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
6/22/1961,2/1/2019,2019,57.7,White,Non-Hispanic,White,Male,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/29/1958,2/1/2019,2019,60.1,White,Non-Hispanic,White,Female,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
9/16/1947,2/21/2019,2019,71.5,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1996,4/3/2019,2019,23,Asian,Non-Hispanic,Asian,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/2/1996,4/10/2019,2019,22.7,White; Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/3/2014,4/29/2019,2019,5.3,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/25/1992,5/9/2019,2019,26.6,White; Black or African American,Non-Hispanic,Black,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1999,5/10/2019,2019,19.7,White,Hispanic or Latino,Hispanic/Latino,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/15/1999,5/14/2019,2019,19.8,White,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/26/1948,6/5/2019,2019,71.3,Asian,Non-Hispanic,Asian,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
7/25/1945,6/5/2019,2019,73.9,Black or African American,Non-Hispanic,Black,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
8/23/1952,6/5/2019,2019,66.8,Black or African American,Non-Hispanic,Black,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
11/17/1989,6/5/2019,2019,29.6,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/12/1961,6/6/2019,2019,57.9,White,Hispanic or Latino,Hispanic/Latino,Female,71805,Pro2018000419,,,,Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
10/26/1959,6/6/2019,2019,59.7,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
10/19/1998,6/7/2019,2019,20.6,White,Unknown,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/26/1965,6/10/2019,2019,53.6,Black or African American,Non-Hispanic,Black,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
10/23/1990,6/11/2019,2019,28.7,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/13/1940,6/11/2019,2019,79.4,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
10/24/1957,6/12/2019,2019,61.7,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
7/28/1992,6/14/2019,2019,26.9,Asian,Non-Hispanic,Asian,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
9/28/1957,6/14/2019,2019,61.8,Black or African American,Non-Hispanic,Black,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
9/1/1993,6/18/2019,2019,25.8,White,Non-Hispanic,White,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1952,6/19/2019,2019,66.9,White,Non-Hispanic,White,Female,1006,CCSG P30CA072720-11; Pro20170000331,,,,NTS / Lab Studies,N/A,Other,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Ancillary or Correlative,New Brunswick,Enrolled Patients
11/4/1994,6/20/2019,2019,24.6,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/15/1946,6/21/2019,2019,73.4,Black or African American,Non-Hispanic,Black,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
6/3/1999,6/24/2019,2019,20.1,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/29/1957,6/27/2019,2019,61.5,White,Non-Hispanic,White,Female,71805,Pro2018000419,,,,Gastrointestinal,Early Phase I,Basic Science,Gastrointestinal,Gastrointestinal,Ancillary or Correlative,New Brunswick,Enrolled Patients
8/9/1966,6/29/2019,2019,52.9,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/30/1971,7/8/2019,2019,47.8,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
7/14/1963,7/8/2019,2019,56,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
7/16/1952,7/8/2019,2019,67,White,Non-Hispanic,White,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
4/5/1966,7/15/2019,2019,53.3,White,Non-Hispanic,White,Male,171701,EAY131; NCI CIRB Pro2018000037,,,,Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
5/27/1993,7/17/2019,2019,26.2,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/21/1964,7/18/2019,2019,54.6,Unknown,Hispanic or Latino,Hispanic/Latino,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
1/13/1949,7/18/2019,2019,70.6,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/1/1949,7/19/2019,2019,69.8,Asian,Non-Hispanic,Asian,Male,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
7/14/1963,7/19/2019,2019,56.1,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/23/1995,7/23/2019,2019,24.1,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/7/1955,7/24/2019,2019,64.2,White,Hispanic or Latino,Hispanic/Latino,Female,101701,Pro20160001014,,,,Gynecologic,N/A,Other,Gynecologic,Gynecologic,Observational,New Brunswick,Enrolled Patients
11/25/1989,7/26/2019,2019,29.7,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/13/1961,7/29/2019,2019,58.3,White,Non-Hispanic,White,Female,31504,A151216; NCI CIRB                   Pro20150001769 ,,,,Lung / Head and Neck,N/A,Screening,Lung / Head and Neck,Lung / Head and Neck,Ancillary or Correlative,New Brunswick,Enrolled Patients
1/5/1960,8/2/2019,2019,59.6,Black or African American,Non-Hispanic,Black,Male,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
12/23/1951,8/5/2019,2019,67.7,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
6/3/1954,8/5/2019,2019,65.2,Unknown,Non-Hispanic,Unknown,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/19/1941,8/5/2019,2019,78,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/29/1955,8/6/2019,2019,63.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/10/1944,8/6/2019,2019,74.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/3/1945,8/6/2019,2019,74,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/30/1955,8/7/2019,2019,63.7,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/31/1942,8/7/2019,2019,77,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/8/1956,8/8/2019,2019,63.6,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/26/1953,8/9/2019,2019,66.3,American Indian or Alaska Native,Non-Hispanic,Native American,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/24/1949,8/12/2019,2019,70,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/26/1951,8/12/2019,2019,67.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/26/1939,8/13/2019,2019,79.7,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
10/19/1952,8/13/2019,2019,66.9,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/10/1952,8/13/2019,2019,67,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
6/30/1946,8/14/2019,2019,73.2,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/1/1981,8/26/2019,2019,38.2,Black or African American,Hispanic or Latino,Hispanic/Latino,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
10/28/1950,8/30/2019,2019,68.9,White,Hispanic or Latino,Hispanic/Latino,Female,81407,Pro2013003918,,,,Genitourinary,Early Phase I,Diagnostic,Genitourinary,Genitourinary,Interventional,New Brunswick,Enrolled Patients
2/28/1979,9/5/2019,2019,40.5,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/8/1970,9/6/2019,2019,48.9,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
5/15/1989,9/6/2019,2019,30.3,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/27/2001,9/10/2019,2019,18.5,White; Unknown,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/29/1990,9/15/2019,2019,29.3,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/25/1989,9/15/2019,2019,29.8,Unknown,Non-Hispanic,Unknown,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/4/1994,9/15/2019,2019,24.9,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/15/1991,9/15/2019,2019,27.9,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/25/1995,9/15/2019,2019,24.5,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/5/1990,9/15/2019,2019,29.2,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/17/1989,9/15/2019,2019,29.8,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/27/1991,9/15/2019,2019,28.6,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/2/1992,9/17/2019,2019,27.5,White,Hispanic or Latino,Hispanic/Latino,Male,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/9/1945,9/18/2019,2019,74.7,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/22/1960,9/23/2019,2019,59.3,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/26/1964,9/23/2019,2019,54.9,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/25/1997,9/24/2019,2019,21.8,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
9/12/1938,9/24/2019,2019,81.1,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/6/1949,9/27/2019,2019,70.1,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
5/18/1996,10/10/2019,2019,23.4,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/29/1967,10/11/2019,2019,52.5,White,Non-Hispanic,White,Female,1919,,,,,Breast,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/9/1996,10/14/2019,2019,23.3,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/31/1959,10/15/2019,2019,60.4,White,Non-Hispanic,White,Female,1919,,,,,Breast,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
5/26/1966,10/16/2019,2019,53.4,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/21/2001,10/21/2019,2019,18.1,Black or African American,Non-Hispanic,Black,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/12/1953,10/22/2019,2019,66.4,White,Non-Hispanic,White,Female,1919,,,,,Breast,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/7/1945,10/23/2019,2019,74.2,Asian,Non-Hispanic,Asian,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
7/8/1964,10/23/2019,2019,55.3,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
8/27/1973,10/24/2019,2019,46.2,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/7/1947,10/24/2019,2019,72.4,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/14/1962,10/28/2019,2019,56.9,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1969,10/28/2019,2019,50.6,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
4/2/1998,10/29/2019,2019,21.6,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/14/1967,10/29/2019,2019,52.7,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
10/17/1965,10/29/2019,2019,54.1,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/30/1973,10/30/2019,2019,45.9,Black or African American; Asian,Non-Hispanic,Black,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
9/19/1971,10/30/2019,2019,48.1,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
2/22/2000,10/30/2019,2019,19.7,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/23/1995,10/31/2019,2019,24.4,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/9/1990,11/1/2019,2019,29.2,White,Non-Hispanic,White,Male,171701,EAY131; NCI CIRB Pro2018000037,,,,Precision Medicine,Phase II,Screening,Precision Medicine Investigational Therapeutics,Precision Medicine Investigational Therapeutics,Interventional,New Brunswick,Enrolled Patients
9/21/1946,11/4/2019,2019,73.2,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/14/1957,11/5/2019,2019,62.4,White,Hispanic or Latino,Hispanic/Latino,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/10/2000,11/8/2019,2019,19.3,White,Hispanic or Latino,Hispanic/Latino,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/28/1995,11/9/2019,2019,24.7,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/21/1965,11/11/2019,2019,54.3,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/9/1975,11/12/2019,2019,44.2,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
1/30/1952,11/13/2019,2019,67.8,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/22/1965,11/14/2019,2019,53.9,White,Hispanic or Latino,Hispanic/Latino,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
12/10/1969,11/14/2019,2019,50,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
3/7/2001,11/14/2019,2019,18.7,White; American Indian or Alaska Native,Non-Hispanic,Native American,Female,131711,Pro20170001905,,,,Population Science,N/A,Supportive Care,Population Science; Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/27/2001,11/16/2019,2019,18.1,White,Hispanic or Latino,Hispanic/Latino,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/11/1998,11/17/2019,2019,21.5,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/13/1998,11/18/2019,2019,21.6,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/6/1980,11/19/2019,2019,39.6,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
5/28/1970,11/20/2019,2019,49.5,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/14/1997,11/20/2019,2019,22.3,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/11/1963,11/21/2019,2019,56.2,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/22/1955,11/21/2019,2019,64.5,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
6/14/1945,11/21/2019,2019,74.5,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/12/1969,11/21/2019,2019,50.1,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/25/2015,11/24/2019,2019,4.4,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
9/15/2017,11/26/2019,2019,2.2,Asian,Non-Hispanic,Asian,Female,110101,617; ANBL00B1; NCI CIRB Pro0220003367,,,,Pediatric Oncology,N/A,Basic Science,Pediatric Oncology,Pediatric Oncology,Ancillary or Correlative,New Brunswick,Enrolled Patients
3/25/1996,11/26/2019,2019,23.7,Asian,Non-Hispanic,Asian,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/20/2015,11/26/2019,2019,4.8,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
7/4/2005,12/3/2019,2019,14.4,White,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
2/27/2001,12/3/2019,2019,18.8,White; Unknown,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/5/2003,12/3/2019,2019,16.6,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
1/15/1953,12/4/2019,2019,66.9,Black or African American,Non-Hispanic,Black,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/25/1968,12/4/2019,2019,51.5,White,Non-Hispanic,White,Female,1919,,,,,NTS / Lab Studies,N/A,Basic Science,Breast; Not tumor specific / Laboratory studies,CINJ Oncology Group; Not tumor specific / Laboratory studies,Observational,New Brunswick,Enrolled Patients
11/24/1968,12/4/2019,2019,51.1,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/30/1956,12/5/2019,2019,63,White,Hispanic or Latino,Hispanic/Latino,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/30/1995,12/5/2019,2019,24.3,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/17/2003,12/5/2019,2019,16.6,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/7/2001,12/5/2019,2019,18.8,White; American Indian or Alaska Native,Non-Hispanic,Native American,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/6/2000,12/6/2019,2019,19.3,Black or African American; American Indian or Alaska Native,Hispanic or Latino,Hispanic/Latino,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/26/1963,12/6/2019,2019,56.9,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/10/1996,12/8/2019,2019,23.3,Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/23/2014,12/9/2019,2019,5,White,Hispanic or Latino,Hispanic/Latino,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
8/4/1988,12/9/2019,2019,31.4,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
1/22/2000,12/17/2019,2019,19.9,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
11/4/1959,12/17/2019,2019,60.2,Asian,Non-Hispanic,Asian,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
4/1/1996,12/17/2019,2019,23.7,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/18/1945,12/19/2019,2019,74.2,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
5/14/1998,12/19/2019,2019,21.6,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/6/1953,12/20/2019,2019,66.2,White,Hispanic or Latino,Hispanic/Latino,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
1/14/1985,12/20/2019,2019,35,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/5/1987,12/20/2019,2019,32.5,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/11/1977,12/20/2019,2019,42.1,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/6/1995,12/20/2019,2019,24.5,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
4/3/1997,12/26/2019,2019,22.7,Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/31/2014,12/26/2019,2019,5.7,White,Non-Hispanic,White,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
5/6/2001,12/28/2019,2019,18.7,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/29/1996,12/30/2019,2019,23.9,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/20/1960,1/7/2020,2020,59.1,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/29/1969,1/7/2020,2020,50.5,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
3/31/2000,1/8/2020,2020,19.8,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
3/27/1951,1/8/2020,2020,68.8,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/6/1994,1/8/2020,2020,25.4,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/7/1959,1/9/2020,2020,60.9,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/17/1942,1/10/2020,2020,77.1,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/12/1999,1/12/2020,2020,20.9,Unknown,Hispanic or Latino,Hispanic/Latino,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/8/1994,1/12/2020,2020,25.4,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/4/1946,1/13/2020,2020,73.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/12/1960,1/13/2020,2020,59.2,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/25/1952,1/13/2020,2020,67.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
3/25/2000,1/13/2020,2020,19.8,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/21/1998,1/14/2020,2020,21.1,Black or African American,Non-Hispanic,Black,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/12/1953,1/14/2020,2020,66.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/30/1998,1/15/2020,2020,21.4,White,Hispanic or Latino,Hispanic/Latino,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/7/1945,1/15/2020,2020,74.9,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/31/1944,1/15/2020,2020,75.1,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/8/1956,1/15/2020,2020,63.2,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/2/1948,1/16/2020,2020,71.8,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/25/1948,1/16/2020,2020,71.4,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/4/1955,1/16/2020,2020,64.4,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/18/1954,1/17/2020,2020,65.1,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
5/4/1952,1/17/2020,2020,67.8,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/24/1949,1/17/2020,2020,71,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/17/1960,1/17/2020,2020,59.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/26/1995,1/20/2020,2020,24.1,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/31/1947,1/21/2020,2020,72.7,Asian,Non-Hispanic,Asian,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
10/12/1948,1/21/2020,2020,71.3,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/10/1998,1/21/2020,2020,21.2,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/12/1996,1/21/2020,2020,23.5,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/25/1995,1/21/2020,2020,24.3,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
2/27/1955,1/22/2020,2020,64.9,Unknown,Hispanic or Latino,Hispanic/Latino,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
10/17/1963,1/22/2020,2020,56.3,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
3/4/1950,1/22/2020,2020,69.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
5/27/1968,1/22/2020,2020,51.7,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
1/28/1949,1/22/2020,2020,71,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
3/17/1944,1/23/2020,2020,75.9,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/1/1953,1/23/2020,2020,66.6,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
8/5/1943,1/23/2020,2020,76.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/24/1998,1/23/2020,2020,21.3,White; Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
9/11/1952,1/24/2020,2020,67.4,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/23/2000,1/24/2020,2020,19.3,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/19/2000,1/24/2020,2020,19.5,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/24/1997,1/27/2020,2020,22.6,White; Black or African American; Asian; American Indian or Alaska Native,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/30/1973,1/29/2020,2020,46.3,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
4/23/1948,1/29/2020,2020,71.8,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/30/1939,1/29/2020,2020,80.6,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/3/1986,1/31/2020,2020,33.2,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/24/2001,1/31/2020,2020,18.6,Black or African American,Non-Hispanic,Black,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/6/1999,2/4/2020,2020,20.6,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
6/2/1997,2/4/2020,2020,22.7,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1964,2/7/2020,2020,55.5,White,Non-Hispanic,White,Female,21807,INCB 18424-MA-GD-301; Pro2018001833; WIRB20171533,,,,Leukemia,N/A,Treatment,Leukemia; Lymphoma / Myeloma,Leukemia; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/26/1960,2/7/2020,2020,59.2,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/14/1995,2/9/2020,2020,24.7,Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/28/1949,2/10/2020,2020,70.5,Asian,Non-Hispanic,Asian,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
1/13/1964,2/10/2020,2020,56.1,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/29/1996,2/13/2020,2020,23.1,Black or African American,Non-Hispanic,Black,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/14/1980,2/13/2020,2020,39.5,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
9/1/1960,2/14/2020,2020,59.5,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/21/1997,2/14/2020,2020,23,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
1/2/1998,2/15/2020,2020,22.1,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/24/1949,2/18/2020,2020,70.8,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/26/1999,2/22/2020,2020,20.3,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
12/31/1997,2/23/2020,2020,22.2,Asian,Non-Hispanic,Asian,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
8/7/1976,2/24/2020,2020,43.6,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/10/1972,2/26/2020,2020,48.1,Asian,Non-Hispanic,Asian,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/2/1964,2/26/2020,2020,55.8,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
12/31/1954,2/27/2020,2020,65.2,Black or African American,Non-Hispanic,Black,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
3/28/1951,3/3/2020,2020,69,Black or African American,Non-Hispanic,Black,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
4/15/1984,3/3/2020,2020,35.9,White,Non-Hispanic,White,Female,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
4/19/1984,3/6/2020,2020,35.9,Unknown,Non-Hispanic,Unknown,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/7/1997,3/8/2020,2020,22.7,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/21/1955,3/9/2020,2020,64.7,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
11/15/1941,3/10/2020,2020,78.4,Black or African American,Non-Hispanic,Black,Female,11815,BTCRC-HEM15-028; Pro2018001816,,,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
9/10/1958,3/11/2020,2020,61.5,Asian,Non-Hispanic,Asian,Male,11815,BTCRC-HEM15-028; Pro2018001816,,,Adult T-Cell Leukemia/Lymphoma (Htlv-1 Pos.),Lymphoma / Myeloma,Phase I/II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/5/1999,3/12/2020,2020,20.9,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
9/3/2000,3/13/2020,2020,19.5,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
3/29/1942,3/16/2020,2020,78,White,Non-Hispanic,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
6/24/1998,3/16/2020,2020,21.7,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
7/28/1962,4/1/2020,2020,57.7,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/31/1939,4/6/2020,2020,80.7,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/2/1949,4/8/2020,2020,70.5,Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/17/1958,4/8/2020,2020,61.5,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/16/1964,4/8/2020,2020,56.1,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/16/1945,4/8/2020,2020,74.4,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/25/1953,4/8/2020,2020,66.5,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/27/1987,4/8/2020,2020,33,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/20/1945,4/8/2020,2020,75.2,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/29/1961,4/9/2020,2020,58.4,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/15/1980,4/9/2020,2020,39.9,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/4/1986,4/9/2020,2020,34,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/15/1956,4/9/2020,2020,63.8,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/10/1991,4/9/2020,2020,29.2,Asian,Non-Hispanic,Asian,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/11/1958,4/9/2020,2020,61.4,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/5/1976,4/11/2020,2020,43.5,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/7/1988,4/11/2020,2020,31.5,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/28/1959,4/13/2020,2020,61.2,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/16/1956,4/13/2020,2020,63.8,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/13/1960,4/13/2020,2020,60,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/2/1961,4/13/2020,2020,58.5,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/5/1970,4/14/2020,2020,49.4,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/26/1988,4/14/2020,2020,31.7,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/13/1998,4/14/2020,2020,22.3,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/23/1970,4/15/2020,2020,49.8,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/28/1971,4/15/2020,2020,48.5,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/15/1954,4/15/2020,2020,66.1,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/21/1970,4/15/2020,2020,49.9,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/9/1966,4/15/2020,2020,54.2,Asian,Non-Hispanic,Asian,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/25/1964,4/15/2020,2020,56.3,Black or African American,Non-Hispanic,Black,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/15/1992,4/15/2020,2020,28,White; Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/11/1967,4/16/2020,2020,52.6,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
7/28/1968,4/16/2020,2020,51.8,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/13/1977,4/16/2020,2020,43.3,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/10/1960,4/16/2020,2020,59.7,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/3/1999,4/16/2020,2020,20.9,White,Non-Hispanic,White,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
10/7/1961,4/17/2020,2020,58.6,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/28/1958,4/17/2020,2020,62,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/16/1954,4/17/2020,2020,65.6,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/20/2000,4/17/2020,2020,20,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
10/29/1944,4/17/2020,2020,75.5,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/27/1931,4/17/2020,2020,88.6,Black or African American,Non-Hispanic,Black,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
5/17/1965,4/17/2020,2020,55,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/21/1969,4/17/2020,2020,50.4,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/15/1975,4/19/2020,2020,45,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/20/1984,4/19/2020,2020,36.2,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
3/4/1977,4/19/2020,2020,43.2,Black or African American,Non-Hispanic,Black,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/18/1979,4/19/2020,2020,41,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/9/1943,4/20/2020,2020,76.5,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/14/1945,4/20/2020,2020,74.7,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/20/1974,4/21/2020,2020,46,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/21/1979,4/21/2020,2020,40.9,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/2/1958,4/21/2020,2020,61.4,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/21/1940,4/21/2020,2020,79.4,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/16/1955,4/21/2020,2020,64.7,White; Black or African American,Non-Hispanic,Black,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/20/1985,4/22/2020,2020,34.4,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/8/1964,4/22/2020,2020,55.7,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/7/1955,4/22/2020,2020,64.7,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/21/1955,4/22/2020,2020,65.3,White; Black or African American,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
11/23/1959,4/22/2020,2020,60.5,Asian,Non-Hispanic,Asian,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/8/1958,4/22/2020,2020,61.4,White,Non-Hispanic,White,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/11/1986,4/23/2020,2020,34.2,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
6/11/1966,4/24/2020,2020,53.9,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
4/27/1970,4/27/2020,2020,50,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/12/1983,4/27/2020,2020,36.7,White,Hispanic or Latino,Hispanic/Latino,Male,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/3/1968,4/28/2020,2020,51.4,Asian,Non-Hispanic,Asian,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
12/22/1944,4/28/2020,2020,75.4,Asian,Non-Hispanic,Asian,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
9/7/1970,4/29/2020,2020,49.7,Native Hawaiian or Other Pacific Islander,Non-Hispanic,Asian,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
1/24/1969,5/2/2020,2020,51.3,White,Hispanic or Latino,Hispanic/Latino,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
8/12/1983,5/2/2020,2020,36.7,White,Non-Hispanic,White,Female,2011,Pro2020000712,,,,NTS / Lab Studies,Phase II,Treatment,Not tumor specific / Laboratory studies,Not tumor specific / Laboratory studies,Interventional,New Brunswick,Enrolled Patients
2/17/1999,5/8/2020,2020,21.2,Asian,Non-Hispanic,Asian,Male,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
11/6/1998,5/13/2020,2020,21.5,White,Non-Hispanic,White,Female,131507,P30CA072720; Pro20150001955,,,,Supportive Care,N/A,Supportive Care,Supportive Care,Population Science,Interventional,New Brunswick,Enrolled Patients
5/2/1997,5/15/2020,2020,23.1,White,Non-Hispanic,White,Male,11505,E4412; NCI CIRB Pro2018002913,,,"Hodgkin Lymphoma, Nos",Lymphoma / Myeloma,Phase I,Treatment,Lymphoma / Myeloma,Developmental Therapeutics-phase I; Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
12/28/1966,6/5/2020,2020,53.5,White,Non-Hispanic,White,Male,51706,Pro20170000522 ; WIRB20171268; R3767-ONC-1613,,,,DT - Phase I,Phase I,Treatment,Developmental Therapeutics-Phase I,Developmental Therapeutics-phase I,Interventional,New Brunswick,Enrolled Patients
5/28/1968,6/9/2020,2020,52.1,Black or African American,Non-Hispanic,Black,Female,11909,68284528MMY2003; Pro2019001776,,,Multiple Myeloma,Lymphoma / Myeloma,Phase II,Treatment,Lymphoma / Myeloma,Lymphoma / Myeloma,Interventional,New Brunswick,Enrolled Patients
5/6/1994,6/22/2020,2020,26.1,White,Unknown,White,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
2/8/1979,7/7/2020,2020,41.4,Asian,Non-Hispanic,Asian,Female,1932,Pro2019001647,,,,Population Science,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
9/12/1943,7/7/2020,2020,76.9,White,Non-Hispanic,White,Female,1932,Pro2019001647,,,,Population Science,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
8/6/1963,7/7/2020,2020,57,White,Non-Hispanic,White,Female,1932,Pro2019001647,,,,Gastrointestinal,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
11/1/1964,7/7/2020,2020,55.7,White,Non-Hispanic,White,Female,1932,Pro2019001647,,,,Population Science,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
4/28/1973,7/7/2020,2020,47.2,White,Non-Hispanic,White,Male,1932,Pro2019001647,,,,Gastrointestinal,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
1/14/1976,7/7/2020,2020,44.5,White,Non-Hispanic,White,Male,1932,Pro2019001647,,,,Gastrointestinal,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
6/7/1984,7/7/2020,2020,36.1,White,Non-Hispanic,White,Male,1932,Pro2019001647,,,,Gastrointestinal,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
7/24/1961,7/7/2020,2020,59,White,Non-Hispanic,White,Male,1932,Pro2019001647,,,,Population Science,N/A,Basic Science,Gastrointestinal; Population Science,Supportive Care,Not Applicable,New Brunswick,Enrolled Patients
9/7/1977,7/8/2020,2020,42.9,Black or African American,Non-Hispanic,Black,Male,131901,19488,,,,Population Science,N/A,Health Services Research,Population Science,Population Science,Observational,New Brunswick,Enrolled Patients
7/24/1997,7/27/2020,2020,23,White,Non-Hispanic,White,Female,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
12/22/1970,8/10/2020,2020,49.7,Asian,Unknown,Asian,Male,72004,20-041-NCP; Pro00041473,,,,Gastrointestinal,N/A,Diagnostic,Gastrointestinal,Gastrointestinal,Observational,New Brunswick,Enrolled Patients
10/29/1967,8/12/2020,2020,52.8,White,Non-Hispanic,White,Male,72004,20-041-NCP; Pro00041473,,,,Gastrointestinal,N/A,Diagnostic,Gastrointestinal,Gastrointestinal,Observational,New Brunswick,Enrolled Patients
5/11/2017,8/27/2020,2020,3.3,White,Hispanic or Latino,Hispanic/Latino,Male,111509,APEC14B1; NCI CIRB Pro2019001948,,,,Pediatric Oncology,N/A,Other,Pediatric Oncology,Pediatric Oncology,Observational,New Brunswick,Enrolled Patients
12/18/1960,8/31/2020,2020,59.7,Asian,Non-Hispanic,Asian,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/2/1951,8/31/2020,2020,68.8,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/21/1945,8/31/2020,2020,75,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/25/1955,8/31/2020,2020,64.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/10/1954,9/1/2020,2020,65.9,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
3/12/1942,9/1/2020,2020,78.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/8/1957,9/1/2020,2020,63.4,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/30/1958,9/2/2020,2020,62.1,Asian,Non-Hispanic,Asian,Female,72004,20-041-NCP; Pro00041473,,,,Gastrointestinal,N/A,Diagnostic,Gastrointestinal,Gastrointestinal,Observational,New Brunswick,Enrolled Patients
1/7/1964,9/4/2020,2020,56.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/2/1960,9/4/2020,2020,60.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/29/1944,9/4/2020,2020,76.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/3/1963,9/4/2020,2020,56.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
8/16/1956,9/8/2020,2020,64.1,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/18/1954,9/14/2020,2020,66,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
4/3/1946,9/14/2020,2020,74.5,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
5/16/1961,9/14/2020,2020,59.4,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
10/29/1960,9/14/2020,2020,59.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
3/29/1947,9/29/2020,2020,73.6,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
6/11/1950,9/29/2020,2020,70.4,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/21/1959,9/30/2020,2020,61.2,Black or African American,Non-Hispanic,Black,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/3/1950,9/30/2020,2020,70.8,White,Non-Hispanic,White,Male,72004,20-041-NCP; Pro00041473,,,,Gastrointestinal,N/A,Diagnostic,Gastrointestinal,Gastrointestinal,Observational,New Brunswick,Enrolled Patients
7/14/1949,10/1/2020,2020,71.3,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
5/18/1948,10/2/2020,2020,72.4,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/23/1954,10/5/2020,2020,65.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
12/28/1953,10/5/2020,2020,66.8,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
11/21/1946,10/6/2020,2020,73.9,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
7/25/1955,10/6/2020,2020,65.2,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
9/10/1951,10/7/2020,2020,69.1,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
2/28/1955,10/7/2020,2020,65.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
1/28/1937,10/7/2020,2020,83.7,White,Non-Hispanic,White,Male,131816,CINJ 081804; Pro2018002020,,,,Population Science,Phase III,Supportive Care,Population Science,Population Science,Interventional,New Brunswick,Enrolled Patients
